Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ACY1,Aminoacylase-1,29478,0.18543966165257,0.00424710414970904,0.17711533751914,0.193763985786,0
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,28916,0.28378394452348,0.00570836371732906,0.272595551637515,0.294972337409445,0
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADIPOQ,Adiponectin,24966,-0.24146442667414,0.00456089093809769,-0.250403772912811,-0.232525080435468,0
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AFM,Afamin,24966,0.0572148577820062,0.00133963313382267,0.0545891768397138,0.0598405387242986,0
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AGR3,Anterior gradient protein 3,28764,0.168783599866737,0.00411624407473585,0.160715761480255,0.17685143825322,0
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AGRP,Agouti-related protein,29786,0.290534654119775,0.00335998248171505,0.283949088455614,0.297120219783937,0
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,APCS,Serum amyloid P-component,24726,0.115504887976487,0.00236099002040893,0.110877347536486,0.120132428416489,0
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ASGR1,Asialoglycoprotein receptor 1,29218,0.0877274135803326,0.00205347199840077,0.0837026084634671,0.0917522186971981,0
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BCHE,Cholinesterase,24528,0.0900007294399506,0.0019155777646646,0.086246197021208,0.0937552618586932,0
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,C9,Complement component C9,24951,-0.163784182543565,0.00364305302954625,-0.170924566481475,-0.156643798605654,0
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,29218,0.208645130203494,0.00509111336246406,0.198666548013065,0.218623712393924,0
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCL16,C-C motif chemokine 16,29820,0.144366748041302,0.00362161521555942,0.137268382218805,0.151465113863798,0
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCL23,C-C motif chemokine 23,29581,0.140838299227924,0.00283926800643571,0.13527333393531,0.146403264520538,0
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCL27,C-C motif chemokine 27,29478,0.242373279484781,0.00412148550450149,0.234295167895959,0.250451391073604,0
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCN1,CCN family member 1,29301,0.384091553672504,0.00487194157977731,0.374542548176141,0.393640559168868,0
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD300LG,CMRF35-like molecule 9,29443,-0.103368913851952,0.00260032770063213,-0.108465556145191,-0.0982722715587131,0
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD4,T-cell surface glycoprotein CD4,29383,0.105109058319323,0.00203665048805682,0.101117223362731,0.109100893275914,0
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CDKN1A,Cyclin-dependent kinase inhibitor 1,29349,0.339610616749088,0.00724725286589362,0.325406001131936,0.353815232366239,0
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CES1,Liver carboxylesterase 1,29489,0.331527590046708,0.00540954000403629,0.320924891638797,0.342130288454619,0
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CFH,Complement factor H,23693,0.070192202756673,0.00160165767263555,0.0670529537183073,0.0733314517950387,0
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CFI,Complement factor I,24966,0.0597227876703366,0.00136785993288834,0.0570417822018754,0.0624037931387977,0
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CFP,Properdin,24966,0.0696772120951326,0.00158114923042067,0.0665781596035081,0.0727762645867571,0
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CHMP6,Charged multivesicular body protein 6,24922,0.164410371808391,0.00388899398700398,0.156787943593863,0.172032800022919,0
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CNTN3,Contactin-3,29443,0.100617734588143,0.00221726503207001,0.0962718951252858,0.104963574051,0
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CPM,Carboxypeptidase M,29584,0.114259774807593,0.00234346661255682,0.109666580246982,0.118852969368205,0
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CRIP2,Cysteine-rich protein 2,29218,0.113187509191882,0.00249368173742137,0.108299892986536,0.118075125397228,0
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CXCL6,C-X-C motif chemokine 6,29786,0.240461885570553,0.00528135747691095,0.230110424915807,0.250813346225298,0
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DEFB4A_DEFB4B,Beta-defensin 4A,29036,0.487032788596848,0.0100722383998186,0.467291201333203,0.506774375860492,0
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DNAJB1,DnaJ homolog subfamily B member 1,29349,0.300832196214301,0.00591709854178627,0.2892346830724,0.312429709356202,0
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DSG2,Desmoglein-2,29443,-0.0890262844113882,0.00184811174190562,-0.0926485834255232,-0.0854039853972532,0
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ENO3,Beta-enolase,24240,0.166978167061821,0.00415841562368708,0.158827672439395,0.175128661684248,0
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ERBB2,Receptor tyrosine-protein kinase erbB-2,29566,0.0682881055824009,0.00171808351995164,0.0649206618832957,0.0716555492815061,0
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ERBB3,Receptor tyrosine-protein kinase erbB-3,29369,0.0592524414469828,0.00134239206783514,0.0566213529940259,0.0618835298999397,0
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ERP44,Endoplasmic reticulum resident protein 44,29301,0.0716086386171001,0.00178834613587901,0.0681034801907772,0.0751137970434229,0
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,F7,Coagulation factor VII,29544,0.118543337727145,0.00206484215621842,0.114496247100957,0.122590428353333,0
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,F9,Coagulation factor IX,29545,0.0519809137820844,0.00125584220114631,0.0495194630678376,0.0544423644963312,0
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FGF21,Fibroblast growth factor 21,29674,0.323599347140526,0.00821193315015469,0.307503958166223,0.339694736114829,0
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FGFR2,Fibroblast growth factor receptor 2,29566,0.0601967219053064,0.00152974914867432,0.0571984135739047,0.063195030236708,0
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FLI1,Friend leukemia integration 1 transcription factor,28797,0.312208090688584,0.00761884537230206,0.297275153758872,0.327141027618296,0
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FURIN,Furin,29566,0.132368160788121,0.00225386711384617,0.127950581244982,0.136785740331259,0
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GCG,Pro-glucagon,28797,0.492550512828238,0.00836783284520572,0.476149560451635,0.508951465204841,0
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GHR,Growth hormone receptor,24381,0.112278332858963,0.00191660289511359,0.10852179118454,0.116034874533385,0
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GPR37,Prosaposin receptor GPR37,28916,0.218294010083834,0.00452944700435434,0.209416293955299,0.227171726212368,0
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GSTA1,Glutathione S-transferase A1,29426,0.253670588908045,0.00579749849429318,0.24230749185923,0.26503368595686,0
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GSTA3,Glutathione S-transferase A3,28797,0.228776409656574,0.00528021682880085,0.218427184672124,0.239125634641024,0
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GUSB,Beta-glucuronidase,29604,0.184249377823984,0.00410912801582948,0.176195486912958,0.19230326873501,0
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HHEX,Hematopoietically-expressed homeobox protein HHEX,24845,0.302246074433759,0.00508368332443513,0.292282055117866,0.312210093749652,0
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,29725,0.111721363792151,0.00234448027213177,0.107126182458773,0.116316545125529,0
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IGFBP1,Insulin-like growth factor-binding protein 1,29761,-0.375669654890558,0.00838685105533471,-0.392107882959014,-0.359231426822102,0
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IGFBP2,Insulin-like growth factor-binding protein 2,29757,-0.192626763748031,0.00428185919955388,-0.201019207779157,-0.184234319716906,0
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IGSF8,Immunoglobulin superfamily member 8,29478,0.0823685997849695,0.00211184733998919,0.0782293789985906,0.0865078205713483,0
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IGSF9,Protein turtle homolog A,24922,0.317843195815604,0.00555173062869829,0.306961803783356,0.328724587847853,0
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,INHBC,Inhibin beta C chain,29443,0.145704501437145,0.00281025283711069,0.140196405876408,0.151212596997881,0
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KYNU,Kynureninase,29786,0.129613387008219,0.00313650700522287,0.123465833277982,0.135760940738455,0
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LAMP2,Lysosome-associated membrane glycoprotein 2,28595,0.0577344979346889,0.00135200382093849,0.0550845704456494,0.0603844254237283,0
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LCAT,Phosphatidylcholine-sterol acyltransferase,24951,0.0868582456835653,0.00148422019047455,0.0839491741102352,0.0897673172568954,0
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LDLR,Low-density lipoprotein receptor,29500,0.43250183181692,0.00277508187585132,0.427062671340251,0.437940992293588,0
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LPL,Lipoprotein lipase,29478,-0.193961176326474,0.0031449026256953,-0.200125185472836,-0.187797167180111,0
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MFGE8,Lactadherin,29443,0.244776396058313,0.00277141730620106,0.239344418138158,0.250208373978467,0
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MXRA8,Matrix remodeling-associated protein 8,24381,-0.0893843595799171,0.00210519936128975,-0.093510550328045,-0.0852581688317892,0
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NCS1,Neuronal calcium sensor 1,29725,0.0788383207678117,0.00198166957763907,0.0749542483956391,0.0827223931399843,0
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NOS3,"Nitric oxide synthase, endothelial",28774,0.147806379806227,0.0036550653048412,0.140642451808738,0.154970307803716,0
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NOTCH3,Neurogenic locus notch homolog protein 3,29820,-0.0931545606527179,0.00236443115064406,-0.0977888457079803,-0.0885202755974556,0
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NPY,Pro-neuropeptide Y,29725,0.368506110848015,0.004162359322757,0.360347886575411,0.376664335120619,0
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NRP1,Neuropilin-1,29628,-0.0923395101856817,0.0019016187787719,-0.0960666829920746,-0.0886123373792887,0
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,28916,0.153790856826309,0.0038034881238769,0.14633602010351,0.161245693549108,0
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PAMR1,Inactive serine protease PAMR1,29443,0.0842860194829047,0.00189844859308443,0.0805650602404592,0.0880069787253502,0
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PLA2G7,Platelet-activating factor acetylhydrolase,29443,0.126333959563639,0.00214036183952578,0.122138850358169,0.13052906876911,0
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PLAT,Tissue-type plasminogen activator,29736,0.15264640333476,0.00346079331242674,0.145863248442404,0.159429558227116,0
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PLTP,Phospholipid transfer protein,29702,-0.114645872006545,0.00246504948604887,-0.1194773689992,-0.109814375013889,0
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PON3,Serum paraoxonase/lactonase 3,29581,-0.0792823247109232,0.00196228166977888,-0.0831283967836898,-0.0754362526381566,0
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRAP1,Proline-rich acidic protein 1,24938,0.150559280373991,0.00275090847786612,0.145167499757373,0.155951060990608,0
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRCP,Lysosomal Pro-X carboxypeptidase,29655,0.0906442612047179,0.00217055202443449,0.0863899792368263,0.0948985431726095,0
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PROC,Vitamin K-dependent protein C,29545,0.0901104873165672,0.00176161450524013,0.0866577228862966,0.0935632517468379,0
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PSRC1,Proline/serine-rich coiled-coil protein 1,28797,0.175645324666949,0.0040829371527666,0.167642767847526,0.183647881486371,0
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PTH,Parathyroid hormone,24195,0.301075312871116,0.00543982503143994,0.290413255809493,0.311737369932738,0
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RARRES2,Retinoic acid receptor responder protein 2,29628,0.18332012922909,0.00318079979579589,0.17708576162933,0.18955449682885,0
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RBP5,Retinol-binding protein 5,29349,0.162279236828803,0.00387394030800813,0.154686313825107,0.169872159832499,0
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SERPINA4,Kallistatin,24557,0.0722556552933306,0.0016382782930017,0.0690446298390473,0.075466680747614,0
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SERPINA5,Plasma serine protease inhibitor,24644,0.0983238763273259,0.00218129734418613,0.0940485335327211,0.102599219121931,0
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SERPIND1,Heparin cofactor 2,24914,0.0784380229161108,0.00194643740617328,0.0746230056000112,0.0822530402322104,0
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SERPINF1,Pigment epithelium-derived factor,24579,0.075779698336452,0.00179931029909558,0.0722530501502247,0.0793063465226793,0
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SHBG,Sex hormone-binding globulin,24951,-0.151183344194187,0.00354898805738429,-0.15813936078666,-0.144227327601714,0
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SKAP1,Src kinase-associated phosphoprotein 1,29163,0.199972667883294,0.0050402609743121,0.190093756373642,0.209851579392946,0
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SLC39A5,Zinc transporter ZIP5,29434,0.179761484301252,0.003647754449898,0.172611885579452,0.186911083023052,0
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SMAD1,Mothers against decapentaplegic homolog 1,28797,0.285399349124172,0.00559967273891162,0.274423990555905,0.296374707692438,0
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SMOC1,SPARC-related modular calcium-binding protein 1,29725,0.13156889621383,0.0022055551505978,0.127246008118658,0.135891784309002,0
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SNCA,Alpha-synuclein,24381,0.33732020073715,0.00796567154508457,0.321707484508785,0.352932916965516,0
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,29433,0.354436582106761,0.00785144070454111,0.339047758325861,0.369825405887662,0
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,29594,0.158242917084144,0.00287811290271411,0.152601815794824,0.163884018373463,0
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,29694,0.154316967303564,0.00360118014142667,0.147258654226368,0.16137528038076,0
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TFPI,Tissue factor pathway inhibitor,29435,0.0973430349387228,0.00217797778641987,0.0930741984773399,0.101611871400106,0
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TMPRSS15,Enteropeptidase,29349,0.295006569129273,0.00618458280906664,0.282884786823503,0.307128351435044,0
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TTR,Transthyretin,24707,0.0804685885350397,0.00173332323225828,0.0770712749998134,0.0838659020702659,0
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,UPB1,Beta-ureidopropionase,24922,0.262026595593887,0.006303713611663,0.249671316915028,0.274381874272747,0
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VMO1,Vitelline membrane outer layer protein 1 homolog,29349,0.211144263371848,0.00467493332203952,0.201981394060651,0.220307132683045,0
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VPS37A,Vacuolar protein sorting-associated protein 37A,29349,0.262560224869982,0.00543890087444053,0.251899979156078,0.273220470583885,0
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FTCD,Formimidoyltransferase-cyclodeaminase,24804,0.2295582827962,0.005893173708995,0.21800766232657,0.24110890326583,1.11253692925362e-308
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,P4HB,Protein disulfide-isomerase,29313,0.104111521496228,0.00268598527221419,0.098846990362688,0.109376052629768,1.11253692925434e-308
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SMAD2,Mothers against decapentaplegic homolog 2,24793,0.185328390002469,0.0048001956593321,0.175920006510178,0.19473677349476,1.11253693432891e-308
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,29100,0.126419239649877,0.00328893291850844,0.1199729311296,0.132865548170153,1.11253705014462e-308
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CDHR2,Cadherin-related family member 2,29349,0.193173813934377,0.00502844776393045,0.183318056317074,0.203029571551681,1.11253715865735e-308
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LAT2,Linker for activation of T-cells family member 2,29349,0.330058390658792,0.0086051351954338,0.313192325675741,0.346924455641842,1.11253900430263e-308
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NUMB,Protein numb homolog,24229,0.222488764920073,0.00578637782562368,0.211147464381851,0.233830065458296,1.11253949474739e-308
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LATS1,Serine/threonine-protein kinase LATS1,24229,0.226919598477111,0.00590837082942574,0.215339191651437,0.238500005302786,1.11254956046877e-308
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,29349,0.084351114723234,0.00220471048498039,0.0800298821726724,0.0886723472737955,1.1126071974019e-308
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,28797,0.180025306864723,0.00470758290423826,0.170798444372416,0.18925216935703,1.11272449617951e-308
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GRP,Gastrin-releasing peptide,24240,0.143033759259905,0.00373941001525419,0.135704515630006,0.150363002889803,1.11607627131029e-308
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PLA2G10,Group 10 secretory phospholipase A2,29218,-0.156068136671706,0.0040966983907586,-0.164097665517593,-0.148038607825819,1.1415552650743e-308
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DTYMK,Thymidylate kinase,24922,0.180985887001564,0.00474093884759361,0.171693646860281,0.190278127142847,1.14313900262839e-308
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HEG1,Protein HEG homolog 1,24381,0.0719864719128843,0.00188666583777873,0.0682886068708379,0.0756843369549306,1.20915728622953e-308
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GLA,Alpha-galactosidase A,24329,0.0986656615646016,0.00260341072393794,0.0935629765456833,0.10376834658352,2.0424709179502e-305
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MEGF9,Multiple epidermal growth factor-like domains protein 9,29736,0.0538024925298704,0.00142369828729927,0.0510120438867638,0.0565929411729769,2.74943863796335e-305
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PROS1,Vitamin K-dependent protein S,24966,0.0669328100650479,0.00176778522509633,0.0634679510238591,0.0703976691062368,4.50496505639355e-305
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KDR,Vascular endothelial growth factor receptor 2,29566,0.0665149038511988,0.00176259425032152,0.0630602191205686,0.0699695885818289,2.09240012147106e-304
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CKB,Creatine kinase B-type,24938,-0.154940760314565,0.00410445980501699,-0.162985501532399,-0.146896019096732,2.63874703080537e-303
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,STAB2,Stabilin-2,24938,0.0737134129616587,0.00195328456614601,0.0698849752120126,0.0775418507113049,3.93475077897213e-303
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,F10,Coagulation factor X,24951,0.0719651280674968,0.00190764974883493,0.0682261345597804,0.0757041215752133,6.35258991668127e-303
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GH1,Somatotropin,29433,-0.463133319213396,0.0123240606993921,-0.487288478184205,-0.438978160242587,6.43903257759321e-302
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NOMO1,Nodal modulator 1,29443,0.0611838516032878,0.00163357118206865,0.0579820520864333,0.0643856511201424,5.75732254236261e-300
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FAM20A,Pseudokinase FAM20A,24922,0.0737195028961568,0.00196609032456164,0.0698659658600159,0.0775730399322976,2.2629975641058e-299
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL16,Pro-interleukin-16,29786,0.107307861877864,0.00287153490959032,0.101679653455067,0.112936070300661,9.86790695801463e-299
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SNAPIN,SNARE-associated protein Snapin,24867,0.149800196695482,0.00401335045276664,0.14193402980806,0.157666363582905,9.7548035846822e-297
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,24805,0.360429171693516,0.00969962248061972,0.341417911631501,0.379440431755531,3.6244376319679e-294
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MTSS1,Protein MTSS 1,24805,0.284887910110308,0.0076995082128872,0.269796874013049,0.299978946207567,9.46761820960221e-292
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ANGPTL2,Angiopoietin-related protein 2,29491,0.102026850640138,0.00276732767168986,0.0966028884036258,0.10745081287665,6.09305272180352e-291
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SORT1,Sortilin,29433,0.0953866401065228,0.00258751520347924,0.0903151103077035,0.100458169905342,7.26974438533463e-291
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ATRN,"Attractin, Isoform 2",24966,0.0424987592704988,0.00115314313887154,0.0402385987183106,0.044758919822687,1.41205473202335e-289
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,29594,-0.0973439971539644,0.00265035195448086,-0.102538686984747,-0.0921493073231819,7.91278735188062e-289
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DPY30,Protein dpy-30 homolog,29604,0.152217796111752,0.00415629159509478,0.144071464585366,0.160364127638138,3.16819407771314e-287
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EPHA1,Ephrin type-A receptor 1,29536,0.084726093943362,0.00231446683387324,0.0801897389489704,0.0892624489377535,5.79578423105005e-287
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SNAP29,Synaptosomal-associated protein 29,29566,0.231716072041261,0.00635107046016118,0.219267973939345,0.244164170143177,4.16863743559378e-285
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IGFBP3,Insulin-like growth factor-binding protein 3,29594,0.0751798074354013,0.00207229453626076,0.0711181101443302,0.0792415047264724,5.40158187397649e-282
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CDHR5,Cadherin-related family member 5,29478,0.0981261768878835,0.00270621886981486,0.0928219879030464,0.103430365872721,1.10458425500244e-281
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SCLY,Selenocysteine lyase,29632,0.122067816655275,0.00337049661752937,0.115461643284918,0.128673990025633,4.56640821810058e-281
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MYH9,Myosin-9,24938,0.284178320620836,0.00784043525389662,0.268811067523199,0.299545573718474,2.22657600298574e-280
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",24240,0.144048627070225,0.00398202415456531,0.136243859727277,0.151853394413173,4.00419426245481e-279
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,29349,0.0993986073379237,0.00275411069509583,0.0940005503755359,0.104796664300312,4.03639724573306e-279
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EEF1D,Elongation factor 1-delta,24922,0.229170515325309,0.00634169089647495,0.216740801168219,0.2416002294824,9.27786888624799e-279
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SYAP1,Synapse-associated protein 1,24381,0.144165021021973,0.00399258930835696,0.136339545977593,0.151990496066352,3.57741077204547e-278
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KLKB1,Plasma kallikrein,24454,0.062834600753254,0.00174607416833873,0.0594122953833101,0.0662569061231979,2.22016890494044e-276
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,24381,0.0545912682675647,0.00151819583046412,0.051615604439855,0.0575669320952743,6.11371751166312e-276
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,24111,0.170063923824098,0.00473067931280624,0.160791792370998,0.179336055277198,9.89239488103463e-276
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BPIFB1,BPI fold-containing family B member 1,29333,-0.157291495471609,0.00438674165127171,-0.165889509108101,-0.148693481835116,1.33814675521771e-275
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADH1B,All-trans-retinol dehydrogenase,24381,0.188523433130203,0.00524943208168153,0.178234546250107,0.198812320010299,2.83117697052406e-275
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,F11R,Junctional adhesion molecule A,29443,0.139807098048508,0.00390780074683054,0.13214780858472,0.147466387512296,1.96641601461286e-274
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NAA80,N-alpha-acetyltransferase 80,24195,0.300684387141244,0.00839882844161267,0.284222683395683,0.317146090886805,1.47190529991104e-273
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,28797,0.157605222828914,0.0044134254195505,0.148954909006595,0.166255536651233,2.5339401873395e-273
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SORD,Sorbitol dehydrogenase,29595,0.169114672613404,0.00473867914253519,0.159826861494035,0.178402483732773,3.78800229882603e-273
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ELN,Elastin,24922,0.0871885576859737,0.0024417639216813,0.0824027003994783,0.091974414972469,2.23482428343467e-272
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,YES1,Tyrosine-protein kinase Yes,29349,0.28038824184966,0.00791416639212927,0.264876475721087,0.295900007978233,2.95420942895536e-269
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,29349,0.107326105267647,0.00303928656886429,0.101369103592673,0.113283106942621,1.50233158905887e-267
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ABL1,Tyrosine-protein kinase ABL1,29349,0.166208990510836,0.00471154489689829,0.156974362512916,0.175443618508757,5.08183133115627e-267
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FYB1,FYN-binding protein 1,29400,0.225464737811376,0.00639934215482564,0.212922027187918,0.238007448434834,2.24100860987442e-266
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FCN2,Ficolin-2,29381,0.10051076466615,0.00285668282676102,0.0949116663256983,0.106109863006602,1.14690888718699e-265
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AP1G2,AP-1 complex subunit gamma-like 2,24793,0.193983219182799,0.00553439197608729,0.183135810909668,0.20483062745593,9.91604158902775e-263
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KHK,Ketohexokinase,24240,0.155937593116578,0.00446081657320322,0.1471943926331,0.164680793600057,3.08591619161127e-261
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AMBP,Protein AMBP,29683,0.0488680855605761,0.00140177090580558,0.0461206145851972,0.051615556535955,5.28421914498746e-261
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CXCL13,C-X-C motif chemokine 13,29694,0.147660168496458,0.00423779026811382,0.139354099570955,0.155966237421961,9.61918284691687e-261
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL1RN,Interleukin-1 receptor antagonist protein,29379,0.130923062271633,0.00376089642528303,0.123551705278078,0.138294419265187,3.1866611503228e-260
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MLN,Promotilin,29434,0.216040091080087,0.00620638608622342,0.203875574351089,0.228204607809085,3.37081999779186e-260
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LECT2,Leukocyte cell-derived chemotaxin-2,24922,0.159598799109575,0.00458784423665172,0.150606624405737,0.168590973813412,5.91871972225928e-259
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IPCEF1,Interactor protein for cytohesin exchange factors 1,29169,0.216214088600832,0.00622724704733823,0.204008684388049,0.228419492813615,7.26062646154028e-259
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NPPC,C-type natriuretic peptide,29434,0.115738656047569,0.003337226628573,0.109197691855565,0.122279620239572,2.44332165483268e-258
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,YTHDF3,YTH domain-containing family protein 3,28931,0.205856404181799,0.00593725539507991,0.194219383607443,0.217493424756156,4.05444169980366e-258
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL18R1,Interleukin-18 receptor 1,29786,0.0792557068079882,0.00228658069057322,0.0747740086544647,0.0837374049615117,4.12714763479895e-258
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CXCL17,C-X-C motif chemokine 17,29786,0.100945604708129,0.00292726101718004,0.0952081731144557,0.106683036301801,1.46773135728463e-255
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GGT1,Glutathione hydrolase 1 proenzyme,29390,0.120816168215283,0.00350477024255929,0.113946818539867,0.1276855178907,2.60733947655615e-255
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,24381,0.118777068321072,0.00344150899277954,0.112031710695224,0.12552242594692,6.94604733016178e-255
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SELPLG,P-selectin glycoprotein ligand 1,29434,0.0666969161270324,0.00193731489726274,0.0628997789283975,0.0704940533256674,1.1171514344931e-254
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLUL1,Clusterin-like protein 1,29435,-0.108215302759345,0.00314439039170276,-0.114378307927082,-0.102052297591607,1.66999526532537e-254
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SEMA3F,Semaphorin-3F,29478,0.0629768400449129,0.00183727230556421,0.0593757863260071,0.0665778937638188,1.57164532077585e-252
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCL22,C-C motif chemokine 22,29169,0.123409145637059,0.00360132400042593,0.116350550596225,0.130467740677894,2.43041400089474e-252
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SARG,Specifically androgen-regulated gene protein,24820,0.260567558650302,0.00760232038401831,0.245667010697626,0.275468106602978,1.37220035807203e-251
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SOST,Sclerostin,29433,0.0920605869953091,0.00269851329429944,0.0867715009384822,0.097349673052136,3.31513048228834e-250
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DNAJC6,Putative tyrosine-protein phosphatase auxilin,24240,0.201312765838654,0.00588951101138448,0.18976932425634,0.212856207420967,3.94136695308721e-250
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PTPRB,Receptor-type tyrosine-protein phosphatase beta,24922,0.0701544121984525,0.00205733290438309,0.0661220397058616,0.0741867846910433,3.97006210055403e-249
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SERPINF2,Alpha-2-antiplasmin,24515,0.0322785538702736,0.000949298038003236,0.0304179297157873,0.03413917802476,1.15827632185471e-247
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MVK,Mevalonate kinase,28931,0.188234879506539,0.00555631081627223,0.177344510306645,0.199125248706433,9.53917084994834e-247
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MME,Neprilysin,29349,0.188954022392492,0.00559590094074229,0.177986056548637,0.199921988236347,3.05810331182956e-245
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,24365,0.11061210143188,0.00329134034842707,0.104161074348962,0.117063128514797,4.4642753055799e-242
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TJAP1,Tight junction-associated protein 1,29566,0.193372243172111,0.00577747112714105,0.182048399762914,0.204696086581307,4.21104166017876e-241
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GPD1,Glycerol-3-phosphate dehydrogenase,24793,0.1223674547351,0.00365456057556887,0.115204516006985,0.129530393463215,1.90482752299311e-240
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PTS,6-pyruvoyl tetrahydrobiopterin synthase,28643,0.127526388969477,0.00383985872476734,0.120000265868933,0.135052512070021,2.38181449730657e-237
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD2AP,CD2-associated protein,29478,0.14705341840984,0.00443437862813761,0.138362036298691,0.15574480052099,8.60952332532594e-237
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TXLNA,Alpha-taxilin,29218,0.204674401623398,0.00618325964397877,0.1925552127212,0.216793590525597,6.54693169215979e-236
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CES3,Carboxylesterase 3,29349,0.160982191490933,0.00486810223766734,0.151440711105105,0.170523671876761,1.77409982761876e-235
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DNAJA2,DnaJ homolog subfamily A member 2,29704,0.188549288665609,0.00571326915786746,0.177351281116189,0.199747296215029,1.32882309534606e-234
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SIT1,Signaling threshold-regulating transmembrane adapter 1,28931,0.127147482798491,0.00385635846898175,0.119589020199287,0.134705945397695,4.61625420963207e-234
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FN1,Fibronectin,24966,0.0616066722460369,0.00186641982875393,0.0579484893816792,0.0652648551103946,6.67915360703069e-234
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HJV,Hemojuvelin,24867,0.101667678655424,0.00308692668271847,0.0956173023572959,0.107718054953552,7.02902909564491e-233
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EZR,Ezrin,29694,0.0550620124097884,0.00167810981117807,0.0517729171798793,0.0583511076396974,5.59806229919121e-232
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,24845,0.0931060714236017,0.00283837305888612,0.0875428602281849,0.0986692826190185,4.59903952768794e-231
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",29434,0.222870131626215,0.00681073319261815,0.209521094568683,0.236219168683746,1.00186572765603e-230
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CTSD,Cathepsin D,27442,0.0927830010691472,0.00283746476476376,0.0872215701302102,0.0983444320080841,4.20528559398168e-230
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CANT1,Soluble calcium-activated nucleotidase 1,29370,0.0461185358213371,0.00141292854336763,0.0433491958763366,0.0488878757663377,1.4032098089163e-229
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",29349,0.221299925055257,0.00679584440577616,0.207980070019936,0.234619780090579,1.56542540952462e-228
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BECN1,Beclin-1,24240,0.137229029410509,0.00420823252045989,0.128980893670408,0.14547716515061,2.56826569357105e-228
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,29218,0.121498679086947,0.003735276584323,0.114177536981674,0.128819821192221,5.16202730029656e-228
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TIMP4,Metalloproteinase inhibitor 4,29443,-0.0914324763948327,0.00281317792941873,-0.0969463051364934,-0.085918647653172,1.08480059849914e-227
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DKK1,Dickkopf-related protein 1,29694,0.134631329309366,0.00414361456729071,0.126509844757476,0.142752813861256,1.3848067662086e-227
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DCXR,L-xylulose reductase,29566,0.121539335495597,0.00374724430710631,0.114194736653669,0.128883934337525,8.59628077497094e-227
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MAPK9,Mitogen-activated protein kinase 9,29434,0.0973349840245821,0.00300109071494766,0.0914528462232847,0.10321712182588,9.26855261119903e-227
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRSS8,Prostasin,29347,0.0929494068055493,0.00286754143976476,0.0873290255836103,0.0985697880274882,1.7199963995443e-226
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RTN4R,Reticulon-4 receptor,29725,0.0765466921649468,0.00236298406287081,0.07191524340172,0.0811781409281736,2.89209394379278e-226
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,24805,0.184076639554199,0.00567719637660924,0.172949334656045,0.195203944452353,6.59378403610246e-226
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,YOD1,Ubiquitin thioesterase OTU1,24111,0.140979415349924,0.00435192644870019,0.132449639510472,0.149509191189377,2.2114697313195e-225
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,24805,0.0677315421505884,0.00209210034507216,0.063631025474247,0.0718320588269299,3.02493188098434e-225
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,THOP1,Thimet oligopeptidase,29343,0.0695604503136103,0.00215596367421939,0.0653347615121403,0.0737861391150803,1.87831465708485e-224
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BTD,Biotinidase,24966,0.0466736117696636,0.00144475867978975,0.0438418847572756,0.0495053387820515,2.44389200826559e-224
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PPY,Pancreatic prohormone,29400,0.22917446617435,0.00711142351176378,0.215236076091293,0.243112856257407,6.02890587618092e-224
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CREG1,Protein CREG1,29079,0.0855437542778531,0.00266137771336342,0.0803274539596608,0.0907600545960454,8.94385441797188e-223
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CEP20,Centrosomal protein 20,28797,0.166814085955946,0.00519735018407732,0.156627279595154,0.177000892316737,4.14933972388026e-222
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,24445,0.252832603425592,0.00786572098238035,0.237415790300127,0.268249416551058,4.5603212969006e-222
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DCTN1,Dynactin subunit 1,29725,0.145359095600607,0.00453567532277596,0.136469171967966,0.154249019233248,1.39861417975712e-221
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,S100A4,Protein S100-A4,29566,0.127268924939876,0.00398278165467715,0.119462672896709,0.135075176983043,2.61961209947404e-220
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EHBP1,EH domain-binding protein 1,24922,0.166915533198242,0.00521708489196757,0.156690046809986,0.177141019586499,3.76174859815729e-220
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,29566,0.0801275960308435,0.00250872893186008,0.0752104873243978,0.0850447047372893,4.19902535521436e-220
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DAAM1,Disheveled-associated activator of morphogenesis 1,24381,0.185347215285543,0.00579313657912799,0.173992667590452,0.196701762980634,4.6583023632905e-220
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MAMDC4,Apical endosomal glycoprotein,24793,0.123983431823828,0.00387933594738821,0.116379933366947,0.131586930280709,1.12893912792853e-219
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD63,CD63 antigen,29169,0.114427988285306,0.00358710205939522,0.107397268248892,0.121458708321721,1.60312149111518e-219
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LDLRAP1,Low density lipoprotein receptor adapter protein 1,24867,0.217206358499553,0.00681326886181399,0.203852351530398,0.230560365468709,1.27910521303689e-218
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HBEGF,Proheparin-binding EGF-like growth factor,29632,0.161423218800523,0.00507766070379272,0.151471003821089,0.171375433779957,4.03628199319938e-218
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MASP1,Mannan-binding lectin serine protease 1,29163,0.0524488108606253,0.00165122154059703,0.0492124166410552,0.0556852050801955,1.06446529113985e-217
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PAXX,Protein PAXX,24381,0.101704226458258,0.00319717230450501,0.0954377687414282,0.107970684175088,1.29531084802397e-217
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KRT18,"Keratin, type I cytoskeletal 18",29349,0.180148527163582,0.00567856830220873,0.169018533291253,0.191278521035911,3.38207613868943e-217
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BANK1,B-cell scaffold protein with ankyrin repeats,29434,0.235455146001604,0.00742305166640738,0.220905964735445,0.250004327267762,3.83039566439611e-217
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AP3S2,AP-3 complex subunit sigma-2,24845,0.104806601702939,0.00330409191692928,0.0983305815457573,0.11128262186012,1.70416479061619e-216
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HGF,Hepatocyte growth factor,29786,0.0760888799050907,0.00240546897584031,0.0713741607124437,0.0808035990977377,5.14021078088599e-216
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RNF41,E3 ubiquitin-protein ligase NRDP1,28797,0.14761292213592,0.00466654858555056,0.138466486908241,0.156759357363599,6.67175053316475e-216
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MTSS2,Protein MTSS 2,24793,0.219361676996425,0.00693369813967803,0.205771628642656,0.232951725350194,2.19584312852603e-215
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ARF6,ADP-ribosylation factor 6,24805,0.236027357787933,0.00746553589995248,0.221394907424026,0.25065980815184,4.19737916077285e-215
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AGRN,Agrin,29581,0.0759347182286229,0.00240761238683426,0.0712157979504277,0.080653638506818,9.11634254392321e-215
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TARBP2,RISC-loading complex subunit TARBP2,28774,0.174140593092744,0.00552125905148886,0.163318925351825,0.184962260833662,1.12133321018969e-214
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EFCAB14,EF-hand calcium-binding domain-containing protein 14,24805,0.0606782121518982,0.00192338771730639,0.0569083722259777,0.0644480520778187,3.31721982855393e-214
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,STC1,Stanniocalcin-1,29694,0.0956508331179642,0.00303956680971729,0.0896932821709183,0.10160838406501,7.68351792807873e-214
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ZBTB16,Zinc finger and BTB domain-containing protein 16,28797,0.157342705980979,0.00499964497627845,0.147543401827474,0.167142010134485,9.19578821944369e-214
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AXIN1,Axin-1,29434,0.209287336394122,0.00665515074926738,0.196243240925558,0.222331431862686,1.56968561441304e-213
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,COL4A1,Collagen alpha-1(IV) chain,29478,-0.087150030067032,0.0027733612316693,-0.0925858180811038,-0.0817142420529602,3.16737754004215e-213
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NPL,N-acetylneuraminate lyase,24922,0.0985712231556824,0.0031356236223087,0.0924254008559573,0.104717045455407,9.36248882523801e-213
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PBLD,Phenazine biosynthesis-like domain-containing protein,28774,0.113071958736753,0.00361259930555059,0.105991264097874,0.120152653375633,1.69089112057987e-211
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PYY,Peptide YY,24111,0.212346065401043,0.006788268661489,0.199041058824524,0.225651071977561,1.35665005377659e-210
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NHLRC3,NHL repeat-containing protein 3,23825,0.0700556807333199,0.0022409448865353,0.0656634287557107,0.0744479327109291,2.74411550331403e-210
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLEC1B,C-type lectin domain family 1 member B,29694,0.208558566284183,0.00670925555414601,0.195408425398057,0.221708707170309,8.55106026212637e-209
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,24922,0.157582899406398,0.00507002754951501,0.147645645409349,0.167520153403448,4.06386256849246e-208
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CEP85,Centrosomal protein of 85 kDa,28797,0.138919742457316,0.00447578687054248,0.130147200191052,0.147692284723579,4.46794600314628e-208
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ATP6V1G1,V-type proton ATPase subunit G 1,24240,0.157538051820181,0.00507368799915187,0.147593623341844,0.167482480298519,1.33041580785813e-207
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",29307,0.226960618747486,0.00732744686960263,0.212598822883065,0.241322414611907,2.67431401153335e-207
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GCC1,GRIP and coiled-coil domain-containing protein 1,24845,0.234074160097742,0.00754960269389819,0.219276938817701,0.248871381377782,4.11169018920677e-207
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PDGFC,Platelet-derived growth factor C,28797,0.062593714756633,0.0020258191098781,0.0586231093012719,0.0665643202119941,2.98711864737197e-206
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,COL18A1,Collagen alpha-1(XVIII) chain,29559,0.0505881418035056,0.00163883616545299,0.0473760229192177,0.0538002606877934,5.966321487512e-206
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CXCL10,C-X-C motif chemokine 10,29581,0.143544885079249,0.00467641464470806,0.134379112375621,0.152710657782877,1.03383178287061e-203
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LSP1,Lymphocyte-specific protein 1,29434,0.0863129389732624,0.00281414883985798,0.0807972072471407,0.091828670699384,2.2180064468419e-203
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PLIN1,Perilipin-1,28774,0.0747766798325965,0.00244005712560415,0.0699941678664124,0.0795591917987806,5.60247656484811e-203
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PLXNA4,Plexin-A4,29434,0.174778199793985,0.0057147707162642,0.163577249190107,0.185979150397863,2.98357195651265e-202
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ERBIN,Erbin,29349,0.218153273641592,0.00716408538928859,0.204111666278586,0.232194881004598,1.54621835489699e-200
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NUCB2,Nucleobindin-2,29652,0.0793991301983979,0.00260906186493486,0.0742853689431255,0.0845128914536702,2.51488840972429e-200
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ACE2,Angiotensin-converting enzyme 2,28916,0.110094600356328,0.00361815580789562,0.103003014972852,0.117186185739803,3.34730961189598e-200
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FUOM,Fucose mutarotase,24381,0.135710779691276,0.00445500280142533,0.126978974200483,0.14444258518207,4.59729847803201e-200
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CPB2,Carboxypeptidase B2,24914,0.0481028751064352,0.00158093097996178,0.0450042503857101,0.0512014998271603,1.09349801983311e-199
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",24740,0.232023586493538,0.00762746677164093,0.217073751621122,0.246973421365954,1.44168246031754e-199
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD6,T-cell differentiation antigen CD6,29760,0.111773835402,0.00368660122126277,0.104548097008325,0.118999573795675,6.89476400279708e-199
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SELP,P-selectin,29594,0.120504420924156,0.00397562854699464,0.112712188972047,0.128296652876266,9.10752419511122e-199
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KAZN,Kazrin,24805,0.221001161368176,0.00729001086021223,0.20671274008216,0.235289582654192,2.96215243341252e-198
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NFKBIE,NF-kappa-B inhibitor epsilon,28797,0.104905767594725,0.00346587100800552,0.0981126604190346,0.111698874770416,3.84616621966777e-198
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DAB2,Disabled homolog 2,29725,0.233336604193357,0.00773668143617295,0.218172708578458,0.248500499808256,7.44769167340615e-197
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ISM1,Isthmin-1,29434,0.0828393578237347,0.00275475452421557,0.0774400389562722,0.0882386766911973,1.05496133291009e-195
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CTBS,Di-N-acetylchitobiase,24653,0.0574486457631834,0.0019076394346715,0.0537096724712272,0.0611876190551395,1.08163768860431e-195
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CTSO,Cathepsin O,29786,0.0638896164955293,0.00212536546482955,0.0597239001844634,0.0680553328065952,1.33941259327478e-195
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LEP,Leptin,29478,0.141223508792196,0.00470580533427267,0.132000130337022,0.150446887247371,6.18008778676808e-195
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EIF4B,Eukaryotic translation initiation factor 4B,29218,0.121240176384268,0.00405114611669058,0.113299929995555,0.129180422772982,7.36556234342663e-194
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ATG16L1,Autophagy-related protein 16-1,24805,0.178501258142487,0.00597187865570048,0.166796375977314,0.190206140307659,6.94654167902196e-193
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BCR,Breakpoint cluster region protein,29434,0.191367595638238,0.00641844910447784,0.178787435393462,0.203947755883015,1.81817038069578e-192
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PPP1R9B,Neurabin-2,29786,0.196599341849547,0.00660289895240284,0.183657659902837,0.209541023796256,5.44948880921246e-192
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PDLIM7,PDZ and LIM domain protein 7,29581,0.260650681593702,0.00876539490569519,0.243470507578539,0.277830855608864,1.72773718130641e-191
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CRHBP,Corticotropin-releasing factor-binding protein,29454,0.0579558428113974,0.00194918716243243,0.0541354359730299,0.061776249649765,1.93624761615736e-191
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NFKB1,Nuclear factor NF-kappa-B p105 subunit,24111,0.154994271486652,0.00520436607129699,0.14479371398691,0.165194828986394,1.98609952063556e-191
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PSIP1,PC4 and SFRS1-interacting protein,29434,0.132821118367688,0.00447288166752424,0.12405427029934,0.141587966436035,5.92680466704685e-191
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ARHGEF12,Rho guanine nucleotide exchange factor 12,29434,0.215597755256872,0.00727512425305716,0.20133851172088,0.229856998792864,3.32721284861897e-190
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCL17,C-C motif chemokine 17,29414,0.188612755688744,0.00637136507208376,0.17612488014746,0.201100631230028,8.33161483369731e-190
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VEGFC,Vascular endothelial growth factor C,29566,0.115321414299631,0.00389847559755299,0.107680402128427,0.122962426470835,1.52074915711689e-189
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NFX1,Transcriptional repressor NF-X1,24111,0.140225355616636,0.00473647079526694,0.130941872857913,0.149508838375359,3.10226540119622e-189
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TGFB1,Transforming growth factor beta-1 proprotein,29760,0.0792789061630778,0.00268521297131041,0.0740158887393094,0.0845419235868462,7.49335503620779e-189
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNIP1,TNFAIP3-interacting protein 1,24845,0.183076711202908,0.00619200078640368,0.170940389661557,0.19521303274426,7.51598155910029e-189
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PDCD5,Programmed cell death protein 5,29694,0.119682533600203,0.00405515472566115,0.111734430337907,0.127630636862499,1.0291189245295e-188
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PAK4,Serine/threonine-protein kinase PAK 4,28774,0.1260829011186,0.00428926475896303,0.117675942191032,0.134489860046167,3.74544037943587e-187
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TCTN3,Tectonic-3,24922,0.0613352964559337,0.00208747239028395,0.0572438505709772,0.0654267423408903,1.39851550293251e-186
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CDH2,Cadherin-2,29478,0.0727923501693245,0.00248182882891482,0.0679279656646515,0.0776567346739976,2.05671548032704e-186
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SNAP23,Synaptosomal-associated protein 23,29478,0.17852079053805,0.00609049233768937,0.166583425556179,0.190458155519921,3.50963185558911e-186
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL13RA1,Interleukin-13 receptor subunit alpha-1,29019,0.0459917747544913,0.00157041439829295,0.0429137625338371,0.0490697869751455,7.87107068906779e-186
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IKBKG,NF-kappa-B essential modulator,29434,0.187450171215279,0.00642590882341625,0.174855389921383,0.200044952509175,1.92187371382663e-184
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FETUB,Fetuin-B,29545,0.0674673281383232,0.00231374260723722,0.0629323926281382,0.0720022636485081,2.61265312021211e-184
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RAB11FIP3,Rab11 family-interacting protein 3,24922,0.219197909208202,0.00751787382790416,0.204462876505509,0.233932941910894,8.35774648842581e-184
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SRPK2,SRSF protein kinase 2,29434,0.171038413820477,0.00587838889786266,0.159516771580666,0.182560056060287,1.60477586360482e-183
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,STAT5B,Signal transducer and activator of transcription 5B,29349,0.280007112279755,0.00962359966649922,0.261144856933417,0.298869367626094,1.64424776913542e-183
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NFE2,Transcription factor NF-E2 45 kDa subunit,24240,0.152028265504175,0.00522180153952127,0.141793534486713,0.162262996521637,3.39161207102703e-183
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CXCL5,C-X-C motif chemokine 5,29384,0.231747763886141,0.00797489277656121,0.216116974044081,0.247378553728201,4.54897256217076e-183
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PSME1,Proteasome activator complex subunit 1,29192,0.0754320214667558,0.00259992660854626,0.0703361653140052,0.0805278776195065,1.76071899735873e-182
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IRAK1,Interleukin-1 receptor-associated kinase 1,28931,0.141177256413485,0.00486985916350702,0.131632332453012,0.150722180373959,3.56486220484145e-182
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SLA2,Src-like-adapter 2,24867,0.212340480787247,0.0073355975062623,0.197962709674973,0.226718251899522,3.14952175584319e-181
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,29786,0.200353201542184,0.00693511642033369,0.18676037335833,0.213946029726038,5.08876436231905e-181
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BACH1,Transcription regulator protein BACH1,29434,0.149249904166932,0.00516709646080308,0.139122395103758,0.159377413230106,6.26516657905562e-181
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,29566,0.192070937063196,0.00666907272012479,0.178999554531752,0.205142319594641,6.54181114876902e-180
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SCAMP3,Secretory carrier-associated membrane protein 3,29349,0.169976719928108,0.00592408392066755,0.1583655154436,0.181587924412617,1.3923557775336e-178
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TOP2B,DNA topoisomerase 2-beta,24229,0.160220565388806,0.00558103311176942,0.149281740489738,0.171159390287874,2.92702446249197e-178
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SELE,E-selectin,29820,0.101230278467686,0.00353209828875285,0.09430736582173,0.108153191113641,3.15149153564458e-178
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TANK,TRAF family member-associated NF-kappa-B activator,28931,0.141093533100867,0.00492741340870866,0.131435802819798,0.150751263381936,7.6341426330489e-178
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NCK2,Cytoplasmic protein NCK2,29581,0.211715555746534,0.00740163107567973,0.197208358838202,0.226222752654866,1.57912867231639e-177
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SMAD5,Mothers against decapentaplegic homolog 5,29349,0.0407588292388251,0.00142542056797284,0.0379650049255983,0.0435526535520518,2.15796855865495e-177
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,24867,0.168865637064228,0.00589863447146426,0.157304313500158,0.180426960628298,2.28187464213938e-177
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,OTUD7B,OTU domain-containing protein 7B,24867,0.12677041161131,0.0044292204394494,0.118089139549989,0.135451683672631,2.73570671651695e-177
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LAT,Linker for activation of T-cells family member 1,29786,0.151558180975632,0.00530538448345546,0.141159627388059,0.161956734563205,4.26780018248354e-177
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LBR,Delta(14)-sterol reductase LBR,29694,0.13349540846679,0.00467931633644052,0.124323948447366,0.142666868486213,1.25022572846353e-176
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NT5E,5'-nucleotidase,29566,0.112301243885876,0.00393828734003356,0.10458220069941,0.120020287072341,1.86649946755773e-176
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TGFBI,Transforming growth factor-beta-induced protein ig-h3,29361,0.0539900553664817,0.0018937734915569,0.0502782593230302,0.0577018514099332,2.29003481447637e-176
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PLSCR3,Phospholipid scramblase 3,24804,0.117440831535684,0.0041251627510751,0.109355512543577,0.125526150527791,1.86577038180931e-175
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SERPINE1,Plasminogen activator inhibitor 1,29820,0.133534584432115,0.00470033559880169,0.124321926658463,0.142747242205766,3.34298565010378e-175
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CMIP,C-Maf-inducing protein,24793,0.165145099439651,0.00581462542275815,0.153748433611046,0.176541765268257,1.21003551756517e-174
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SUGP1,SURP and G-patch domain-containing protein 1,24805,0.0796405086800705,0.00280979199806218,0.0741333163638686,0.0851477009962723,5.91087790620047e-174
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RBPMS2,RNA-binding protein with multiple splicing 2,24240,0.204315517508152,0.00720831949951006,0.190187211289112,0.218443823727192,6.74743600536337e-174
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CRELD1,Protein disulfide isomerase CRELD1,24381,0.0745014266130034,0.00263015281173497,0.0693463271020028,0.0796565261240039,1.08110885014293e-173
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ITGA5,Integrin alpha-5,29443,0.049614526085297,0.00175625362529982,0.0461722689797094,0.0530567831908847,2.91592443344202e-173
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AAMDC,Mth938 domain-containing protein,24240,0.105935078531695,0.00374750713950769,0.0985899645382597,0.11328019252513,5.46653536606756e-173
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,24922,0.152557484181492,0.00540173603342904,0.141970081555971,0.163144886807013,9.33381227467891e-173
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SERPINH1,Serpin H1,24445,0.254762495893868,0.00902063158873006,0.237082057979957,0.272442933807779,1.05518875441589e-172
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNFSF10,Tumor necrosis factor ligand superfamily member 10,29786,0.0514684058038475,0.00182582015499077,0.0478897983000656,0.0550470133076294,1.47131541772851e-172
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GFER,FAD-linked sulfhydryl oxidase ALR,28797,0.126732920133658,0.00449632781183166,0.117920117622468,0.135545722644848,1.92271902555594e-172
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CA5A,"Carbonic anhydrase 5A, mitochondrial",28916,0.181454127421796,0.00644069693766174,0.168830361423979,0.194077893419613,2.67459886064473e-172
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PLEKHO1,Pleckstrin homology domain-containing family O member 1,24845,0.137057320808457,0.00485955947696296,0.127532584233609,0.146582057383304,2.74140076879466e-172
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IGF2R,Cation-independent mannose-6-phosphate receptor,29443,0.0463476619523055,0.00164580392719506,0.0431218862550032,0.0495734376496078,3.37900936836177e-172
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCN2,CCN family member 2,29478,0.112713733993131,0.00400340228409661,0.104867065516302,0.12056040246996,4.02787429636128e-172
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ARHGEF1,Rho guanine nucleotide exchange factor 1,24845,0.178494257651025,0.00633848641485797,0.166070824277903,0.190917691024146,8.94701354538514e-172
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BTN3A2,Butyrophilin subfamily 3 member A2,29434,0.0746956660695041,0.00265634634449332,0.0694892272342972,0.079902104904711,1.05407325551813e-171
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FABP5,Fatty acid-binding protein 5,29624,0.134135498216953,0.00477349446117358,0.124779449073053,0.143491547360853,1.74719867439011e-171
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL1R2,Interleukin-1 receptor type 2,29404,0.0392429616127542,0.0013972341195904,0.036504382738357,0.0419815404871514,2.65544117797735e-171
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CRELD2,Protein disulfide isomerase CRELD2,29536,0.102452268965837,0.00364897888303773,0.0953002703550831,0.109604267576591,3.33941340185727e-171
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MINK1,Misshapen-like kinase 1,24845,0.182998493457594,0.00651025677035226,0.170238390187704,0.195758596727485,3.61339357612853e-171
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SDCCAG8,Serologically defined colon cancer antigen 8,24793,0.224793577450401,0.0080007839122997,0.209112040982294,0.240475113918509,5.1902516973153e-171
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",28797,0.162688998030149,0.00579704955607524,0.151326780900241,0.174051215160056,5.41134169659135e-171
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TPD52L2,Tumor protein D54,24381,0.213328385768087,0.00759617624775992,0.198439880322477,0.228216891213696,8.14493825539324e-171
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCL5,C-C motif chemokine 5,29594,0.197171411447316,0.00704217703171501,0.183368744465155,0.210974078429478,2.81551766374141e-170
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IGSF3,Immunoglobulin superfamily member 3,29349,0.0703437437371985,0.00251839199205242,0.0654076954327758,0.0752797920416212,1.80761044000314e-169
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FOXO1,Forkhead box protein O1,29434,0.167626674011486,0.00600185761520868,0.155863033085677,0.179390314937295,1.92674234788428e-169
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,24922,0.12490768408529,0.00446936392684148,0.116147730788681,0.1336676373819,2.8885831990973e-169
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCL13,C-C motif chemokine 13,29732,0.135124276999304,0.00484420080035104,0.125629643430616,0.144618910567992,4.76646235170244e-169
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,STK11,Serine/threonine-protein kinase STK11,28916,0.142759043605097,0.00511834117540554,0.132727094901302,0.152790992308891,5.84258769654871e-169
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DOK2,Docking protein 2,29478,0.238093858245663,0.00853793386107076,0.221359507877964,0.254828208613362,6.08926670978185e-169
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,OXT,Oxytocin-neurophysin 1,29694,0.271902987849606,0.00976029598141915,0.252772807726025,0.291033167973188,1.27565945285435e-168
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,OGFR,Opioid growth factor receptor,29349,0.0638333920658885,0.00229310796756244,0.0593389004494661,0.0683278836823109,2.39129327162614e-168
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AKT1S1,Proline-rich AKT1 substrate 1,28774,0.130688737919977,0.00470533513659531,0.12146628105225,0.139911194787703,1.43650153942573e-167
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,USP8,Ubiquitin carboxyl-terminal hydrolase 8,28916,0.186664588926246,0.00672685895510005,0.173479945374249,0.199849232478242,2.79111868667787e-167
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,29218,0.184339108862871,0.00664432976038649,0.171316222532514,0.197361995193229,3.06231041661365e-167
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CEP43,Centrosomal protein 43,28705,0.135469682227396,0.00488465682098802,0.125895754858259,0.145043609596532,4.3945498981626e-167
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DLK1,Protein delta homolog 1,29820,0.108299422220514,0.00391213337577156,0.100631640804002,0.115967203637026,1.43893131299179e-166
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLIP2,CAP-Gly domain-containing linker protein 2,29434,0.2180415699056,0.00788543489668966,0.202586117508088,0.233497022303112,3.61312964319223e-166
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SIGLEC7,Sialic acid-binding Ig-like lectin 7,29478,0.0544758965529521,0.00197168373339213,0.0506113964355035,0.0583403966704006,6.50338088024875e-166
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,F13B,Coagulation factor XIII B chain,24833,0.0501593980239313,0.00181376849998928,0.0466044117639523,0.0537143842839103,7.97952331327727e-166
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RNASE4,Ribonuclease 4,24194,0.0533534626250915,0.00193169788592967,0.0495673347686693,0.0571395904815136,2.35849761469171e-165
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,24805,0.209832900134085,0.00761513832911119,0.194907229009028,0.224758571259143,1.17607456705883e-164
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PCBP2,Poly(rC)-binding protein 2,24867,0.139667837081062,0.00507633856385942,0.129718213495897,0.149617460666226,3.49270791533282e-164
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EGLN1,Egl nine homolog 1,29434,0.10477556798725,0.0038171254507516,0.097294002103777,0.112257133870723,8.34336586387635e-164
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HCLS1,Hematopoietic lineage cell-specific protein,29786,0.106918503808262,0.003903518288161,0.0992676079634668,0.114569399653058,3.78409120076299e-163
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",29349,0.0846126727570851,0.00309266390843302,0.0785510514965564,0.0906742940176138,9.31190028690769e-163
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,USO1,General vesicular transport factor p115,29349,0.172375930520937,0.00630374527833621,0.160020589775398,0.184731271266476,1.35892970506373e-162
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HEXIM1,Protein HEXIM1,29434,0.155967697974118,0.00570497950784056,0.14478593813875,0.167149457809485,1.57942975134961e-162
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HDGFL2,Hepatoma-derived growth factor-related protein 2,24845,0.12124004774024,0.00443060088569555,0.112556070004277,0.129924025476204,1.87862608726783e-162
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PCSK9,Proprotein convertase subtilisin/kexin type 9,29820,0.0757760494127338,0.00277336002318887,0.0703402637672837,0.081211835058184,2.2833743776363e-162
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VPS53,Vacuolar protein sorting-associated protein 53 homolog,29349,0.147047786139666,0.00538432702038698,0.136494505179707,0.157601067099624,3.42717880240798e-162
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ALDH1A1,Retinal dehydrogenase 1,29443,0.102029251821119,0.00373688880998121,0.0947049497535559,0.109353553888682,4.0785731967911e-162
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FABP4,"Fatty acid-binding protein, adipocyte",29820,0.095663926880164,0.00350904792335922,0.0887861929503799,0.102541660809948,1.15374532605326e-161
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HAO1,Hydroxyacid oxidase 1,29725,0.244549930301377,0.0089905646163837,0.226928423653265,0.262171436949489,5.98571576657972e-161
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NIT2,Omega-amidase NIT2,24813,0.142117420534287,0.00522847734704837,0.131869604934072,0.152365236134501,2.41072501664798e-160
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",24240,0.132466654577432,0.00487358662488458,0.122914424792659,0.142018884362206,2.79785040115352e-160
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PXN,Paxillin,28774,0.0981652647602216,0.00361615299618052,0.0910776048877078,0.105252924632735,2.93835200909113e-160
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RABEP1,Rab GTPase-binding effector protein 1,24381,0.148687323958229,0.00547885403556211,0.137948770048527,0.159425877867931,8.24437993606912e-160
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PHACTR2,Phosphatase and actin regulator 2,24867,0.217125346017082,0.00800637096949058,0.201432858916881,0.232817833117284,1.23610319706293e-159
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,METAP2,Methionine aminopeptidase 2,29674,0.108889952107491,0.00403508888591408,0.1009811778911,0.116798726323883,1.78702173982561e-158
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,QDPR,Dihydropteridine reductase,29345,0.0817441002572841,0.00302912305810481,0.0758070190633987,0.0876811814511695,1.86144485156564e-158
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AP3B1,AP-3 complex subunit beta-1,24805,0.145281802312861,0.00538078478485069,0.134735464134554,0.155828140491169,2.86724894818678e-158
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GMPR,GMP reductase 1,29786,0.0938522816445617,0.00348634519749069,0.08701904505748,0.100685518231643,9.95295314667091e-158
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NSFL1C,NSFL1 cofactor p47,29694,0.122665188359002,0.00456553376153153,0.1137167421864,0.131613634531604,3.98970566209628e-157
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,29163,0.210614103859275,0.00784232924340343,0.195243138542204,0.225985069176345,5.84500907468575e-157
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NTproBNP,N-terminal prohormone of brain natriuretic peptide,29478,-0.196732741848289,0.00734123850005655,-0.2111215693084,-0.182343914388179,2.53808184513838e-156
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IDUA,Alpha-L-iduronidase,29725,0.0867929117646792,0.00323906881038196,0.0804443368963306,0.0931414866330279,2.62730699153299e-156
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ACP5,Tartrate-resistant acid phosphatase type 5,29604,0.061593560259091,0.00230426952758791,0.0570771919850186,0.0661099285331633,1.48165750189816e-155
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BID,BH3-interacting domain death agonist,29434,0.125100120123888,0.00468544295941203,0.115916651923441,0.134283588324336,3.36220686361987e-155
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LGALS9,Galectin-9,29453,0.0598107437201019,0.00224117370272338,0.0554180432627641,0.0642034441774397,4.64668997709423e-155
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NAGK,N-acetyl-D-glucosamine kinase,24209,0.106855617933326,0.00399907018044884,0.0990174403796467,0.114693795487006,4.88418393737366e-155
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MUC13,Mucin-13,28774,0.0965203211055316,0.00361697793399069,0.0894310443549098,0.103609597856153,5.3883206317977e-155
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GOLM2,Protein GOLM2,29694,0.0423509363756128,0.00158805018956332,0.0392383580040687,0.0454635147471569,7.3214377812449e-155
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",24867,0.145172829996543,0.00543957881774059,0.134511255513771,0.155834404479314,9.77501632169327e-155
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CDC42BPB,Serine/threonine-protein kinase MRCK beta,24805,0.192227650557509,0.00720285573438911,0.178110053318106,0.206345247796912,1.00382875164517e-154
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CDC27,Cell division cycle protein 27 homolog,28797,0.11390759080949,0.00427701706807969,0.105524637356054,0.122290544262927,2.12873669757181e-154
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DNAJB6,DnaJ homolog subfamily B member 6,24170,0.158607809593719,0.00595440079915203,0.146937184027381,0.170278435160057,4.24900241843984e-154
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RAPGEF2,Rap guanine nucleotide exchange factor 2,24445,0.0996254162546575,0.00374213288606266,0.0922908357979746,0.10695999671134,5.83808376550509e-154
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ZFYVE19,Abscission/NoCut checkpoint regulator,24805,0.169553580816776,0.00637048858047277,0.157067423199049,0.182039738434503,6.53864057188459e-154
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",29820,0.054418598136698,0.00204841475827241,0.0504037052104841,0.0584334910629119,1.03242820096811e-153
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SRP14,Signal recognition particle 14 kDa protein,29349,0.111007203077297,0.00417988521755385,0.102814628050892,0.119199778103703,1.38225596033859e-153
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,USP25,Ubiquitin carboxyl-terminal hydrolase 25,24793,0.13482859076519,0.00507139011240974,0.124888666144867,0.144768515385514,1.40178840686379e-153
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PDGFB,Platelet-derived growth factor subunit B,29581,0.159584931218368,0.00601684143792864,0.147791922000027,0.171377940436708,3.27173645957587e-153
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VWA1,von Willebrand factor A domain-containing protein 1,29674,0.0785497057509571,0.00296186262742979,0.0727444550011947,0.0843549565007195,3.46165861871557e-153
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,STAMBP,STAM-binding protein,29163,0.119081481912174,0.00449012765868481,0.110280831701152,0.127882132123196,3.6819612641336e-153
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SMNDC1,Survival of motor neuron-related-splicing factor 30,24805,0.111139883291612,0.00418703481763967,0.102933295049038,0.119346471534186,4.17723842867617e-153
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SYTL4,Synaptotagmin-like protein 4,24922,0.135937584799345,0.00512419448397528,0.125894163610754,0.145981005987937,6.05437382781763e-153
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SEC31A,Protein transport protein Sec31A,24240,0.143358394108892,0.00540714586484917,0.132760388213788,0.153956400003997,1.04226212535329e-152
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DAG1,Dystroglycan,29581,0.0882119146779451,0.00333244340103838,0.0816803256119099,0.0947435037439804,1.27236116089694e-152
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GPKOW,G-patch domain and KOW motifs-containing protein,28774,0.0520156903076975,0.00196505391486139,0.0481641846345692,0.0558671959808258,1.43513743201522e-152
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DNMBP,Dynamin-binding protein,29218,0.113572785114368,0.00429404066016222,0.10515646542045,0.121989104808286,2.34626981359716e-152
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SH2D1A,SH2 domain-containing protein 1A,29434,0.106251764548486,0.00401758049459639,0.0983773067790774,0.114126222317895,2.41218992751364e-152
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FKBPL,FK506-binding protein-like,24805,0.109793843228946,0.00415779271576002,0.101644569506056,0.117943116951836,1.43086183171193e-151
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LYN,Tyrosine-protein kinase Lyn,29349,0.156267302860001,0.00592504173817472,0.144654221053178,0.167880384666823,1.59487970814879e-151
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EREG,Proepiregulin,29163,0.148396629310864,0.00563719277839935,0.137347731465202,0.159445527156527,5.8570901226687e-151
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GP1BA,Platelet glycoprotein Ib alpha chain,29374,0.0605973454950208,0.00230598172253807,0.0560776213188462,0.0651170696711954,1.87014160380726e-150
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SCPEP1,Retinoid-inducible serine carboxypeptidase,24138,0.0927340652118986,0.00352668999712183,0.0858217528175398,0.0996463776062574,2.87254386643866e-150
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLEC4A,C-type lectin domain family 4 member A,29434,-0.0646157046475289,0.00246099983339247,-0.0694392643209782,-0.0597921449740797,3.30377279808304e-150
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SNX15,Sorting nexin-15,24381,0.0998311474026443,0.00380033596608984,0.0923824889091082,0.10727980589618,5.31378347689978e-150
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,APOA2,Apolipoprotein A-II,24951,-0.0891913688641385,0.00339905862674355,-0.0958535237725558,-0.0825292139557211,1.00203859136285e-149
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,29349,0.0823719933608032,0.00314336791757883,0.0762109922423487,0.0885329944792577,1.23286781221156e-149
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SH2B3,SH2B adapter protein 3,28797,0.180637188153377,0.00689381733200421,0.167125306182649,0.194149070124105,1.40696627297897e-149
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MTDH,Protein LYRIC,24229,0.171481340960203,0.00654490514873245,0.158653326868687,0.184309355051719,3.13320253673178e-149
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MMP10,Stromelysin-2,29439,-0.108496540897959,0.00415256518686755,-0.11663556866422,-0.100357513131699,8.84562747586732e-149
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,29608,0.18919492642211,0.00724145466204543,0.175001675284501,0.203388177559719,8.86562975376235e-149
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FGFBP3,Fibroblast growth factor-binding protein 3,24845,0.0677578529871314,0.0025922017816055,0.0626771374951846,0.0728385684790782,1.34249003055688e-148
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CNST,Consortin,29478,0.19875959621143,0.00761267831540601,0.183838746713235,0.213680445709626,1.4148348507334e-148
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,29604,0.106180664346626,0.00407324541352436,0.0981971033361182,0.114164225357134,3.98586656451326e-148
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ARSB,Arylsulfatase B,29349,0.100721558419713,0.00387523095608213,0.0931261057457923,0.108317011093634,2.90919761293495e-147
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CMC1,COX assembly mitochondrial protein homolog,24922,0.165604818598338,0.00636785841904075,0.153123816097018,0.178085821099658,3.86547179773044e-147
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GIT1,ARF GTPase-activating protein GIT1,24229,0.178001305685861,0.00684368746229732,0.164587678259759,0.191414933111964,4.04737547508026e-147
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SKAP2,Src kinase-associated phosphoprotein 2,29581,0.189905398864719,0.00732272862530271,0.175552850759126,0.204257946970313,1.21558963067001e-146
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TRIM5,Tripartite motif-containing protein 5,29434,0.156228736911583,0.00603976806777308,0.144390791498748,0.168066682324418,6.77583181150244e-146
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AMN,Protein amnionless,28931,0.0863505723004017,0.00333901334452427,0.0798061061451341,0.0928950384556692,8.32170909600408e-146
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NUDT5,ADP-sugar pyrophosphatase,29443,0.0929852355456691,0.00359787204431252,0.0859334063388166,0.100037064752522,1.18643439293622e-145
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SH3GLB2,Endophilin-B2,24845,0.120641963322354,0.00467533604668812,0.111478304670845,0.129805621973862,6.51882872494894e-145
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LZTFL1,Leucine zipper transcription factor-like protein 1,24381,0.129979733511404,0.00503856517566376,0.120104145767103,0.139855321255705,8.42743497631829e-145
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CST3,Cystatin-C,29530,0.0512957402149773,0.00199335713533703,0.0473887602297168,0.0552027202002379,1.94526974451903e-144
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RGCC,Regulator of cell cycle RGCC,24867,0.136924697439339,0.00531579255479274,0.126505744031945,0.147343650846733,2.05532107824032e-144
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PLXNB3,Plexin-B3,29383,0.0856220851539293,0.00332928648760983,0.0790966836382141,0.0921474866696446,2.9267117117317e-144
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,28931,0.0794063443617768,0.00308852959849538,0.0733528263487258,0.0854598623748278,3.76638426641951e-144
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ASAH2,Neutral ceramidase,29218,0.0954633638392926,0.00372234714524447,0.0881675634346134,0.102759164243972,1.81961917284677e-143
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AZI2,5-azacytidine-induced protein 2,24867,0.0994125111016862,0.00388646107414823,0.0917950473963556,0.107029974807017,1.8145017474829e-142
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BIRC2,Baculoviral IAP repeat-containing protein 2,28797,0.113795148346663,0.00445365281724372,0.105065988824865,0.122524307868461,2.07757450767698e-142
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PGF,Placenta growth factor,29786,0.0471280762167596,0.00184558923911038,0.0435107213081032,0.0507454311254159,2.71353284049109e-142
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PON2,Serum paraoxonase/arylesterase 2,28916,0.0623335045017809,0.00244113285388952,0.0575488841081574,0.0671181248954043,3.07809749919599e-142
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CES2,Cocaine esterase,29349,0.098113760809051,0.0038432488613553,0.0905809930407946,0.105646528577307,3.37575163206991e-142
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VEGFA,Vascular endothelial growth factor A,29683,0.103638458163462,0.00406038092296434,0.0956801115544523,0.111596804772473,3.63462530978992e-142
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,WASF1,Wiskott-Aldrich syndrome protein family member 1,28916,0.167648011206815,0.00657203009737212,0.154766832215965,0.180529190197664,5.79997684539694e-142
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,29426,0.10944440673046,0.00430731641446499,0.101002066558109,0.117886746902811,6.66819417088392e-141
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TRIM21,E3 ubiquitin-protein ligase TRIM21,29434,0.137392144180568,0.00540891732704887,0.126790666219553,0.147993622141584,8.1122787374119e-141
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MEP1A,Meprin A subunit alpha,24805,0.128795238449389,0.0050673075311095,0.118863315688415,0.138727161210364,1.04033097457773e-140
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TAX1BP1,Tax1-binding protein 1,24845,0.112724623274332,0.00444117887293641,0.104019912683376,0.121429333865287,2.47425283716845e-140
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RTBDN,Retbindin,29349,0.0528588001249374,0.00208509127841741,0.0487720212192393,0.0569455790306356,2.85619395044022e-140
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD5,T-cell surface glycoprotein CD5,29683,0.0612301933477095,0.00242007305642511,0.0564868501571163,0.0659735365383027,9.47738974990236e-140
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ELOA,Elongin-A,29349,0.0929634604685972,0.00367532766316006,0.0857598182488035,0.100167102688391,1.17271524470511e-139
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",24240,0.0465387154875568,0.00183793900263879,0.0429363550423848,0.0501410759327288,1.22393766642404e-139
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",24867,0.142473742365186,0.00562764653311352,0.131443555160283,0.153503929570088,1.22978208914867e-139
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SHMT1,"Serine hydroxymethyltransferase, cytosolic",29536,0.153270187671529,0.0060651171311224,0.14138255809453,0.165157817248529,2.03732974060701e-139
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MYDGF,Myeloid-derived growth factor,24922,0.177767050700937,0.00702852014727838,0.163991151212272,0.191542950189603,2.233528024621e-139
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,29434,0.179546472584776,0.00711123066623024,0.165608460478965,0.193484484690587,3.59588212564996e-139
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCL11,Eotaxin,29786,0.0668104226732016,0.00265000395903815,0.0616164149134868,0.0720044304329164,8.60036104075215e-139
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PARP1,Poly [ADP-ribose] polymerase 1,29434,0.0999803698535224,0.00396833770596542,0.0922024279498302,0.107758311757215,1.35920819354845e-138
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MITD1,MIT domain-containing protein 1,29218,0.171060845610365,0.00679161911640336,0.157749272142214,0.184372419078516,1.67549456618347e-138
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SIAE,Sialate O-acetylesterase,29495,0.0825706783315052,0.00327910119170836,0.0761436399957568,0.0889977166672536,1.89022919570481e-138
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,COCH,Cochlin,24922,0.0819681103531341,0.00325600887383382,0.0755863329604198,0.0883498877458484,4.07439034414489e-138
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ANGPTL7,Angiopoietin-related protein 7,29725,0.0652951365502091,0.0025996000162704,0.0601999205183191,0.070390352582099,8.82279860867748e-138
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VNN1,Pantetheinase,24951,0.128637563781969,0.00511838685043447,0.118605525555117,0.13866960200882,1.13743275801875e-137
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ANG,Angiogenin,29435,0.0595362791802711,0.00237193356688615,0.0548872893891743,0.064185268971368,1.38689257419296e-137
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TALDO1,Transaldolase,24888,0.0786204003105604,0.00313279422591122,0.0724801236277744,0.0847606769933464,2.81285686045064e-137
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BRAP,BRCA1-associated protein,24565,0.193582339676572,0.00771699882949117,0.178457021970769,0.208707657382375,3.85159842506728e-137
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GIGYF2,GRB10-interacting GYF protein 2,24867,0.133959614167702,0.00534801589092756,0.123477503021484,0.14444172531392,9.02510993457042e-137
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CIRBP,Cold-inducible RNA-binding protein,24805,0.168672045699987,0.0067432772408743,0.155455222307874,0.181888869092101,2.15001647899325e-136
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CRKL,Crk-like protein,29491,0.186320497391211,0.00745932634288961,0.171700217759147,0.200940777023274,2.76524970886407e-136
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,24805,0.156442051578058,0.00626268183694034,0.144167195177655,0.168716907978461,4.85126686754091e-136
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GASK1A,Golgi-associated kinase 1A,24111,0.075683012418143,0.00303047503314268,0.0697432813531833,0.0816227434831026,6.27663082772908e-136
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ST13,Hsc70-interacting protein,24381,0.0981056666857019,0.0039291636444664,0.0904045059425477,0.105806827428856,6.85437524386198e-136
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SSNA1,Sjoegren syndrome nuclear autoantigen 1,24805,0.0897224779953057,0.00359810951965335,0.0826701833367851,0.0967747726538263,1.4197582371271e-135
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,24867,0.11539718466936,0.0046314179724394,0.106319605443379,0.124474763895341,2.28015683886587e-135
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CSNK2A1,Casein kinase II subunit alpha,24867,-0.0787677832497959,0.00316172607135215,-0.0849647663496461,-0.0725708001499456,2.46860289807123e-135
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AHSG,Alpha-2-HS-glycoprotein,24951,0.0471035471672588,0.00189244187135671,0.0433943610993997,0.050812733235118,4.21993882687267e-135
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GLB1,Beta-galactosidase,29218,0.0732363464389456,0.00294512856510319,0.0674638944513433,0.0790087984265479,4.32276273315683e-135
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TBCC,Tubulin-specific chaperone C,29218,0.1413820656463,0.00568630627814372,0.130236905341138,0.152527225951461,4.68964362745847e-135
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NIT1,Deaminated glutathione amidase,24240,0.0829573540847771,0.00333327413504594,0.0764241367800871,0.0894905713894672,5.0287604565737e-135
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL17RB,Interleukin-17 receptor B,29034,-0.0939479743423554,0.00378183163262504,-0.101360364342301,-0.0865355843424103,8.11741576394165e-135
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RRM2,Ribonucleoside-diphosphate reductase subunit M2,28797,0.0891211723797525,0.00359106555367953,0.0820826838945406,0.0961596608649643,1.51152474929783e-134
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,OPHN1,Oligophrenin-1,24845,0.187876532625098,0.00756522592365166,0.173048689814741,0.202704375435455,1.6768800306713e-134
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GFRA1,GDNF family receptor alpha-1,29674,0.0494132520378912,0.0019919288320074,0.0455090715271567,0.0533174325486257,1.78511224893559e-134
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FAM13A,Protein FAM13A,24805,0.118044426775072,0.00475479853862422,0.108725021639369,0.127363831910776,2.04088524120141e-134
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,28797,0.135822430735845,0.00548188434666485,0.125077937416382,0.146566924055308,4.08437152500724e-134
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GORASP2,Golgi reassembly-stacking protein 2,24805,0.0824808993565001,0.00332619313379981,0.0759615608142525,0.0890002378987478,4.12229080899694e-134
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,23850,0.0577829504692087,0.0023323574309936,0.0532115299044612,0.0623543710339561,8.32265483280309e-134
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TIMP3,Metalloproteinase inhibitor 3,29581,0.226216532886407,0.00914239809075924,0.208297432628519,0.244135633144295,8.35047041997709e-134
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LGALS8,Galectin-8,29694,0.105550791331361,0.0042674547374682,0.097186580045923,0.113915002616798,1.04637456017273e-133
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MPHOSPH8,M-phase phosphoprotein 8,28916,0.131683403662848,0.00532724680959392,0.121241999916044,0.142124807409652,1.63751257188055e-133
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EVI5,Ecotropic viral integration site 5 protein homolog,24229,0.157104574413356,0.00634921384589137,0.144660115275409,0.169549033551303,1.64071767884085e-133
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IFNLR1,Interferon lambda receptor 1,29434,0.0645225808038247,0.00261056218987165,0.0594058789116763,0.0696392826959732,1.66105191526997e-133
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",29443,0.0801143087237278,0.00324146445855151,0.0737610383849668,0.0864675790624887,1.67990039773976e-133
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",29301,0.131337158401704,0.00532118439984256,0.120907636978012,0.141766679825395,3.84289425184499e-133
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,24445,0.183921831185766,0.00744784097858248,0.169324062867744,0.198519599503788,5.22033422495712e-133
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,COMMD1,COMM domain-containing protein 1,24240,0.106582753429615,0.00431725382572978,0.0981209359311848,0.115044570928046,6.3805486185854e-133
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,STIP1,Stress-induced-phosphoprotein 1,29386,0.112266447515866,0.00455716931398982,0.103334395660446,0.121198499371286,1.18231995622556e-132
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GOLGA3,Golgin subfamily A member 3,24867,0.135239777492709,0.00548829520002612,0.124482718900658,0.14599683608476,1.76707731918619e-132
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TDRKH,Tudor and KH domain-containing protein,28774,0.147198139195731,0.00598122373499167,0.135474940675147,0.158921337716315,2.31316528986597e-132
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IST1,IST1 homolog,24636,0.172263740962975,0.00699589047797616,0.158551795626142,0.185975686299808,2.81470811821121e-132
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ORM1,Alpha-1-acid glycoprotein 1,24846,0.0346682706234476,0.0014088692307936,0.0319068869310922,0.0374296543158031,4.05098395512715e-132
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD36,Platelet glycoprotein 4,24229,0.0784923075245746,0.00319098125776288,0.0722379842593594,0.0847466307897899,5.50899629478822e-132
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FUS,RNA-binding protein FUS,28765,0.0684092002376175,0.00278496700970007,0.0629506648986053,0.0738677355766296,7.07339197178547e-132
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DBNL,Drebrin-like protein,29581,0.159585096156956,0.00650748467850737,0.146830426187082,0.172339766126831,1.720107484874e-131
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VAMP8,Vesicle-associated membrane protein 8,24229,0.152518136889929,0.0062158647038013,0.140335042070478,0.164701231709379,2.39790897661085e-131
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ASPSCR1,Tether containing UBX domain for GLUT4,24867,0.116613209873191,0.00475364029065162,0.107296074903514,0.125930344842869,2.49626251937344e-131
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DDHD2,Phospholipase DDHD2,24867,0.114352037455645,0.00466523611940326,0.105208174661615,0.123495900249676,4.01601029613229e-131
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,WASHC3,WASH complex subunit 3,24845,0.130039239036658,0.00530742656454718,0.119636682970146,0.140441795103171,5.13795118475273e-131
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BAG4,BAG family molecular chaperone regulator 4,24229,0.0854355766470616,0.00348755693994956,0.0785999650447605,0.0922711882493627,6.20220475897217e-131
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IGBP1,Immunoglobulin-binding protein 1,24867,0.104497961750993,0.00427220926831784,0.09612443158509,0.112871491916896,1.38145782727598e-130
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AHNAK,Neuroblast differentiation-associated protein AHNAK,24240,0.0545427782816083,0.00223078982005547,0.0501704302342996,0.058915126328917,1.918496604121e-130
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD40,Tumor necrosis factor receptor superfamily member 5,29453,0.0858143964548974,0.00351453676538227,0.0789259043947481,0.0927028885150466,2.24126363897955e-130
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RBKS,Ribokinase,28795,0.0855041007305871,0.00350284002041673,0.0786385342905703,0.0923696671706039,2.83870498299366e-130
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HYOU1,Hypoxia up-regulated protein 1,29820,0.0382074597382144,0.00156869268793857,0.0351328220698548,0.041282097406574,9.25827114480654e-130
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,C1S,Complement C1s subcomponent,24966,0.0358894651406949,0.00147290442937065,0.0330025724591284,0.0387763578222614,1.27024854345992e-129
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ATP5IF1,"ATPase inhibitor, mitochondrial",29581,0.188322986271312,0.00774126710285428,0.173150102749718,0.203495869792906,1.89952882045059e-129
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KRT5,"Keratin, type II cytoskeletal 5",28774,0.0871712679127778,0.00358689231045758,0.0801409589842809,0.0942015768412746,3.69020565146539e-129
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RAB27B,Ras-related protein Rab-27B,24922,0.140689392821184,0.00578473290690479,0.12935131632365,0.152027469318717,3.7906078041096e-129
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SNCG,Gamma-synuclein,29218,0.114264519570377,0.00470444395165217,0.105043809425138,0.123485229715615,4.9374325999315e-129
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ARHGAP45,Rho GTPase-activating protein 45,24381,0.141381348579645,0.00581594365659753,0.129982099012714,0.152780598146576,5.38020320936064e-129
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TACC3,Transforming acidic coiled-coil-containing protein 3,29349,0.198650338803524,0.00818478522273025,0.182608159766973,0.214692517840075,7.47680590941566e-129
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,24867,0.182925068798321,0.00753873323486991,0.168149151657976,0.197700985938666,1.44963083185501e-128
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL1RL2,Interleukin-1 receptor-like 2,28931,0.0670077168535305,0.00277175660364798,0.0615750739103804,0.0724403597966805,7.5549622054695e-128
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,A1BG,Alpha-1B-glycoprotein,24966,0.0291234105369659,0.00120383259288528,0.0267638986549108,0.0314829224190211,7.971222351169e-128
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SAMD9L,Sterile alpha motif domain-containing protein 9-like,29434,0.12302462169177,0.00509916550367489,0.113030257304567,0.133018986078973,2.28624617008176e-127
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PACS2,Phosphofurin acidic cluster sorting protein 2,24111,0.105790072967901,0.00438401614672356,0.0971974013203225,0.114382744615479,3.82741862157654e-127
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TBC1D23,TBC1 domain family member 23,29349,0.152188264219474,0.00631790608984262,0.139805168283382,0.164571360155565,5.6710233938211e-127
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,29497,0.0453318338690821,0.00188208192298348,0.0416429533000345,0.0490207144381297,5.91816619010545e-127
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,24793,0.141026708903692,0.00585259532985451,0.129555622057177,0.152497795750207,7.84886554415496e-127
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",24805,0.248872647012878,0.0103314926640365,0.228622921391367,0.26912237263439,9.39632890484087e-127
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LEFTY2,Left-right determination factor 2,29674,0.0879689693427665,0.00365564352406618,0.0808039080355968,0.0951340306499362,9.82271315168733e-127
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,STAT2,Signal transducer and activator of transcription 2,24229,0.131487392361608,0.0054638917946065,0.120778164444179,0.142196620279037,1.78693028515473e-126
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,OGA,Protein O-GlcNAcase,24805,0.119811539778318,0.0049796198557751,0.110051484860999,0.129571594695638,1.8332350851258e-126
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CXCL3,C-X-C motif chemokine 3,29453,0.159172113986363,0.00662551614085024,0.146186102350297,0.17215812562243,2.56601922049758e-126
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DGKA,Diacylglycerol kinase alpha,24229,0.0927329559226811,0.003857250042372,0.085172745839632,0.10029316600573,3.11220906608109e-126
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,24381,0.0983118087752856,0.00409077947170184,0.09029388101075,0.106329736539821,3.73740725748754e-126
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TIA1,Nucleolysin TIA-1 isoform p40,28538,0.206185107274342,0.00859014257785644,0.189348427821743,0.22302178672694,4.66433781277973e-126
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TRAF2,TNF receptor-associated factor 2,29434,0.118769875315086,0.0049590901362363,0.109050058648063,0.12848969198211,1.47651965623346e-125
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HS1BP3,HCLS1-binding protein 3,24240,0.152357346657628,0.00636159035726521,0.139888629557388,0.164826063757868,2.67203876479651e-125
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CASC3,Protein CASC3,24195,0.070698048931825,0.00295804508317172,0.0649002805688084,0.0764958172948416,8.52843764132253e-125
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SUSD1,Sushi domain-containing protein 1,28916,0.0822477200646852,0.00344843872474338,0.0754887801641881,0.0890066599651822,1.59295837970082e-124
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,THPO,Thrombopoietin,28916,0.0647228881584564,0.00271830729870487,0.0593950058529949,0.070050770463918,4.13228589990209e-124
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,28797,0.0747835615431098,0.00314090729299619,0.0686273832488373,0.0809397398373823,4.22376724170337e-124
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GMPR2,GMP reductase 2,24381,0.112765018743371,0.00473376373915656,0.103486841814624,0.122043195672118,5.24368117760049e-124
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,24793,0.0809037013905225,0.00339665782970335,0.0742462520443039,0.0875611507367411,5.30735515978176e-124
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RWDD1,RWD domain-containing protein 1,29694,0.106277050313563,0.00446989578408407,0.0975160545767578,0.115038046050367,8.48640009956409e-124
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MSRA,Mitochondrial peptide methionine sulfoxide reductase,29566,0.121041129624535,0.00509618099162995,0.11105261488094,0.13102964436813,1.53348488518241e-123
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PDLIM5,PDZ and LIM domain protein 5,24867,0.1982234489901,0.00834014706026111,0.181876760751989,0.214570137228212,1.73529201220108e-123
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,29349,0.0467076535226452,0.00196754534130049,0.0428512646536963,0.0505640423915942,2.08321876534867e-123
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GZMA,Granzyme A,29786,0.0578856015441982,0.00244238425977805,0.0530985283950332,0.0626726746933632,4.92945875843931e-123
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PENK,Proenkephalin-A,24381,0.0515674007900346,0.00217789538056892,0.0472987258441195,0.0558360757359497,1.48535709952224e-122
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KYAT1,Kynurenine--oxoglutarate transaminase 1,29444,0.0943450755992282,0.003997240614588,0.0865104839946357,0.102179667203821,4.94832569331437e-122
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SERPINC1,Antithrombin-III,24914,0.0245424289263166,0.00104184096811905,0.0225004206288033,0.02658443722383,2.27550877651019e-121
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MARS1,"Methionine--tRNA ligase, cytoplasmic",24329,0.142267450293063,0.0060398811001655,0.130429283336739,0.154105617249388,2.56873350713326e-121
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HSPA1A,Heat shock 70 kDa protein 1A,29536,0.117503401900077,0.0049941421199508,0.107714883344974,0.127291920455181,2.74619267783424e-121
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FLT4,Vascular endothelial growth factor receptor 3,29566,0.0556078041723649,0.00236676640761799,0.0509689420134337,0.0602466663312962,5.87200747588906e-121
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GTPBP2,GTP-binding protein 2,24195,0.134011540803734,0.00570108547102629,0.122837413280522,0.145185668326945,7.96365953885152e-121
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SULT2A1,Bile salt sulfotransferase,29434,0.0926900011281872,0.00394870633730458,0.0849505367070702,0.100429465549304,9.81499411894794e-121
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TXNDC5,Thioredoxin domain-containing protein 5,29694,0.112053900007307,0.00477648624509822,0.102691986966915,0.1214158130477,1.32705002918486e-120
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GAS6,Growth arrest-specific protein 6,29639,-0.0420988775401373,0.00179541626754916,-0.0456178934245337,-0.038579861655741,1.73854687470687e-120
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,C19orf12,Protein C19orf12,28774,0.10650689076111,0.00454318106532938,0.0976022558730643,0.115411525649155,2.09024112998878e-120
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RABGAP1L,Rab GTPase-activating protein 1-like,28931,0.0987691962207215,0.00421984340427044,0.0904983031483514,0.107040089293092,4.87200259394057e-120
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GPC5,Glypican-5,29218,0.092712071887446,0.00396247445956589,0.0849456219466968,0.100478521828195,5.76157165978011e-120
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TWF2,Twinfilin-2,24938,0.13840444063185,0.0059111409697484,0.126818604331144,0.149990276932557,6.04777063260945e-120
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,UBXN1,UBX domain-containing protein 1,24381,0.113795303979646,0.00486138699191313,0.104266985475497,0.123323622483796,7.45217805207543e-120
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,29218,0.092519032961989,0.00396095338728534,0.0847555643229097,0.100282501601068,1.43690135611844e-119
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SIRT2,NAD-dependent protein deacetylase sirtuin-2,29349,0.145153193636856,0.00621944850899345,0.132963074559228,0.157343312714483,2.20700948434464e-119
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CNPY4,Protein canopy homolog 4,29349,0.122951583623256,0.00527782274684282,0.112607051039444,0.133296116207068,5.87709883611272e-119
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ATXN3,Ataxin-3,24845,0.101473681666942,0.00435393392725215,0.0929399711695274,0.110007392164356,7.24539118030586e-119
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ANGPTL3,Angiopoietin-related protein 3,29518,0.0582881234664807,0.00250966140571316,0.0533691871112829,0.0632070598216785,2.90192414056119e-118
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MCAM,Cell surface glycoprotein MUC18,29594,-0.0543988200384099,0.00234403728867853,-0.0589931331242199,-0.0498045069526,4.3681004209706e-118
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PPP1R2,Protein phosphatase inhibitor 2,29478,0.130583902550934,0.00562761149441314,0.119553784021884,0.141614021079984,4.74117224135504e-118
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SPART,Spartin,24381,0.126672334359708,0.00545542296369029,0.115979705350876,0.137364963368541,5.52442266821165e-118
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCL7,C-C motif chemokine 7,29434,0.0960085672984195,0.00413922472976144,0.0878956868280871,0.104121447768752,5.88682465069473e-118
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HMOX2,Heme oxygenase 2,28774,0.0762552171878094,0.00329038942882182,0.0698060539073186,0.0827043804683002,9.74584130949056e-118
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GYS1,"Glycogen [starch] synthase, muscle",28916,0.151431862036666,0.00654707299791897,0.138599598960745,0.164264125112587,2.70953010650411e-117
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TBL1X,F-box-like/WD repeat-containing protein TBL1X,28797,0.138182811585266,0.00598249986001166,0.126457111859644,0.149908511310889,5.6478740337519e-117
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADD1,Alpha-adducin,24381,0.114088876169515,0.00493530559595675,0.104415677201439,0.12376207513759,5.68444283586393e-117
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GPRC5C,G-protein coupled receptor family C group 5 member C,24793,0.0928665433900034,0.00401963075055015,0.0849880671189251,0.100745019661082,7.38260419523758e-117
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FMNL1,Formin-like protein 1,28774,0.0998083460102979,0.00432831867019661,0.0913248414167125,0.108291850603883,1.35482197325363e-116
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CTSZ,Cathepsin Z,29487,0.0511497656692715,0.00222587545327056,0.0467870497808612,0.0555124815576818,7.78719933580803e-116
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FARSA,Phenylalanine--tRNA ligase alpha subunit,24195,0.111955848071446,0.0048676755635822,0.102415203966825,0.121496492176067,8.18567493201158e-116
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MAX,Protein max,28774,0.170356515110073,0.00741466228609607,0.155823777029325,0.184889253190821,9.02635620424995e-116
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL18,Interleukin-18,29335,0.074485965226488,0.00324269629049958,0.0681302804971088,0.0808416499558672,9.71207032127783e-116
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD99L2,CD99 antigen-like protein 2,29443,0.0391819271652438,0.00170674871087509,0.0358366996919286,0.042527154638559,1.30130947256726e-115
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD22,B-cell receptor CD22,29786,0.067715645938828,0.00294987885305712,0.061933883386836,0.0734974084908199,1.31545924654578e-115
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TRIM58,E3 ubiquitin-protein ligase TRIM58,24793,0.139977506273235,0.00609431884385503,0.128032641339279,0.151922371207191,1.5498896032366e-115
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AP2B1,AP-2 complex subunit beta,24195,0.0789687062311946,0.00344100021611378,0.0722243458076116,0.0857130666547776,2.55395095314156e-115
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ICA1,Islet cell autoantigen 1,28931,0.128547415008435,0.00561185734009632,0.117548174621847,0.139546655395024,4.25254254997596e-115
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,24867,0.0775793479514865,0.00338941848693889,0.0709360877170863,0.0842226081858867,9.26257688131525e-115
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IMPACT,Protein IMPACT,24845,0.0899026539076914,0.00392865530516407,0.0822024895095698,0.0976028183058129,1.03568665678755e-114
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,YJU2,Splicing factor YJU2,24793,0.0523450989148461,0.00229045117104696,0.0478558146195941,0.0568343832100981,2.05127512384108e-114
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",24209,0.128725372341918,0.00563273509573938,0.117685211554269,0.139765533129567,2.21505031902927e-114
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MAVS,Mitochondrial antiviral-signaling protein,28797,0.147112983473518,0.00647097010200648,0.134429882073585,0.15979608487345,2.05034386575984e-113
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,29478,0.133031302764707,0.00586966618390522,0.121526757044252,0.144535848485161,9.32114421659148e-113
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IRAK4,Interleukin-1 receptor-associated kinase 4,29434,0.166840870194311,0.00736220338206058,0.152410951565472,0.181270788823149,9.86422937415802e-113
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCL3,C-C motif chemokine 3,29434,0.0966537610446825,0.00426888910381772,0.0882867384011998,0.105020783688165,1.55418030401368e-112
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ANXA11,Annexin A11,29373,0.106629129038325,0.00471093496092045,0.0973956965149214,0.11586256156173,1.82672887298149e-112
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MOCS2,Molybdopterin synthase catalytic subunit,24381,0.107381662265435,0.00474320905594917,0.0980849725157742,0.116678352015095,2.57923322880405e-112
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRSS2,Trypsin-2,29594,0.0852944234085047,0.00377304623612418,0.0778992527857013,0.0926895940313081,3.36371056228713e-112
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,28787,0.125035570403621,0.00553645120934979,0.114184126033296,0.135887014773947,5.8548096317825e-112
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SCGB3A2,Secretoglobin family 3A member 2,29536,-0.13038912871464,0.00577838331661757,-0.141714760015211,-0.11906349741407,8.45917495974804e-112
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DOK1,Docking protein 1,24845,0.217551114045887,0.00963563336351134,0.198665272653405,0.23643695543837,9.56445479763183e-112
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GLOD4,Glyoxalase domain-containing protein 4,29408,0.0563534708258346,0.00249910293337137,0.0514552290764267,0.0612517125752425,1.20503723563208e-111
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LGALS1,Galectin-1,29478,0.0543386846706757,0.00241680682175696,0.0496017433000321,0.0590756260413193,5.16037644307428e-111
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,29218,0.12421006766852,0.00552490847742201,0.113381247052773,0.135038888284267,5.47733229864374e-111
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CHMP1A,Charged multivesicular body protein 1a,29218,0.125671372422492,0.0055923820155459,0.114710303672022,0.136632441172962,6.82650895342333e-111
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,APOD,Apolipoprotein D,23787,-0.06898372947995,0.00307278089899368,-0.0750063800419776,-0.0629610789179224,1.804179878445e-110
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SDC4,Syndecan-4,29478,0.0731980385997831,0.00326783453669041,0.0667930829078699,0.0796029942916963,3.3135871625737e-110
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SPRY2,Protein sprouty homolog 2,28931,0.145967041166515,0.00651919144737384,0.133189425929663,0.158744656403368,4.22281271262382e-110
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NT5C1A,Cytosolic 5'-nucleotidase 1A,24845,0.0496468547826475,0.0022173420694681,0.04530086432649,0.0539928452388049,6.00736691441243e-110
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TRIM40,E3 ubiquitin ligase TRIM40,24195,0.114159592717491,0.00510417252008764,0.104155414578119,0.124163770856863,1.0954008401053e-109
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ESM1,Endothelial cell-specific molecule 1,29454,-0.0540040446028801,0.00241694848575516,-0.0587412636349603,-0.0492668255708,1.13198014723557e-109
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PCDH9,Protocadherin-9,24805,0.0533311200357305,0.00238959884739214,0.0486475062948419,0.0580147337766191,2.94571042575196e-109
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TP53I3,Quinone oxidoreductase PIG3,23906,0.0840675152097918,0.00376644437459928,0.0766852842355772,0.0914497461840064,3.08406201021093e-109
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",29434,0.151026049983721,0.00677703898341935,0.137743053576219,0.164309046391222,4.14196371915115e-109
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TP53,Cellular tumor antigen p53,28797,0.068694351546481,0.00308271031752468,0.0626522393241327,0.0747364637688294,4.45151358835748e-109
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FGFBP1,Fibroblast growth factor-binding protein 1,29566,0.0515329489388862,0.00231334356407591,0.0469987955532974,0.056067102324475,4.95361253654066e-109
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCL4,C-C motif chemokine 4,29498,0.102460082178332,0.00460260389703639,0.0934389785401405,0.111481185816523,6.92668227979223e-109
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,28738,0.0915268050302652,0.0041125636525865,0.0834661802711956,0.0995874297893347,8.32427406091917e-109
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NUDC,Nuclear migration protein nudC,29786,0.0993401311453925,0.00446638916373684,0.0905860083844683,0.108094253906317,1.04425842364145e-108
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FGF19,Fibroblast growth factor 19,29581,0.12081349979941,0.005434677196504,0.110161532494262,0.131465467104558,1.36531676153341e-108
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,24867,0.124251650724056,0.00558599830968069,0.113303094037082,0.13520020741103,1.49898517772017e-108
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CETN3,Centrin-3,24805,0.121580961831134,0.00547344787338759,0.110853003999294,0.132308919662973,2.93830127118502e-108
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DLG4,Disks large homolog 4,24845,0.111109359545712,0.00500676723491163,0.101296095765285,0.120922623326139,4.630646315698e-108
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,C3,Complement C3,23779,0.072887001329703,0.00328457769821792,0.0664492290411959,0.0793247736182101,5.28586125501139e-108
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,UROD,Uroporphyrinogen decarboxylase,24381,0.108323557214608,0.00488253495266922,0.0987537887073768,0.11789332572184,5.51230423455011e-108
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RILPL2,RILP-like protein 2,24922,0.153212463991255,0.00690851909578514,0.139671766563516,0.166753161418994,6.30708186539702e-108
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VSNL1,Visinin-like protein 1,24845,0.059767552045274,0.00269514711024326,0.0544850637091972,0.0650500403813508,6.54122919847277e-108
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ATXN2L,Ataxin-2-like protein,24867,0.0753094086695835,0.00339648655583635,0.0686522950201442,0.0819665223190227,7.00645198680539e-108
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNFSF11,Tumor necrosis factor ligand superfamily member 11,29434,0.0953668416569917,0.00431117974909371,0.086916929348768,0.103816753965215,1.50310627200181e-107
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SEMA4D,Semaphorin-4D,29694,0.0467201258914002,0.00211331108774429,0.0425780361594214,0.050862215623379,1.97271602079054e-107
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CRADD,Death domain-containing protein CRADD,29163,0.118097461599677,0.00534243942220214,0.107626280332161,0.128568642867194,2.13688192833709e-107
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ESYT2,Extended synaptotagmin-2,24845,0.128435099478404,0.00580725788957239,0.117052874014842,0.139817324941966,2.39716848717791e-107
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SMOC2,SPARC-related modular calcium-binding protein 2,29581,0.0603254560292893,0.00273017227142644,0.0549743183772935,0.0656765936812851,2.56508291861399e-107
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TRIM24,Transcription intermediary factor 1-alpha,24396,0.101492944942842,0.00458982105302561,0.0924968956789117,0.110488994206772,2.71254378777624e-107
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADGRD1,Adhesion G-protein coupled receptor D1,24381,0.0606501615992526,0.00274303901176381,0.0552738051361956,0.0660265180623097,2.83979975387023e-107
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HTRA2,"Serine protease HTRA2, mitochondrial",29566,0.0952749083938549,0.00431555328428394,0.0868164239566584,0.103733392831051,3.86136862015873e-107
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RBM17,Splicing factor 45,24867,0.119176257737307,0.00539683394336779,0.108598463208307,0.129754052266308,4.97146049656334e-107
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,29497,0.0474809545827417,0.00215491679995849,0.0432573176548231,0.0517045915106604,9.95044263367441e-107
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ANKRD54,Ankyrin repeat domain-containing protein 54,28797,0.0889713919656343,0.00404036656817018,0.0810522734920208,0.0968905104392479,1.38856212910734e-106
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LPP,Lipoma-preferred partner,24111,0.103492465973329,0.00469638447478403,0.0942875524027527,0.112697379543906,1.44946645214611e-106
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NUB1,NEDD8 ultimate buster 1,29434,0.130095166789587,0.00590927765319285,0.118512982589329,0.141677350989845,1.48886516917654e-106
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,24381,0.0447877803115215,0.0020336839808279,0.0408017597090988,0.0487738009139442,1.89656056793377e-106
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNFSF12,Tumor necrosis factor ligand superfamily member 12,29786,0.0444502533711628,0.00202073241758035,0.0404896178327053,0.0484108889096202,2.1643222276596e-106
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DFFA,DNA fragmentation factor subunit alpha,29786,0.104464775054554,0.00475098016667765,0.0951528539278662,0.113776696181243,2.63380755987951e-106
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FOXJ3,Forkhead box protein J3,24229,0.0689213477808308,0.00313166717590266,0.0627832801160616,0.0750594154456,2.66839251549208e-106
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HARS1,"Histidine--tRNA ligase, cytoplasmic",29443,0.119471776236996,0.00544041312514309,0.108808566511715,0.130134985962276,4.93971620739508e-106
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GIP,Gastric inhibitory polypeptide,24240,0.0794054119935376,0.00361398939527591,0.0723219927787968,0.0864888312082784,5.82667519257943e-106
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RFC4,Replication factor C subunit 4,24793,0.0329860218641197,0.00150151185623668,0.0300430586258958,0.0359289851023436,5.91637862319969e-106
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,29218,0.0681863336702558,0.00310866262166732,0.0620933549317879,0.0742793124087238,8.75428587102204e-106
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CPB1,Carboxypeptidase B,29820,0.0911436642284738,0.00416529495449086,0.0829796861176717,0.0993076423392758,2.62324167862739e-105
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLEC4G,C-type lectin domain family 4 member G,29434,0.0513663714067744,0.00234786321881095,0.046764559497905,0.0559681833156439,2.91632584167005e-105
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KCTD5,BTB/POZ domain-containing protein KCTD5,24429,0.0680750039926395,0.00311044706008535,0.0619785277548722,0.0741714802304068,3.63155632311368e-105
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PEBP1,Phosphatidylethanolamine-binding protein 1,29443,0.088407704849725,0.00404309246298653,0.0804832436222714,0.0963321660771786,3.74035935906145e-105
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GRAP2,GRB2-related adapter protein 2,29478,0.197117971637966,0.00901884752605723,0.179441030486894,0.214794912789039,4.64278550954951e-105
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,XIAP,E3 ubiquitin-protein ligase XIAP,24229,0.0891554042399276,0.00408375227014562,0.0811512497904422,0.097159558689413,1.1853117276637e-104
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IQGAP2,Ras GTPase-activating-like protein IQGAP2,29349,0.0831836100044826,0.00381498927933649,0.075706231016983,0.0906609889919821,1.42817091363981e-104
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MED18,Mediator of RNA polymerase II transcription subunit 18,28797,0.117465439000139,0.00538707674463814,0.106906768580648,0.12802410941963,1.46112590831225e-104
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MPRIP,Myosin phosphatase Rho-interacting protein,24729,0.0682530519958642,0.00312994243496643,0.06211836482333,0.0743877391683984,1.94486583075609e-104
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD207,C-type lectin domain family 4 member K,28835,0.05938306043972,0.00272686661245269,0.0540384018793128,0.0647277190001273,2.66025504680309e-104
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,24381,0.131168226423145,0.00602188170299717,0.119365338285271,0.14297111456102,3.39798428744063e-104
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RRAS,Ras-related protein R-Ras,24195,0.201038041425857,0.00923604155132499,0.18293539998526,0.219140682866454,4.79134596554947e-104
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,28595,0.132692968146446,0.00610163316777296,0.120733767137611,0.144652169155281,5.13522640674795e-104
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NEXN,Nexilin,24951,0.105657116532319,0.00486157205847905,0.0961284352977001,0.115185797766938,9.17076463773696e-104
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KLK10,Kallikrein-10,29466,0.0612701510786656,0.00282191524093917,0.0557391972064248,0.0668011049509064,1.02419502781235e-103
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,F2,Prothrombin,24966,0.0226914966455748,0.00104555456930811,0.0206422096897309,0.0247407836014187,1.7489003111047e-103
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DRG2,Developmentally-regulated GTP-binding protein 2,29349,0.086264574916846,0.00397902010235868,0.0784656955162229,0.094063454317469,2.06410864727904e-103
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DNAJB2,DnaJ homolog subfamily B member 2,24381,0.0818416555268441,0.00378236920057323,0.0744282118937206,0.0892550991599677,7.38606332656288e-103
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD226,CD226 antigen,24229,0.0643872066921755,0.00297647774671914,0.058553310308606,0.070221103075745,8.4462525713166e-103
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,YWHAQ,14-3-3 protein theta,24381,0.112771931503076,0.00521750963473177,0.102545612619001,0.12299825038715,1.21841923127011e-102
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SPARC,SPARC,29566,0.10703781866193,0.00496226255163709,0.0973117840607216,0.116763853263139,2.1049510198551e-102
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,APOF,Apolipoprotein F,24951,-0.0381010300274593,0.00176569831311113,-0.0415617987211572,-0.0346402613337615,2.47311786784994e-102
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRKG1,cGMP-dependent protein kinase 1,24381,0.191232216162924,0.00886566697099356,0.173855508899776,0.208608923426071,3.11132046495549e-102
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,29694,-0.069654162375052,0.00323496439932267,-0.0759946925977245,-0.0633136321523796,4.75655691304624e-102
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CASP10,Caspase-10,28774,0.108635674036704,0.00504603144971075,0.0987454523952707,0.118525895678137,5.33580312796038e-102
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,OCLN,Occludin,24867,0.0667974457378407,0.00310084902574545,0.0607197816473797,0.0728751098283018,5.4350752408609e-102
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GHRL,Appetite-regulating hormone,29478,0.122671696504535,0.00570056471688385,0.111498589659443,0.133844803349627,6.27687070181888e-102
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PDGFA,Platelet-derived growth factor subunit A,29820,0.108975367792424,0.00506630071106762,0.0990454183987315,0.118905317186117,7.50248525814945e-102
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD69,Early activation antigen CD69,29344,0.133092877850433,0.00619030417830818,0.120959881660949,0.145225874039917,9.47159457363425e-102
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MGLL,Monoglyceride lipase,29536,0.131539461358778,0.00611898262759396,0.119546255408694,0.143532667308862,1.00335752977075e-101
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LRRC59,Leucine-rich repeat-containing protein 59,24922,0.0721453792634345,0.0033589279360187,0.0655618805088378,0.0787288780180311,2.05090397381423e-101
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SETMAR,Histone-lysine N-methyltransferase SETMAR,29132,0.0455425313210626,0.0021233440462079,0.0413807769904952,0.0497042856516301,2.87055703664628e-101
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SUOX,"Sulfite oxidase, mitochondrial",24867,0.094767144102523,0.00441552447826038,0.0861127161251327,0.103421572079913,2.91537262641654e-101
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CPPED1,Serine/threonine-protein phosphatase CPPED1,29694,0.0989515782012447,0.00461627174158212,0.0899036855877438,0.107999470814746,3.66185971603723e-101
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EGF,Pro-epidermal growth factor,29379,0.156055816519934,0.00728632369295333,0.141774622081745,0.170337010958122,5.43090487807921e-101
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",24445,0.0748712036708849,0.00349711582184411,0.0680168566600705,0.0817255506816994,9.21141508805695e-101
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PHLDB1,Pleckstrin homology-like domain family B member 1,24805,0.0800806693188533,0.00374155868868833,0.0727472142890241,0.0874141243486824,1.02212666193367e-100
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,24793,0.0573780607821136,0.00268085072415054,0.0521235933627786,0.0626325282014487,1.02517189365581e-100
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DDT,D-dopachrome decarboxylase,24938,0.0617152764975778,0.00288418813312429,0.0560622677566542,0.0673682852385014,1.12846622001446e-100
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PF4,Platelet factor 4,24822,0.146755240825899,0.00686525834724587,0.133299334465298,0.160211147186501,1.78353654529819e-100
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CETN2,Centrin-2,28774,0.101749821305121,0.00476659616776508,0.0924072928163017,0.111092349793941,2.53065142181897e-100
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KIFBP,KIF-binding protein,29349,0.123931318112336,0.00581194815021831,0.112539899737908,0.135322736486764,3.95757324764665e-100
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CPA1,Carboxypeptidase A1,29820,0.0914814834525843,0.00429186444708057,0.0830694291363064,0.0998935377688622,4.60002576257937e-100
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,STK24,Serine/threonine-protein kinase 24,28774,0.0930298192141206,0.00436898298997369,0.0844666125537721,0.101593025874469,7.74655251075247e-100
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",24845,0.146778978377384,0.00689343466199817,0.133267846439867,0.1602901103149,1.03701677808447e-99
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,APPL2,DCC-interacting protein 13-beta,24381,0.168496898113495,0.00791593037538298,0.152981674577744,0.184012121649245,1.24226159541001e-99
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VPS28,Vacuolar protein sorting-associated protein 28 homolog,24445,0.099968628387538,0.00470009235240093,0.0907564473768322,0.109180809398244,1.7379288010189e-99
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,28797,0.147395341756233,0.00693888036474338,0.133795136241336,0.16099554727113,2.26973000232749e-99
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SERPINE2,Glia-derived nexin,24922,0.0966482891680608,0.00454893109591521,0.087732384220067,0.105564194116055,2.71112204319975e-99
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,24240,0.115008366876563,0.00541357773488459,0.10439775451619,0.125618979236937,2.98755790094407e-99
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MAP2,Microtubule-associated protein 2,24845,0.0691832536762491,0.00326524583904216,0.0627833718317265,0.0755831355207717,9.27842382134607e-99
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AMOT,Angiomotin,24381,0.0602981078411154,0.00284623594303217,0.0547194853927724,0.0658767302894585,1.01633091090588e-98
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RILP,Rab-interacting lysosomal protein,29632,0.0888356719137614,0.00419683835691752,0.0806098687342031,0.0970614750933198,1.03150274654593e-98
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,OTUD6B,Deubiquitinase OTUD6B,24805,0.0872646348797346,0.00412575695328338,0.0791781512512992,0.0953511185081701,1.99502304900891e-98
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,28797,0.12651147054797,0.00599678435736043,0.114757773207543,0.138265167888396,4.73305779612334e-98
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TMED8,Protein TMED8,24805,0.153265414686197,0.00726489782510452,0.139026214948992,0.167504614423402,6.19392489104729e-98
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,28931,0.0814769690180695,0.00386454710201887,0.0739024566981125,0.0890514813380265,6.2023910407573e-98
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PPCDC,Phosphopantothenoylcysteine decarboxylase,29694,0.0695975628250131,0.00330182378281448,0.0631259882106967,0.0760691374393295,6.54580030723739e-98
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PLPBP,Pyridoxal phosphate homeostasis protein,29478,0.100565570750644,0.00477094565768464,0.0912145172615822,0.109916624239706,6.59338666730848e-98
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PSMG3,Proteasome assembly chaperone 3,29434,0.0749979481830527,0.00356017102753633,0.0680200129690815,0.0819758833970239,8.64858836038039e-98
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LRP11,Low-density lipoprotein receptor-related protein 11,29478,0.0536162076337688,0.00254851605553229,0.0486211161649255,0.058611299102612,1.53187116006571e-97
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PPBP,Platelet basic protein,24816,0.125707004804653,0.00597339260939105,0.113999155290246,0.137414854319059,1.82832924508286e-97
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD72,B-cell differentiation antigen CD72,24381,0.0636645397033114,0.00302560336498907,0.0577343571079328,0.06959472229869,1.99576021360363e-97
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DNM3,Dynamin-3,24867,0.0814479189719643,0.00387701089478138,0.0738489776181928,0.0890468603257358,3.88339430043075e-97
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD244,Natural killer cell receptor 2B4,29786,0.0400998473944432,0.0019106144983036,0.0363550429777681,0.0438446518111182,4.27543746525316e-97
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ATP6AP2,Renin receptor,28797,0.0601710740198235,0.00286765614025555,0.0545504679849226,0.0657916800547244,5.03839037806271e-97
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ARHGEF10,Rho guanine nucleotide exchange factor 10,24867,0.138525699793043,0.00659827827144181,0.125593074381018,0.151458325205069,5.15506560252682e-97
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ELAC1,Zinc phosphodiesterase ELAC protein 1,24867,0.126449817961019,0.00602332222151766,0.114644106406844,0.138255529515194,5.24661520077136e-97
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ATOX1,Copper transport protein ATOX1,29566,0.105551213020267,0.00503975122308819,0.0956733006230144,0.11542912541752,1.08044108819486e-96
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GPI,Glucose-6-phosphate isomerase,24951,0.0698422551445589,0.0033376945324978,0.0633003738608632,0.0763841364282545,2.1248440482501e-96
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,24922,0.0911629219678904,0.00435795574534544,0.0826213287070133,0.0997045152287674,2.43794073980254e-96
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FHIT,Bis(5'-adenosyl)-triphosphatase,28774,0.108982834614764,0.00521723698474803,0.0987570501246577,0.11920861910487,3.496937797177e-96
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MFAP5,Microfibrillar-associated protein 5,29820,0.0602204306300298,0.00288367716379499,0.0545684233889916,0.0658724378710679,3.72124843576031e-96
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ANGPT1,Angiopoietin-1,29322,0.124058990529601,0.00594082398761877,0.112414975513868,0.135703005545333,3.88178022463087e-96
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MENT,Protein MENT,24381,-0.0334568230810357,0.00160231946494758,-0.0365973692323329,-0.0303162769297384,5.61299308575451e-96
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TBCB,Tubulin-folding cofactor B,29218,0.147832155244469,0.00709537859532373,0.133925213197635,0.161739097291304,1.03781871661342e-95
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PALM2,Paralemmin-2,24845,0.0557945952576076,0.00267628794331699,0.0505490708887063,0.0610401196265089,1.05596475560491e-95
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BMPER,BMP-binding endothelial regulator protein,24381,0.0336432064151616,0.00161387251668685,0.0304800162824553,0.0368063965478678,1.12826726463032e-95
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,COMT,Catechol O-methyltransferase,28591,0.123931289180567,0.00594931080959989,0.112270639993751,0.135591938367382,1.16177630328599e-95
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TADA3,Transcriptional adapter 3,24793,0.0582865954047683,0.00279696221686159,0.0528045494597196,0.063768641349817,1.26236449142163e-95
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,24793,0.0518193038606073,0.00248962641401397,0.0469396360891399,0.0566989716320746,2.11529156654783e-95
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CTF1,Cardiotrophin-1,28916,0.123840981106963,0.00596383650073986,0.112151861565513,0.135530100648414,4.41405269419455e-95
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,STX4,Syntaxin-4,29349,0.0868959544569227,0.00418761058136224,0.0786882377174527,0.0951036711963927,5.81654251555997e-95
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ATG4A,Cysteine protease ATG4A,28797,0.0862903813684053,0.00416096541799809,0.078134889149129,0.0944458735876815,7.76679654874861e-95
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DYNLT1,Dynein light chain Tctex-type 1,24195,0.117653721192234,0.00566954342283874,0.10654141608347,0.128766026300998,7.91001679557675e-95
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ARHGAP25,Rho GTPase-activating protein 25,28797,0.0878177380055306,0.00423668492291006,0.0795138355566269,0.0961216404544343,9.55707003879934e-95
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HNMT,Histamine N-methyltransferase,29082,0.0689045547544816,0.00332580260221619,0.0623859816541378,0.0754231278548253,1.14919179940116e-94
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PARK7,Parkinson disease protein 7,29443,0.0763532412635109,0.00368572104909597,0.0691292280072828,0.083577254519739,1.17969068082355e-94
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SMAD3,Mothers against decapentaplegic homolog 3,24793,0.075163926416708,0.00362646936177421,0.0680560464676306,0.0822718063657855,1.2704189109422e-94
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MIF,Macrophage migration inhibitory factor,29386,0.0993385896572912,0.00480121181082529,0.0899282145080736,0.108748964806509,1.99907900274953e-94
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCL8,C-C motif chemokine 8,29683,0.0883598160103434,0.00427175144517105,0.0799871831778081,0.0967324488428787,2.20887017016297e-94
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CASP7,Caspase-7,24845,0.122851501602198,0.00593622624494142,0.111216498162113,0.134486505042283,2.39490014982295e-94
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNFSF14,Tumor necrosis factor ligand superfamily member 14,29218,0.0840138941464839,0.00406380185360469,0.0760488425134187,0.0919789457795491,2.83102326225344e-94
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL32,Interleukin-32,29434,-0.0636311367971454,0.00307898620923695,-0.0696659497672498,-0.0575963238270409,3.25952957444491e-94
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EHD3,EH domain-containing protein 3,24240,0.171735777922343,0.00830531102492233,0.155457368313496,0.188014187531191,3.57152443810737e-94
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TSC22D1,TSC22 domain family protein 1,24867,0.0973548079452622,0.0047091864206203,0.0881248025608464,0.106584813329678,3.73151407951599e-94
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,JAM3,Junctional adhesion molecule C,24381,0.0739926732095763,0.00358000136590964,0.0669758705323934,0.0810094758867592,4.28672851548311e-94
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ERP29,Endoplasmic reticulum resident protein 29,24381,0.173637577842591,0.00840125844799979,0.157171111284512,0.190104044400671,4.31235507894878e-94
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HPSE,Heparanase,24688,0.136940791775559,0.00663893284088376,0.123928483407427,0.149953100143691,9.72865735901063e-94
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CACYBP,Calcyclin-binding protein,24329,0.14985372843141,0.00727258434431916,0.135599463116545,0.164107993746276,1.55036279886035e-93
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PLG,Plasminogen,24421,0.0322635747535676,0.00156592948741151,0.029194352958241,0.0353327965488942,1.59793382894446e-93
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SIGLEC8,Sialic acid-binding Ig-like lectin 8,24240,0.0669062274295353,0.00324883546460228,0.0605385099189148,0.0732739449401558,1.96627500795408e-93
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RASSF2,Ras association domain-containing protein 2,28797,0.0811962039719419,0.00394993600001407,0.0734543294119143,0.0889380785319694,3.16084667163119e-93
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MDH1,"Malate dehydrogenase, cytoplasmic",24852,0.0581592021484514,0.00283003399571486,0.0526123355168503,0.0637060687800525,4.51395289351918e-93
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",24381,0.15107824634852,0.00735861742725352,0.136655356191103,0.165501136505937,6.98890714683178e-93
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FAM172A,Cotranscriptional regulator FAM172A,24240,0.0890760234872029,0.00434728676226117,0.080555341433171,0.0975967055412348,1.60953114074155e-92
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SCG2,Secretogranin-2,29559,0.0471515093649031,0.00230406374834441,0.0426355444181481,0.0516674743116581,1.95494741321595e-92
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KLK13,Kallikrein-13,28845,0.0637463955695764,0.00311519922941926,0.0576406050799147,0.0698521860592382,2.08844317167772e-92
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NACC1,Nucleus accumbens-associated protein 1,24793,0.0797730515336432,0.00389695605990531,0.0721350176562287,0.0874110854110576,2.28903043028898e-92
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PKD2,Polycystin-2,24111,0.0852352155959273,0.00417295653393004,0.0770562207894244,0.0934142104024301,5.95220421888905e-92
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCT5,T-complex protein 1 subunit epsilon,28797,0.065339532620722,0.0032024032649439,0.059062822221432,0.0716162430200121,6.99411939108304e-92
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PTP4A3,Protein tyrosine phosphatase type IVA 3,24229,0.0756494971695855,0.00370642539034951,0.0683849034045005,0.0829140909346705,8.0204996535749e-92
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,STX8,Syntaxin-8,29434,0.06966279054029,0.00341667090911448,0.0629661155584256,0.0763594655221544,9.01723222264925e-92
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LACTB2,Endoribonuclease LACTB2,29478,0.0949537984989829,0.0046584933731895,0.0858231514875315,0.104084445510434,1.01833024043426e-91
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FIS1,Mitochondrial fission 1 protein,29453,0.110859757972906,0.00544372218437463,0.100190062491532,0.121529453454281,1.47225481209802e-91
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,WDR46,WD repeat-containing protein 46,24793,0.0518924558769365,0.00254733057379488,0.0468996879522985,0.0568852238015745,1.68960835646595e-91
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,24381,0.0913575989329415,0.00448659082246671,0.0825638809209068,0.100151316944976,2.08109116341811e-91
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ECHS1,"Enoyl-CoA hydratase, mitochondrial",24240,0.139957147278647,0.00687656588414311,0.126479078145726,0.153435216411567,2.54855878023827e-91
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,THTPA,Thiamine-triphosphatase,24755,0.126685613418018,0.00623229183689726,0.1144703214177,0.138900905418337,4.09676047987589e-91
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",24805,0.148284087464524,0.00730679300850014,0.133962773167864,0.162605401761184,7.95184971928624e-91
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GGCT,Gamma-glutamylcyclotransferase,24904,0.068767518927263,0.00338916766343069,0.0621247503069388,0.0754102875475871,8.49198446485352e-91
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VASP,Vasodilator-stimulated phosphoprotein,24951,0.10406217098419,0.00512928745537406,0.0940087675716565,0.114115574396723,8.90729720892688e-91
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SPON2,Spondin-2,29311,-0.0499153727074104,0.00246324672585801,-0.0547433362900922,-0.0450874091247287,1.11863381008211e-90
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CIAPIN1,Anamorsin,29566,0.0896361648268399,0.00442515335995661,0.0809628642413249,0.0983094654123548,1.29704072434096e-90
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SERPINB1,Leukocyte elastase inhibitor,29354,0.127514017822375,0.00629767016824523,0.115170584292614,0.139857451352136,1.54560494108469e-90
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCL2,C-C motif chemokine 2,29169,0.0749757629242354,0.0037072929434843,0.0677094687550062,0.0822420570934646,2.51808260585282e-90
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,F12,Coagulation factor XII,24966,0.0594051536296347,0.00293728934219654,0.0536480665189295,0.06516224074034,3.15507970784959e-90
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,29694,0.0809674190065017,0.00400801004060972,0.0731117193269066,0.0888231186860967,3.84697000747603e-90
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SLMAP,Sarcolemmal membrane-associated protein,24805,0.118793301235818,0.00588248242397581,0.107263635684825,0.13032296678681,5.80614957612973e-90
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCL18,C-C motif chemokine 18,29166,0.100074027809644,0.00496438650880757,0.0903438302523809,0.109804225366907,9.30448235469155e-90
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EIF4E,Eukaryotic translation initiation factor 4E,24229,0.129370966745885,0.0064137631361146,0.116799990999101,0.14194194249267,9.6534725929551e-90
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MPI,Mannose-6-phosphate isomerase,29349,0.121582781827729,0.00603854152133937,0.109747240445903,0.133418323209554,1.48558623836577e-89
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BAG6,Large proline-rich protein BAG6,28916,0.0517589199228561,0.00257165431891151,0.0467184774577896,0.0567993623879227,1.76992039997839e-89
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DUSP13,Dual specificity protein phosphatase 13 isoform A,24793,0.0598492087223438,0.00297471134547047,0.0540187744852217,0.0656796429594659,2.58522058689827e-89
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FNDC1,Fibronectin type III domain-containing protein 1,24845,0.066365175306638,0.00329945829740081,0.0598982370437324,0.0728321135695436,2.86625508722981e-89
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",24922,0.125866105645126,0.00625814934553839,0.11360013292787,0.138132078362381,2.94440788136187e-89
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ABRAXAS2,BRISC complex subunit Abraxas 2,24111,0.0947623011729587,0.00471404000156197,0.0855227827698972,0.10400181957602,3.80634649002455e-89
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VAV3,Guanine nucleotide exchange factor VAV3,24101,0.141072528588804,0.00701977885887287,0.127313762025413,0.154831295152195,4.26505404303658e-89
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DTNB,Dystrobrevin beta,24752,0.0617495107585464,0.00307359871683931,0.0557252572735413,0.0677737642435514,4.61034965855995e-89
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SCRG1,Scrapie-responsive protein 1,24922,0.0390582361753704,0.00194506455863528,0.0352459096404452,0.0428705627102955,5.51585558081081e-89
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DNAJB14,DnaJ homolog subfamily B member 14,24805,0.0911406139684255,0.00454012374894847,0.0822419714204865,0.100039256516364,6.28528123359944e-89
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BIN2,Bridging integrator 2,29443,0.127514489209008,0.00635632515392365,0.115056091907317,0.139972886510698,6.36377402336535e-89
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",29349,0.0470917493651438,0.00234985768511737,0.0424860283023137,0.0516974704279738,9.65116112134875e-89
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,24922,0.12699703715413,0.00633496623004922,0.114580503343233,0.139413570965026,1.07461165504858e-88
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",29132,0.0578417780898675,0.00289206235371029,0.0521733358765953,0.0635102203031397,2.15530047299687e-88
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SERPINB6,Serpin B6,29623,0.0835760495133685,0.00418076315989011,0.0753817537199839,0.0917703453067531,2.54615826352494e-88
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PPIB,Peptidyl-prolyl cis-trans isomerase B,29467,0.134018037894443,0.0067058010283823,0.120874667878814,0.147161407910073,2.84360336752568e-88
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HSPB1,Heat shock protein beta-1,29039,0.0970402436604029,0.00485993647808582,0.0875147681633547,0.106565719157451,4.1385460518197e-88
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RNF5,E3 ubiquitin-protein ligase RNF5,24240,0.103780029815721,0.00519615836773901,0.0935955594149521,0.113964500216489,4.892969306672e-88
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PMVK,Phosphomevalonate kinase,28757,0.154657054115359,0.00775316095762801,0.139460858638408,0.16985324959231,6.19575532897189e-88
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ERMAP,Erythroid membrane-associated protein,24229,0.0630657944339891,0.00316065762347014,0.0568709054919876,0.0692606833759906,7.12857131357315e-88
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,29349,0.053600482981564,0.00268993325969708,0.0483282137925577,0.0588727521705702,9.17275605254533e-88
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,29536,0.107354968702232,0.00539163408018864,0.0967873659050627,0.117922571499402,1.2206388816643e-87
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,29573,0.156909947223594,0.00789828735422038,0.141429304009322,0.172390590437866,2.9580948766925e-87
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DIABLO,"Diablo homolog, mitochondrial",29395,0.153557159560816,0.00773641945711429,0.138393777424872,0.16872054169676,4.22264098816022e-87
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,28774,0.156718754990566,0.00790660278210253,0.141221813537645,0.172215696443487,7.42818743851707e-87
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,F11,Coagulation factor XI,24606,0.0434601262435768,0.00219227745854836,0.039163262424822,0.0477569900623315,8.7749703899912e-87
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,APP,Amyloid-beta precursor protein,29395,0.0930735395784385,0.0047022822498317,0.0838570663687683,0.102290012788109,1.24983525598902e-86
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,24805,0.0904904128077507,0.00457084186461149,0.0815315627531122,0.0994492628623892,1.46565351673021e-86
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CRYZL1,Quinone oxidoreductase-like protein 1,24240,0.128941954642572,0.00651499665730718,0.11617256119425,0.141711348090894,1.69942583460876e-86
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GP1BB,Platelet glycoprotein Ib beta chain,24111,0.0956443502517906,0.0048344271880854,0.0861688729631432,0.105119827540438,1.98586891192556e-86
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CDNF,Cerebral dopamine neurotrophic factor,29349,0.0454767456236082,0.00230143231529796,0.0409659382856241,0.0499875529615922,2.39222192548023e-86
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NARS1,"Asparagine--tRNA ligase, cytoplasmic",24867,0.0660836748391853,0.00334321166909109,0.0595309799677668,0.0726363697106039,2.66378813472574e-86
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FOXO3,Forkhead box protein O3,28797,0.13469096285865,0.00681921729091698,0.121325296968453,0.148056628748847,2.8958334079669e-86
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,REEP4,Receptor expression-enhancing protein 4,24867,0.0868253309658845,0.00439533110033779,0.0782104820092224,0.0954401799225465,3.4014500867118e-86
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TRIAP1,TP53-regulated inhibitor of apoptosis 1,29725,0.0873638989058483,0.0044268834493658,0.0786872073450913,0.0960405904666052,3.86179080339349e-86
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CERT,Ceramide transfer protein,28774,0.0855784476176092,0.00434021547639355,0.0770716252838778,0.0940852699513405,5.64242567889456e-86
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CASP2,Caspase-2,29434,0.0946095978625456,0.00479904540059907,0.0852034688773715,0.10401572684772,5.8454232215834e-86
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CEBPB,CCAAT/enhancer-binding protein beta,28916,0.05247909890157,0.00266324155842304,0.0472591454470609,0.0576990523560792,7.16609072917946e-86
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,24381,0.0841652984927915,0.00426964077291927,0.0757968025778697,0.0925337944077133,7.86310948631464e-86
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RAB33A,Ras-related protein Rab-33A,24111,0.0926856246179965,0.0047020716743769,0.0834695641362178,0.101901685099775,8.13095456847116e-86
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,C2,Complement C2,29545,0.032496329473715,0.00164991015593657,0.0292625055680793,0.0357301533793507,8.33429502726037e-86
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",24922,0.102495870269525,0.00520352726472681,0.0922969568306606,0.11269478370839,1.0207639638776e-85
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,24240,0.0669421117598153,0.00339868571736916,0.0602806877537717,0.0736035357658588,1.08346719161913e-85
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FGL1,Fibrinogen-like protein 1,24951,-0.088758208455855,0.00451064511448759,-0.0975990728802507,-0.0799173440314594,1.49977365188932e-85
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,29478,0.0880766646824868,0.00447998407400192,0.079295895897443,0.0968574334675306,1.67756499511304e-85
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,POSTN,Periostin,24938,-0.0527592737483512,0.00268238169817598,-0.0580167418767761,-0.0475018056199263,1.77657848134943e-85
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,29434,0.0849587035147847,0.00432203991738268,0.0764875052767146,0.0934299017528547,1.78016626956561e-85
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PDIA4,Protein disulfide-isomerase A4,24938,0.0844966232296152,0.00429820399338645,0.0760721434025777,0.0929211030566526,2.16679888061729e-85
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL7,Interleukin-7,29434,0.0894962163010415,0.00455590248017076,0.0805666474399068,0.0984257851621762,2.29528141414813e-85
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MAPKAPK2,MAP kinase-activated protein kinase 2,24445,0.102290826921631,0.00520651018414697,0.092086066960703,0.112495586882559,2.81032258927928e-85
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MESD,LRP chaperone MESD,29443,0.168275715606882,0.00857117506973595,0.151476212470199,0.185075218743564,2.8560767340501e-85
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,29434,0.138739008968828,0.0070675167654234,0.124886676108598,0.152591341829058,2.98368972691164e-85
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD74,HLA class II histocompatibility antigen gamma chain,29694,0.0479963668379091,0.00245125504647682,0.0431919069468146,0.0528008267290037,7.81651781466144e-85
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SCARA5,Scavenger receptor class A member 5,29694,0.0416385273227651,0.00212683259684005,0.0374699354329586,0.0458071192125716,8.22144911967679e-85
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HAVCR1,Hepatitis A virus cellular receptor 1,29683,0.0870902622196253,0.00444907675475978,0.0783700717802961,0.0958104526589545,8.6855527861547e-85
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TMEM106A,Transmembrane protein 106A,24793,0.097992043101765,0.00500305160067218,0.0881860619644475,0.107798024239082,8.83987684630741e-85
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL10RB,Interleukin-10 receptor subunit beta,29581,0.0401498776141722,0.00205298788554949,0.0361260213584952,0.0441737338698492,1.23850775207958e-84
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FAS,Tumor necrosis factor receptor superfamily member 6,29736,0.0450381136311712,0.00230629056319628,0.0405177841273065,0.0495584431350359,2.13271445182169e-84
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CEMIP2,Cell surface hyaluronidase,24229,0.0458065626477997,0.00234424192872236,0.0412118484675038,0.0504012768280955,2.24141343574072e-84
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,28797,0.0899993212255046,0.00462225209779078,0.0809397071138347,0.0990589353371745,6.72793114874855e-84
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,29218,0.129550511743642,0.00665414735865456,0.116508382920679,0.142592640566605,6.83518276065559e-84
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CTSS,Cathepsin S,23389,0.0336710124948602,0.00172849811171151,0.0302831561959057,0.0370588687938148,7.51770304453459e-84
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TBC1D5,TBC1 domain family member 5,29434,0.107425617308438,0.00552344892357917,0.0965996574182229,0.118251577198653,9.9826897590018e-84
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BPIFB2,BPI fold-containing family B member 2,24852,0.0892080520145469,0.00459099630035615,0.0802096992658489,0.098206404763245,1.7571689884455e-83
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BCL2L1,Bcl-2-like protein 1,24845,0.136897217424433,0.00704769210402213,0.123083740900549,0.150710693948316,1.99840475917092e-83
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LARP1,La-related protein 1,24793,0.0859628956175573,0.00444524486575314,0.0772502156806812,0.0946755755544335,1.04443321830942e-82
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TXNDC9,Thioredoxin domain-containing protein 9,24845,0.0728504332316229,0.00376789075575129,0.0654653673503504,0.0802354991128954,1.11614412095634e-82
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VPS4B,Vacuolar protein sorting-associated protein 4B,24793,0.128873559571635,0.00667902920554864,0.11578266232876,0.14196445681451,2.36870131998387e-82
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NFASC,Neurofascin,29786,0.038610284212537,0.00200383970511539,0.0346827583905108,0.0425378100345631,3.15292700136286e-82
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MYO9B,Unconventional myosin-IXb,28931,0.0900596872149936,0.00467364663170908,0.0808993398168438,0.0992200346131434,3.16746682975506e-82
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,24229,0.0665935357724508,0.00346005127759918,0.0598118352683564,0.0733752362765452,6.19731083699957e-82
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PPP3R1,Calcineurin subunit B type 1,29218,0.0555442353699804,0.00289368820277865,0.0498726064925342,0.0612158642474265,1.29908292329384e-81
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SUGT1,Protein SGT1 homolog,28797,0.109497601715514,0.00570527530050915,0.0983152621265161,0.120679941304512,1.388505534437e-81
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AIF1,Allograft inflammatory factor 1,28797,0.0712283068579631,0.00371310730620065,0.0639506165378098,0.0785059971781164,1.66013028259421e-81
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DBI,Acyl-CoA-binding protein,29329,0.106173466932114,0.00554032340545066,0.0953144330574309,0.117032500806797,2.33916141240577e-81
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MSTN,Growth/differentiation factor 8,28916,0.0711929817182812,0.00371989542405678,0.06390198668713,0.0784839767494325,3.84346692444101e-81
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CXCL16,C-X-C motif chemokine 16,29786,0.0318574802164833,0.00166566207384991,0.0285927825517375,0.0351221778812291,4.70303987362251e-81
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",24922,0.101597234285441,0.00531036742687169,0.0911889141287721,0.112005554442109,5.22976750897319e-81
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,JPT2,Jupiter microtubule associated homolog 2,24805,0.118594720679719,0.00620221922764442,0.106438370993536,0.130751070365902,6.42127365460401e-81
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,29349,0.127091787161471,0.00665183340258405,0.114054193692406,0.140129380630535,6.94786931532431e-81
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GNPDA2,Glucosamine-6-phosphate isomerase 2,24381,0.0499133438142038,0.00261211593206843,0.0447935965873497,0.0550330910410579,8.39066783647544e-81
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ANXA3,Annexin A3,29640,0.0940248108711978,0.00492562126476203,0.0843705931922642,0.103679028550131,9.54202118587906e-81
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DNAJC9,DnaJ homolog subfamily C member 9,24805,0.103093146907239,0.00539917913540394,0.0925107558018475,0.113675538012631,1.07135415519207e-80
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SERPINB9,Serpin B9,29218,0.0447619739764152,0.00234638422895917,0.0401630608876552,0.0493608870651752,1.21467714498603e-80
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,28797,0.091105034728261,0.00477570110495871,0.081744660562542,0.10046540889398,1.23975098100525e-80
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ACYP1,Acylphosphatase-1,24297,0.088624626857685,0.00464413620968104,0.0795221198867102,0.0977271338286598,1.35789035923906e-80
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CTRB1,Chymotrypsinogen B,29443,0.0749024633067358,0.00393472213606803,0.0671904079200425,0.0826145186934292,2.59760631805519e-80
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,28797,0.0780477580661327,0.00410010038512916,0.0700115613112796,0.0860839548209859,2.69837117840097e-80
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NBN,Nibrin,28931,0.0706501924778405,0.00371350274018005,0.0633717271070876,0.0779286578485934,3.26285668296588e-80
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MICALL2,MICAL-like protein 2,24195,0.0921414040492715,0.00484090400708921,0.0826532321953766,0.101629575903166,3.44843381930182e-80
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GMFG,Glia maturation factor gamma,24922,0.0966163016652568,0.00507789659125105,0.0866636243464047,0.106568978984109,3.78944114161206e-80
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ASRGL1,Isoaspartyl peptidase/L-asparaginase,24240,0.137554243564039,0.00723981182640051,0.123364212384294,0.151744274743784,6.54368932352551e-80
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,24793,0.144913713089598,0.0076294643046497,0.129959963052485,0.159867463126711,7.07608425143578e-80
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DXO,Decapping and exoribonuclease protein,24845,0.0612086706143436,0.00322454369110835,0.0548885649797713,0.067528776248916,8.81259167504026e-80
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CALCA,Calcitonin,29163,0.0833026817462861,0.00439277953615694,0.0746928338554185,0.0919125296371536,1.03183167616028e-79
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,24381,0.0565710924563099,0.00298177009851306,0.0507268230632243,0.0624153618493955,1.08536606648584e-79
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,29561,-0.0419415418795718,0.00221245443554169,-0.0462779525732335,-0.0376051311859101,1.14931949653981e-79
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,24701,0.0407086771327602,0.00214856192186789,0.0364974957658991,0.0449198584996212,1.71681590468237e-79
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,24922,0.0537096500926782,0.0028350949676515,0.0481528639560812,0.0592664362292751,1.7744605578003e-79
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PDAP1,28 kDa heat- and acid-stable phosphoprotein,24922,0.13135902447695,0.00693782610000656,0.117760885320937,0.144957163632963,2.17307960738007e-79
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,F2R,Proteinase-activated receptor 1,29536,0.0766504899619063,0.0040530421446264,0.0687065273584385,0.084594452565374,2.68475426607657e-79
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RELT,Tumor necrosis factor receptor superfamily member 19L,29443,0.0383706973772047,0.00202938734179819,0.0343930981872803,0.0423482965671292,2.92060588130772e-79
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GET3,ATPase GET3,24922,0.0737322704825012,0.0039014343036524,0.0660854592473425,0.0813790817176599,4.18018660227934e-79
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EDAR,Tumor necrosis factor receptor superfamily member EDAR,29434,0.122501670644703,0.00648920441752792,0.109782829986348,0.135220511303057,5.09999220406273e-79
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SOD1,Superoxide dismutase [Cu-Zn],28826,0.0643584063657721,0.00341323269610083,0.0576684702814145,0.0710483424501298,7.89931047035513e-79
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SPINT2,Kunitz-type protease inhibitor 2,29581,0.0543638483424295,0.00288516016088995,0.0487089344270852,0.0600187622577738,9.79171027499646e-79
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BOLA2_BOLA2B,BolA-like protein 2,24240,0.0729277149091074,0.00386836782051903,0.0653457139808901,0.0805097158373247,1.030020823214e-78
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LEPR,Leptin receptor,29478,-0.0413908329185522,0.00219725472373434,-0.0456974521770715,-0.0370842136600329,1.08003045141698e-78
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD164,Sialomucin core protein 24,29443,0.0356620244780659,0.00189374155145016,0.0319502910372236,0.0393737579189083,1.20963733068748e-78
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CASP3,Caspase-3,29820,0.117097037668509,0.00621944410061117,0.104906927231311,0.129287148105707,1.28470018038271e-78
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL12A_IL12B,Interleukin-12,29349,0.103320921862187,0.00548881003204975,0.0925628541993699,0.114078989525005,1.39851525102046e-78
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TBCA,Tubulin-specific chaperone A,24381,0.114049600420108,0.00606314018720099,0.102165845653194,0.125933355187022,2.23434681031279e-78
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,STXBP1,Syntaxin-binding protein 1,24867,0.10318925225761,0.00548807711073404,0.0924326211205714,0.113945883394649,2.52345995795614e-78
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TTF2,Transcription termination factor 2,24195,0.0652416599064295,0.00347715003726721,0.0584264458333858,0.0720568739794733,5.43525105822273e-78
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NUDT16,U8 snoRNA-decapping enzyme,24769,0.115870039763955,0.00619223489175495,0.103733259376116,0.128006820151795,1.35329762780436e-77
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DTD1,D-aminoacyl-tRNA deacylase 1,24381,0.115464707929792,0.00617637977439844,0.103359003571971,0.127570412287612,1.9103320043766e-77
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KITLG,Kit ligand,29478,-0.0492676013082987,0.00263895187763212,-0.0544399469884576,-0.0440952556281397,2.45766003289267e-77
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LAP3,Cytosol aminopeptidase,28931,0.0642523707839099,0.00344147652192117,0.0575070768009444,0.0709976647668754,2.47703324658697e-77
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AGXT,Serine--pyruvate aminotransferase,29478,0.101729844344139,0.00545268090059044,0.0910425897789819,0.112417098909296,3.09889471278502e-77
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NPDC1,Neural proliferation differentiation and control protein 1,29478,0.0422726783465244,0.00226672190602482,0.0378299034107158,0.0467154532823331,3.56589647321517e-77
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TSNAX,Translin-associated protein X,24111,0.0519786393779078,0.00278744215114691,0.0465152527616599,0.0574420259941558,4.62275780063278e-77
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VASH1,Tubulinyl-Tyr carboxypeptidase 1,29434,0.107780553346079,0.00578446939111765,0.0964429933394886,0.11911811335267,4.84511939013985e-77
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PQBP1,Polyglutamine-binding protein 1,28797,0.0734641434314563,0.00394487192475255,0.0657321944589413,0.0811960924039713,5.96535780321178e-77
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CRYBB1,Beta-crystallin B1,24922,0.0861039166475977,0.00462363701547564,0.0770415880972655,0.09516624519793,7.02359205887546e-77
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BAP18,Chromatin complexes subunit BAP18,24845,0.0874205977570545,0.00469475862934912,0.0782188708435302,0.0966223246705788,7.26821775505857e-77
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BLMH,Bleomycin hydrolase,29820,0.0417353393889642,0.00224953238239103,0.0373262559194778,0.0461444228584506,2.08362593347135e-76
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PNMA1,Paraneoplastic antigen Ma1,24240,0.0741608328847224,0.00400231768828402,0.0663162902156857,0.0820053755537591,4.01447677132996e-76
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RP2,Protein XRP2,29349,0.0548086670651987,0.00296028055531702,0.0490065171767774,0.0606108169536201,4.27121013749304e-76
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GBP1,Guanylate-binding protein 1,24816,0.084644250954412,0.00457407513290881,0.0756790636939107,0.0936094382149132,6.08797400317297e-76
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DCTD,Deoxycytidylate deaminase,24381,0.12435281670595,0.00672086368551547,0.11117992388234,0.137525709529561,6.53235801209315e-76
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CFB,Complement factor B,24538,0.0430020077021828,0.00232529735615644,0.0384444248841162,0.0475595905202495,7.69713994045732e-76
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SCARF1,Scavenger receptor class F member 1,29820,0.0553469114551594,0.00299720741217441,0.0494723849272975,0.0612214379830212,1.0235960951257e-75
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BGLAP,Osteocalcin,24938,0.115888987327734,0.00627499439582395,0.103589998311919,0.128187976343549,1.18735738600727e-75
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CDC37,Hsp90 co-chaperone Cdc37,29566,0.109131104838767,0.00591260196040321,0.0975424049963763,0.120719804681157,1.21221775198018e-75
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CDCP1,CUB domain-containing protein 1,29218,0.067919389886816,0.00368175204222816,0.0607031558840488,0.0751356238895832,1.46715689361997e-75
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NRGN,Neurogranin,24951,0.119073640387179,0.0064603130783209,0.10641142675367,0.131735854020688,2.32403841661959e-75
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TIMP1,Metalloproteinase inhibitor 1,29173,0.0370068798185555,0.00200948349596206,0.0330682921664698,0.0409454674706411,2.61082346797413e-75
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,24229,0.104350405575306,0.00567074885942477,0.0932357378108334,0.115465073339779,4.15587987396548e-75
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ZNRD2,Protein ZNRD2,24805,0.0895083895858798,0.004865368584808,0.0799722671596561,0.0990445120121034,4.38813642146496e-75
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AKT2,RAC-beta serine/threonine-protein kinase,24867,0.16451911106394,0.00895238672951492,0.146972433074091,0.182065789053789,6.28682920272543e-75
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CHM,Rab proteins geranylgeranyltransferase component A 1,24195,0.0795685259229342,0.00433026582074659,0.0710812049142708,0.0880558469315975,6.74628133252076e-75
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,24867,0.129228012079978,0.00703595505735397,0.115437540167564,0.143018483992392,7.58394796537228e-75
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TMSB10,Thymosin beta-10,29443,0.0983965953340554,0.00536517988271361,0.0878808427639368,0.108912347904174,1.03861938702632e-74
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,APOC1,Apolipoprotein C-I,24914,0.0486320891269899,0.00265046820744808,0.0434371714403917,0.0538270068135882,1.05550425695458e-74
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,23721,0.0643208651303236,0.00350821560909348,0.0574447625365003,0.0711969677241468,1.4433806433214e-74
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,29655,0.039667193878683,0.00216522165447116,0.0354233594359195,0.0439110283214465,1.47568847143473e-74
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NECAP2,Adaptin ear-binding coat-associated protein 2,24111,0.0864532961424752,0.00471626081771486,0.0772094249397541,0.0956971673451964,1.50773259348037e-74
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TREH,Trehalase,24938,0.0970973845890856,0.00530581597587464,0.0866979852763713,0.1074967839018,2.53200213953656e-74
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RNASEH2A,Ribonuclease H2 subunit A,24867,0.0629747891214564,0.00345046603896895,0.0562118756850772,0.0697377025578355,6.17152149657782e-74
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MRI1,Methylthioribose-1-phosphate isomerase,24195,0.0880247315815945,0.00482449679472263,0.0785687178639382,0.0974807452992509,7.05666834544999e-74
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,APOA1,Apolipoprotein A-I,24966,-0.0354822001196421,0.00194562155100296,-0.0392956183596079,-0.0316687818796763,7.93314502894168e-74
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,XCL1,Lymphotactin,29725,0.0714255500829171,0.00392490328665692,0.0637327396410695,0.0791183605247646,1.34423859704881e-73
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MANF,Mesencephalic astrocyte-derived neurotrophic factor,29581,0.153606429979738,0.00844589567626906,0.13705247445425,0.170160385505225,1.64466909391786e-73
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,23623,0.139114371231884,0.00764606950360814,0.124128075004812,0.154100667458956,1.82275247348137e-73
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CRIM1,Cysteine-rich motor neuron 1 protein,29581,-0.0262876538566728,0.00144914376398402,-0.0291279756340815,-0.0234473320792641,3.83440367210053e-73
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CXCL1,Growth-regulated alpha protein,29420,0.12212484571855,0.0067367215476213,0.108920871485212,0.135328819951888,4.77305684740513e-73
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADGRF5,Adhesion G protein-coupled receptor F5,24922,0.0365812382986693,0.00201781878665884,0.032626313476818,0.0405361631205206,5.53750303362111e-73
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SLAMF6,SLAM family member 6,28797,0.0490186666608087,0.00270923300376377,0.0437085699734317,0.0543287633481857,9.13453184085822e-73
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PCYT2,Ethanolamine-phosphate cytidylyltransferase,24805,0.0977543439468737,0.00540770849803669,0.0871552352907218,0.108353452603026,1.41957480104279e-72
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PNLIPRP1,Inactive pancreatic lipase-related protein 1,24845,0.101880991381278,0.0056411161410254,0.090824403744868,0.112937579017688,1.9009868003632e-72
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SCARB2,Lysosome membrane protein 2,28762,0.0406278773482801,0.00225165751557343,0.0362146286177562,0.045041126078804,2.2261578279618e-72
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ITGB1BP2,Integrin beta-1-binding protein 2,28916,0.141688520682283,0.00785558389722952,0.126291576243713,0.157085465120852,2.50552930039985e-72
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,24229,0.0570511669149102,0.00316593591227459,0.050845932526852,0.0632564013029683,3.9971597196941e-72
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LTBP2,Latent-transforming growth factor beta-binding protein 2,29820,-0.040558106734037,0.00225267844343912,-0.0449733564831777,-0.0361428569848963,4.34054517412031e-72
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FEN1,Flap endonuclease 1,28797,0.0801597763022154,0.00445950106768534,0.0714191542095521,0.0889003983948787,7.55771362986566e-72
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GRPEL1,"GrpE protein homolog 1, mitochondrial",29349,0.0767389148021085,0.00428177627117834,0.068346633310599,0.0851311962936181,1.90420075442069e-71
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ARL13B,ADP-ribosylation factor-like protein 13B,24111,0.0877306823369573,0.00490442696594678,0.0781180054837016,0.097343359190213,4.21524757098311e-71
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD274,Programmed cell death 1 ligand 1,29218,0.0433072349131798,0.00242339727389164,0.0385573762563522,0.0480570935700074,4.79183675773765e-71
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MSR1,Macrophage scavenger receptor types I and II,29694,0.0580383712151937,0.0032494247407563,0.0516694987233114,0.0644072437070761,5.57714690001559e-71
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PECAM1,Platelet endothelial cell adhesion molecule,29443,0.037982164190115,0.00212903921820517,0.0338092473224329,0.0421550810577972,8.15982142968598e-71
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,24229,0.0707162414939909,0.00396901027126058,0.0629369813623201,0.0784955016256616,1.47007122937222e-70
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DPT,Dermatopontin,29820,0.0332061337548512,0.00186506830466146,0.0295505998777147,0.0368616676319876,1.52072310030939e-70
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CXCL11,C-X-C motif chemokine 11,29694,0.0991004214767193,0.00557292061621404,0.0881774970689398,0.110023345884499,2.24095517081745e-70
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IFT20,Intraflagellar transport protein 20 homolog,24195,0.054606004851296,0.00306933916321342,0.0485901000913977,0.0606219096111943,2.34036880052219e-70
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AKT3,RAC-gamma serine/threonine-protein kinase,28662,0.0725589601169218,0.0040805398197132,0.0645611020702839,0.0805568181635597,2.34170745395747e-70
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADAMTSL2,ADAMTS-like protein 2,24938,0.0414272064604029,0.00232965928231556,0.0368610742670644,0.0459933386537414,2.62669999133867e-70
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GGACT,Gamma-glutamylaminecyclotransferase,24922,0.0892621808820275,0.00501981251549054,0.079423348351666,0.0991010134123889,2.6535999128066e-70
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLEC3B,Tetranectin,24381,0.0269517740133285,0.00151677760806629,0.0239788899015186,0.0299246581251384,3.40277125915341e-70
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KLRB1,Killer cell lectin-like receptor subfamily B member 1,29786,0.0476255824561526,0.00268780538683562,0.0423574838979548,0.0528936810143504,6.82595691464216e-70
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCS,Copper chaperone for superoxide dismutase,29218,0.0594294643941825,0.00335657399773291,0.052850579358626,0.066008349429739,8.83079261925337e-70
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BLNK,B-cell linker protein,24229,0.0500391627889242,0.00282694031459333,0.0444983597723213,0.0555799658055271,1.13604503690807e-69
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LGALS3BP,Galectin-3-binding protein,24966,0.0380516785899629,0.00215004613517991,0.0338375881650103,0.0422657690149156,1.15727178706364e-69
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BMP6,Bone morphogenetic protein 6,28884,0.0515970081855507,0.00292008966155746,0.0458736324488981,0.0573203839222033,1.66940489885032e-69
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,28797,0.0747291385904489,0.00423277665410435,0.0664328963484044,0.0830253808324934,2.16901985425231e-69
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MCEMP1,Mast cell-expressed membrane protein 1,24229,0.113278482001356,0.00641312529515919,0.100708756422844,0.125848207579868,2.1824604694609e-69
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CTSL,Cathepsin L1,29478,0.0304108215749171,0.00172318306130858,0.0270333827747523,0.0337882603750819,2.39764995544131e-69
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LONP1,"Lon protease homolog, mitochondrial",24240,0.108835397883845,0.00617257394449617,0.0967371529526321,0.120933642815057,3.77968324163724e-69
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CEP170,Centrosomal protein of 170 kDa,24240,0.0964450315967224,0.0054699622338014,0.0857239056184717,0.107166157574973,3.8020895064988e-69
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PAGR1,PAXIP1-associated glutamate-rich protein 1,24240,0.0544658123340579,0.00308942468016887,0.0484105399609269,0.0605210847071889,3.9369280472845e-69
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PLA2G4A,Cytosolic phospholipase A2,29581,0.10899736474468,0.00619218472835527,0.0968606826771036,0.121134046812256,5.3136349719866e-69
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ARSA,Arylsulfatase A,29443,0.0557447847532069,0.00316919405831245,0.0495331643989145,0.0619564051074993,6.67381991905889e-69
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KLF4,Krueppel-like factor 4,24101,0.0495777535689707,0.00281760221795098,0.0440552532217867,0.0551002539161546,7.16923251779524e-69
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ICAM1,Intercellular adhesion molecule 1,29391,0.0358606656861152,0.00204035699549095,0.031861565974953,0.0398597653972775,8.51794276145018e-69
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KLRD1,Natural killer cells antigen CD94,29786,0.0575964653730208,0.00328305902197596,0.0511616696899479,0.0640312610560937,1.47605614900195e-68
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SH3BP1,SH3 domain-binding protein 1,24805,0.0595646348793904,0.0033947163473465,0.0529109908385913,0.0662182789201896,1.64899704020698e-68
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EGFL7,Epidermal growth factor-like protein 7,28797,0.0492064508905431,0.00280613909240982,0.0437064182694198,0.0547064835116663,1.75092594484401e-68
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RAB10,Ras-related protein Rab-10,24922,0.0664378889554656,0.00379165263802703,0.0590062497849327,0.0738695281259986,2.49689767380182e-68
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ING1,Inhibitor of growth protein 1,28719,0.0569709112869331,0.00325606225714416,0.0505890292629305,0.0633527933109356,3.42198817683581e-68
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SNRPB2,U2 small nuclear ribonucleoprotein B'',24845,0.0517151097497147,0.00295509210353476,0.0459231292267866,0.0575070902726428,3.6561050677262e-68
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LTBP3,Latent-transforming growth factor beta-binding protein 3,28797,0.0666207142538046,0.0038101859778318,0.0591527497372543,0.0740886787703549,4.20369460520863e-68
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SEPTIN9,Septin-9,29349,0.0350567419381922,0.00200991709409799,0.0311173044337602,0.0389961794426243,8.72907351086906e-68
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MMP7,Matrilysin,28870,0.06166828966797,0.0035356144020808,0.0547384854398917,0.0685980938960484,8.82114601741414e-68
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ABHD14B,Protein ABHD14B,29121,0.0707409671978396,0.00405633463230723,0.0627905513185174,0.0786913830771617,9.13276490515666e-68
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NID1,Nidogen-1,29518,0.0467742044318008,0.00268435364807587,0.0415128712815721,0.0520355375820295,1.16898576265486e-67
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,24190,0.0443238084815567,0.00254279862767602,0.0393399231713117,0.0493076937918017,1.24238979794436e-67
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GP5,Platelet glycoprotein V,24381,0.0445944761308209,0.00256299586267488,0.0395710042399781,0.0496179480216636,2.13330189086027e-67
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CPXM2,Inactive carboxypeptidase-like protein X2,24922,0.0311779350120143,0.00179244890514155,0.0276647351579368,0.0346911348660917,2.29111451474003e-67
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,24240,0.0652980115303621,0.00375458869353291,0.0579390176910376,0.0726570053696866,2.45498092491441e-67
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IMMT,MICOS complex subunit MIC60,24793,0.0547208729974038,0.00315280686243106,0.0485413715470389,0.0609003744477687,4.41430990969288e-67
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SMTN,Smoothelin,24776,0.116178593378583,0.00669588232567724,0.103054664020255,0.12930252273691,4.85436934767177e-67
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TST,Thiosulfate sulfurtransferase,28706,0.0926217344775676,0.00535496675849934,0.0821259996309089,0.103117469324226,1.09159217794517e-66
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ZHX2,Zinc fingers and homeoboxes protein 2,24845,0.0389691710083528,0.00225370603055787,0.0345519071884594,0.0433864348282462,1.34739883075792e-66
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,INPP1,Inositol polyphosphate 1-phosphatase,29349,0.0652687851567537,0.00378811953645273,0.0578440708653063,0.072693499448201,3.35952220697869e-66
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PTX3,Pentraxin-related protein PTX3,29434,-0.0602979276166792,0.0035030433593942,-0.0671638926010918,-0.0534319626322665,4.47240781718145e-66
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,29594,0.0512334337826899,0.0029799910874791,0.0453926512512309,0.0570742163141489,6.32696628040975e-66
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GIPC3,PDZ domain-containing protein GIPC3,24805,0.119669999946813,0.00695867822462287,0.106030990626552,0.133309009267073,6.72161911367683e-66
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EPPK1,Epiplakin,24240,0.0898438888278253,0.00522958546425883,0.079593901317878,0.100093876337773,9.21265697339297e-66
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",24240,0.0553302125631889,0.00322105035207201,0.0490169538731277,0.06164347125325,9.56972536463621e-66
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BDNF,Brain-derived neurotrophic factor,24938,0.101122339547646,0.00589105976117042,0.0895758624157516,0.11266881667954,1.15092873494698e-65
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,29434,0.146006753741087,0.00852022860212186,0.129307105680928,0.162706401801246,1.65043932738275e-65
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PTPRM,Receptor-type tyrosine-protein phosphatase mu,29398,0.0296300793431079,0.00173064370246332,0.0262380176862798,0.033022140999936,2.15561367566849e-65
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NADK,NAD kinase,29478,0.0653837629081656,0.00382780232448196,0.0578812703521809,0.0728862554641502,4.21353656337574e-65
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GP6,Platelet glycoprotein VI,29400,0.10624390062436,0.00622571600576444,0.094041497253062,0.118446303995659,5.53317730330834e-65
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,28774,0.0773758191934546,0.00453755067723673,0.0684822198660706,0.0862694185208386,7.00509313399953e-65
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GGH,Gamma-glutamyl hydrolase,28984,0.0411364931297897,0.00241391181252013,0.0364052259772503,0.0458677602823292,8.38194195636136e-65
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GLO1,Lactoylglutathione lyase,28916,0.0698157463338597,0.00410054565326183,0.0617786768534665,0.0778528158142528,1.09066298983303e-64
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NPC2,NPC intracellular cholesterol transporter 2,24609,0.0385085215191369,0.0022613420590639,0.0340762910833717,0.0429407519549021,1.17457471434977e-64
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TPK1,Thiamin pyrophosphokinase 1,24922,0.0332174168713429,0.00195201462580109,0.0293914682047727,0.037043365537913,1.42470901482418e-64
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ITPA,Inosine triphosphate pyrophosphatase,24111,0.0813325808874024,0.00478440189242975,0.0719551531782401,0.0907100085965648,1.96704954471635e-64
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CSTB,Cystatin-B,29030,0.0510999058321747,0.00301203227669684,0.0451963225698489,0.0570034890945005,3.03143207925644e-64
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DBN1,Drebrin,24229,0.0617653148375913,0.00363936541548603,0.0546321586232387,0.0688984710519439,3.14328876324683e-64
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,C1R,Complement C1r subcomponent,24966,0.0233232061909653,0.00137494501689433,0.0206283139578524,0.0260180984240782,3.53345354902249e-64
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TCOF1,Treacle protein,24922,0.03758817685577,0.0022181507316451,0.0332406014217456,0.0419357522897944,4.73229195866419e-64
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LAMP1,Lysosome-associated membrane glycoprotein 1,24256,0.0338778324473033,0.00199997270142353,0.0299578859525132,0.0377977789420934,5.4059780526588e-64
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,OPLAH,5-oxoprolinase,24240,0.0823660203686224,0.0048673816796904,0.0728259522764292,0.0919060884608155,7.20899445045879e-64
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCL24,C-C motif chemokine 24,29536,0.0991157025052586,0.00586315211298303,0.0876239243638119,0.110607480646705,8.2777734034087e-64
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,29536,0.0610793569078205,0.00361394194381796,0.0539960306979373,0.0681626831177037,8.82563710812799e-64
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GLRX,Glutaredoxin-1,29291,0.067044533996409,0.00397324817148623,0.059256967580296,0.074832100412522,1.39762118053453e-63
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FADD,FAS-associated death domain protein,29478,0.0911348473547843,0.00540183800600454,0.0805472448630154,0.101722449846553,1.4609924387371e-63
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SWAP70,Switch-associated protein 70,24805,0.0427949345552502,0.00253951523141905,0.0378174847016689,0.0477723844088315,2.30115865993231e-63
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD83,CD83 antigen,29434,0.0405763169293601,0.00240983613547282,0.0358530381038334,0.0452995957548868,2.55436408531038e-63
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MGMT,Methylated-DNA--protein-cysteine methyltransferase,29434,0.144571609153633,0.0085945699076343,0.12772625213467,0.161416966172596,3.36726732775422e-63
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SDHB,Succinate dehydrogenase,24805,0.0820378852487611,0.00487591524889906,0.0724810913609189,0.0915946791366032,3.58216235697793e-63
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TREM2,Triggering receptor expressed on myeloid cells 2,29454,0.0619329654694962,0.00368300670602814,0.054714272325681,0.0691516586133113,3.68382915792564e-63
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FAM3C,Protein FAM3C,29433,0.0357101662371042,0.0021247863394605,0.0315455850117616,0.0398747474624467,4.31223385087946e-63
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL12B,Interleukin-12 subunit beta,29786,0.0647958710468547,0.00385563506385168,0.0572388263217054,0.072352915772004,4.34815180085572e-63
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CDC26,Anaphase-promoting complex subunit CDC26,24764,0.0836330614590885,0.00497823954107535,0.0738757119585808,0.0933904109595962,5.47929562589139e-63
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CARHSP1,Calcium-regulated heat-stable protein 1,28774,0.0609517893783814,0.00363406418977176,0.0538290235664287,0.068074555190334,7.73915313606547e-63
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CPA2,Carboxypeptidase A2,29577,0.0773390561343278,0.00461961132235175,0.0682846179425184,0.0863934943261372,1.27073430446773e-62
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FGR,Tyrosine-protein kinase Fgr,28774,0.0672128449646355,0.00402351849199013,0.0593267487203348,0.0750989412089361,2.37318680489887e-62
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BAG3,BAG family molecular chaperone regulator 3,29169,0.0474053307744126,0.00283863530356837,0.0418416055794186,0.0529690559694066,2.55305582176538e-62
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCDC80,Coiled-coil domain-containing protein 80,29478,0.0416386885785262,0.00249464083191559,0.0367491925479717,0.0465281846090808,2.93344700140241e-62
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNF,Tumor necrosis factor,28868,0.0451337778809825,0.00270863995262797,0.0398248435738317,0.0504427121881334,4.75972839860919e-62
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRDX5,"Peroxiredoxin-5, mitochondrial",29786,0.0797859518161383,0.00480537799897351,0.0703674109381502,0.0892044926941264,1.24597863806013e-61
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,24845,0.101650304751761,0.0061251080116759,0.0896450930488764,0.113655516454646,1.60728488254173e-61
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KLB,Beta-klotho,28774,-0.0869818729376375,0.00524908239157922,-0.0972700744251328,-0.0766936714501423,2.18099802009892e-61
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DTX3,Probable E3 ubiquitin-protein ligase DTX3,29349,0.0283457964692084,0.0017120455218234,0.0249901872464346,0.0317014056919823,2.72012691643688e-61
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CYB5R2,NADH-cytochrome b5 reductase 2,24523,0.0654931914094176,0.0039566267832019,0.0577382029143419,0.0732481799044933,3.28723353840595e-61
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FXYD5,FXYD domain-containing ion transport regulator 5,28931,0.0769685348260596,0.00465231995705311,0.0678499877102355,0.0860870819418837,3.37581515623821e-61
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FCN1,Ficolin-1,24919,0.0657010542261648,0.00397014698054721,0.0579195661442923,0.0734825423080374,3.46912358213901e-61
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RAD23B,UV excision repair protein RAD23 homolog B,28797,0.0550214328805735,0.00332817988156405,0.0484982003127079,0.061544665448439,4.13330236121656e-61
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AK2,"Adenylate kinase 2, mitochondrial",24845,0.124348042373605,0.00752075079741874,0.109607370810664,0.139088713936546,4.43173899771833e-61
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NFAT5,Nuclear factor of activated T-cells 5,24229,0.101257056354653,0.00612682397562031,0.089248481362437,0.113265631346869,5.07890221536988e-61
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FRMD4B,FERM domain-containing protein 4B,24111,0.0823397512526734,0.00498234761780701,0.0725743499217716,0.0921051525835751,5.14387013331149e-61
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EFNA4,Ephrin-A4,29169,0.0359697185985148,0.00217827069914113,0.0317003080281982,0.0402391291688314,5.60298235253371e-61
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CPXM1,Probable carboxypeptidase X1,29566,0.0802120587088518,0.00486161365509817,0.0706832959448594,0.0897408214728442,6.98032173333672e-61
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DPP4,Dipeptidyl peptidase 4,28990,0.0350296324759399,0.00212400992150734,0.0308665730297855,0.0391926919220943,7.90695949247062e-61
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SNX9,Sorting nexin-9,29478,0.0797634308162691,0.00483665750115508,0.0702835821140051,0.089243279518533,7.92499914696231e-61
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AFP,Alpha-fetoprotein,29132,0.0794470244137948,0.00481809864775862,0.0700035510641879,0.0888904977634017,8.27010495230061e-61
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ANXA2,Annexin A2,23907,0.0830652884463455,0.00503736536755481,0.0731920523259381,0.0929385245667529,9.40984597040289e-61
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ITGAL,Integrin alpha-L,24229,0.0509755391807608,0.00309334136893468,0.0449125900976488,0.0570384882638727,1.10980069578238e-60
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SFRP4,Secreted frizzled-related protein 4,24381,0.0483361842894919,0.00293331147300331,0.0425868938024054,0.0540854747765784,1.11823584364383e-60
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GSR,"Glutathione reductase, mitochondrial",24867,0.026462400023944,0.00160620835458724,0.0233142316489531,0.029610568398935,1.16294667248691e-60
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FAP,Prolyl endopeptidase FAP,29820,0.0320100190075279,0.00194674106361456,0.0281944065228433,0.0358256314922124,1.74306076067908e-60
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MTIF3,"Translation initiation factor IF-3, mitochondrial",24805,0.102226237014012,0.00621554658976731,0.0900437656980678,0.114408708329956,1.84751404646577e-60
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IGFBP4,Insulin-like growth factor-binding protein 4,28967,0.0510855893736977,0.00310796345111193,0.0449939810095183,0.0571771977378771,1.95362098528902e-60
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SCRN1,Secernin-1,29434,0.0650102063145358,0.00395735509173838,0.0572537903347285,0.072766622294343,2.25203399821116e-60
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CALB2,Calretinin,28774,0.0355305122329902,0.00216401740220783,0.0312890381246628,0.0397719863413175,2.64213552486962e-60
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,24805,0.0547677096331728,0.00334174759523776,0.0482178843465068,0.0613175349198388,4.74927381491917e-60
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FGF23,Fibroblast growth factor 23,29693,0.0659057378024737,0.00402318117696909,0.0580203026956142,0.0737911729093331,4.75968571380459e-60
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MIA,Melanoma-derived growth regulatory protein,29566,0.0428365002617917,0.00261598335733769,0.0377091728814098,0.0479638276421736,5.31250678798749e-60
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FST,Follistatin,29536,0.0585072061570631,0.00357818743125887,0.0514939587917957,0.0655204535223305,7.83571322138836e-60
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MATN2,Matrilin-2,29497,0.0344210387490025,0.00210726842125213,0.0302907926433483,0.0385512848546567,1.02776604508368e-59
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PTGDS,Prostaglandin-H2 D-isomerase,29291,0.0352611644917553,0.00215929458453021,0.0310289471060761,0.0394933818774345,1.11019186381389e-59
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",29434,0.0953411990722135,0.00584498128818736,0.0838850357473663,0.106797362397061,1.49015066994235e-59
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADM,Pro-adrenomedullin,29725,0.0306826742104694,0.00188219527360701,0.0269935714741997,0.0343717769467392,1.74513524287264e-59
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SRC,Proto-oncogene tyrosine-protein kinase Src,29525,0.137815304646574,0.0084587597826664,0.121236135472548,0.1543944738206,2.0248461013151e-59
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RAB2B,Ras-related protein Rab-2B,24793,0.0713241582340836,0.0043810771687482,0.0627372469833372,0.0799110694848301,2.77888467769053e-59
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,24230,0.0449231679082242,0.00276020920577107,0.0395131578649129,0.0503331779515355,3.05132053269439e-59
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HEPH,Hephaestin,24922,0.03047821127707,0.00187404851857946,0.0268050761806543,0.0341513463734857,3.6296127099599e-59
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SERPINA9,Serpin A9,29227,0.0832223202380756,0.00512186382305546,0.0731834671448869,0.0932611733312643,4.16379022991904e-59
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PKN3,Serine/threonine-protein kinase N3,24445,0.0869589308681855,0.0053531699181143,0.0764667178286815,0.0974511439076896,4.99325909533609e-59
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CBLN4,Cerebellin-4,29725,0.0364885507002721,0.00224997427599606,0.0320786011193198,0.0408985002812243,6.81531082993152e-59
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DCTN6,Dynactin subunit 6,28774,0.0819642357331285,0.00505398663479291,0.0720584219289344,0.0918700495373226,6.90027006916846e-59
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LRG1,Leucine-rich alpha-2-glycoprotein,24966,-0.0299349487257974,0.00184629547459264,-0.033553687855999,-0.0263162095955958,8.09124992131156e-59
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ENTR1,Endosome-associated-trafficking regulator 1,24240,0.0681862274514352,0.00420785118971594,0.059938839119592,0.0764336157832785,9.54661540410401e-59
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,S100P,Protein S100-P,28916,0.0614676678051377,0.0037949949695442,0.0540294776648311,0.0689058579454443,9.60615257977524e-59
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CA13,Carbonic anhydrase 13,29114,0.119635297010227,0.00738788111430257,0.105155050026194,0.13411554399426,1.01361329307004e-58
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCL26,C-C motif chemokine 26,29434,0.102274865314253,0.00631855136307215,0.0898905046426316,0.114659225985874,1.12753706370942e-58
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BRSK2,Serine/threonine-protein kinase BRSK2,24867,0.044020097993023,0.00271963274777528,0.0386896178073834,0.0493505781786625,1.26243668072279e-58
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TPP1,Tripeptidyl-peptidase 1,29286,0.0525653088850026,0.0032506229461469,0.0461940879105547,0.0589365298594505,1.4536492227268e-58
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,29510,0.0261158242126945,0.00161530214483399,0.0229498320088199,0.0292818164165692,1.52069941932952e-58
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AKR1B1,Aldo-keto reductase family 1 member B1,28797,0.0865214756914576,0.00535496030364639,0.0760257534963107,0.0970171978866046,1.82644679035219e-58
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DNAJC21,DnaJ homolog subfamily C member 21,24845,0.0439955015916132,0.00272251701717823,0.0386593682379439,0.0493316349452826,1.92373761572859e-58
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,UMOD,Uromodulin,29750,-0.0617477233322625,0.00382390919328008,-0.0692425853510915,-0.0542528613134336,2.08650497326345e-58
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,24229,0.0511563174753941,0.00316664773975659,0.0449496879054711,0.057362947045317,2.12568368268667e-58
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NT5C3A,Cytosolic 5'-nucleotidase 3A,29373,0.100449038377068,0.00622139733725931,0.0882550995960399,0.112642977158096,2.17270296902713e-58
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PARD3,Partitioning defective 3 homolog,24445,0.0848213263395151,0.00525756080682528,0.0745165071581376,0.0951261455208927,2.98287111989837e-58
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TCL1A,T-cell leukemia/lymphoma protein 1A,29194,0.111956948397887,0.00694670795094346,0.0983414008140378,0.125572495981736,3.48325793844894e-58
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,29218,0.0812170108840006,0.00503986679895772,0.0713388719580435,0.0910951498099578,3.57411001072793e-58
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TREML2,Trem-like transcript 2 protein,29443,0.0387198878332443,0.00240305220136542,0.034009905518568,0.0434298701479205,3.68129631186322e-58
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD40LG,CD40 ligand,29786,0.088656763256238,0.00550350934564511,0.0778698849387735,0.0994436415737024,3.87835370737175e-58
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TACSTD2,Tumor-associated calcium signal transducer 2,25976,-0.03561577602535,0.00221169314355447,-0.0399506945867168,-0.0312808574639833,4.61725668310934e-58
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,UNC79,Protein unc-79 homolog,24016,0.0639982267501247,0.00398203669138891,0.0561934348350025,0.071803018665247,8.0711134130919e-58
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",28931,0.0820396617298702,0.00510698284852415,0.0720299753467629,0.0920493481129776,8.09305673678986e-58
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IDO1,"Indoleamine 2,3-dioxygenase 1",24240,0.0730135057621034,0.00454336563468212,0.0641085091181265,0.0819185024060804,8.19778409126503e-58
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SLC27A4,Long-chain fatty acid transport protein 4,28774,0.0764086566189039,0.00476293484215011,0.0670733043282897,0.0857440089095181,1.15118122588098e-57
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FGF2,Fibroblast growth factor 2,29434,0.076707949720856,0.0047822415597335,0.0673347562637783,0.0860811431779337,1.17673892275088e-57
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCN4,CCN family member 4,29725,0.0455008521760826,0.00284004244524322,0.0399343689834059,0.0510673353687593,1.58416676199195e-57
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,STXBP3,Syntaxin-binding protein 3,28797,0.0497072856370089,0.00310622320112673,0.0436190881628005,0.0557954831112173,2.17243906691954e-57
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GRK5,G protein-coupled receptor kinase 5,28916,0.0589779549890401,0.00368567890032137,0.0517540243444102,0.06620188563367,2.18675461618519e-57
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SORCS2,VPS10 domain-containing receptor SorCS2,28797,0.0405757547453509,0.0025387758175866,0.0355997541428812,0.0455517553478207,2.99005125708085e-57
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CTSE,Cathepsin E,24381,0.0592165825246965,0.00370540712582878,0.0519539845580721,0.0664791804913209,3.37988367912076e-57
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",29349,0.0784223620118338,0.00491092050635301,0.0687969578193819,0.0880477662042857,3.66300731880273e-57
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MCFD2,Multiple coagulation factor deficiency protein 2,29327,0.0499410995209721,0.00312845541222856,0.0438093269130041,0.0560728721289401,3.99752071577876e-57
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ESAM,Endothelial cell-selective adhesion molecule,29820,0.0359870481353665,0.00225634695831178,0.0315646080970754,0.0404094881736576,4.96712167086283e-57
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ASAH1,Acid ceramidase,24732,0.0526589595312834,0.00330535126873782,0.0461804710445572,0.0591374480180095,7.36259699054866e-57
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DYNLT3,Dynein light chain Tctex-type 3,24793,0.0491856090332043,0.00309442934079289,0.0431205275252503,0.0552506905411584,1.31001235139181e-56
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FAM3B,Protein FAM3B,29349,0.0401043846141808,0.00252496997089361,0.0351554434712293,0.0450533257571323,1.42860647907826e-56
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GNAS,Neuroendocrine secretory protein 55,24867,0.099642145988739,0.00627253273995407,0.087347981818429,0.111936310159049,1.51714189006786e-56
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,24111,0.0315025501003075,0.00198729487277847,0.0276074521496617,0.0353976480509533,2.62461499605155e-56
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ASS1,Argininosuccinate synthase,24111,0.0891020898352722,0.00562685909166911,0.0780734460156007,0.100130733654944,3.42122305491678e-56
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MZT1,Mitotic-spindle organizing protein 1,28797,0.0589710320196996,0.00372818371817209,0.0516637919320823,0.0662782721073169,4.05551322034146e-56
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ABCA2,ATP-binding cassette sub-family A member 2,24111,0.0408903517279194,0.00258901281658418,0.0358158866074144,0.0459648168484244,6.55075367866202e-56
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADA,Adenosine deaminase,29786,0.0388717902115145,0.00246591682727333,0.0340385932300587,0.0437049871929702,9.31032659224894e-56
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GDNF,Glial cell line-derived neurotrophic factor,28774,0.0427391176797821,0.00271442485867172,0.0374188449567855,0.0480593904027787,1.26609487371877e-55
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MEP1B,Meprin A subunit beta,29478,0.130108568958643,0.00828138999079814,0.113877044576679,0.146340093340608,2.13651820223798e-55
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LGALS3,Galectin-3,29544,0.0331507470801639,0.00211134913422307,0.0290125027770867,0.0372889913832411,2.48528442432831e-55
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",24845,0.0445981145780314,0.00283950803772716,0.0390326788240862,0.0501635503319767,2.53009615118436e-55
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,24867,0.074626325973691,0.00475730080576059,0.0653020163944002,0.0839506355529817,3.43280743963389e-55
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PTGR1,Prostaglandin reductase 1,24922,0.0907250319585588,0.00578998403598614,0.079376663248026,0.102073400669092,4.49554440604665e-55
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ACRBP,Acrosin-binding protein,24793,0.0430527174259581,0.00275064347089519,0.0376614562230035,0.0484439786289127,5.91610442300056e-55
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DSCAM,Down syndrome cell adhesion molecule,24867,0.0396483574666796,0.0025350633025038,0.0346796333937722,0.0446170815395871,7.10468449419231e-55
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SNAP25,Synaptosomal-associated protein 25,24101,0.0525221616862749,0.00335982718667802,0.045936900400386,0.0591074229721638,8.14756772948681e-55
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PPM1F,Protein phosphatase 1F,24922,0.0584265037042619,0.00373992613369166,0.0510962484822263,0.0657567589262976,9.33028961371693e-55
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DARS1,"Aspartate--tRNA ligase, cytoplasmic",29163,0.0809546776437648,0.0051847746497312,0.0707925193302917,0.091116835957238,9.75659088389129e-55
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LAMP3,Lysosome-associated membrane glycoprotein 3,29760,0.0568136736423066,0.00363902712275247,0.0496811804817118,0.0639461668029015,9.90071766855743e-55
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FUT8,"Alpha-(1,6)-fucosyltransferase",29218,0.0642919739216526,0.00412710696157678,0.0562028442769621,0.0723811035663431,1.70348910527357e-54
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SPINK2,Serine protease inhibitor Kazal-type 2,24381,0.0408780336058607,0.00262872532498226,0.0357257319688954,0.0460303352428259,2.87856687288103e-54
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MARCO,Macrophage receptor MARCO,29478,0.0289694757529009,0.00186557029717584,0.0253129579704363,0.0326259935353656,3.65059574787843e-54
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,C1RL,Complement C1r subcomponent-like protein,24925,0.0214805543056101,0.00138361118019611,0.0187686763924257,0.0241924322187944,4.21486043459161e-54
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",24867,0.100696689082254,0.00649187627699783,0.0879726115793378,0.113420766585169,5.22303447218673e-54
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PVR,Poliovirus receptor,29694,0.0406793795220116,0.00262409184384505,0.0355361595080753,0.0458225995359479,5.4542801001406e-54
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,C4BPB,C4b-binding protein beta chain,29566,0.0439873978721981,0.00284225960230778,0.0384165690516749,0.0495582266927214,8.17106225648218e-54
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BTC,Probetacellulin,28797,0.0816068345163638,0.00527586887542828,0.0712661315205244,0.0919475375122032,9.4015632280954e-54
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",29163,0.105288962452189,0.00680737170016982,0.0919465139198561,0.118631410984522,9.49387618212484e-54
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ITGA6,Integrin alpha-6,29434,0.0570367536424433,0.0036947881420393,0.0497949688840462,0.0642785384008403,1.49558883629215e-53
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CORO1A,Coronin-1A,28847,0.0975502107957082,0.00633041401046106,0.0851425993352045,0.109957822256212,2.29771799409147e-53
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,POMC,Pro-opiomelanocortin,24240,0.0773382487478945,0.00501935748859081,0.0675003080702565,0.0871761894255324,2.59007078552788e-53
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NGRN,Neugrin,24845,0.0242290188522593,0.0015727955716785,0.0211463395317694,0.0273116981727491,2.67115531392202e-53
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LGMN,Legumain,29581,0.0391057611501747,0.00253980806284188,0.0341277373470046,0.0440837849533448,2.75576714302709e-53
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",28916,0.0962365512618957,0.00625262230191345,0.0839814115501453,0.108491690973646,3.04239755169731e-53
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DDX58,Antiviral innate immune response receptor RIG-I,28797,0.0620853566123075,0.00403661706998719,0.0541735871551326,0.0699971260694823,3.59987997098464e-53
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RGS10,Regulator of G-protein signaling 10,24867,0.0650952436343646,0.00423286605575639,0.0567988261650821,0.0733916611036471,4.00814425110339e-53
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CNDP1,Beta-Ala-His dipeptidase,29594,0.0500114003078358,0.00325506876816225,0.0436314655222378,0.0563913350934338,4.5662698903775e-53
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,29349,-0.0214929855392185,0.00139998299855316,-0.0242369522163826,-0.0187490188620543,5.49479025331873e-53
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,STX16,Syntaxin-16,28797,0.0632173607491624,0.0041197655861036,0.0551426202003994,0.0712921012979255,6.21143834564066e-53
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DCTN2,Dynactin subunit 2,29349,0.102394262036461,0.00668024438888396,0.0893009830342481,0.115487541038673,7.97766405345991e-53
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PLA2G15,Phospholipase A2 group XV,29566,0.0287650285689477,0.00188069058338516,0.0250788750255128,0.0324511821123826,1.31511437449209e-52
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SFRP1,Secreted frizzled-related protein 1,29120,0.0469237239445102,0.00307040753072366,0.0409057251842918,0.0529417227047285,1.59873707043263e-52
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PSAP,Prosaposin,24761,0.0308230040611097,0.00201899318659136,0.0268657774153906,0.0347802307068287,2.21529939009651e-52
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ENO2,Gamma-enolase,29694,0.0707483201380986,0.00464060922938455,0.0616527260485048,0.0798439142276923,2.78516690452758e-52
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ITGA2,Integrin alpha-2,24381,0.0369730500174316,0.00243488733621256,0.032200670838455,0.0417454291964082,7.71478337883032e-52
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,COX6B1,Cytochrome c oxidase subunit 6B1,24922,0.0347184825543104,0.00229386283141623,0.0302225114047346,0.0392144537038862,1.60468091286407e-51
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PSG1,Pregnancy-specific beta-1-glycoprotein 1,29218,-0.123024537131518,0.00813618724799386,-0.138971464137585,-0.10707761012545,1.85429855722331e-51
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD84,SLAM family member 5,29434,0.0334786344690964,0.00221664384865114,0.0291340125257402,0.0378232564124527,2.40061979865767e-51
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCDC134,Coiled-coil domain-containing protein 134,24793,0.0521832694210562,0.00345704692391475,0.0454074574501833,0.0589590813919291,2.9646147678951e-51
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NPPB,Natriuretic peptides B,28916,-0.143255138713839,0.00949980265718844,-0.161874751921928,-0.12463552550575,3.44529028387168e-51
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SF3B4,Splicing factor 3B subunit 4,29349,0.0776601987657167,0.0051634622695405,0.0675398127174173,0.0877805848140161,6.18924573160201e-51
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD46,Membrane cofactor protein,29331,0.0304858764225972,0.00203015775448367,0.0265067672238092,0.0344649856213852,8.84632572801223e-51
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ARFIP1,Arfaptin-1,24867,0.0733330167309225,0.00488498098289341,0.0637584540044514,0.0829075794573935,1.02371324696117e-50
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FXN,"Frataxin, mitochondrial",29725,0.0779542982176392,0.0051965376418104,0.0677690844396908,0.0881395119955876,1.10592663571708e-50
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,APOE,Apolipoprotein E,24966,0.0773471285469204,0.00515717743811249,0.0672390607682199,0.0874551963256209,1.25883271398213e-50
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,WARS,"Tryptophan--tRNA ligase, cytoplasmic",29443,0.0406500525469709,0.00271222699649011,0.0353340876338503,0.0459660174600915,1.35864391817476e-50
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PSME2,Proteasome activator complex subunit 2,29081,0.0384763026060451,0.00256722419125695,0.0334445431911815,0.0435080620209087,1.369814397844e-50
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PAM,Peptidyl-glycine alpha-amidating monooxygenase,29652,0.0298957848809248,0.00199563860342948,0.025984333218203,0.0338072365436465,1.50705189499881e-50
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ERI1,3'-5' exoribonuclease 1,24445,0.0360823252150998,0.00240848975375693,0.0313616852977362,0.0408029651324634,1.63126964867627e-50
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DMD,Dystrophin,24240,0.0549526770729589,0.0036709944493515,0.04775752795223,0.0621478261936879,1.9557842460294e-50
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FCRL1,Fc receptor-like protein 1,29478,0.0481734834130108,0.00322095173844068,0.0418604180056671,0.0544865488203545,2.17021971535938e-50
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLTA,Clathrin light chain A,28916,0.0498939643778642,0.00333641797089891,0.0433545851549023,0.0564333436008261,2.25231564530343e-50
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BPIFA2,BPI fold-containing family A member 2,23405,-0.117737592228363,0.00787415968107669,-0.133170945203273,-0.102304239253453,2.56671186193693e-50
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NID2,Nidogen-2,29443,0.0776441833139166,0.00519550142293375,0.0674610005249665,0.0878273661028668,2.58826363805669e-50
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TLR3,Toll-like receptor 3,29786,0.0645557042320181,0.00433134832492866,0.0560662615151579,0.0730451469488783,4.68486963105106e-50
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,24240,-0.0372265067485392,0.00249967295533743,-0.0421258657410006,-0.0323271477560779,6.12998122296959e-50
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AMOTL2,Angiomotin-like protein 2,24711,0.0511229480102941,0.00343321953531659,0.0443938377210736,0.0578520582995146,6.24253723438115e-50
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PTPRC,Receptor-type tyrosine-protein phosphatase C,24938,0.0240767171902944,0.00161827551915748,0.0209048971727457,0.027248537207843,7.49724968170469e-50
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PCDH7,Protocadherin-7,24805,0.0367668137590946,0.00247162088346182,0.0319224368275094,0.0416111906906798,7.79139211937404e-50
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DKK4,Dickkopf-related protein 4,29169,0.048364568037087,0.00325243606271984,0.0419897933541562,0.0547393427200179,7.83231978229653e-50
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ARAF,Serine/threonine-protein kinase A-Raf,24445,0.0714461698459741,0.00480343010823158,0.0620314468338402,0.080860892858108,8.03606956986947e-50
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,APOL1,Apolipoprotein L1,24951,0.063230261724252,0.00426011821736469,0.0548804300182172,0.0715800934302868,1.26993087809858e-49
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AK1,Adenylate kinase isoenzyme 1,29478,0.0661004269503553,0.00445779029212365,0.057363157977793,0.0748376959229177,1.45629959518433e-49
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MAN2B2,Epididymis-specific alpha-mannosidase,24922,0.0626180661756072,0.00422236327569723,0.0543422341552407,0.0708938981959738,1.52323393901566e-49
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,24111,0.0425230997556438,0.00287530190532454,0.0368875080212077,0.0481586914900799,2.83401274833567e-49
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",24381,0.0933117048256824,0.00631311830501525,0.0809379929478526,0.105685416703512,3.19351082178912e-49
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LAMB1,Laminin subunit beta-1,24240,0.0319253480659802,0.0021612632121075,0.0276892721702495,0.0361614239617109,3.65539398333028e-49
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PAEP,Glycodelin,29218,-0.137881097748164,0.00934333205299288,-0.15619402857203,-0.119568166924298,4.15921199217723e-49
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IGF1R,Insulin-like growth factor 1 receptor,29349,0.0227542788653996,0.00154227424553994,0.0197314213441413,0.0257771363866578,4.36772839322093e-49
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TPMT,Thiopurine S-methyltransferase,28797,0.0760566157959256,0.00516529824768209,0.0659326312304687,0.0861806003613825,6.75870311111321e-49
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,28931,0.044379590723426,0.00301570689528854,0.0384688052086604,0.0502903762381915,7.6296081560348e-49
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,24805,0.085915901856631,0.00583712685723615,0.0744751332164482,0.0973566704968139,7.8424416094816e-49
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SERPING1,Plasma protease C1 inhibitor,24914,0.019615343929398,0.00133327847415444,0.0170021181200553,0.0222285697387408,8.6406841459831e-49
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PDZD2,PDZ domain-containing protein 2,24111,0.0627692807134686,0.00427349215825504,0.0543932360832887,0.0711453253436485,1.24817005660808e-48
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PTGES2,Prostaglandin E synthase 2,24037,0.0574251419587037,0.00391005774497414,0.0497614287785544,0.065088855138853,1.2783650276595e-48
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SLIT2,Slit homolog 2 protein,28774,0.0541695581795952,0.00369152521282963,0.0469341687624491,0.0614049475967413,1.41733718842837e-48
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SCRIB,Protein scribble homolog,24240,0.0943338017716484,0.00642674481217302,0.0817373819397893,0.106930221603507,1.43541656861766e-48
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,24867,0.0611113321562829,0.0041719253896386,0.0529343583925913,0.0692883059199746,2.20071164719087e-48
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,29434,-0.0405426039899467,0.00277673574995205,-0.0459850060598527,-0.0351002019200407,4.09032795074182e-48
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TPR,Nucleoprotein TPR,24111,0.0493829460385371,0.0033895215503435,0.0427394837998639,0.0560264082772104,7.0399905437946e-48
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,24178,0.0287052160680287,0.00197028531802078,0.024843456844708,0.0325669752913494,7.05453460976436e-48
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BST2,Bone marrow stromal antigen 2,29694,0.0541887090709577,0.00372178050046436,0.0468940192900476,0.0614833988518679,7.39258924259006e-48
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MDK,Midkine,29455,0.052405548506311,0.00360489739319678,0.0453399496156453,0.0594711473969766,1.02889093930862e-47
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCL19,C-C motif chemokine 19,29694,0.126672288542048,0.00871436443702778,0.109592134245474,0.143752442838623,1.04508508344049e-47
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,APOM,Apolipoprotein M,29545,0.0285348647676161,0.00196522380094938,0.0246830261177554,0.0323867034174769,1.32275583867372e-47
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GDF2,Growth/differentiation factor 2,29478,0.0366611502173503,0.00252766494198601,0.0317069269310577,0.0416153735036429,1.66766391679432e-47
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CDA,Cytidine deaminase,24890,0.048067847411022,0.00331577355248627,0.0415689312481489,0.0545667635738951,1.98411521151357e-47
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HPCAL1,Hippocalcin-like protein 1,29786,0.0752289522194682,0.00520123234882106,0.0650345368157789,0.0854233676231575,2.97313742283748e-47
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,APLP1,Amyloid-like protein 1,29478,-0.0527686770334092,0.0036485938050968,-0.0599199208913989,-0.0456174331754195,3.02511056954479e-47
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AKR7L,Aflatoxin B1 aldehyde reductase member 4,24229,0.0715427582358399,0.00494860116326836,0.0618434999558339,0.0812420165158459,3.55252033514368e-47
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MMP1,Interstitial collagenase,28424,0.0937614763472897,0.00649218777175638,0.0810367883146472,0.106486164379932,4.12411876889207e-47
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SGSH,N-sulphoglucosamine sulphohydrolase,24571,0.0574429564556175,0.00397808359200714,0.0496459126152835,0.0652400002959515,4.52935867409523e-47
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SPAG1,Sperm-associated antigen 1,24867,0.0592112131127726,0.00410927300760485,0.0511570380178671,0.0672653882076781,7.00323344960043e-47
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,24805,0.120447754106923,0.00836765009103701,0.10404715992849,0.136848348285355,8.6593241976995e-47
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DENR,Density-regulated protein,24229,0.058737412584385,0.0040803563392977,0.0507399141593615,0.0667349110094085,8.65975991895252e-47
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RPL14,60S ribosomal protein L14,24240,0.0411883845619329,0.00286142301107922,0.0355799954602176,0.0467967736636482,8.75746517563939e-47
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,24381,0.0698574534869767,0.00486567320150717,0.0603207340120227,0.0793941729619308,1.48756543842388e-46
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FRZB,Secreted frizzled-related protein 3,29123,0.0262086506482062,0.00182639114020191,0.0226289240134104,0.0297883772830019,1.53695555091768e-46
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",24938,0.0636234977637246,0.00443255029758483,0.0549356991804583,0.0723112963469908,1.54884975913214e-46
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCL14,C-C motif chemokine 14,29435,0.0402786398024589,0.0028077093057279,0.0347755295632322,0.0457817500416856,1.62674979362303e-46
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IMPA1,Inositol monophosphatase 1,29218,0.0618817307423892,0.00432305515311987,0.0534085426422742,0.0703549188425041,2.55468779781699e-46
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRG2,Bone marrow proteoglycan,24938,-0.0526299838057802,0.00368106295600319,-0.0598448671995465,-0.045415100412014,3.45542407992433e-46
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,STX7,Syntaxin-7,24229,0.0504276986461697,0.00352852902862263,0.0435117817500693,0.05734361554227,3.81413967957304e-46
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DMP1,Dentin matrix acidic phosphoprotein 1,24240,-0.0615897189942953,0.00432498028608977,-0.0700666803550313,-0.0531127576335594,7.86925852658602e-46
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD302,CD302 antigen,29349,0.0307874736253584,0.00216420306427029,0.0265456356193886,0.0350293116313281,9.00388124709027e-46
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CASP8,Caspase-8,29632,0.0619429956570127,0.00436527122592476,0.0533870640542002,0.0704989272598252,1.49147574570438e-45
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BOLA1,BolA-like protein 1,24101,0.0550315204620032,0.00388063855898207,0.0474254688863983,0.062637572037608,1.82985674887595e-45
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SERPINB8,Serpin B8,29786,0.0565863093402412,0.00399260572178324,0.0487608021255461,0.0644118165549364,1.89864707144199e-45
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MNDA,Myeloid cell nuclear differentiation antigen,29426,0.0977805875026195,0.00690365759661783,0.0842494186132486,0.11131175639199,2.17098772136033e-45
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",24922,0.0302656864840418,0.00213828671268149,0.0260746445271861,0.0344567284408975,2.63779502583518e-45
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KIF22,Kinesin-like protein KIF22,24111,0.123564828505848,0.00872954576751551,0.106454918801518,0.140674738210179,2.65096012957477e-45
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NAP1L4,Nucleosome assembly protein 1-like 4,24764,0.0411518821713899,0.00291146351100971,0.0354454136898109,0.0468583506529689,3.49353520454197e-45
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCL25,C-C motif chemokine 25,29786,0.0492412692717878,0.00348579257637043,0.0424091158221017,0.0560734227214738,3.66173337293169e-45
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,C7orf50,Uncharacterized protein C7orf50,24845,0.0223609824639262,0.00158418217669657,0.0192559853976009,0.0254659795302514,4.57680448590472e-45
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RANBP1,Ran-specific GTPase-activating protein,24240,0.0525703737443706,0.00372461172221355,0.045270134768832,0.0598706127199092,4.67731825444678e-45
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ATP6V1F,V-type proton ATPase subunit F,28719,0.0663036667611983,0.00470313983594685,0.0570855126827425,0.0755218208396541,5.54127142740901e-45
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IFNGR2,Interferon gamma receptor 2,29218,0.0520594156731901,0.00369394171379746,0.0448192899141471,0.0592995414322332,5.87353745171997e-45
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MAGED1,Melanoma-associated antigen D1,28797,0.0483832134361705,0.00343307570190954,0.0416543850604278,0.0551120418119132,5.89705045746085e-45
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LETM1,Mitochondrial proton/calcium exchanger protein,24867,0.0524167021789892,0.003739351348004,0.0450875735369014,0.0597458308210771,1.79757679805687e-44
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LTA,Lymphotoxin-alpha,29434,0.0398226810920628,0.00284600378035434,0.0342445136825683,0.0454008485015573,2.40393441294817e-44
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CXADR,Coxsackievirus and adenovirus receptor,29434,0.0508668959663381,0.00363968990044365,0.0437331037614685,0.0580006881712076,3.0427387569964e-44
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RPE,Ribulose-phosphate 3-epimerase,24445,0.070119203762014,0.00501559885061528,0.060288630014808,0.0799497775092199,3.048635779194e-44
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ENAH,Protein enabled homolog,28931,0.0472729129519237,0.00338412188266754,0.0406400340618954,0.0539057918419521,3.35406030805212e-44
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SLITRK2,SLIT and NTRK-like protein 2,29725,0.0387733327443501,0.00277597338759254,0.0333324249046687,0.0442142405840315,3.39782201315334e-44
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ZBTB17,Zinc finger and BTB domain-containing protein 17,28916,0.0409276848507656,0.00293112784828341,0.0351826742681302,0.0466726954334011,3.64305231810477e-44
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCL20,C-C motif chemokine 20,29786,0.0868555340198678,0.00622288930608568,0.0746586709799398,0.0990523970597957,3.90599365952824e-44
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DNM1,Dynamin-1,24805,0.113284516152925,0.00811886207678362,0.0973715464824296,0.129197485823421,4.41377776132959e-44
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TSPYL1,Testis-specific Y-encoded-like protein 1,24229,0.0400883344739654,0.00287826144158368,0.0344469420484614,0.0457297268994694,6.32963466410409e-44
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRSS27,Serine protease 27,29395,0.039747935736871,0.00285660291569247,0.0341489940221137,0.0453468774516282,7.13780210500148e-44
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ANXA4,Annexin A4,29341,0.0710876048900098,0.00510924590471255,0.0610734829167732,0.0811017268632464,7.23037194987174e-44
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HDGF,Hepatoma-derived growth factor,29688,0.0922028399694169,0.00663131630771503,0.0792054600062954,0.105200219932538,8.20440294454733e-44
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ARHGAP1,Rho GTPase-activating protein 1,28797,0.0455403701181334,0.00327727427795645,0.0391169125333388,0.051963827702928,9.30236984866973e-44
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BGN,Biglycan,28750,-0.118090700152385,0.00850478499846202,-0.13476007874937,-0.101421321555399,1.07812035134197e-43
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,29786,0.0382189635819436,0.0027530774729,0.0328229317350596,0.0436149954288275,1.11035172659895e-43
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CA2,Carbonic anhydrase 2,29368,0.0674632466976066,0.00486892859967375,0.0579201466422461,0.0770063467529672,1.60759054230436e-43
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCL15,C-C motif chemokine 15,29820,0.0432393517899365,0.00312230975089634,0.0371196246781797,0.0493590789016933,1.77135109315668e-43
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PTN,Pleiotrophin,28916,0.0490517584079615,0.00354922189785037,0.0420952834881748,0.0560082333277483,2.63646204138801e-43
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SPINK6,Serine protease inhibitor Kazal-type 6,29725,0.0527798349592107,0.00381981268509517,0.0452930020964241,0.0602666678219972,2.7257830433049e-43
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AARSD1,Alanyl-tRNA editing protein Aarsd1,29349,0.0536282913413165,0.00388285757769651,0.0460178904890313,0.0612386921936016,2.96597618750376e-43
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NECTIN2,Nectin-2,29433,0.0291938167117831,0.00211422730762746,0.0250499311888333,0.033337702234733,3.10068610707656e-43
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,STK4,Serine/threonine-protein kinase 4,29478,0.0847162766134782,0.00613725411680225,0.0726872585445458,0.0967452946824106,3.30468571958938e-43
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NCF2,Neutrophil cytosol factor 2,29395,0.0811846956746727,0.00589168066728385,0.0696370015667963,0.092732389782549,4.60748161832798e-43
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EFCAB2,Dynein regulatory complex protein 8,24445,0.034101309365771,0.00248493896007649,0.0292308290040211,0.038971789727521,1.06212851662346e-42
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL6R,Interleukin-6 receptor subunit alpha,29361,0.0329464557785635,0.0024042342193932,0.0282341567085528,0.0376587548485741,1.30871182857233e-42
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CXCL8,Interleukin-8,29218,0.0659110839693475,0.00481184519423757,0.0564798673886419,0.0753423005500531,1.4196869638638e-42
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,WAS,Wiskott-Aldrich syndrome protein,28931,0.0650364370342944,0.00475350902172431,0.0557195593517147,0.0743533147168741,1.76973477623444e-42
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ROBO2,Roundabout homolog 2,29694,0.0224415938963511,0.0016426400063132,0.0192220194839772,0.025661168308725,2.30339576615495e-42
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MMP3,Stromelysin-1,29443,-0.0475392810397112,0.00347970797613518,-0.0543595086729361,-0.0407190534064862,2.3106610557026e-42
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD1C,T-cell surface glycoprotein CD1c,29566,0.0235328116563889,0.00172435648066031,0.0201530729542946,0.0269125503584831,2.81480168473298e-42
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,29218,0.0344137699829155,0.00252296690214916,0.0294687548547031,0.0393587851111278,3.1117765568296e-42
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,28797,0.0423879760671113,0.00311067064243738,0.036291061607934,0.0484848905262886,3.75931935915785e-42
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SFTPA2,Pulmonary surfactant-associated protein A2,28797,0.0489420844565903,0.00359662958313073,0.0418926904736541,0.0559914784395266,4.85954600143378e-42
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MTUS1,Microtubule-associated tumor suppressor 1,24445,0.0542698968981236,0.00399039773580813,0.0464487173359396,0.0620910764603075,5.68478276647968e-42
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLSTN3,Calsyntenin-3,24845,0.0294674324375867,0.00216844680930638,0.0252172766913462,0.0337175881838273,6.55665756743028e-42
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HIP1R,Huntingtin-interacting protein 1-related protein,24788,0.0415524237055678,0.00306649037056478,0.0355421025792608,0.0475627448318748,1.10832320185433e-41
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TGFA,Protransforming growth factor alpha,29434,0.044872605374632,0.0033171302524129,0.0383710300799027,0.0513741806693612,1.43248882207297e-41
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HLA_E,,29434,0.027817765022535,0.00205981599746838,0.023780525667497,0.0318550043775731,1.94279858385141e-41
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD8A,T-cell surface glycoprotein CD8 alpha chain,29694,0.0473493971033968,0.00350666694424465,0.0404763298926773,0.0542224643141163,1.99899146403781e-41
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",28931,0.0572150579318225,0.0042394098683748,0.0489058145898079,0.0655243012738371,2.20380706578192e-41
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,29820,0.0221583645653313,0.00164279923566477,0.0189384780634284,0.0253782510672343,2.42795550393083e-41
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NCAM2,Neural cell adhesion molecule 2,29443,-0.0257468402322394,0.0019125028552734,-0.0294953458285752,-0.0219983346359035,3.44860143186449e-41
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,APRT,Adenine phosphoribosyltransferase,29192,0.0456031877594821,0.00338774606448602,0.0389632054730895,0.0522431700458747,3.51137980538629e-41
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HRG,Histidine-rich glycoprotein,24833,0.0299551352747199,0.00222876361763393,0.0255867585841574,0.0343235119652824,4.88940700478116e-41
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PLXNB2,Plexin-B2,29701,0.0227401692530536,0.00169349284745153,0.0194209232720486,0.0260594152340586,5.46255626929426e-41
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,24445,0.0828286578326414,0.00618534034078898,0.070705390764695,0.0949519249005878,9.48874431971121e-41
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,24240,0.0401867840445343,0.00300207762634676,0.0343027118968946,0.0460708561921739,1.01455522907577e-40
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ACOT13,Acyl-coenzyme A thioesterase 13,24805,0.107961222620801,0.00807794908640266,0.0921284424114519,0.12379400283015,1.33986657981501e-40
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",24240,0.0868969205239269,0.00650668337555528,0.0741438211078385,0.0996500199400152,1.54059707904651e-40
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,COLEC12,Collectin-12,29454,0.0249424977351068,0.00187066240472135,0.021275999421853,0.0286089960483607,1.93644049492323e-40
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TXN,Thioredoxin,24647,0.0412609457442771,0.00311149242571491,0.0351624205898759,0.0473594708986783,5.35695196326869e-40
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FSHB,Follitropin subunit beta,24240,0.0610073960386492,0.004601947677611,0.0519875785905316,0.0700272134867668,5.67493805918075e-40
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PPME1,Protein phosphatase methylesterase 1,29349,0.0561219285440405,0.00424011745038237,0.047811298341291,0.0644325587467899,7.08176676869632e-40
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HSPB6,Heat shock protein beta-6,29725,0.0360701302807002,0.00272700752154598,0.0307251955384701,0.0414150650229303,7.94400451210259e-40
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DHPS,Deoxyhypusine synthase,24793,0.0381987733280335,0.00289575156683633,0.0325231002570342,0.0438744463990327,1.3390507440404e-39
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,24845,0.0446834824633094,0.00339218332716131,0.0380348031420733,0.0513321617845456,1.71468410566395e-39
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,STX6,Syntaxin-6,28797,0.0628791366434606,0.00477755623678294,0.0535151264193661,0.0722431468675552,1.90393818365097e-39
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,XRCC4,DNA repair protein XRCC4,28774,0.034588956809437,0.00262877209140853,0.0294365635102763,0.0397413501085978,1.99464758186087e-39
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,24229,0.0335609955270169,0.00255163018745545,0.0285598003596042,0.0385621906944296,2.23921757379941e-39
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD80,T-lymphocyte activation antigen CD80,24922,0.0319412024250749,0.00243014223568659,0.0271781236431292,0.0367042812070206,2.49878905451084e-39
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRDX6,Peroxiredoxin-6,29725,-0.0557723405392913,0.00424467392360291,-0.064091901429553,-0.0474527796490296,2.52161945511759e-39
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GRSF1,G-rich sequence factor 1,23862,0.0754363533218114,0.00574065999085648,0.0641846597397327,0.0866880469038901,2.63567504805461e-39
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CIT,Citron Rho-interacting kinase,24195,0.0422935373836914,0.00322284603483298,0.0359767591554188,0.0486103156119641,3.30870328924535e-39
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SMS,Spermine synthase,24101,0.059597815023384,0.0045480907927016,0.0506835570696889,0.0685120729770791,4.25522287010516e-39
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LAMA4,Laminin subunit alpha-4,29581,0.0309993431710615,0.00237161712173776,0.0263509736124555,0.0356477127296675,6.18689942752968e-39
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,29497,0.0313223858825073,0.0024045809563218,0.0266094072081166,0.036035364556898,1.11148667725477e-38
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AMIGO2,Amphoterin-induced protein 2,29349,0.0212102093272559,0.00162834762902745,0.0180186479743621,0.0244017706801497,1.12054258875677e-38
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,COL15A1,Collagen alpha-1(XV) chain,24938,0.0244781760130795,0.00188154431130408,0.0207903491629235,0.0281660028632355,1.44085479836154e-38
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SPRR3,Small proline-rich protein 3,24845,0.0627992746858203,0.00482776940801938,0.0533368466461024,0.0722617027255383,1.47448327736891e-38
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NEK7,Serine/threonine-protein kinase Nek7,24445,0.0693396747475599,0.00533086235401925,0.0588911845336821,0.0797881649614376,1.49524970746713e-38
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RARRES1,Retinoic acid receptor responder protein 1,28797,0.0308947381035672,0.00237776943802257,0.026234310005043,0.0355551662020915,1.71700809326308e-38
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HPGDS,Hematopoietic prostaglandin D synthase,28797,0.0347494586130203,0.00268293004242451,0.0294909157298682,0.0400080014961723,2.92655875003186e-38
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PNLIP,Pancreatic triacylglycerol lipase,24951,0.0581042986650664,0.00448518694627435,0.0493133322503686,0.0668952650797641,2.93672057845717e-38
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TF,Serotransferrin,24966,0.0198583650753867,0.00153505416386714,0.0168496589142071,0.0228670712365663,3.71183153690246e-38
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,COL2A1,Collagen alpha-1(II) chain,24240,0.0741874301360497,0.00574184811149322,0.062933407837523,0.0854414524345764,4.60909056031667e-38
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CWC15,Spliceosome-associated protein CWC15 homolog,24681,0.0554678146636521,0.0042976158399822,0.047044487617287,0.0638911417100173,5.48128499600469e-38
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,THBD,Thrombomodulin,29478,0.0261416500836172,0.00203403017202846,0.0221549509464414,0.030128349220793,1.0565354142442e-37
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,29218,0.0354864219971214,0.00276158827768734,0.0300737089728542,0.0408991350213886,1.0882569671354e-37
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,WFDC1,WAP four-disulfide core domain protein 1,24326,0.0495466645913713,0.00386241912713704,0.0419763231021827,0.0571170060805599,1.51513152882544e-37
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,24195,0.0490430704013698,0.0038251059623765,0.0415458627151119,0.0565402780876277,1.64968529341204e-37
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,24867,0.0602285669723212,0.0047048166780138,0.0510071262834142,0.0694500076612283,2.1121732660016e-37
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KLK7,Kallikrein-7,23801,0.0356057099220856,0.00278231422933405,0.0301523740325908,0.0410590458115803,2.25922385340095e-37
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CAT,Catalase,24587,0.0486451494795196,0.00380241076659264,0.041192424376998,0.0560978745820412,2.35388819877246e-37
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,29218,0.0297892262802024,0.00232977695840221,0.0252228634417341,0.0343555891186708,2.46322564633877e-37
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,28916,0.0517404442536497,0.00406201337352597,0.0437788980415388,0.0597019904657606,4.59603921701183e-37
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LBP,Lipopolysaccharide-binding protein,29594,-0.0527160155202521,0.00414153553112167,-0.0608334251612506,-0.0445986058792537,5.12874883523993e-37
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RBP2,Retinol-binding protein 2,29349,-0.0693549239326768,0.00545224860303341,-0.0800413311946223,-0.0586685166707313,5.70304636721557e-37
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EDF1,Endothelial differentiation-related factor 1,24867,0.0614387714012109,0.00483485804324011,0.0519624496364602,0.0709150931659615,7.00188029491646e-37
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PPL,Periplakin,24229,0.0295507106859579,0.00232573794205739,0.0249922643195255,0.0341091570523904,7.18721257798589e-37
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FBP1,"Fructose-1,6-bisphosphatase 1",29478,0.0659207361193055,0.00519517782092891,0.0557381875902848,0.0761032846483261,8.51363520489857e-37
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NTRK3,NT-3 growth factor receptor,29694,-0.0194592141244281,0.00153751983754952,-0.0224727530060251,-0.016445675242831,1.28511142774722e-36
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,C5,Complement C5,24966,0.0136223198379541,0.00107697726186396,0.0115114444047008,0.0157331952712075,1.47374811370767e-36
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PMM2,Phosphomannomutase 2,24111,0.0540499160734516,0.00427411296283902,0.0456726546662871,0.062427177480616,1.54049465052092e-36
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IFNAR1,Interferon alpha/beta receptor 1,24805,0.0230240422904471,0.00182165308572342,0.0194536022424292,0.026594482338465,1.66599575263886e-36
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,29434,0.0336529262398355,0.00266839208561487,0.0284228777520303,0.0388829747276406,2.26148636838468e-36
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SV2A,Synaptic vesicle glycoprotein 2A,24195,0.0555467773241223,0.00440513756754952,0.0469127076917252,0.0641808469565193,2.43469720607665e-36
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD200R1,Cell surface glycoprotein CD200 receptor 1,29341,0.0312208431175836,0.0024782816042664,0.0263634111732215,0.0360782750619457,2.69705390772714e-36
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ELOB,Elongin-B,24111,0.0355027131109316,0.00281823714638838,0.0299789683040103,0.0410264579178528,2.83661736233688e-36
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CSNK1D,Casein kinase I isoform delta,24229,0.0572086096327888,0.00454285801871113,0.0483046079161149,0.0661126113494626,2.99444471006669e-36
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TDP1,Tyrosyl-DNA phosphodiesterase 1,24793,0.0612090825326188,0.00486108853288523,0.0516813490081638,0.0707368160570739,3.03144177752195e-36
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NAA10,N-alpha-acetyltransferase 10,24111,0.0455392815840947,0.003620490937887,0.0384431193458362,0.0526354438223532,3.61562952325902e-36
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ROBO1,Roundabout homolog 1,29497,0.021494117957291,0.00171028527478487,0.0181419588187126,0.0248462770958693,3.94141545382792e-36
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DAPK2,Death-associated protein kinase 2,24229,0.0479555056320592,0.00381539088982443,0.0404773394880033,0.0554336717761151,4.0559608793521e-36
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PER3,Period circadian protein homolog 3,24229,0.106988095719434,0.00853391297738461,0.0902616262837605,0.123714565155108,6.07162633458814e-36
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CA14,Carbonic anhydrase 14,29725,-0.0316291568149751,0.00252571888646816,-0.0365795658324527,-0.0266787477974975,6.90051221643182e-36
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ECI2,Enoyl-CoA delta isomerase 2,24111,0.0547072518905309,0.00439091193099365,0.0461010645057833,0.0633134392752784,1.60348479899237e-35
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",24867,0.0420404355868804,0.00337516633821199,0.0354251095639849,0.0486557616097759,1.65991195642995e-35
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CA6,Carbonic anhydrase 6,29372,-0.0558185891174411,0.00448546088693694,-0.0646100924558375,-0.0470270857790447,1.84490025650939e-35
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,S100A12,Protein S100-A12,29023,0.0662431926130224,0.00532553524415056,0.0558051435344873,0.0766812416915575,1.98186588481462e-35
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GIMAP8,GTPase IMAP family member 8,24016,0.0450416020891703,0.0036251015123735,0.0379364031249182,0.0521468010534223,2.45872317590272e-35
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,COL6A3,Collagen alpha-3(VI) chain,29820,0.0308419718035889,0.00248401261599816,0.0259733070762325,0.0357106365309453,2.61076281493395e-35
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,B4GAT1,"Beta-1,4-glucuronyltransferase 1",29443,0.0214075885256417,0.0017246519930012,0.0180272706193593,0.024787906431924,2.73348907611387e-35
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RNASET2,Ribonuclease T2,29697,0.023383642223249,0.00188569140999958,0.0196876870596498,0.0270795973868481,3.17264246366426e-35
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,XPNPEP2,Xaa-Pro aminopeptidase 2,29566,0.0864901388344105,0.00698414577834531,0.0728012131088536,0.100179064559967,3.91066592692076e-35
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,29478,0.0429502553570362,0.00347888710371463,0.0361316366337555,0.0497688740803169,6.24865827409146e-35
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CR1,Complement receptor type 1,24903,0.0314497951990842,0.00255379867846032,0.026444349789302,0.0364552406088665,9.50700452243605e-35
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ANGPTL4,Angiopoietin-related protein 4,29536,-0.0393543836906451,0.00320647876090373,-0.0456390820620164,-0.0330696853192738,1.52814142027913e-34
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BSG,Basigin,29760,0.0178850094860967,0.00145793981499778,0.0150274474487011,0.0207425715234923,1.64427897953525e-34
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LY75,Lymphocyte antigen 75,29434,0.0338070976819741,0.00276042301493105,0.0283966685727092,0.0392175267912389,2.11263741352155e-34
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CBS,Cystathionine beta-synthase,24240,0.0446421975471444,0.00364473213002802,0.0374985225722895,0.0517858725219993,2.16555555596538e-34
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,INSL5,Insulin-like peptide INSL5,24805,0.0846760565530343,0.00694558760805593,0.0710627048412447,0.098289408264824,4.32826987719204e-34
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TEK,Angiopoietin-1 receptor,29566,0.0188777180309357,0.00155108782341183,0.0158375858970485,0.0219178501648229,5.37515685032435e-34
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TREML1,Trem-like transcript 1 protein,24951,0.045639448005396,0.00374974974745046,0.0382899385003931,0.0529889575103989,5.51691115587775e-34
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PIGR,Polymeric immunoglobulin receptor,29115,0.0311867277124458,0.00256707936433259,0.0261552521583539,0.0362182032665377,7.03954649685252e-34
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CBLIF,Cobalamin binding intrinsic factor,29433,0.0641913079754869,0.00528775842666384,0.0538273014592257,0.074555314491748,7.84880540000535e-34
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GAST,Gastrin,24845,0.112274480207557,0.00925893512949141,0.0941269673537541,0.13042199306136,9.57407826166203e-34
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FABP2,"Fatty acid-binding protein, intestinal",29478,-0.0674984405527337,0.00557135996737703,-0.0784183060887927,-0.0565785750166747,1.05478290530015e-33
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DEFB103A_DEFB103B,Beta-defensin 103,24109,0.0355790467239907,0.00293732498408169,0.0298218897551906,0.0413362036927908,1.13294562294405e-33
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,C7,Complement component C7,24374,-0.0279405434585213,0.00230962422342741,-0.032467406936439,-0.0234136799806035,1.36025625426278e-33
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SNX5,Sorting nexin-5,24240,0.0256912580739284,0.00212413862931232,0.0215279463604763,0.0298545697873806,1.40435577558877e-33
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CA4,Carbonic anhydrase 4,29820,-0.0204085250365611,0.00168836586382822,-0.0237177221296644,-0.0170993279434578,1.46932781995861e-33
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,UBAC1,Ubiquitin-associated domain-containing protein 1,29349,0.0295030810752897,0.00244085904601431,0.0247189973451017,0.0342871648054778,1.48374594989574e-33
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD101,Immunoglobulin superfamily member 2,24805,0.0367815316120806,0.00304526001937326,0.030812821974109,0.0427502412500522,1.70836043659904e-33
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD28,T-cell-specific surface glycoprotein CD28,28797,0.0312977438086789,0.00259430749047298,0.0262129011273518,0.0363825864900059,1.97047845143494e-33
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CRYM,Ketimine reductase mu-crystallin,24101,0.0652808240177205,0.00542768308392253,0.0546425651732323,0.0759190828622086,3.17678666791588e-33
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PSMD9,26S proteasome non-ATPase regulatory subunit 9,29349,0.0460527117805031,0.00384402267178025,0.0385184273438138,0.0535869962171924,5.37903578978064e-33
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DGKZ,Diacylglycerol kinase zeta,28931,0.0299799818453108,0.00252297532395765,0.0250349502103538,0.0349250134802678,1.73115302448793e-32
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",24240,0.0418986105123866,0.00352685156005696,0.034985981454675,0.0488112395700983,1.8531110712133e-32
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CASP9,Caspase-9,24229,0.0531963408083187,0.00447994242387561,0.0444156536575225,0.0619770279591149,1.97982885741334e-32
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GRN,Progranulin,29313,0.0207034887750753,0.00175182301575816,0.0172699156641893,0.0241370618859613,3.71727088050257e-32
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",24922,0.0448261768021,0.00379482858202452,0.0373883127813319,0.0522640408228681,4.10154788669635e-32
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SMARCA2,Probable global transcription activator SNF2L2,28774,0.0614450252822069,0.00520316882346666,0.0512468143882122,0.0716432361762016,4.15313556492828e-32
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CSDE1,Cold shock domain-containing protein E1,24111,0.0992633819118888,0.00842013135463998,0.0827599244567944,0.115766839366983,5.45806791287368e-32
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,C1QA,Complement C1q subcomponent subunit A,29646,-0.0189907494199888,0.00161211127799646,-0.0221504875248619,-0.0158310113151157,5.8296673238644e-32
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,24445,0.0319169772784328,0.00270932353651604,0.0266067031468614,0.0372272514100043,6.00978227602223e-32
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RGMB,RGM domain family member B,29694,0.0225104212266305,0.00191228899458072,0.0187623347972523,0.0262585076560087,6.45047986507679e-32
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PALM,Paralemmin-1,24657,0.0249904516403564,0.00212584731143475,0.0208237909099443,0.0291571123707685,8.0455180946754e-32
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CHCHD6,MICOS complex subunit MIC25,24793,0.0242267617562957,0.00206270162549327,0.0201838665703289,0.0282696569422625,9.07953214485772e-32
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FLT3LG,Fms-related tyrosine kinase 3 ligand,29786,0.0283063221755447,0.0024108904238274,0.023580976944843,0.0330316674062464,9.22831650228796e-32
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IGFBP6,Insulin-like growth factor-binding protein 6,29394,0.02501083136555,0.00213266593030686,0.0208308061421485,0.0291908565889514,1.08433636657959e-31
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,C2orf69,UPF0565 protein C2orf69,24195,0.0496855841921429,0.00424073612293634,0.0413737413911877,0.0579974269930982,1.28106478349619e-31
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VCAM1,Vascular cell adhesion protein 1,29545,-0.0227095115789179,0.00193953074532676,-0.0265109918397583,-0.0189080313180774,1.35009254656607e-31
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KLRF1,Killer cell lectin-like receptor subfamily F member 1,24229,0.0363442186208796,0.0031037545231527,0.0302608597555003,0.0424275774862589,1.38226118931584e-31
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,24793,0.0451701959041523,0.00385904218042907,0.0376064732305113,0.0527339185777932,1.45463883329806e-31
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LRRC37A2,Leucine-rich repeat-containing protein 37A2,24805,0.0355954968281653,0.00304552501765893,0.0296262677935538,0.0415647258627768,1.77974491862421e-31
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SBSN,Suprabasin,24905,-0.028588208541569,0.00245225590520177,-0.0333946301157645,-0.0237817869673735,2.52215911202233e-31
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PTPRR,Receptor-type tyrosine-protein phosphatase R,24845,0.0304371480567953,0.00261085734385215,0.0253198676628451,0.0355544284507455,2.52356597378143e-31
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FGFBP2,Fibroblast growth factor-binding protein 2,24938,0.0417765751732381,0.00358983900929439,0.0347404907150211,0.0488126596314551,3.20189670534395e-31
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SERPINI2,Serpin I2,24805,0.0469706521712082,0.00403701001051411,0.0390581125506006,0.0548831917918159,3.29758644450447e-31
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,28719,0.0395812794303471,0.00340563521384668,0.0329062344112076,0.0462563244494866,3.72882178213998e-31
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ZBP1,Z-DNA-binding protein 1,24229,0.0336377490752367,0.00289504336211711,0.0279634640854871,0.0393120340649862,3.9873169214059e-31
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ASGR2,Asialoglycoprotein receptor 2,24951,0.0215052306766827,0.00185347311835953,0.0178724233646981,0.0251380379886674,4.79992258262198e-31
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,29462,0.0478315002275768,0.00412846598960037,0.0397397068879601,0.0559232935671935,5.67950421931221e-31
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VGF,Neurosecretory protein VGF,24867,0.0249924337256517,0.00215811418177305,0.0207625299293765,0.0292223375219269,6.19998962722447e-31
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ACP6,Lysophosphatidic acid phosphatase type 6,29674,0.0547842225477599,0.00474397708483943,0.0454860274614746,0.0640824176340452,8.77680218281785e-31
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LGALS7_LGALS7B,Galectin-7,29320,0.0342559733865076,0.00297958193293664,0.0284159927979518,0.0400959539750634,1.5898969912623e-30
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",29378,0.0533659329213866,0.00464222578768196,0.04426717037753,0.0624646954652432,1.61048839637835e-30
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD300A,CMRF35-like molecule 8,24381,0.0245182296771567,0.00213243930419242,0.0203386486409396,0.0286978107133739,1.62342984670602e-30
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SFTPD,Pulmonary surfactant-associated protein D,29478,0.0545363882151537,0.00474961211428851,0.0452271484711482,0.0638456279591592,1.88020249387786e-30
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRSS22,Brain-specific serine protease 4,24229,0.0285492455738469,0.00248985015416065,0.023669139271692,0.0334293518760017,2.3348581145807e-30
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",24240,0.0303707642324617,0.00264967095261989,0.0251774091653267,0.0355641192995966,2.44899097093459e-30
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TOR1AIP1,Torsin-1A-interacting protein 1,24240,0.0417617945354138,0.00364655962373182,0.0346145376728995,0.0489090513979282,2.73770452679049e-30
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SPOCK1,Testican-1,29218,0.0208921293695872,0.00182836561900507,0.0173085327563373,0.0244757259828372,3.56668774420306e-30
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AHCY,Adenosylhomocysteinase,29478,0.0547908877525522,0.00479598886593937,0.045390749575311,0.0641910259297934,3.65947636671971e-30
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",29349,-0.0342409821145347,0.00299792457154587,-0.0401169142747646,-0.0283650499543048,3.77916724756008e-30
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CAPG,Macrophage-capping protein,29174,0.047278465832162,0.00414206929630091,0.0391600100114122,0.0553969216529118,4.11459358851377e-30
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL12RB1,Interleukin-12 receptor subunit beta-1,28931,0.030606995373266,0.00268879327189121,0.0253369605603592,0.0358770301861728,5.87499791106753e-30
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CTSC,Dipeptidyl peptidase 1,29446,0.0350451743878831,0.00308020302114893,0.0290079764664312,0.041082372309335,6.24813860550302e-30
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PDIA3,Protein disulfide-isomerase A3,24381,0.0202905167558225,0.00178315102488531,0.0167955407470472,0.0237854927645977,6.33045266701059e-30
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BRDT,Bromodomain testis-specific protein,24111,0.0297953894323287,0.00262178361835449,0.0246566935403539,0.0349340853243035,7.48032025917637e-30
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MANSC1,MANSC domain-containing protein 1,29566,-0.0222215837223821,0.00195842165488048,-0.0260600901659479,-0.0183830772788164,8.87845105737942e-30
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",29434,0.0348980110274061,0.00308086164381675,0.0288595222055252,0.0409364998492869,1.10682156486214e-29
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CPQ,Carboxypeptidase Q,24920,0.0296195225547863,0.00262343186591626,0.0244775960975904,0.0347614490119822,1.72697278975539e-29
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VWC2,Brorin,29114,0.0319754501435168,0.0028327999842786,0.0264231621743307,0.0375277381127028,1.74071831586038e-29
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VIT,Vitrin,24922,0.0302287822333905,0.00267776335001141,0.0249803660673682,0.0354771983994129,1.75760812062904e-29
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,29725,0.0257780777577524,0.00228907620669369,0.0212914883926327,0.030264667122872,2.33539135770721e-29
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADAMTSL4,ADAMTS-like protein 4,24240,0.0192497478598638,0.00171006385529652,0.0158980227034826,0.022601473016245,2.5372063379517e-29
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD276,CD276 antigen,29454,-0.0286047743007683,0.0025541731955624,-0.0336109537640706,-0.023598594837466,4.70889452602918e-29
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RNF149,E3 ubiquitin-protein ligase RNF149,24240,0.0245901224636089,0.00219651203082372,0.0202849588831944,0.0288952860440234,5.07894429116542e-29
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MOG,Myelin-oligodendrocyte glycoprotein,29725,0.0261129594365257,0.00233629702605795,0.0215338172654521,0.0306921016075993,6.03176374876256e-29
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KLK4,Kallikrein-4,29725,-0.0499042439067192,0.0044700272609595,-0.0586654973381998,-0.0411429904752385,6.96877539515096e-29
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AMFR,E3 ubiquitin-protein ligase AMFR,28774,0.0505538943858325,0.00453623463056928,0.0416628745099167,0.0594449142617483,8.72917178682598e-29
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SEL1L,Protein sel-1 homolog 1,24240,0.0253462246389774,0.00227419105361822,0.0208888101738856,0.0298036391040691,8.88354619665076e-29
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL5RA,Interleukin-5 receptor subunit alpha,29434,-0.0444670889914957,0.00399091862548035,-0.0522892894974371,-0.0366448884855542,8.93879044763149e-29
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AHSP,Alpha-hemoglobin-stabilizing protein,29400,0.0668191327543134,0.00599712879226223,0.0550647603214795,0.0785735051871474,8.96164863486879e-29
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FCER2,Low affinity immunoglobulin epsilon Fc receptor,29443,0.0401153146997813,0.00360283104928767,0.0330537658431775,0.0471768635563851,9.73996345985702e-29
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NOTCH1,Neurogenic locus notch homolog protein 1,29820,0.0125282602774417,0.00112600434171541,0.0103212917676795,0.0147352287872039,1.06433582147209e-28
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FABP6,Gastrotropin,28872,0.0443724768047677,0.00399601721419421,0.036540283064947,0.0522046705445883,1.36809623722565e-28
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,28797,0.0374035300392189,0.00336960293998753,0.0307991082768433,0.0440079518015944,1.42931636429831e-28
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CGREF1,Cell growth regulator with EF hand domain protein 1,29478,0.0335079009273857,0.00302475196578032,0.0275793870744562,0.0394364147803151,1.82798236139153e-28
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD248,Endosialin,24938,-0.031683724031052,0.00286194710522311,-0.0372931403572893,-0.0260743077048147,2.02757734880012e-28
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GCLM,Glutamate--cysteine ligase regulatory subunit,24111,0.0352784052466196,0.00319451248884012,0.029017160768493,0.0415396497247463,2.75728148306841e-28
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD163,Scavenger receptor cysteine-rich type 1 protein M130,29594,0.0334997810965177,0.00304811803437117,0.0275254697491502,0.0394740924438852,4.82078868032084e-28
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CENPF,Centromere protein F,24445,0.042372117927002,0.00386047705539414,0.0348055828984295,0.0499386529555745,5.80257232374335e-28
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FCRL2,Fc receptor-like protein 2,29645,0.038373914643795,0.00350170177588616,0.0315105791630581,0.0452372501245319,6.8325248350197e-28
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CTSB,Cathepsin B,29480,-0.0408245727983775,0.00372706803501186,-0.0481296261470008,-0.0335195194497543,7.23272659934321e-28
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TAFA5,Chemokine-like protein TAFA-5,29349,0.0281662768348554,0.00257272492358298,0.0231237359846328,0.033208817685078,7.68811650935028e-28
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MPO,Myeloperoxidase,29443,0.0356527407893923,0.00326050897841911,0.0292621431916909,0.0420433383870938,8.89583409522114e-28
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SLITRK6,SLIT and NTRK-like protein 6,28916,-0.0265257497707495,0.00243677877613031,-0.0313018361719649,-0.0217496633695341,1.52735597392835e-27
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GAS2,Growth arrest-specific protein 2,24445,0.0408808033107018,0.00376101953808172,0.0335092050160616,0.0482524016053419,1.85958539318633e-27
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CA1,Carbonic anhydrase 1,28867,0.0460483430168388,0.00424324198056392,0.0377315887349336,0.0543650972987441,2.20011065604829e-27
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL17D,Interleukin-17D,28931,0.0263523599084191,0.00242851389977626,0.0215924726648576,0.0311122471519805,2.2219663686082e-27
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LRRN1,Leucine-rich repeat neuronal protein 1,28931,0.0303352112284789,0.00280790884437564,0.0248317098935026,0.0358387125634551,3.73416608315882e-27
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLEC5A,C-type lectin domain family 5 member A,29395,-0.0223775063505948,0.00207652166434529,-0.0264474888127115,-0.018307523888478,4.99693654574804e-27
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CFC1,Cryptic protein,28797,0.0359302824781752,0.00334562944560941,0.0293728487647808,0.0424877161915697,7.4687063157392e-27
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KIT,Mast/stem cell growth factor receptor Kit,29545,-0.0224073798406071,0.00208795287357625,-0.0264997674728165,-0.0183149922083976,8.09340837920188e-27
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IGFBPL1,Insulin-like growth factor-binding protein-like 1,29478,0.0258020943381382,0.00240897905967773,0.0210804953811698,0.0305236932951065,1.01442829552011e-26
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CELA3A,Chymotrypsin-like elastase family member 3A,29789,0.0437680963804661,0.00408928615866619,0.0357530955094803,0.0517830972514518,1.10057300469322e-26
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SLC16A1,Monocarboxylate transporter 1,28774,0.0439073362557364,0.00410629226713934,0.0358590034121433,0.0519556690993295,1.23581061812385e-26
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CFHR5,Complement factor H-related protein 5,24623,0.03177850043953,0.00297277059104668,0.0259518700810785,0.0376051307979815,1.29896028943081e-26
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,24111,0.0503194101237828,0.00471216671673563,0.041083563358981,0.0595552568885847,1.46965467555724e-26
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LPA,Apolipoprotein(a),24484,-0.135619022499919,0.0127020258871878,-0.160514993238808,-0.110723051761031,1.49283971676314e-26
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SNX2,Sorting nexin-2,24793,0.0617204939876216,0.00578741836711434,0.0503771539880774,0.0730638339871657,1.70138349294732e-26
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CRYGD,Gamma-crystallin D,24845,0.0733746000773338,0.00688462842879093,0.0598807283569036,0.086868471797764,1.83043049896957e-26
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ACVRL1,Serine/threonine-protein kinase receptor R3,29169,0.0188222171276504,0.00176858567224651,0.0153557892100473,0.0222886450452536,2.11256431149039e-26
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IGHMBP2,DNA-binding protein SMUBP-2,24111,0.0421909188581752,0.0039651172601066,0.0344192890283663,0.0499625486879842,2.20926560117895e-26
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PTPRH,Receptor-type tyrosine-protein phosphatase H,24805,0.037074691398346,0.00348633564392501,0.030241473536253,0.043907909260439,2.35255617779433e-26
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CSPG4,Chondroitin sulfate proteoglycan 4,24938,-0.0249619333439988,0.00235058285027184,-0.0295690757305316,-0.020354790957466,2.75374045067501e-26
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL7R,Interleukin-7 receptor subunit alpha,29443,-0.0395389639223531,0.00372530323237114,-0.0468405582578006,-0.0322373695869057,2.87348734900248e-26
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,STAM,Signal transducing adapter molecule 1,24793,0.0276744559190235,0.00262286744693679,0.0225336357230274,0.0328152761150196,5.6925286918649e-26
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LACRT,Extracellular glycoprotein lacritin,24732,0.0373560104346868,0.00354314373509227,0.0304114487139059,0.0443005721554676,6.20047185916341e-26
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SCN4B,Sodium channel subunit beta-4,24240,0.0320311275157629,0.00304049941410813,0.026071748664111,0.0379905063674149,6.79135918437321e-26
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RNASE6,Ribonuclease K6,24828,0.022989197382413,0.0021857447163398,0.018705137738387,0.027273257026439,8.10702268137486e-26
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RNASE3,Eosinophil cationic protein,29343,0.0811110917443474,0.00771678241874919,0.065986198203599,0.0962359852850958,8.54417981789739e-26
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DKK3,Dickkopf-related protein 3,29820,-0.0219732605145435,0.00209153858028745,-0.0260726761319069,-0.0178738448971801,9.01245475454517e-26
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,24966,0.0193378237410798,0.00184119300727655,0.0157290854468177,0.0229465620353418,9.4824856069342e-26
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AGR2,Anterior gradient protein 2 homolog,28553,0.0752631626444643,0.00716711738187785,0.0612156125759837,0.0893107127129449,9.50562079896879e-26
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CILP,Cartilage intermediate layer protein 1,24938,0.0406469405997477,0.00387527528027399,0.0330514010504107,0.0482424801490847,1.10025191517091e-25
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PDCD1,Programmed cell death protein 1,29661,0.031969062230665,0.00304852121132538,0.0259939606564673,0.0379441638048628,1.10241140182116e-25
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FES,Tyrosine-protein kinase Fes/Fps,28797,0.0353288324876347,0.00337357006338417,0.0287166351634017,0.0419410298118677,1.2883779696247e-25
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ERBB4,Receptor tyrosine-protein kinase erbB-4,29566,-0.0178060833033921,0.00170125144296827,-0.0211405361316099,-0.0144716304751743,1.36537818725746e-25
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EPCAM,Epithelial cell adhesion molecule,29457,-0.0720577711636909,0.00688596075033088,-0.0855542542343395,-0.0585612880930424,1.39515979228392e-25
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TGFBR2,TGF-beta receptor type-2,29566,0.0243199125001633,0.0023279024939467,0.0197572236120278,0.0288826013882989,1.67294976777473e-25
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RCOR1,REST corepressor 1,28916,0.0331454183863093,0.00317355523841079,0.0269252501190241,0.0393655866535944,1.72829410829371e-25
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CDH5,Cadherin-5,29820,-0.0225093668494882,0.0021579277954317,-0.0267389053285343,-0.018279828370442,1.97970696880852e-25
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SUSD2,Sushi domain-containing protein 2,29443,-0.0211510429100025,0.00202958339097927,-0.0251290263563218,-0.0171730594636831,2.1929895600382e-25
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SCGB3A1,Secretoglobin family 3A member 1,24381,-0.0189355334314664,0.00181701167215292,-0.0224968763088862,-0.0153741905540467,2.24256337920691e-25
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SERPINA12,Serpin A12,28628,0.0828096903792048,0.00795073300110335,0.0672262536970423,0.0983931270613674,2.3424362358303e-25
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LMNB2,Lamin-B2,24845,0.0206959008851031,0.00199207439316862,0.0167914350744926,0.0246003666957136,3.13057138763546e-25
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ANGPTL1,Angiopoietin-related protein 1,29030,0.0215293771576993,0.00207407786538048,0.0174641845415536,0.025594569773845,3.37717856215075e-25
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CRH,Corticoliberin,28751,0.0639914578173374,0.00617659443295028,0.0518853327287548,0.0760975829059199,4.16004858036717e-25
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MEGF10,Multiple epidermal growth factor-like domains protein 10,29454,0.0290908016171587,0.00281458301675703,0.0235742189043149,0.0346073843300024,5.35903091585881e-25
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ITGA11,Integrin alpha-11,29434,-0.0251806599406551,0.00243651647106579,-0.0299562322239441,-0.0204050876573662,5.41785323794761e-25
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CST5,Cystatin-D,28890,0.0408141558252592,0.00394947235013717,0.0330731900189904,0.0485551216315281,5.46292103377714e-25
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",24793,0.0272681431321935,0.00263966924701207,0.0220943914080499,0.0324418948563372,5.7860589130647e-25
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,COPB2,Coatomer subunit beta',24111,0.0316318877984838,0.00306280126294737,0.0256287973231069,0.0376349782738606,5.94985818353305e-25
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RABEPK,Rab9 effector protein with kelch motifs,28797,0.0432388581550165,0.00419202928642224,0.0350224807536289,0.0514552355564041,6.69339386915514e-25
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CX3CL1,Fractalkine,29218,-0.0247494342718411,0.00240039895461739,-0.0294542162228912,-0.020044652320791,6.96618613195543e-25
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ALCAM,CD166 antigen,29820,0.0143136666072297,0.00139034618201335,0.0115885880904835,0.0170387451239759,8.16465615799134e-25
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,24805,-0.0250587808872103,0.00243621956571328,-0.0298337712360083,-0.0202837905384123,9.14618038835358e-25
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MCTS1,Malignant T-cell-amplified sequence 1,24805,0.0190600535839548,0.00185338897248234,0.0154274111978895,0.0226926959700202,9.34069006583957e-25
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BTN2A1,Butyrophilin subfamily 2 member A1,29581,0.0193149913479569,0.00187927551126148,0.0156316113458844,0.0229983713500294,9.75671614832588e-25
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD300C,CMRF35-like molecule 6,29694,0.0251617797597727,0.00245682212577813,0.0203464083932475,0.0299771511262978,1.41841780738534e-24
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",24805,0.0748564222044402,0.00730790445762255,0.0605329294675001,0.0891799149413804,1.42108777124103e-24
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",28719,0.0341643351404174,0.0033378303098172,0.0276221877331757,0.0407064825476591,1.51526054824684e-24
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AGER,Advanced glycosylation end product-specific receptor,29378,0.0296084452484467,0.00289400715516315,0.0239361912243269,0.0352806992725665,1.58431065576271e-24
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",28797,0.0367471554654145,0.00359699358288799,0.0296970480429541,0.043797262887875,1.84969087111445e-24
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,REG4,Regenerating islet-derived protein 4,29497,0.0359872354876762,0.00353152746651089,0.0290654416533149,0.0429090293220376,2.40494906814996e-24
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MYOM3,Myomesin-3,24381,-0.0676605004102249,0.00664552510408902,-0.0806857296142394,-0.0546352712062104,2.68650949035717e-24
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,29640,0.0209648819550678,0.00206043644310277,0.0169264265265864,0.0250033373835493,2.81183220028622e-24
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,29594,-0.0315278575042446,0.00310375678759803,-0.0376112208079367,-0.0254444942005524,3.34642632817271e-24
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SART1,U4/U6.U5 tri-snRNP-associated protein 1,24111,0.0263800267951517,0.00259912514969867,0.0212857415017423,0.0314743120885611,3.72200413575396e-24
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,24229,0.0430274019654469,0.00424370704132004,0.0347097361644596,0.0513450677664342,4.1392183848515e-24
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,C2CD2L,Phospholipid transfer protein C2CD2L,28719,0.0305057836530897,0.00301297638552632,0.0246003499374581,0.0364112173687213,4.70688408640283e-24
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD300LF,CMRF35-like molecule 1,29725,0.0433902414434436,0.00428667890478544,0.0349883507900642,0.0517921320968231,4.82237656777882e-24
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SORBS1,Sorbin and SH3 domain-containing protein 1,24867,0.0283428090465081,0.00280221692967328,0.0228504638643485,0.0338351542286678,5.30680937357734e-24
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MMP12,Macrophage metalloelastase,29466,0.0381541643396884,0.0037729624924525,0.0307591578544815,0.0455491708248953,5.32104690890244e-24
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD59,CD59 glycoprotein,28277,0.0165743976128811,0.00163901591896077,0.013361926411718,0.0197868688140442,5.34742167488327e-24
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRDX1,Peroxiredoxin-1,28669,-0.0648352136358644,0.0064135625139012,-0.0774057961631108,-0.0522646311086181,5.52446002290838e-24
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CHI3L1,Chitinase-3-like protein 1,28935,0.0565151907414417,0.00559532418373709,0.045548355341317,0.0674820261415664,6.02698662869432e-24
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NTRK2,BDNF/NT-3 growth factors receptor,29478,0.0184612391101821,0.00182915976488869,0.0148760859710003,0.0220463922493639,6.50567350066411e-24
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ICAM4,Intercellular adhesion molecule 4,29434,-0.0377250963121426,0.00374139531762642,-0.0450582311346904,-0.0303919614895948,7.17104541578307e-24
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DNAJB8,DnaJ homolog subfamily B member 8,28916,0.0412017071577355,0.0040881886901523,0.033188857325037,0.0492145569904341,7.55093586130659e-24
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EGFR,Epidermal growth factor receptor,29820,0.0117343366942334,0.00116489444460938,0.00945114358279902,0.0140175298056678,7.91581987179384e-24
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CTSF,Cathepsin F,29566,0.0286824545113692,0.00284916626374722,0.0230980886344246,0.0342668203883138,8.44745073102627e-24
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,S100A13,Protein S100-A13,24229,0.0252071992467083,0.0025038787689063,0.020299596859652,0.0301148016337646,8.58738674998226e-24
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FOLR2,Folate receptor beta,29694,-0.0208869885777559,0.00208092675798913,-0.0249656050234146,-0.0168083721320972,1.13935597700149e-23
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ECE1,Endothelin-converting enzyme 1,28774,0.0251323205768261,0.00250808189478961,0.0202164800630385,0.0300481610906138,1.35381558007502e-23
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CFHR2,Complement factor H-related protein 2,24789,0.0405739174875464,0.00405763075447747,0.0326209612087706,0.0485268737663223,1.69873755412349e-23
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,JAM2,Junctional adhesion molecule B,29694,0.0189660713743968,0.00189799341444146,0.0152460042820915,0.022686138466702,1.78696372926989e-23
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,S100A11,Protein S100-A11,29208,0.0323169727824405,0.00323466849660829,0.0259770225290883,0.0386569230357928,1.82368354990721e-23
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CDH1,Cadherin-1,28477,0.0284561702212346,0.00285182518628901,0.0228665928561082,0.0340457475863611,2.07407878744949e-23
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NPHS1,Nephrin,24229,0.0242166693306338,0.0024268072019528,0.0194601272148063,0.0289732114464613,2.0940900209914e-23
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RALY,RNA-binding protein Raly,24793,0.034177521201496,0.00342534934744737,0.0274638364804992,0.0408912059224928,2.11018088295828e-23
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AZU1,Azurocidin,28534,0.0542870069708363,0.00544229082413311,0.0436201169555354,0.0649538969861372,2.14146597858712e-23
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CA12,Carbonic anhydrase 12,29349,-0.0230762958189524,0.00231623864533731,-0.0276161235638135,-0.0185364680740912,2.41432184153052e-23
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GOT1,"Aspartate aminotransferase, cytoplasmic",24938,0.0296316070345472,0.00297696803732268,0.0237967496813947,0.0354664643876996,2.68795254808506e-23
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KLK6,Kallikrein-6,29519,0.0216358764563561,0.00217596386611559,0.0173709872787695,0.0259007656339426,2.93987225654556e-23
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LIPF,Gastric triacylglycerol lipase,24240,0.0432552951162672,0.00434984702399924,0.0347295949492287,0.0517809952833057,2.96524043030547e-23
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLEC4D,C-type lectin domain family 4 member D,29434,0.0432802649189707,0.00437130119224999,0.0347125145821607,0.0518480152557806,4.47848489928577e-23
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SIGLEC9,Sialic acid-binding Ig-like lectin 9,29683,0.0210834481230967,0.00212954679942404,0.0169095363962256,0.0252573598499678,4.50058423521848e-23
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GALNT7,N-acetylgalactosaminyltransferase 7,29349,0.014729909725153,0.00148988011683498,0.0118097446961564,0.0176500747541496,5.16840455850309e-23
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ULBP2,UL16-binding protein 2,29218,0.0268124784726267,0.00271339362873322,0.0214942269603096,0.0321307299849438,5.44009361007367e-23
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BAX,Apoptosis regulator BAX,28722,0.0630352584673834,0.00641942519569473,0.0504531850838217,0.075617331850945,1.00823365495746e-22
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,29443,0.0250858767087843,0.00255531742962007,0.0200774545467289,0.0300942988708396,1.02962746458275e-22
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL18BP,Interleukin-18-binding protein,29594,0.0215166769975871,0.00219357116989051,0.0172172775046017,0.0258160764905725,1.11558006092792e-22
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HMOX1,Heme oxygenase 1,29165,-0.0333545828024024,0.00341649556515662,-0.0400509141101093,-0.0266582514946954,1.76023189586809e-22
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCL21,C-C motif chemokine 21,29581,0.0281110460546052,0.00288490718942922,0.022456627963324,0.0337654641458865,2.11131525078196e-22
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD93,Complement component C1q receptor,28353,-0.0217805383357496,0.00223748085005845,-0.0261660008018642,-0.0173950758696351,2.33154476823696e-22
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,REPS1,RalBP1-associated Eps domain-containing protein 1,24229,0.0266894041360214,0.00274746808415724,0.0213043666910732,0.0320744415809696,2.88098681335018e-22
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,WASF3,Wiskott-Aldrich syndrome protein family member 3,28774,0.0580327715518189,0.00598680101208845,0.0462986415681255,0.0697669015355122,3.47623380337748e-22
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SPTLC1,Serine palmitoyltransferase 1,24845,0.0255909004895876,0.00264120141831203,0.0204141457096961,0.0307676552694792,3.67157799343245e-22
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NAMPT,Nicotinamide phosphoribosyltransferase,28797,0.0355289597184345,0.00367276055664076,0.0283303490274186,0.0427275704094504,4.21701529129564e-22
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AFAP1,Actin filament-associated protein 1,24381,0.0576804374297838,0.00598635846727775,0.0459471748339194,0.0694137000256482,6.20664532760787e-22
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FASLG,Tumor necrosis factor ligand superfamily member 6,29786,0.025060571975581,0.00261031885819796,0.019944347013513,0.030176796937649,8.54938757643565e-22
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CXCL9,C-X-C motif chemokine 9,29581,0.045313004307344,0.00472247090003545,0.0360569613432745,0.0545690472714135,9.01125465907485e-22
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NFYA,Nuclear transcription factor Y subunit alpha,24111,0.0262270535678794,0.00273525745534929,0.0208659489553948,0.0315881581803641,9.7716980986883e-22
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",28797,0.0540577532767009,0.00564295911682877,0.0429975534077165,0.0651179531456853,1.04881546727988e-21
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,24445,0.0493641269283446,0.00515328889659786,0.0392636806910128,0.0594645731656764,1.06827405656097e-21
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HMBS,Porphobilinogen deaminase,29725,0.0293073130945648,0.00306192458942963,0.0233059408992827,0.0353086852898469,1.131965417076e-21
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GPR15L,Protein GPR15L,24805,0.0415716958683076,0.00435252849610528,0.0330407400159412,0.0501026517206739,1.39706138464078e-21
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PECR,Peroxisomal trans-2-enoyl-CoA reductase,24240,0.0191233166342551,0.00200382134199309,0.0151958268039487,0.0230508064645616,1.50792157922708e-21
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PVALB,Parvalbumin alpha,29599,0.0760546765537198,0.00797831810664201,0.0604171730647014,0.0916921800427381,1.64594385863489e-21
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GC,Vitamin D-binding protein,24966,0.0174983955240365,0.00184144607961157,0.0138891612079979,0.0211076298400752,2.22646762627236e-21
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ITGB6,Integrin beta-6,28931,0.0205343516191215,0.00216277322561133,0.0162953160969233,0.0247733871413197,2.37812156948108e-21
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NRP2,Neuropilin-2,29443,-0.0193367665449609,0.00203678079604394,-0.023328856905207,-0.0153446761847148,2.39033927200191e-21
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VEGFD,Vascular endothelial growth factor D,29732,-0.0241195162418491,0.00254433436234106,-0.0291064115920376,-0.0191326208916606,2.73325259695821e-21
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SEPTIN8,Septin-8,24801,0.0216989067276845,0.00228955531050678,0.0172113783190912,0.0261864351362778,2.83399153942279e-21
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VAMP5,Vesicle-associated membrane protein 5,28916,0.0364138029841344,0.003844548159117,0.0288784885922651,0.0439491173760037,2.96032885658187e-21
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NAGA,Alpha-N-acetylgalactosaminidase,24177,0.039432654684987,0.00416511778766601,0.0312690238211616,0.0475962855488124,3.12402399073664e-21
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SCT,Secretin,24195,0.0315980348997572,0.00334187087957178,0.0250479679757965,0.0381481018237179,3.5077247000142e-21
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,29218,0.0199303389093238,0.00211510868343589,0.0157847258897895,0.0240759519288581,4.70330250491318e-21
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ENSA,Alpha-endosulfine,24793,0.035313803608726,0.00376002330420342,0.0279441579324873,0.0426834492849648,6.38340855186563e-21
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EBI3_IL27,Interleukin-27,29674,-0.0206429003104888,0.00219859451744001,-0.0249521455646712,-0.0163336550563063,6.46775380212386e-21
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],29349,0.0379067475026802,0.0040376624921143,0.0299929290181362,0.0458205659872242,6.52447911287555e-21
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FCRL3,Fc receptor-like protein 3,28931,0.0361207075839675,0.00385207723560549,0.0285706362021808,0.0436707789657543,7.27076975780625e-21
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,XG,Glycoprotein Xg,29693,0.0214407581050914,0.00228836187981273,0.0169555688206585,0.0259259473895244,7.78847787179661e-21
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD14,Monocyte differentiation antigen CD14,28954,0.0275431559311619,0.00294277201544586,0.0217753227808881,0.0333109890814358,8.56458386778335e-21
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MET,Hepatocyte growth factor receptor,29507,-0.0131441814186563,0.0014053732352284,-0.015898712959704,-0.0103896498776087,9.1195998124848e-21
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LTB,Lymphotoxin-beta,24793,0.0231617189790196,0.00248685961505894,0.0182874741335041,0.0280359638245352,1.33473826679961e-20
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SAA4,Serum amyloid A-4 protein,24966,0.0216311434298111,0.00232985664195025,0.0170646244115886,0.0261976624480336,1.75585483137055e-20
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PON1,Serum paraoxonase/arylesterase 1,24951,-0.0174635700921019,0.00188179902680223,-0.0211518961846343,-0.0137752439995696,1.82410550423703e-20
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ARID4B,AT-rich interactive domain-containing protein 4B,28774,0.0271635240516006,0.00292763588053626,0.0214253577257496,0.0329016903774517,1.83888751117022e-20
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NFIC,Nuclear factor 1 C-type,24867,0.0293758863468062,0.00316862758038588,0.0231653762892499,0.0355863964043626,1.99212254538848e-20
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRL,Prolactin,29694,-0.0499044069218064,0.00538670112803121,-0.0604623411327476,-0.0393464727108653,2.09063998991717e-20
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CABP2,Calcium-binding protein 2,24195,0.0430883767868073,0.00465255855044338,0.0339693620279383,0.0522073915456763,2.18422455939062e-20
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CDH15,Cadherin-15,29639,0.0380333444034991,0.00410888789736831,0.0299799241246572,0.0460867646823409,2.25335552867874e-20
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CHRDL1,Chordin-like protein 1,29536,0.020687186141035,0.0022392953837182,0.0162981671889473,0.0250762050931226,2.66836992951599e-20
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,29725,0.0169974862225063,0.00184031582385101,0.0133904672077584,0.0206045052372543,2.71944370155685e-20
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CSF3R,Granulocyte colony-stimulating factor receptor,24229,0.0202675761829821,0.00219510511644395,0.0159651701547519,0.0245699822112122,2.83900716176546e-20
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CR2,Complement receptor type 2,29594,0.0305410592410553,0.00330994586467013,0.0240535653463019,0.0370285531358088,2.96131992544696e-20
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",24240,0.0458353905121678,0.00497392589697832,0.0360864957540903,0.0555842852702453,3.3543448443114e-20
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AMPD3,AMP deaminase 3,24845,0.0464523172215783,0.00504474619026851,0.036564614688652,0.0563400197545046,3.57551088954976e-20
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VEGFB,Vascular endothelial growth factor B,24229,0.0189610965415755,0.00206074464296898,0.0149220370413563,0.0230001560417947,3.82148893516635e-20
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,INSR,Insulin receptor,24229,0.0111050223019442,0.00120939032345846,0.00873461726796567,0.0134754273359228,4.5469374622269e-20
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RHOC,Rho-related GTP-binding protein RhoC,29089,0.0760406634247271,0.00828245140613739,0.0598070586686978,0.0922742681807563,4.54878844582563e-20
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD300E,CMRF35-like molecule 2,29642,0.0265217125902024,0.00289571037374107,0.0208461202576699,0.0321973049227349,5.56744337155405e-20
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ITGAM,Integrin alpha-M,29443,-0.0205308793983954,0.00224894792797264,-0.0249388173372217,-0.016122941459569,7.33614376878147e-20
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MDM1,Nuclear protein MDM1,24195,0.0202672151304894,0.00223100587282202,0.0158944436197583,0.0246399866412206,1.12112685700191e-19
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRKD2,Serine/threonine-protein kinase D2,24111,0.0295112023961764,0.00325563988135201,0.0231301482287265,0.0358922565636264,1.34293413226064e-19
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TBC1D17,TBC1 domain family member 17,28774,0.0287393924159828,0.00317274816804703,0.0225208060066106,0.0349579788253549,1.40795416853091e-19
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DGCR6,Protein DGCR6,24101,0.0282604364197252,0.00311961019002112,0.0221460004472838,0.0343748723921665,1.41446768767375e-19
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,APOBR,Apolipoprotein B receptor,24240,-0.0274851819072921,0.00303526894397544,-0.033434309037484,-0.0215360547771002,1.46240047363626e-19
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCN3,CCN family member 3,29795,0.0217747034784288,0.00240644591622163,0.0170580694826344,0.0264913374742232,1.53542910100659e-19
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",24229,0.0286261709725901,0.00317720032249158,0.0223988583405066,0.0348534836046736,2.2115340422565e-19
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AGT,Angiotensinogen,24951,0.0147895799969622,0.00164386046450909,0.0115676134865243,0.0180115465074,2.48401882458037e-19
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PPM1A,Protein phosphatase 1A,28797,0.0199186093701474,0.0022156746066655,0.0155758871410831,0.0242613315992118,2.62327366237516e-19
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CRLF1,Cytokine receptor-like factor 1,29581,0.016487892348792,0.00183417572584394,0.0128929079261379,0.0200828767714461,2.63347034054729e-19
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SEZ6L2,Seizure 6-like protein 2,29349,-0.0152913044098204,0.00170420870126136,-0.0186315534642927,-0.0119510553553481,3.06231274217171e-19
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SERPINA7,Thyroxine-binding globulin,24966,0.0118253666859196,0.00131802105545315,0.00924204541723143,0.0144086879546078,3.10989324766687e-19
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL1B,Interleukin-1 beta,28745,0.035920258744039,0.00400593103397915,0.0280686339174398,0.0437718835706381,3.23422461006846e-19
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LYAR,Cell growth-regulating nucleolar protein,28797,0.0336760034635838,0.00376047642188318,0.0263054696766928,0.0410465372504748,3.58902399565808e-19
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLU,Clusterin,24966,0.0201972217177526,0.00225944292881236,0.0157687135772803,0.0246257298582248,4.1915730585516e-19
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TRAF3,"TNF receptor-associated factor 3, Isoform 2",24229,0.0229939496147197,0.00257392198287708,0.0179490625282806,0.0280388367011588,4.41732160562952e-19
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,24016,0.0424062451173543,0.00475601703516051,0.0330844517284397,0.0517280385062689,5.15539438754974e-19
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ATP6V1G2,V-type proton ATPase subunit G 2,24111,0.0631154845058709,0.00708310446886803,0.0492325997468896,0.0769983692648522,5.42154493587213e-19
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TPM3,Tropomyosin alpha-3 chain,24111,-0.0279977562076664,0.0031449226426076,-0.0341618045871773,-0.0218337078281555,5.83526062859003e-19
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,24922,0.0207417433839499,0.00233043471019981,0.0161740913519583,0.0253093954159415,5.93622980905977e-19
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",24240,0.048913058566815,0.0055026015219449,0.038127959583803,0.059698157549827,6.58155692037476e-19
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ITGBL1,Integrin beta-like protein 1,24938,0.0235625338816,0.00265284971628086,0.0183629484376895,0.0287621193255105,7.0017920930487e-19
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,24229,0.021335216878818,0.00240322626843741,0.0166248933926807,0.0260455403649553,7.28594485655248e-19
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PDGFRA,Platelet-derived growth factor receptor alpha,29478,-0.0179565959964395,0.00202542489536734,-0.0219264287913595,-0.0139867632015195,8.02909167318352e-19
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HSPA2,Heat shock-related 70 kDa protein 2,24793,0.0215062514070393,0.00242576554655363,0.0167517509357942,0.0262607518782845,8.09889398358051e-19
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL31RA,Interleukin-31 receptor subunit alpha,24134,0.0249608008974489,0.00281764871343777,0.0194382094191109,0.030483392375787,8.63899532524513e-19
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KIF1C,Kinesin-like protein KIF1C,24111,0.0228973740168994,0.00258672901383247,0.0178273851497877,0.027967362884011,9.18655606451209e-19
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,29786,0.0172458503864195,0.00195679954068549,0.0134105232866759,0.021081177486163,1.2799046937246e-18
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LUZP2,Leucine zipper protein 2,24793,0.0280293410992998,0.00318941635396161,0.021778085045535,0.0342805971530645,1.61581213435586e-18
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,INSL3,Insulin-like 3,24845,0.0471338730403294,0.00537544231342277,0.0365980061060208,0.057669739974638,1.92657395917316e-18
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BRK1,Protein BRICK1,28774,0.0278654260197166,0.00318248302019442,0.0216277593001356,0.0341030927392977,2.13403739143228e-18
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PSPN,Persephin,29434,0.0583187261079906,0.00668559733310098,0.0452149553351127,0.0714224968808685,2.84832691521619e-18
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BLVRB,Flavin reductase,29443,0.0403602155940767,0.00462716170278045,0.031290978656627,0.0494294525315264,2.86294573952141e-18
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BCL2,Apoptosis regulator Bcl-2,24805,0.0332398429510953,0.00382196707438108,0.0257487874853084,0.0407308984168823,3.61354386011818e-18
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,29760,0.023512654234803,0.00270645521567088,0.0182080020120881,0.0288173064575179,3.88719888545905e-18
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VSIG2,V-set and immunoglobulin domain-containing protein 2,24793,0.0367836985904318,0.00423702188824827,0.0284791356894652,0.0450882614913984,4.14204195617423e-18
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,YAP1,Transcriptional coactivator YAP1,24845,0.0166856673395257,0.00192513870666615,0.01291239547446,0.0204589392045914,4.69193304343019e-18
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LCP1,Plastin-2,24938,0.0291808763341069,0.0033781199925249,0.0225597611487581,0.0358019915194557,6.04686323750328e-18
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PCDH1,Protocadherin-1,29713,0.0130360633952489,0.00150933658003079,0.0100777636983886,0.0159943630921093,6.05735101412631e-18
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PCSK7,Proprotein convertase subtilisin/kexin type 7,24793,0.0276810194622978,0.00320485070246596,0.0213995120854645,0.0339625268391311,6.10051275438265e-18
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CTSH,Pro-cathepsin H,28852,0.0448136241554838,0.00521312341570676,0.0345959022606985,0.055031346050269,8.64139265814651e-18
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,24195,0.0332958201011588,0.0038818412265198,0.02568741129718,0.0409042289051376,1.0283586310357e-17
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SIGLEC6,Sialic acid-binding Ig-like lectin 6,29725,0.0204991306615437,0.00239066773019451,0.0158134219103625,0.025184839412725,1.04137068912908e-17
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LRRC25,Leucine-rich repeat-containing protein 25,29349,0.0237245965057392,0.00277320788808869,0.0182891090450853,0.029160083966393,1.23593442750452e-17
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD209,CD209 antigen,29527,-0.0236014653409665,0.00276647307830195,-0.0290237525744383,-0.0181791781074947,1.51597216975688e-17
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,B2M,Beta-2-microglobulin,24966,0.0188561445832422,0.00221378827168341,0.0145171195707427,0.0231951695957417,1.71957180515661e-17
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CHAD,Chondroadherin,24381,0.0314130548177523,0.00369053512105257,0.0241796059804892,0.0386465036550153,1.8099472761693e-17
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,COL24A1,Collagen alpha-1(XXIV) chain,24805,0.0336602497022359,0.00395596025163983,0.0259065676090218,0.04141393179545,1.85622488574375e-17
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GLYR1,Putative oxidoreductase GLYR1,24793,0.0359235685421785,0.00422522798330068,0.0276421216949091,0.0442050153894478,1.96431551303611e-17
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,29443,0.0180412602427239,0.0021222753124282,0.0138816006303646,0.0222009198550832,1.96877716076162e-17
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,THBS4,Thrombospondin-4,29518,0.027188215854098,0.00321441804839544,0.0208879564792429,0.0334884752289531,2.83873824896823e-17
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VIPR1,Vasoactive intestinal polypeptide receptor 1,24240,-0.0150166483688919,0.0017780475221486,-0.0185016215123032,-0.0115316752254807,3.19272269854488e-17
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LYZL2,Lysozyme-like protein 2,24016,0.0216815223057424,0.00256778238655332,0.0166486688280979,0.0267143757833869,3.24674826976236e-17
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,COL28A1,Collagen alpha-1(XXVIII) chain,24195,0.0462406072532722,0.00548683019511163,0.0354864200708534,0.056994794435691,3.72337459179234e-17
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ITGB1BP1,Integrin beta-1-binding protein 1,28797,0.0244855841140257,0.00290710468515215,0.0187876589311275,0.0301835092969239,3.84884875049933e-17
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,S100A14,Protein S100-A14,24867,0.0317126338263689,0.00376566096849601,0.0243319383281167,0.0390933293246211,3.91394739464784e-17
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLEC10A,C-type lectin domain family 10 member A,29218,-0.021675675547703,0.00257527054238246,-0.0267232058107726,-0.0166281452846334,4.04165412944518e-17
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FGA,Fibrinogen alpha chain,24407,0.0185218533995506,0.00220181751785328,0.0142062910645582,0.022837415734543,4.24602375933047e-17
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,24922,0.0201632586495617,0.00240257658564753,0.0154542085416925,0.0248723087574308,5.01510809708014e-17
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",29497,-0.0200938764850811,0.0023977333442121,-0.0247934338397368,-0.0153943191304254,5.50796019678779e-17
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",24240,0.0197106790670007,0.0023529752994828,0.0150988474800145,0.024322510653987,5.72409318193389e-17
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GSTT2B,Glutathione S-transferase theta-2B,24845,0.142467180097897,0.0170507239380955,0.10904776117923,0.175886599016564,6.85273475090213e-17
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GZMB,Granzyme B,29434,0.0387290258341424,0.00464008580702147,0.0296344576523804,0.0478235940159045,7.3284104765932e-17
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MEPE,Matrix extracellular phosphoglycoprotein,29454,0.0149404330365509,0.0017920364478734,0.011428041598719,0.0184528244743828,7.93938375539472e-17
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SCARF2,Scavenger receptor class F member 2,29694,-0.0172868691461468,0.00207388440486482,-0.0213516825796818,-0.0132220557126117,8.04605517789231e-17
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,B4GALT1,"Beta-1,4-galactosyltransferase 1",29581,0.0163372938768051,0.0019605728674549,0.0124945710565935,0.0201800166970167,8.22459964685733e-17
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,29218,0.0247415465019306,0.00297095252311754,0.0189184795566203,0.030564613447241,8.59041473792102e-17
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",24867,0.0249679476731494,0.00300888882458329,0.0190705255769661,0.0308653697693326,1.11135306960002e-16
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CSF2,Granulocyte-macrophage colony-stimulating factor,24111,0.021173445626132,0.00255364667967981,0.0161682981339595,0.0261785931183044,1.17649502071006e-16
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,OMD,Osteomodulin,29581,-0.0253979158898053,0.00306675819345191,-0.031408761948971,-0.0193870698306395,1.26513284153516e-16
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",29349,0.0203238876519244,0.00245717286775283,0.0155078288311288,0.0251399464727199,1.38108984367972e-16
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,24805,0.0233680443772008,0.00282652620201834,0.0178280530212449,0.0289080357331568,1.43691180971535e-16
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CSF1R,Macrophage colony-stimulating factor 1 receptor,24951,0.0235333249367053,0.00285242218539196,0.0179425774533371,0.0291240724200735,1.65726258514689e-16
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ANXA1,Annexin A1,24281,0.0250588710743637,0.00304696253861145,0.0190868244986853,0.0310309176500422,2.06224062801716e-16
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CA7,Carbonic anhydrase 7,24445,-0.020118719401495,0.00245056549578179,-0.0249218277732274,-0.0153156110297627,2.32345232363009e-16
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLEC4M,C-type lectin domain family 4 member M,24888,-0.0286290920702935,0.00348824268895466,-0.0354660477406446,-0.0217921363999424,2.37050360649533e-16
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNC,Tenascin,29594,-0.0277371784350342,0.00339118070592473,-0.0343838926186467,-0.0210904642514217,2.9704173111067e-16
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TSHB,Thyrotropin subunit beta,29478,0.0447279626798847,0.00546976635912889,0.0340072206159921,0.0554487047437773,3.01802092978703e-16
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SRPX,Sushi repeat-containing protein SRPX,24922,-0.0206164684194421,0.00252567612851186,-0.0255667936313254,-0.0156661432075589,3.42825645750248e-16
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GZMH,Granzyme H,28916,0.0443260045455837,0.00543642025402527,0.0336706208476942,0.0549813882434732,3.67630265180472e-16
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GNLY,Granulysin,29443,0.0302219313211762,0.00371053081220409,0.0229492909292561,0.0374945717130962,3.94449052760318e-16
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PBK,Lymphokine-activated killer T-cell-originated protein kinase,24016,-0.0177620633480841,0.00218056044091839,-0.0220359618122842,-0.0134881648838841,3.95488392172261e-16
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,28931,0.024685457804728,0.0030315612357283,0.0187435977827005,0.0306273178267554,4.01569705938042e-16
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,24111,0.0324559018730953,0.00400320136920774,0.0246096271894481,0.0403021765567424,5.41154381517463e-16
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PKD1,Polycystin-1,24922,0.0153388245133871,0.00189236034899579,0.0116297982293553,0.0190478507974188,5.4851575843248e-16
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PZP,Pregnancy zone protein,24966,0.0307038972217238,0.00379760284139815,0.0232605956525834,0.0381471987908642,6.49238564913592e-16
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TMPRSS11D,Transmembrane protease serine 11D,24801,0.0220639232802431,0.00273643653162019,0.0167005076782676,0.0274273388822187,7.77736995223128e-16
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AKR1C4,Aldo-keto reductase family 1 member C4,28916,0.0304617969070167,0.00379300262856204,0.0230275117550351,0.0378960820589983,1.0028769128292e-15
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,28916,-0.0175940297935568,0.00219201114987609,-0.0218903716473139,-0.0132976879397996,1.04125427844466e-15
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CGA,Glycoprotein hormones alpha chain,29443,0.0457340044374646,0.00570243447668157,0.0345572328631687,0.0569107760117604,1.09565902970699e-15
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GBP4,Guanylate-binding protein 4,28774,0.0279476809719952,0.00349365017087031,0.0211001266370894,0.034795235306901,1.29520471561874e-15
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RAB37,Ras-related protein Rab-37,28931,0.046451892201485,0.00585390666980442,0.0349782351286683,0.0579255492743016,2.17717613971563e-15
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,29349,0.0252772337616066,0.00319328340943701,0.0190183982791101,0.0315360692441032,2.54386280985101e-15
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KLRK1,NKG2-D type II integral membrane protein,24845,0.0261991987475502,0.0033100606834681,0.0197114798079527,0.0326869176871477,2.5748081156642e-15
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PADI4,Protein-arginine deiminase type-4,28722,0.039977875780326,0.00505372582443699,0.0300725731644295,0.0498831783962225,2.65364427155041e-15
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,29274,0.0146872341036941,0.00185773961419797,0.0110460644598661,0.0183284037475221,2.75156988588866e-15
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IFNG,Interferon gamma,28931,0.0639524775808739,0.00809647033116376,0.0480833957317929,0.0798215594299548,2.91514759937899e-15
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BCAM,Basal cell adhesion molecule,29443,-0.0134632512494072,0.00171194963181893,-0.0168186725277723,-0.0101078299710421,3.83869458620727e-15
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DPP7,Dipeptidyl peptidase 2,29279,0.0336316039872066,0.00428037119070948,0.025242076453416,0.0420211315209972,4.0631861438226e-15
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,OBP2B,Odorant-binding protein 2b,29137,-0.0348522890883585,0.00445418630433313,-0.0435824942448514,-0.0261220839318655,5.26393067150193e-15
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,29786,0.0193615748784666,0.00248779786250126,0.0144854910679641,0.024237658688969,7.33335415961476e-15
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DDR1,Epithelial discoidin domain-containing receptor 1,29694,0.0128776849937401,0.00165775044398895,0.00962849412352177,0.0161268758639584,8.21886862833545e-15
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,28916,0.0268849874612745,0.00346109615948509,0.0201012389886837,0.0336687359338653,8.25194439004871e-15
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SIGLEC10,Sialic acid-binding Ig-like lectin 10,29434,0.0187503787284905,0.00241814328858698,0.0140108178828601,0.023489939574121,9.18806824885098e-15
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LPCAT2,Lysophosphatidylcholine acyltransferase 2,29349,0.0214365540534469,0.00276480051541091,0.0160175450432416,0.0268555630636523,9.23655491912304e-15
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CA9,Carbonic anhydrase 9,29725,-0.0251915474525914,0.00325244812994755,-0.0315663457872886,-0.0188167491178942,9.82968452168705e-15
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL22RA1,Interleukin-22 receptor subunit alpha-1,28931,0.0237420372676917,0.00307170139808072,0.0177215025274535,0.0297625720079299,1.11656281068634e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NRCAM,Neuronal cell adhesion molecule,29478,0.0155478382494091,0.0020151628116842,0.0115981191385081,0.0194975573603102,1.2437941295924e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PDIA5,Protein disulfide-isomerase A5,24016,0.0337157132969256,0.00437504601117876,0.0251406231150153,0.042290803478836,1.34449841451952e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FSTL3,Follistatin-related protein 3,29351,0.0174747179578867,0.00226818521097213,0.0130290749443813,0.0219203609713921,1.35731532324853e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNFSF13,Tumor necrosis factor ligand superfamily member 13,29581,0.0147459009171222,0.00191517414485492,0.0109921595932066,0.0184996422410379,1.40843973196267e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRUNE2,Protein prune homolog 2,24445,0.0160207722793105,0.00208356098895546,0.0119369927409578,0.0201045518176632,1.53708443754815e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MRPL46,"39S ribosomal protein L46, mitochondrial",28774,0.0151022210350711,0.00196638658747508,0.01124810332362,0.0189563387465223,1.63891351835132e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DSG3,Desmoglein-3,29589,0.0186750742783408,0.00243199516222199,0.0139083637603857,0.0234417847962959,1.65389335987443e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SHISA5,Protein shisa-5,24938,0.013836376550329,0.00180373593468521,0.010301054118346,0.017371698982312,1.76951731660321e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IGSF21,Immunoglobulin superfamily member 21,24240,0.0217152610363707,0.00283234719615724,0.0161638605319025,0.0272666615408389,1.82839326371355e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,QPCT,Glutaminyl-peptide cyclotransferase,29517,0.0146345185123957,0.0019136514239519,0.0108837617214499,0.0183852753033414,2.11261890369e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PTPRS,Receptor-type tyrosine-protein phosphatase S,29820,-0.0133721290674966,0.00175141130509157,-0.0168048952254761,-0.00993936290951713,2.32459368911481e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GIMAP7,GTPase IMAP family member 7,24381,-0.0175790549613514,0.00230228189040871,-0.0220915274665525,-0.0130665824561504,2.33206476345569e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCN5,CCN family member 5,29443,0.0210794986683059,0.00276632924689701,0.0156574933443878,0.0265015039922241,2.612408693329e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,OSM,Oncostatin-M,29293,0.0384512770536753,0.00505380988993726,0.0285458096693982,0.0483567444379523,2.85890876529118e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SATB1,DNA-binding protein SATB1,24867,0.0160735848070489,0.00211504474102418,0.0119280971146415,0.0202190724994563,3.07419511863538e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NXPH1,Neurexophilin-1,28774,0.0206218545163838,0.00271825075233554,0.0152940830418061,0.0259496259909614,3.38734976042128e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,24805,0.0273134364925493,0.00360994614787655,0.0202379420427113,0.0343889309423874,3.97764537460134e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,24845,0.0339105696948778,0.00448420303646272,0.0251215317434109,0.0426996076463447,4.09930634820791e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,APOB,Apolipoprotein B-100,24951,0.0120370557543058,0.00160272515877967,0.00889571444309768,0.015178397065514,6.09376886180359e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CEBPA,CCAAT/enhancer-binding protein alpha,24229,0.0200461582312648,0.00266963995589129,0.0148136639177178,0.0252786525448117,6.16663655002222e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HSD17B3,Testosterone 17-beta-dehydrogenase 3,24111,0.0258538245252938,0.00344354066782668,0.0191044848163535,0.0326031642342341,6.21568361400019e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LRRC38,Leucine-rich repeat-containing protein 38,24195,0.0258215266096896,0.00344568584480732,0.0190679823538673,0.032575070865512,6.91636181497715e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL1RAP,Interleukin-1 receptor accessory protein,29443,-0.023271008842479,0.00311760867405854,-0.0293815218436338,-0.0171604958413243,8.60085039635182e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ECM1,Extracellular matrix protein 1,24349,0.0195500145773769,0.002619478022402,0.014415837653469,0.0246841915012849,8.71932278581729e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL6ST,Interleukin-6 receptor subunit beta,29478,0.00934101537841724,0.00125367818175751,0.00688380614217252,0.011798224614662,9.52565308778803e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ICOSLG,ICOS ligand,29349,0.0101189580831092,0.00135815265488029,0.00745697887954382,0.0127809372866746,9.55255285898811e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,28931,0.0193060053729565,0.00259312851661049,0.0142234734804,0.0243885372655131,9.95975967860002e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SEMA7A,Semaphorin-7A,29736,0.0145959365401494,0.00196631979677597,0.0107419497384685,0.0184499233418303,1.17587595573399e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PODXL,Podocalyxin,29349,0.0079964500664392,0.00107760238994652,0.00588434938214403,0.0101085507507344,1.19755733884451e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MYOM2,Myomesin-2,24111,-0.0269096174888853,0.00363727308282106,-0.0340386727312146,-0.0197805622465561,1.42453051754959e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SERPINI1,Neuroserpin,24329,0.0160680004277712,0.00217982556693393,0.0117955423165807,0.0203404585389617,1.74453631023878e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL34,Interleukin-34,28722,0.0189409389463082,0.00257187281442963,0.0139000682300261,0.0239818096625903,1.82388106948823e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DNER,Delta and Notch-like epidermal growth factor-related receptor,29382,0.0133541630043161,0.00181426096629086,0.00979821151038598,0.0169101144982462,1.8779571014136e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PDCD6,Programmed cell death protein 6,29478,-0.0366236518143712,0.00498241481102438,-0.046389184843979,-0.0268581187847634,2.02471883033434e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LAG3,Lymphocyte activation gene 3 protein,29349,-0.0212903303892148,0.00290492816789578,-0.0269839895982905,-0.0155966711801391,2.37788953391161e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FGF16,Fibroblast growth factor 16,24229,0.0250218645326681,0.00341409748245384,0.0183302334670586,0.0317134955982777,2.39168610151866e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,UXS1,UDP-glucuronic acid decarboxylase 1,28797,0.0274008332193719,0.00374389806779525,0.0200627930064933,0.0347388734322506,2.56744424697423e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PFDN2,Prefoldin subunit 2,28774,0.0289652715104132,0.00395768319060025,0.0212082124568367,0.0367223305639897,2.56851928296259e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ACTN2,Alpha-actinin-2,24111,-0.030885391418994,0.00422357097539252,-0.0391635905307633,-0.0226071923072246,2.70146364853597e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CPE,Carboxypeptidase E,29468,-0.0200623566015382,0.00274672267266866,-0.0254459330399688,-0.0146787801631076,2.86187364285278e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLGN,Calmegin,24195,0.0233870486971948,0.0032038070128062,0.0171075869520947,0.029666510442295,2.97163060271547e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MST1,Hepatocyte growth factor-like protein,24615,0.0333675480978715,0.00457318044798534,0.0244041144198202,0.0423309817759228,3.04621307304526e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,29536,0.0460685427868485,0.00633468260958542,0.0336525648720611,0.0584845207016359,3.61848682082317e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,USP47,Ubiquitin carboxyl-terminal hydrolase 47,24111,0.0443218493325234,0.00610003423392299,0.0323657822340344,0.0562779164310125,3.82012240777293e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,UROS,Uroporphyrinogen-III synthase,24195,0.0353474386121052,0.004866580956923,0.0258089399365361,0.0448859372876743,3.89189833604629e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DDI2,Protein DDI1 homolog 2,24381,0.0395348607551413,0.005459837206832,0.0288335798297506,0.050236141680532,4.58488666845017e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,24938,-0.0136216727582156,0.00188551498482864,-0.0173172821284797,-0.00992606338795145,5.17862053412185e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VSIG10,V-set and immunoglobulin domain-containing protein 10,24793,0.018093881350668,0.00250553222846586,0.0131830381828749,0.0230047245184611,5.28727288670353e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",28774,0.0155083947008199,0.00214944627949669,0.0112954799930064,0.0197213094086334,5.52411177996326e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,28916,-0.0109990152908316,0.00152589810614612,-0.013989775578878,-0.00800825500278525,5.80757395518345e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HGFAC,Hepatocyte growth factor activator,24720,0.014397526436012,0.00199952005030839,0.0104784671374076,0.0183165857346165,6.17121740151049e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DNPEP,Aspartyl aminopeptidase,24845,0.0298902178390259,0.00415189599709934,0.0217525016847112,0.0380279339933406,6.23015255032602e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRELP,Prolargin,29454,0.0119001136001051,0.00165456087830059,0.00865717427863593,0.0151430529215742,6.52236880258141e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RAB44,Ras-related protein Rab-44,24793,0.0215350267318869,0.00300170606754433,0.0156516828395,0.0274183706242738,7.47414646376404e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SCGB1A1,Uteroglobin,29523,0.0281892317085758,0.00393209025638593,0.0204823348060594,0.0358961286110922,7.73108980715537e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TDO2,"Tryptophan 2,3-dioxygenase",24195,0.0199151270727067,0.0027797040983011,0.0144669070400365,0.0253633471053768,8.03214045355234e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ATXN10,Ataxin-10,28774,0.0370706548018791,0.00517529231045948,0.0269270818733785,0.0472142277303797,8.08225197705258e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GPC1,Glypican-1,29725,0.0149879771658422,0.00209481554765205,0.0108821386924441,0.0190938156392402,8.57369080812716e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LEO1,RNA polymerase-associated protein LEO1,24867,0.0153357596572596,0.00214452878783561,0.0111324832331018,0.0195390360814174,8.84608138999582e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,OLFM4,Olfactomedin-4,23498,0.0624805819694359,0.00877998053656217,0.0452718201177741,0.0796893438210978,1.14085512954197e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ACP1,Low molecular weight phosphotyrosine protein phosphatase,24229,0.0222983509892788,0.00313549629713347,0.0161527782468972,0.0284439237316604,1.17904358656402e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TFPI2,Tissue factor pathway inhibitor 2,29473,0.01971140578794,0.00277653402957318,0.0142693990899766,0.0251534124859034,1.28242275436606e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FABP3,"Fatty acid-binding protein, heart",24922,0.0255947847703639,0.00360900582090045,0.018521133361399,0.0326684361793287,1.35795047063395e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,24240,0.0316814388158169,0.00447547664107281,0.0229095045993142,0.0404533730323196,1.49268226783848e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRTG,Protogenin,29725,0.0125456697857706,0.00177271614050989,0.00907114615037119,0.01602019342117,1.50476462957537e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SIL1,Nucleotide exchange factor SIL1,24240,0.0163006281772333,0.00230436373247194,0.0117840752615883,0.0208171810928783,1.54836502798899e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NBL1,Neuroblastoma suppressor of tumorigenicity 1,29566,0.0135478972149453,0.00191717462904016,0.00979023494202659,0.017305559487864,1.62298249077833e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SNU13,NHP2-like protein 1,24111,0.0314778647117036,0.00445934081940134,0.022737556705677,0.0402181727177302,1.72424144893836e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MTPN,Myotrophin,28916,0.0164597226134763,0.00233256012405522,0.0118879047703281,0.0210315404566246,1.74588378893664e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CRTAP,Cartilage-associated protein,24195,0.0245353474665611,0.0034772319302833,0.0177199728832059,0.0313507220499164,1.75985671718631e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CRISP3,Cysteine-rich secretory protein 3,24738,-0.0135899051975695,0.00193041488816518,-0.0173735183783732,-0.00980629201676573,1.97421471801413e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ACAN,Aggrecan core protein,29192,0.0141409633850022,0.00201228293079929,0.0101968888406356,0.0180850379293688,2.15153249034871e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MATN3,Matrilin-3,29169,-0.0160379728214511,0.00228733815136547,-0.0205211555981274,-0.0115547900447747,2.40682725535373e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PILRA,Paired immunoglobulin-like type 2 receptor alpha,29443,0.0210839787126457,0.00300739170686823,0.0151894909671839,0.0269784664581074,2.42206817712873e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BCL2L15,Bcl-2-like protein 15,24229,0.0281453776202264,0.00402215036489669,0.0202619629050289,0.0360287923354239,2.67179055950345e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SCGB2A2,Mammaglobin-A,24111,-0.0156929080692526,0.00225166444382904,-0.0201061703791575,-0.0112796457593477,3.2633517227037e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BAMBI,BMP and activin membrane-bound inhibitor homolog,28797,0.0148456833752648,0.00213628943136006,0.0106585560897991,0.0190328106607305,3.74958827346611e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LIF,Leukemia inhibitory factor,28774,0.0253926742085734,0.00365745529115049,0.0182240618379184,0.0325612865792283,3.92795596689436e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RBFOX3,RNA binding protein fox-1 homolog 3,24867,0.019021704774965,0.00274225254374529,0.0136468897892243,0.0243965197607058,4.11711011122684e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PROCR,Endothelial protein C receptor,24111,-0.0177048444248735,0.00255587928303099,-0.0227143678196142,-0.0126953210301328,4.40343886370329e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RSPO3,R-spondin-3,29725,0.013929135993849,0.00201727691233393,0.00997527324567449,0.0178829987420235,5.12413773298686e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ARG1,Arginase-1,29216,0.0253844567468095,0.00368407760137759,0.0181636646481094,0.0326052488455095,5.679798250004e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ICAM5,Intercellular adhesion molecule 5,29478,0.0220129188071509,0.00320017014926581,0.01574058531459,0.0282852522997119,6.16196559954575e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DSG4,Desmoglein-4,29242,0.0242328914720969,0.00352523350764798,0.0173234337971069,0.0311423491470869,6.36243238018445e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CFHR4,Complement factor H-related protein 4,24892,0.0358498076266436,0.00521561262118088,0.0256272068891291,0.0460724083641582,6.40996621542734e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LY9,T-lymphocyte surface antigen Ly-9,29116,0.0144035597065164,0.00209566765240565,0.0102960511078013,0.0185110683052314,6.41247590715794e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SAT2,Thialysine N-epsilon-acetyltransferase,24445,0.034095256041041,0.00496079173280151,0.0243721042447501,0.043818407837332,6.4401378831169e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TK1,"Thymidine kinase, cytosolic",24445,0.0224254737607969,0.00326448714350628,0.0160270789595246,0.0288238685620692,6.59622208035152e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CNTN1,Contactin-1,29820,-0.0133108077426028,0.00193911929352839,-0.0171114815579184,-0.00951013392728716,6.80986624061497e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD7,T-cell antigen CD7,24177,0.0213567544395814,0.00311327114971711,0.0152547429861358,0.0274587658930269,7.05676577923918e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RNASE1,Ribonuclease pancreatic,24951,0.0119056796783958,0.00173642840607462,0.00850228000248958,0.0153090793543021,7.22556011042179e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LAMTOR5,Ragulator complex protein LAMTOR5,24793,0.019935477690555,0.00291080400694576,0.0142303018369413,0.0256406535441687,7.62196080221799e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DUSP3,Dual specificity protein phosphatase 3,28774,0.0414934111935205,0.00606096127609392,0.0296139270923765,0.0533728952946646,7.74620815153598e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FABP1,"Fatty acid-binding protein, liver",29454,0.0456488281627849,0.00668426658306375,0.0325476656599799,0.0587499906655898,8.69903458871031e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MAEA,E3 ubiquitin-protein transferase MAEA,28797,0.0193080504758131,0.00283686265795222,0.0137477996662267,0.0248683012853994,1.02226055502583e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DEFA1_DEFA1B,Neutrophil defensin 1,28862,0.02538580248156,0.00373239419650747,0.0180703098564054,0.0327012951067146,1.05570141866224e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EFNA1,Ephrin-A1,29390,0.0136509033660398,0.00201001661876602,0.0097112707932584,0.0175905359388212,1.13135329435763e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CSF1,Macrophage colony-stimulating factor 1,29581,0.0130159500590195,0.00192092248409612,0.0092509419901911,0.0167809581278479,1.25964969876238e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TSPAN8,Tetraspanin-8,24805,0.0480947891433202,0.00713512572678326,0.034109942718825,0.0620796355678154,1.61231223175298e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLASP1,CLIP-associating protein 1,24016,0.0350678194881208,0.00520503293341367,0.0248659549386301,0.0452696840376116,1.65017540341141e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CHL1,Neural cell adhesion molecule L1-like protein,29542,-0.0148056830232426,0.00219905661111701,-0.0191158339810319,-0.0104955320654532,1.69541578814052e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LMOD1,Leiomodin-1,24867,-0.0169999984305284,0.0025285514123834,-0.0219559591987999,-0.0120440376622569,1.81606266831218e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ATXN2,Ataxin-2,24101,0.0531389729932156,0.00790859305058297,0.037638130614073,0.0686398153723582,1.8687214659291e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SDK2,Protein sidekick-2,24381,0.0184805979345282,0.00276147805328014,0.0130681009500992,0.0238930949189573,2.24479385203156e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CASP1,Caspase-1,28774,0.0323250889628354,0.0048329031306377,0.0228525988267855,0.0417975790988853,2.29528813678317e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FOSB,Protein fosB,28774,0.0184438480865654,0.0027575603445136,0.0130390298113188,0.0238486663618121,2.29652474074534e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PGA4,Pepsin A-4,24951,0.0338797983016582,0.00506559506863058,0.0239512319671423,0.0438083646361741,2.30682868942439e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BRD1,Bromodomain-containing protein 1,24445,-0.0146110605168254,0.00218850897892786,-0.018900538115524,-0.0103215829181268,2.50366514614847e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SDC1,Syndecan-1,29478,0.0190740109928393,0.00286017629288496,0.0134680654587848,0.0246799565268938,2.62417551195351e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ALPP,"Alkaline phosphatase, placental type",29349,0.0490241198763879,0.00735955497260676,0.0345993921300786,0.0634488476226971,2.76232076972712e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SFTPA1,Pulmonary surfactant-associated protein A1,28797,0.0272812546169755,0.00411358214957524,0.019218633603808,0.0353438756301429,3.37041447078643e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,24922,0.0130050850437872,0.0019610505239085,0.00916142601692651,0.0168487440706478,3.38651620203657e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SIRPB1,Signal-regulatory protein beta-1,29409,0.0217492668925327,0.00328362956118142,0.0153133529526171,0.0281851808324483,3.56731269016299e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KEL,Kell blood group glycoprotein,28774,0.0168746808283791,0.00255457132511421,0.0118677210311552,0.0218816406256029,4.025956824363e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CREBZF,CREB/ATF bZIP transcription factor,24016,-0.01229956723857,0.0018695174057867,-0.0159638213539119,-0.00863531312322804,4.83353982611003e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,29114,0.0155495546265477,0.00236818140509403,0.0109079190725634,0.020191190180532,5.25431918848158e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SPARCL1,SPARC-like protein 1,29489,-0.0127829867350929,0.0019540716410073,-0.0166129671514672,-0.00895300631871862,6.18113471684047e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FUCA1,Tissue alpha-L-fucosidase,29623,0.0381574743328888,0.0058499866821726,0.0266915004358305,0.0496234482299471,7.01838879583775e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GGT5,Glutathione hydrolase 5 proenzyme,29218,0.0108109590848293,0.00165785832770553,0.00756155676252646,0.0140603614071322,7.09612185244852e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SLAMF7,SLAM family member 7,29434,-0.0271836997347863,0.00417105720099148,-0.0353589718487296,-0.019008427620843,7.27794043895992e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,STX3,Syntaxin-3,24845,0.0178021630671171,0.00273468860061173,0.0124421734099181,0.0231621527243161,7.67080485547649e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,REG3G,Regenerating islet-derived protein 3-gamma,24793,0.018483442087475,0.00284947875844211,0.0128984637209284,0.0240684204540215,8.94478287764363e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CST1,Cystatin-SN,21656,0.0485828669792774,0.0074905569371017,0.0339013753825581,0.0632643585759967,9.01203190491781e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PMS1,PMS1 protein homolog 1,24195,0.0234008555721105,0.0036212160760965,0.0163032720629613,0.0304984390812596,1.05188560118779e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MRC1,Macrophage mannose receptor 1,24951,0.0130114494208384,0.00201724568893267,0.00905764787053035,0.0169652509711464,1.13819747065977e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FCRLB,Fc receptor-like B,28797,0.0280681078561242,0.0043603801592165,0.0195217627440599,0.0366144529681886,1.23711435055834e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,24195,0.0475470580150205,0.00738782196379595,0.0330669269659804,0.0620271890640605,1.25068899802433e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KLK8,Kallikrein-8,28443,0.0164734909007342,0.00256309314224135,0.0114498283419411,0.0214971534595272,1.32041048480632e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NECTIN1,Nectin-1,24229,0.0148281103681101,0.00230809907925347,0.0103042361727733,0.0193519845634469,1.34866353734142e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EIF5,Eukaryotic translation initiation factor 5,24111,0.0201787610106723,0.00314209655750228,0.0140202517579678,0.0263372702633768,1.36940979160036e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD86,T-lymphocyte activation antigen CD86,24805,0.0136934712855899,0.00213360292676147,0.00951160954913746,0.0178753330220424,1.40568505184417e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BOC,Brother of CDO,28916,-0.0106412978858619,0.00166754985863335,-0.0139096956087832,-0.00737290016294051,1.78136508056051e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PEPD,Xaa-Pro dipeptidase,24951,0.0118999816539243,0.00186493868635758,0.0082447018286634,0.0155552614791851,1.7914544812899e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SSH3,Protein phosphatase Slingshot homolog 3,24016,0.0133548302474742,0.00209296837069957,0.00925261224090306,0.0174570482540454,1.79370367372365e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TGFB2,Transforming growth factor beta-2 proprotein,24793,0.0238427304360781,0.00373704253891511,0.0165181270598045,0.0311673338123517,1.80090734290283e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CDHR1,Cadherin-related family member 1,28774,0.019416206763233,0.00304421967822112,0.0134495361939196,0.0253828773325464,1.82072105542935e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PREB,Prolactin regulatory element-binding protein,28931,0.0131083774306227,0.00206624045442567,0.00905854613994838,0.017158208721297,2.27079776509221e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,C8B,Complement component C8 beta chain,24966,0.0137352089010908,0.00216579289220515,0.00949025483236871,0.0179801629698129,2.30859531908841e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CYTL1,Cytokine-like protein 1,24938,0.0109026692097873,0.0017208915193826,0.00752972183179744,0.0142756165877772,2.4064959325829e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HSBP1,Heat shock factor-binding protein 1,24240,0.043108104834034,0.0068236134529812,0.0297338224661908,0.0564823872018771,2.70468173882293e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",24867,0.0320693301167946,0.00508146303014314,0.022109662577714,0.0420289976558751,2.81838425663211e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EDN1,Endothelin-1,24240,0.0131208586634117,0.00208215506356898,0.00903983473881645,0.0172018825880069,2.99705088578004e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,29218,0.0312706842466376,0.00496876193674194,0.0215319108506234,0.0410094576426517,3.14879538372282e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MUC16,Mucin-16,29349,0.0845859016271405,0.0134406509156882,0.0582422258323917,0.110929577421889,3.15198050725287e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GPNMB,Transmembrane glycoprotein NMB,28733,0.0128312462634305,0.00204025213976112,0.0088323520694987,0.0168301404573623,3.24012091673523e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EPHX2,Bifunctional epoxide hydrolase 2,28916,0.0276061603310949,0.00439750960414384,0.0189870415069729,0.0362252791552168,3.48539739386129e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,29454,0.0172760977459344,0.00276922872935139,0.0118484094364056,0.0227037860554631,4.47520515419328e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GM2A,Ganglioside GM2 activator,24421,0.017049710960383,0.00273890907524907,0.0116814491728948,0.0224179727478711,4.89393756940528e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CST7,Cystatin-F,29498,0.041172422631918,0.0066153475924933,0.0282063413506312,0.0541385039132049,4.91866707155697e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,24867,-0.0167434988801964,0.00269655317990182,-0.0220287431128039,-0.0114582546475888,5.40901395854133e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL6,Interleukin-6,29349,0.0325530245453603,0.00524400242040298,0.0222747798013705,0.0428312692893501,5.44963531557399e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLSTN2,Calsyntenin-2,29786,-0.0174741896898798,0.00281621939897196,-0.0229939797118649,-0.0119543996678948,5.54733162604641e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SERPINA1,Alpha-1-antitrypsin,24548,-0.00359340478426861,0.000579825197298726,-0.00472986217097411,-0.00245694739756311,5.83195524554782e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RAB6A,Ras-related protein Rab-6A,29434,0.0203731951336615,0.00329581863073803,0.0139133906174149,0.026832999649908,6.43172650628632e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LGALS4,Galectin-4,29454,0.0239627934108396,0.0038794482331105,0.016359074873943,0.0315665119477362,6.62456883477871e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EGFLAM,Pikachurin,24805,0.0135512235696335,0.00219516363205778,0.00924870285080029,0.0178537442884668,6.79516175105821e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,24229,0.0137124541050099,0.00222563740905355,0.00935020478326495,0.0180747034267549,7.33632175059045e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PLIN3,Perilipin-3,29478,0.0186259937305175,0.00302785191846602,0.0126914039703241,0.0245605834907109,7.77139856874597e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MYL3,Myosin light chain 3,24240,-0.0319934963041653,0.00521615023900059,-0.0422171507726065,-0.0217698418357242,8.72716932336882e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CNPY2,Protein canopy homolog 2,28916,0.0265528896921277,0.00433471235144712,0.0180568534832913,0.035048925900964,9.14839682683771e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FABP9,Fatty acid-binding protein 9,29434,0.0244237623718376,0.00398739590789456,0.0166084663923642,0.0322390583513109,9.16926606669682e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD48,CD48 antigen,29536,0.0130397535294373,0.00213141444666851,0.00886218121396706,0.0172173258449076,9.60148327342003e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TINAGL1,Tubulointerstitial nephritis antigen-like,29425,0.00967278333109818,0.00158494976308238,0.0065662817954567,0.0127792848667396,1.05464183333284e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RPS10,40S ribosomal protein S10,24111,-0.0182583951388576,0.00299181840762426,-0.0241223592178012,-0.0123944310599141,1.05832625309927e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,F3,Tissue factor,29541,-0.0118502119659781,0.00194448355736943,-0.0156613997384222,-0.00803902419353398,1.11296052786746e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SLURP1,Secreted Ly-6/uPAR-related protein 1,24801,0.0162072485510676,0.00266186988417616,0.0109899835780823,0.0214245135240529,1.15525065432781e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,28498,-0.0369382647938121,0.00608786481373843,-0.0488704798287394,-0.0250060497588848,1.31534411301275e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRDX2,Peroxiredoxin-2,24556,0.0265423954197427,0.00439107017760408,0.0179358978716387,0.0351488929678467,1.51913131720054e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ARHGAP5,Rho GTPase-activating protein 5,24016,0.0330444988376884,0.00546693073888077,0.0223293145894821,0.0437596830858947,1.52147332117149e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EFHD1,EF-hand domain-containing protein D1,24867,0.0151222258897173,0.00251274166673848,0.0101972522229099,0.0200471995565248,1.78816992754022e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EPHB4,Ephrin type-B receptor 4,29820,-0.0106715821841816,0.00177501696151282,-0.0141506154287467,-0.00719254893961646,1.85260745848927e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLC,Galectin-10,29426,-0.0282991378732295,0.00471873447394807,-0.0375478574421677,-0.0190504183042912,2.03104033693934e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NAPRT,Nicotinate phosphoribosyltransferase,24845,0.0141397070621671,0.00236919833405653,0.00949607832741626,0.0187833357969179,2.43227807403703e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RPA2,Replication protein A 32 kDa subunit,24229,0.0135201559309109,0.00226936252568089,0.00907220538057637,0.0179681064812455,2.59363566453647e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SAFB2,Scaffold attachment factor B2,24867,0.0116431183285436,0.00195570872105467,0.00780992923527643,0.0154763074218107,2.66150593176677e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LHB,Lutropin subunit beta,28797,0.0368490618753387,0.00619272495215318,0.0247113209691184,0.0489868027815589,2.70612817177452e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ANPEP,Aminopeptidase N,29531,0.0118772677157224,0.00199621779422611,0.00796468083903925,0.0157898545924056,2.7135158090362e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CHGA,Chromogranin-A,24938,-0.03721918076754,0.00625871719278474,-0.0494862664653981,-0.0249520950696819,2.77120540121454e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GIPC2,PDZ domain-containing protein GIPC2,24845,0.0126142186849043,0.00212174658580608,0.00845559537672437,0.0167728419930842,2.79799035952005e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CKAP4,Cytoskeleton-associated protein 4,29678,0.0114720044960889,0.00193326394794414,0.0076828071581184,0.0152612018340594,2.98904839032263e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,COL1A1,Collagen alpha-1(I) chain,29820,-0.010547086731024,0.0017792112397939,-0.0140343407610201,-0.00705983270102799,3.10099285796014e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GBP2,Guanylate-binding protein 2,28931,0.0252947121205214,0.00426937698210276,0.0169267332356,0.0336626910054428,3.16435177871163e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,29218,0.0440620277413057,0.00744040580708498,0.0294788323594192,0.0586452231231923,3.2161848166968e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CTRL,Chymotrypsin-like protease CTRL-1,24845,-0.0286751052804221,0.00485184100715298,-0.0381847136544419,-0.0191654969064022,3.46258570745845e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MNAT1,CDK-activating kinase assembly factor MAT1,24445,0.0184513085491396,0.0031308041405843,0.0123149324335943,0.0245876846646848,3.83124407005839e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,24111,-0.0132362221670645,0.00224875995575379,-0.0176437916803419,-0.00882865265378707,4.00869069281884e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ERC2,ERC protein 2,24195,0.0315432319443516,0.00537847097803624,0.0210014288274006,0.0420850350613026,4.55739366463896e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RANBP2,E3 SUMO-protein ligase RanBP2,24101,-0.0138822586730452,0.00236807141399705,-0.0185236786444795,-0.00924083870161103,4.6255139485369e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,WFDC2,WAP four-disulfide core domain protein 2,27939,0.0166921917187278,0.00284793278838009,0.0111102434535028,0.0222741399839527,4.64803145919077e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KLK14,Kallikrein-14,29725,-0.0192281863524998,0.00328079422373112,-0.0256585430310127,-0.0127978296739868,4.65408747879567e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GBA,Lysosomal acid glucosylceramidase,24195,0.0224340098909364,0.00384694014946521,0.0148940071979846,0.0299740125838883,5.55799585953058e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PILRB,Paired immunoglobulin-like type 2 receptor beta,29478,0.0238487990050114,0.00409070646382474,0.0158310143359149,0.0318665836741079,5.60064386717212e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VIM,Vimentin,28916,0.0483823764579235,0.00829902954659425,0.0321162785465988,0.0646484743692483,5.60551378474562e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DDC,Aromatic-L-amino-acid decarboxylase,29433,-0.0200232141411222,0.00343680556969648,-0.0267593530577273,-0.0132870752245171,5.73239760922945e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DSC2,Desmocollin-2,29135,-0.0142363687736701,0.00244530061721458,-0.0190291579834107,-0.00944357956392953,5.87818517143635e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EPO,Erythropoietin,29434,0.0314353897791122,0.00540267838544339,0.0208461401436431,0.0420246394145812,5.99990973989566e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,24793,0.0277344861392895,0.00476655398206332,0.0183920403344453,0.0370769319441336,6.00866041946046e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PLA2G2A,"Phospholipase A2, membrane associated",29402,-0.0229737599197795,0.00396099351253405,-0.0307373072043463,-0.0152102126352128,6.699400966762e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NEO1,Neogenin,24867,0.00906065604914361,0.00156282615754873,0.0059975167803481,0.0121237953179391,6.8080357961158e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CALB1,Calbindin,29349,0.0179528918615306,0.00310584821167321,0.0118654293666511,0.0240403543564101,7.52994754590911e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CELA2A,Chymotrypsin-like elastase family member 2A,24938,0.0251461850361146,0.00437237215915733,0.0165763356041662,0.0337160344680629,8.96722508456282e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TPSAB1,Tryptase alpha/beta-1,29753,0.0213811894886194,0.00372567501218605,0.0140788664647348,0.0286835125125041,9.62315471059345e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PSMD1,26S proteasome non-ATPase regulatory subunit 1,24867,0.0199618518045151,0.0034784712366894,0.0131440481806039,0.0267796554284263,9.65231363668255e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MILR1,Allergin-1,28931,-0.0205819474807047,0.00359362332268756,-0.0276254491931723,-0.013538445768237,1.03020396907677e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NPTX2,Neuronal pentraxin-2,24938,-0.0135967512457314,0.00237733726868011,-0.0182563322923444,-0.00893717019911841,1.08174629230069e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DLL4,Delta-like protein 4,24240,0.0349949333158463,0.00613169473387863,0.0229768116374442,0.0470130549942484,1.16176158828812e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NPR1,Atrial natriuretic peptide receptor 1,24111,-0.0167568766614926,0.0029459589133268,-0.0225309561316131,-0.0109827971913721,1.29956457702525e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,24938,-0.0160459063920504,0.00283053763416172,-0.0215937601550074,-0.0104980526290934,1.45343267204926e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GART,Trifunctional purine biosynthetic protein adenosine-3,24867,0.0108828026963543,0.00192089533327172,0.00711784784314172,0.0146477575495669,1.48230112813813e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLIC5,Chloride intracellular channel protein 5,24195,-0.0128613940005016,0.00227415460565446,-0.0173187370275844,-0.00840405097341888,1.57181678176221e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DDX25,ATP-dependent RNA helicase DDX25,24195,-0.0152026762110915,0.00268814433369446,-0.0204714391051326,-0.00993391331705035,1.57188747551553e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KIAA1549L,UPF0606 protein KIAA1549L,24445,-0.0113823904439992,0.0020147398009969,-0.0153312804539531,-0.00743350043404526,1.62649408512079e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRSS53,Serine protease 53,24845,0.0150059242126547,0.0026625782250148,0.00978727089162568,0.0202245775336837,1.76072401917361e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AHNAK2,Protein AHNAK2,24240,0.0119538987505689,0.00212246398501525,0.00779386933993898,0.0161139281611988,1.80016251834208e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VCAN,Versican core protein,29694,-0.0120144550297019,0.00213813577669153,-0.0162052011520173,-0.0078237089073865,1.93644450421646e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NEDD9,Enhancer of filamentation 1,24229,0.0133609717299071,0.00237838713058543,0.00869933295395968,0.0180226105058546,1.95684697994109e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LRP1,Prolow-density lipoprotein receptor-related protein 1,29349,-0.0106106155283312,0.00188921992589909,-0.0143134865830934,-0.00690774447356899,1.96740123950876e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,28916,0.0141103234499119,0.00251276020396626,0.00918531345013803,0.0190353334496858,1.97830016817149e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ODAM,Odontogenic ameloblast-associated protein,28722,0.0213092740080269,0.00381898970068915,0.0138240541946762,0.0287944938213776,2.42937518217041e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL1R1,Interleukin-1 receptor type 1,29390,-0.00913515884355774,0.00163755248225461,-0.0123447617087768,-0.0059255559783387,2.44673589970534e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TDGF1,Teratocarcinoma-derived growth factor 1,28774,0.0575212995685218,0.0103278065228509,0.0372787987837341,0.0777638003533095,2.57669554302967e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,COL9A2,Collagen alpha-2(IX) chain,24445,0.0180641503220458,0.00324600245305675,0.0117019855140546,0.024426315130037,2.64832771169714e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LXN,Latexin,29117,-0.0265159331909515,0.00478670152278439,-0.0358978681756089,-0.0171339982062941,3.05957344825041e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DPEP1,Dipeptidase 1,29163,-0.0191000268755004,0.00345568876175609,-0.0258731768485423,-0.0123268769024585,3.28303153957225e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RBPMS,RNA-binding protein with multiple splicing,24229,0.025405474295469,0.00459642565473472,0.016396480012189,0.0344144685787491,3.28689240553277e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",24845,0.0215311894672685,0.00391342281396663,0.0138608807518939,0.0292014981826431,3.79466850591567e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TPPP3,Tubulin polymerization-promoting protein family member 3,28774,0.0153507621211612,0.00279045174048898,0.0098814767098028,0.0208200475325196,3.80480220876298e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LMNB1,Lamin-B1,24756,0.0230341156717312,0.00419168692139609,0.0148184093057948,0.0312498220376675,3.94137039080953e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GLP1R,Glucagon-like peptide 1 receptor,24101,-0.0148161283850458,0.00270571993317277,-0.0201193394540644,-0.00951291731602717,4.39754209444334e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLPS,Colipase,29400,0.0276182412351549,0.00504589054508436,0.0177282957667895,0.0375081867035202,4.45055439232864e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ITM2A,Integral membrane protein 2A,29434,-0.0234802946504023,0.00429872333870072,-0.0319057923942557,-0.0150547969065489,4.74194369592802e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNFSF8,Tumor necrosis factor ligand superfamily member 8,24938,0.0141134469658838,0.00258384367336624,0.00904911336608599,0.0191777805656816,4.74789119493487e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,24805,-0.0272633069418866,0.00502405274861586,-0.0371104503291737,-0.0174161635545995,5.79897398289655e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EDA2R,Tumor necrosis factor receptor superfamily member 27,29725,-0.0148144637925439,0.00273168659988016,-0.020168569528309,-0.00946035805677879,5.8999878707266e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SNX18,Sorting nexin-18,24805,0.0172399694788192,0.00318043418264378,0.0110063184808373,0.023473620476801,5.99419852277802e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EPHB6,Ephrin type-B receptor 6,29163,0.0122940543778882,0.00226998054369547,0.00784489251224505,0.0167432162435313,6.14529165354791e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EXTL1,Exostosin-like 1,24111,0.0183758971315863,0.00339501160885376,0.0117216743782329,0.0250301198849396,6.27029349446396e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RCC1,Regulator of chromosome condensation,24793,0.0198658799099012,0.00367098395058918,0.0126707513667464,0.027061008453056,6.30448403832864e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD55,Complement decay-accelerating factor,28490,0.0101226096478444,0.00187108706261988,0.00645527900510945,0.0137899402905794,6.35269539674506e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SPON1,Spondin-1,29497,0.0126263318188168,0.0023366343507713,0.00804652849130506,0.0172061351463286,6.58074197376826e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TRIM26,Tripartite motif-containing protein 26,24016,0.0215571055937414,0.0039966285836947,0.0137237135696997,0.029390497617783,6.96261907620624e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PI3,Elafin,29014,0.0211087747934503,0.00392052669236977,0.0134245424764055,0.028793007110495,7.33454253056863e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SIGLEC1,Sialoadhesin,29581,0.0162436663365753,0.00302128872469227,0.0103219404361785,0.0221653922369722,7.65638122786834e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CDH3,Cadherin-3,29694,0.0137984182521973,0.00257605615674435,0.00874934818497833,0.0188474883194162,8.55218155674623e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NELL2,Protein kinase C-binding protein NELL2,29581,0.0108423684981103,0.00203286282765146,0.00685795735591347,0.0148267796403072,9.70196924653578e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,QSOX1,Sulfhydryl oxidase 1,24502,0.0162030204248781,0.003038567592917,0.0102474279427608,0.0221586129069954,9.77530208008457e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MBL2,Mannose-binding protein C,24610,-0.0410547032021118,0.00770380613313202,-0.0561541632230506,-0.0259552431811731,9.95442361409651e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GAL,Galanin peptides,29581,-0.0244475661615086,0.0045888992983406,-0.0334418087862561,-0.015453323536761,1.0027667325026e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SPP1,Osteopontin,29757,-0.0174672801302069,0.0032813265864055,-0.0238986802395617,-0.0110358800208522,1.02674709228614e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RNF43,E3 ubiquitin-protein ligase RNF43,24445,0.0220994019222124,0.00415332372384008,0.0139588874234859,0.030239916420939,1.04166904584856e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,UBE2B,Ubiquitin-conjugating enzyme E2 B,24793,0.0108580968740312,0.00204070539617716,0.00685831429752397,0.0148578794505385,1.04233568245659e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PSMG4,Proteasome assembly chaperone 4,24229,0.0212771098246509,0.00400348409769898,0.0134302809931609,0.0291239386561409,1.07808646773187e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PCDH12,Protocadherin-12,24867,0.00967273780288359,0.00182115168800888,0.00610328049438618,0.013242195111381,1.09763403757181e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NPTX1,Neuronal pentraxin-1,29443,0.0153518596343105,0.00289340550717345,0.00968078484025051,0.0210229344283704,1.12984325225964e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,29694,0.0268185040401781,0.00506313918837004,0.0168947512309728,0.0367422568493834,1.18679639784849e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CPA4,Carboxypeptidase A4,23902,0.0165073006222507,0.00312880976046294,0.0103748334917434,0.0226397677527581,1.33254256562683e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,24240,0.0138814853229361,0.00263278280443938,0.00872123102623491,0.0190417396196373,1.35692545844857e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LYPD3,Ly6/PLAUR domain-containing protein 3,29340,0.0128649464329774,0.00244697603364712,0.00806887340702907,0.0176610194589258,1.47058616661779e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLEC6A,C-type lectin domain family 6 member A,28797,0.0175986001245025,0.00335083479181903,0.0110309639325372,0.0241662363164678,1.5152106835798e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BCL7B,B-cell CLL/lymphoma 7 protein family member B,24793,0.0167652934849261,0.00320322354912661,0.010486975328638,0.0230436116412143,1.673382426749e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,STX5,Syntaxin-5,24229,0.0152493397088848,0.00291475237285155,0.00953642505809579,0.0209622543596739,1.69283445403728e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FMR1,Synaptic functional regulator FMR1,28797,0.0131769521999715,0.00253097785254603,0.00821623560898124,0.0181376687909617,1.93997668085113e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,24445,0.0240870089316528,0.00462726306291571,0.015017573328338,0.0331564445349676,1.95086955632645e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CSF3,Granulocyte colony-stimulating factor,28931,0.0179508575281254,0.00344874631791801,0.0111913147450061,0.0247104003112447,1.95280394182101e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NXPH3,Neurexophilin-3,24229,0.0112321011054973,0.00215826880675794,0.00700189424425174,0.0154623079667429,1.96403384322898e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HEPACAM2,HEPACAM family member 2,24845,-0.0155334450490228,0.0029948240699385,-0.0214033002261022,-0.0096635898719433,2.15658684659576e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ROBO4,Roundabout homolog 4,24240,-0.00666199217952293,0.00128483119061629,-0.00918026131313087,-0.00414372304591499,2.17620476458503e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,24805,0.00791258388748605,0.00152878475273446,0.00491616577212651,0.0109090020028456,2.28785503542225e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,24966,-0.00715609216336,0.00138541590119457,-0.00987150732970136,-0.00444067699701864,2.41894749889851e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,C1QL2,Complement C1q-like protein 2,24229,0.0157729026195737,0.00306350236898072,0.00976843797637151,0.021777367262776,2.64418889389407e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,24111,0.0188461051760592,0.00366677928651037,0.0116592177744989,0.0260329925776196,2.77341355561253e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CHRM1,Muscarinic acetylcholine receptor M1,24195,-0.013537338748615,0.00263556580483081,-0.0187030477260834,-0.00837162977114665,2.82213399204662e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CDK1,Cyclin-dependent kinase 1,24016,0.0133433856247408,0.0026037532386088,0.00824002927706753,0.018446741972414,3.00362647805734e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,APOA4,Apolipoprotein A-IV,24966,0.01295038049855,0.00254755171969252,0.00795717912795266,0.0179435818691473,3.73294780834844e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DCN,Decorin,28916,-0.00827898470068436,0.00162937052677932,-0.0114725509331718,-0.0050854184681969,3.77602115513976e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CNTN4,Contactin-4,29443,-0.00867048662044808,0.00171288677514934,-0.0120277446997408,-0.00531322854115538,4.17565935445936e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VWF,von Willebrand factor,29820,-0.0260941441888139,0.00516188369613434,-0.0362114362332372,-0.0159768521443906,4.32574890648358e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DCTPP1,dCTP pyrophosphatase 1,29478,0.0113864094676367,0.00226125006596104,0.00695435933835305,0.0158184595969203,4.79539286871482e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SOD2,"Superoxide dismutase [Mn], mitochondrial",29443,0.0134559091837126,0.00267714437849557,0.00820870620186123,0.0187031121655639,5.03179797619485e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NCR1,Natural cytotoxicity triggering receptor 1,29375,0.0132367434666238,0.00263801583994585,0.0080662324203299,0.0184072545129176,5.26017696539725e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PDCD1LG2,Programmed cell death 1 ligand 2,29349,0.0111669874220997,0.00222561619763846,0.00680477967472832,0.0155291951694711,5.26589435647743e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KLK11,Kallikrein-11,29296,0.0110124943608154,0.00219634980528452,0.00670764874245777,0.0153173399791731,5.36213717933152e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SLC13A1,Solute carrier family 13 member 1,24793,0.0218310354720629,0.00435479126492624,0.0132956445928075,0.0303664263513184,5.39270876354518e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FCAR,Immunoglobulin alpha Fc receptor,29434,0.0170240934490621,0.00339960036042006,0.0103608767426388,0.0236873101554855,5.54097355254863e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL10RA,Interleukin-10 receptor subunit alpha,28931,0.0207598886171278,0.00414957141107361,0.0126267286514235,0.028893048582832,5.68051065240092e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MSLN,Mesothelin,29293,0.0198573812061887,0.00398324589371986,0.0120502192544977,0.0276645431578796,6.22424790855306e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VSTM1,V-set and transmembrane domain-containing protein 1,28774,0.0174164614056309,0.00351103806668301,0.0105348267949322,0.0242980960163296,7.07170095113432e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD99,CD99 antigen,29443,-0.00692940911171632,0.00139982039811164,-0.00967305709201515,-0.0041857611314175,7.45417568967413e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,M6PR,Cation-dependent mannose-6-phosphate receptor,24240,0.0143562134634844,0.00290197002738472,0.00866835220981033,0.0200440747171585,7.58481166840683e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GFRA2,GDNF family receptor alpha-2,29349,0.00739543588333027,0.00149720075664181,0.00446092240031233,0.0103299493663482,7.8750076659911e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL17RA,Interleukin-17 receptor A,29443,0.0154731726244317,0.00313570493613234,0.00932719094961235,0.0216191542992511,8.07899248862413e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FGFR4,Fibroblast growth factor receptor 4,24381,0.0186145305123505,0.00377417443421877,0.0112171486212818,0.0260119124034193,8.18938655354293e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LSM1,U6 snRNA-associated Sm-like protein LSm1,28797,0.0195017220708443,0.00395893687394553,0.011742205797911,0.0272612383437775,8.43952021414495e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SMPD1,Sphingomyelin phosphodiesterase,29530,-0.0172486206268402,0.00350495713713821,-0.0241183366156311,-0.0103789046380493,8.6474999308667e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PDRG1,p53 and DNA damage-regulated protein 1,24195,0.0182799598387251,0.00373022562069684,0.0109687176221593,0.0255912020552909,9.62127690851361e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SLAMF8,SLAM family member 8,28797,0.0186916924690106,0.00381722856466155,0.0112099244822739,0.0261734604557472,9.80042746249489e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NDRG1,Protein NDRG1,28774,0.0235077848619822,0.00480213041760387,0.0140956092434786,0.0329199604804858,9.86960508616909e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ACHE,Acetylcholinesterase,24381,0.011451034617233,0.00235550061812084,0.00683425340571619,0.0160678158287499,1.17282822499412e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PDGFRB,Platelet-derived growth factor receptor beta,29820,0.0120158069007794,0.00247413493874927,0.00716650242083081,0.0168651113807279,1.20042243049015e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD200,OX-2 membrane glycoprotein,29434,-0.00913120672597825,0.00188943719638518,-0.0128345036308932,-0.00542790982106329,1.35327514042418e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EP300,Histone acetyltransferase p300,24229,0.0103807178192848,0.00215497118601422,0.00615697429469698,0.0146044613438727,1.4653811916158e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LYPD8,Ly6/PLAUR domain-containing protein 8,28797,0.0176595246830316,0.00368341535925225,0.0104400305788972,0.024879018787166,1.64030609447271e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VTCN1,V-set domain-containing T-cell activation inhibitor 1,28797,-0.0109423587883873,0.00229153893819771,-0.0154337751072548,-0.0064509424695198,1.80488592590205e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RAB39B,Ras-related protein Rab-39B,24111,0.0307707083486875,0.00644479859910519,0.0181389030944413,0.0434025136029337,1.81209380777652e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IFNGR1,Interferon gamma receptor 1,29581,0.00710849775939644,0.00149703775839695,0.00417430375293841,0.0100426917658545,2.06016926599328e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADAMTSL5,ADAMTS-like protein 5,24922,-0.0132821635574101,0.00281016989588949,-0.0187900965533535,-0.00777423056146666,2.29712394449575e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SERPINA11,Serpin A11,29820,-0.0137393215891766,0.00291419118982989,-0.0194511363212432,-0.00802750685711002,2.43249348950071e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SIRT1,NAD-dependent protein deacetylase sirtuin-1,24229,0.0292412261087007,0.00620477322234486,0.0170798705929048,0.0414025816244966,2.45815748612572e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RLN1,Prorelaxin H1,24867,-0.0231007887077792,0.0049107755487182,-0.0327259087832669,-0.0134756686322915,2.56356350427986e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,29820,0.00917789815002214,0.00195274320284066,0.00535052147245444,0.0130052748275898,2.6131979733477e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SYT1,Synaptotagmin-1,24845,0.0132418249308576,0.00281794743695362,0.00771864795442847,0.0187650019072867,2.62706780309775e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NTF4,Neurotrophin-4,28797,0.0131544967194302,0.00281140925399676,0.00764413458159655,0.0186648588572638,2.89631460562735e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EPHA4,Ephrin type-A receptor 4,24381,0.00953853171118391,0.00204073313831356,0.00553869476008933,0.0135383686622785,2.96866520678308e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FAM171B,Protein FAM171B,24793,0.00903846474987625,0.00193616681398885,0.0052435777944581,0.0128333517052944,3.0540151901128e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,C9orf40,Uncharacterized protein C9orf40,24805,0.0266007634317778,0.00571859955093934,0.0153923083119367,0.0378092185516189,3.31033965749122e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,24445,0.0146293439941465,0.00315804269880052,0.00843958030449744,0.0208191076837955,3.63298952483142e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD34,Hematopoietic progenitor cell antigen CD34,29593,0.00799693655185266,0.00172666650813147,0.00461267019591497,0.0113812029077903,3.64691476379362e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CENPJ,Centromere protein J,24445,0.0236915139004237,0.00512507077865082,0.0136463751742681,0.0337366526265793,3.8076794625135e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",28774,0.017618687241573,0.00383913110104378,0.0100939902835272,0.0251433841996188,4.46744951267426e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,24101,0.0202093757147557,0.00440709594860785,0.0115714676554843,0.0288472837740271,4.54863625278182e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,29218,-0.0093083793134135,0.002033770650884,-0.0132945697891461,-0.00532218883768085,4.73843040803421e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KRT8,"Keratin, type II cytoskeletal 8",24101,0.0237251747242001,0.00519086263299762,0.0135510839635248,0.0338992654848755,4.8882621485299e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD160,CD160 antigen,29786,0.0151624540422182,0.0033371970394507,0.00862154784489484,0.0217033602395416,5.55529191841541e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,JCHAIN,Immunoglobulin J chain,28931,-0.01992086818729,0.00438920538792562,-0.0285237107476242,-0.0113180256269558,5.68555818594689e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FAM3D,Protein FAM3D,24805,0.0272601286043548,0.00602742813049649,0.0154463694685816,0.0390738877401279,6.13444051966893e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PLA2G1B,Phospholipase A2,29787,-0.013867071399502,0.00306723423705867,-0.019878850504137,-0.00785529229486697,6.1775179725704e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MUC2,Mucin-2,24938,0.0294983660758852,0.00652475687884901,0.0167098425933411,0.0422868895584292,6.18340711256263e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TYMP,Thymidine phosphorylase,29301,0.0213379467888629,0.00473456160351228,0.0120582060459788,0.030617687531747,6.6052424653489e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PCDHB15,Protocadherin beta-15,24793,-0.0128443217957271,0.00285481659719651,-0.0184397623262323,-0.00724888126522199,6.85273558923806e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,24240,-0.00674011928275488,0.00149879455444257,-0.00967775660946232,-0.00380248195604744,6.92299592154335e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ART3,Ecto-ADP-ribosyltransferase 3,29594,-0.0110006492705946,0.00244908385472251,-0.0158008536258507,-0.00620044491533852,7.09105388822004e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NTF3,Neurotrophin-3,29434,0.0111019529336532,0.00247210339380648,0.00625663028179251,0.0159472755855139,7.11944477572098e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DRAXIN,Draxin,29218,0.0136895821735823,0.00305381918268382,0.00770409657552201,0.0196750677716426,7.39588473342092e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ACSL1,Long-chain-fatty-acid--CoA ligase 1,24111,-0.0120333382522154,0.00268688519498715,-0.0172996332343902,-0.00676704327004059,7.54982637741282e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SLC28A1,Sodium/nucleoside cotransporter 1,24016,0.018916591842759,0.00423657139140917,0.0106129119155971,0.027220271769921,8.04068850326796e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,COMP,Cartilage oligomeric matrix protein,29214,0.0106805117181501,0.00239398517241397,0.00598830078021871,0.0153727226560815,8.17320041825455e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BRD3,Bromodomain-containing protein 3,24111,0.0152370410002595,0.00341692032517336,0.00853987716291972,0.0219342048375993,8.26026411419412e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GSTP1,Glutathione S-transferase P,28604,-0.0221359221749857,0.00496679654619797,-0.0318708434055337,-0.0124010009444377,8.3515576170538e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,COL9A1,Collagen alpha-1(IX) chain,29434,0.0148119513909769,0.00333471278886734,0.00827591432479688,0.0213479884571569,8.95563063134995e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EPHA2,Ephrin type-A receptor 2,28347,0.00991411862679399,0.00224057696848833,0.00552258776855688,0.0143056494850311,9.6888704657891e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,29345,0.0583597773540533,0.0131932727673229,0.0325009627301004,0.0842185919780062,9.74865736656154e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NMRK2,Nicotinamide riboside kinase 2,24016,-0.0130966669816194,0.0029655648451258,-0.018909174078066,-0.00728415988517285,1.00867983885461e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,29454,0.00922324007310799,0.00210289667518666,0.00510156258974213,0.0133449175564739,1.15870872187998e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CHRDL2,Chordin-like protein 2,29478,0.0166535453609166,0.00380040467167679,0.00920475220443004,0.0241023385174031,1.17976340388142e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SOD3,Extracellular superoxide dismutase,24951,-0.0186870232465187,0.00426883441561091,-0.0270539387011161,-0.0103201077919213,1.2051036553678e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CEP290,Centrosomal protein of 290 kDa,24445,0.0165376338356987,0.00378838838875551,0.00911239259373788,0.0239628750776595,1.27441538234107e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FOLH1,Glutamate carboxypeptidase 2,24229,0.0329661763566686,0.00756953144091665,0.018129894732472,0.0478024579808652,1.33543297065515e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TYRO3,Tyrosine-protein kinase receptor TYRO3,29478,0.00874431541673791,0.00201857875505945,0.00478790105682138,0.0127007297766544,1.48305204792699e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NME1,Nucleoside diphosphate kinase A,24229,-0.00674695057552377,0.00156316113480702,-0.00981074639974553,-0.00368315475130201,1.59351893747388e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ELAVL4,ELAV-like protein 4,24101,0.0260588358325768,0.00604422612298361,0.0142121526315289,0.0379055190336247,1.62897594628156e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TGFBR3,Transforming growth factor beta receptor type 3,29820,-0.00969867948980782,0.00225362748841328,-0.0141157893670979,-0.00528156961251779,1.68591031894422e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CFD,Complement factor D,24966,0.00599500896532493,0.00139396989385019,0.00326282797337855,0.0087271899572713,1.70926501908845e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ATP6V1D,V-type proton ATPase subunit D,29349,0.00798150672975906,0.00185681477725336,0.00434214976634247,0.0116208636931757,1.72516875978469e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CDH6,Cadherin-6,29478,-0.0117283114826843,0.00273088076650474,-0.0170808377850336,-0.006375785180335,1.75489678035398e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL15RA,Interleukin-15 receptor subunit alpha,28931,0.010756821783147,0.00250637541304719,0.00584432597357449,0.0156693175927195,1.77819329204845e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KIAA1549,UPF0606 protein KIAA1549,24445,0.0212296320196422,0.00497044390950139,0.0114875619570195,0.0309717020822649,1.95180852921993e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IDS,Iduronate 2-sulfatase,29786,0.00269897598681598,0.000632581573061178,0.00145911610361607,0.00393883587001589,1.99082210759037e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MAPK13,Mitogen-activated protein kinase 13,24016,0.0128628421830418,0.00301715832324831,0.00694921186947513,0.0187764724966085,2.02261447836253e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TMOD4,Tropomodulin-4,24016,-0.01241615660194,0.00292596235042402,-0.0181510428087711,-0.00668127039510893,2.20941108141055e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SPINK1,Serine protease inhibitor Kazal-type 1,29443,0.0128981716759701,0.00304399718307636,0.0069319371971404,0.0188644061547997,2.26964044012382e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NRTN,Neurturin,28931,0.0148731231321938,0.00352334366621369,0.00796736954641492,0.0217788767179726,2.43628475218507e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRKCQ,Protein kinase C theta type,28931,0.0131005353896822,0.00310498239394748,0.00701476989754517,0.0191863008818193,2.4591948905362e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,24229,0.0105612113207983,0.00250719538084079,0.00564710837435033,0.0154753142672462,2.53629038652972e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LEG1,Protein LEG1 homolog,23603,-0.0210132136995884,0.00499514602218839,-0.0308036999030777,-0.0112227274960992,2.60052814278283e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TERF1,Telomeric repeat-binding factor 1,24229,-0.00881138239358035,0.00209565608838403,-0.0129188683268131,-0.00470389646034765,2.62490370195613e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ARTN,Artemin,28931,0.013407216989375,0.00319010407780521,0.00715461299687678,0.0196598209818732,2.64480266941502e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,REN,Renin,29478,-0.0227064597750166,0.00541121538812033,-0.0333124419357325,-0.0121004776143008,2.72243271775698e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MFAP4,Microfibril-associated glycoprotein 4,24381,-0.00963070356609599,0.00229600984722225,-0.0141308828666516,-0.00513052426554038,2.7439317582575e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CEP152,Centrosomal protein of 152 kDa,24016,0.0124634131128553,0.00297703602344799,0.00662842250689722,0.0182984037188134,2.84276319679288e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GUK1,Guanylate kinase,24111,-0.0119597799634652,0.00286246243084875,-0.0175702063279288,-0.00634935359900169,2.94932598894035e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DCC,Netrin receptor DCC,24195,0.00681897139719616,0.00163273814766263,0.0036188046277774,0.0100191381666149,2.97193409832407e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,COMMD9,COMM domain-containing protein 9,24793,0.0116890125831388,0.00281448298759697,0.00617262592744874,0.0172053992388289,3.29005466818415e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GFAP,Glial fibrillary acidic protein,28753,0.0136667453088241,0.00329446097649559,0.00720960179489277,0.0201238888227555,3.35767358313889e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NUP50,Nuclear pore complex protein Nup50,24111,-0.0100029216202453,0.00241178724714285,-0.0147300246246452,-0.00527581861584529,3.3725563267491e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL1RL1,Interleukin-1 receptor-like 1,29736,-0.013658950028998,0.0033087857143592,-0.020144170029142,-0.00717373002885393,3.66793534442308e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NINJ1,Ninjurin-1,28797,0.0162617041014271,0.00394299538141937,0.00853343315384513,0.0239899750490091,3.73068129604114e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RNF31,E3 ubiquitin-protein ligase RNF31,24229,0.0107522297713611,0.00261029871729235,0.0056360442854681,0.0158684152572541,3.81523634691128e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",24111,-0.0119783777743834,0.00291185527938989,-0.0176856141219875,-0.00627114142677917,3.90730251786046e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCL28,C-C motif chemokine 28,29327,0.0172924006041121,0.00422088505011726,0.00901946590588224,0.0255653353023419,4.19905851612256e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SLC12A2,Solute carrier family 12 member 2,24111,-0.00805970514854739,0.00196765452127631,-0.011916308010249,-0.00420310228684582,4.21544762814248e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,24922,0.0215093623855893,0.00526785033676648,0.011184375725527,0.0318343490456516,4.45702129498543e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADGRE1,Adhesion G protein-coupled receptor E1,24805,0.0159546762099422,0.00390844168374182,0.00829413050980826,0.0236152219100762,4.47691112871626e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TXNL1,Thioredoxin-like protein 1,24069,0.0285076848435151,0.0070054604363434,0.014776982388282,0.0422383872987482,4.72944944034798e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MELTF,Melanotransferrin,24922,0.00858854416900405,0.00211200294032481,0.00444901840596743,0.0127280699320407,4.78629753473073e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CNTN2,Contactin-2,29725,0.0129110786737884,0.00317648540715524,0.00668516727576409,0.0191369900718126,4.82427902944657e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,OSCAR,Osteoclast-associated immunoglobulin-like receptor,29497,0.00982164567773166,0.00241788533316257,0.00508259042473302,0.0145607009307303,4.87629673851086e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MKI67,Proliferation marker protein Ki-67,24229,0.0113105015660754,0.00278486504717676,0.00585216607360898,0.0167688370585419,4.89289758021057e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FDX2,"Ferredoxin-2, mitochondrial",24111,0.0163320736074055,0.00402359232969067,0.00844583264121179,0.0242183145735992,4.94223661074944e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLEC14A,C-type lectin domain family 14 member A,29443,-0.0091493631600679,0.00225935866519258,-0.0135777061438454,-0.00472102017629044,5.14497832380884e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ENO1,Alpha-enolase,29392,0.0227006063874665,0.00561298094822884,0.0116991637289379,0.033702049045995,5.26124957120054e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNN,Tenascin-N,24938,0.0125373705822807,0.00310140767553592,0.0064586115382303,0.0186161296263311,5.30482292259733e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,29443,0.00794554950364366,0.00196997967186306,0.00408438934679205,0.0118067096604953,5.51340173055168e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CALCB,Calcitonin gene-related peptide 2,24845,0.0115425318533661,0.00286385157210229,0.00592938277204564,0.0171556809346866,5.5842616103784e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",24445,0.0202235236174115,0.00502816525301759,0.010368319721497,0.030078727513326,5.78676107871319e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ALDH2,"Aldehyde dehydrogenase, mitochondrial",24793,0.0148638798077899,0.00370243217825719,0.00760711273840578,0.0221206468771739,5.97153706210013e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CDKL5,Cyclin-dependent kinase-like 5,24101,-0.015259330837203,0.00380336339439115,-0.0227139230902096,-0.00780473858419634,6.03723737869231e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SCN2B,Sodium channel subunit beta-2,24195,-0.00827535458455065,0.0020675886516039,-0.0123278283416943,-0.004222880827407,6.28852150547578e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RAD51,DNA repair protein RAD51 homolog 1,24445,0.015242867638886,0.0038124029348335,0.00777055788661233,0.0227151773911596,6.40051778406853e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL15,Interleukin-15,29434,0.00933887090092898,0.0023359192428936,0.00476046918485753,0.0139172726170004,6.40513034025748e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD3D,T-cell surface glycoprotein CD3 delta chain,24101,-0.0097642310098669,0.00244948877009629,-0.0145652289992556,-0.00496323302047817,6.73286348991277e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,REG3A,Regenerating islet-derived protein 3-alpha,29820,-0.0175666443484349,0.00440741247130834,-0.0262051727921992,-0.00892811590467055,6.74402659373649e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BABAM1,BRISC and BRCA1-A complex member 1,24229,0.00835704154484251,0.00209980852177381,0.00424141684216584,0.0124726662475192,6.91432523347441e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AOC3,Membrane primary amine oxidase,29594,-0.00854931933136078,0.00214842538593387,-0.0127602330877912,-0.00433840557493039,6.92709826967022e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GSAP,Gamma-secretase-activating protein,28797,0.0246177131917371,0.0061932690540951,0.0124789058457107,0.0367565205377635,7.05763565539202e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD109,CD109 antigen,29443,-0.00953419018725508,0.00240180797229057,-0.0142417338129446,-0.00482664656156557,7.2167634877185e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NFKB2,Nuclear factor NF-kappa-B p100 subunit,24445,0.0157674492729929,0.00397897052252441,0.00796866704884504,0.0235662314971407,7.43187488028974e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,METAP1,Methionine aminopeptidase 1,28774,0.00841488900394739,0.00213000388163511,0.00424008139594258,0.0125896966119522,7.81267901866669e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MYOM1,Myomesin-1,24101,0.0134120888876108,0.00340623662099338,0.00673586511046377,0.0200883126647578,8.25632641045801e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GUCA2A,Guanylin,29333,-0.00958650942540538,0.00243790164211728,-0.0143647966439552,-0.00480822220685552,8.43377549883254e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CEP164,Centrosomal protein of 164 kDa,28931,0.0176438723970538,0.00449497319918138,0.00883372492665824,0.0264540198674493,8.68419812625883e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DNAJA4,DnaJ homolog subfamily A member 4,24845,0.0196372956784061,0.00500311008123223,0.0098311999191909,0.0294433914376213,8.69571410548688e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DPP6,Dipeptidyl aminopeptidase-like protein 6,29349,-0.00935973449757618,0.00238563256713677,-0.0140355743291642,-0.00468389466598812,8.75154727050468e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,24966,0.00520507301979996,0.00133132343009147,0.00259567909682067,0.00781446694277924,9.26557172636828e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PTK7,Inactive tyrosine-protein kinase 7,28774,0.0106592609052521,0.00273526701654826,0.00529813755281754,0.0160203842576867,9.76232028132095e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLSTN1,Calsyntenin-1,28774,0.0143186940255628,0.00367893761082418,0.00710797630834739,0.0215294117427782,9.96153438207377e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GPR101,Probable G-protein coupled receptor 101,24101,-0.0170746596795241,0.00440107005554874,-0.0257007569883997,-0.00844856237064861,0.000104880367967658
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLEC12A,C-type lectin domain family 12 member A,24229,0.00562635595256529,0.00145526989581052,0.00277402695677667,0.0084786849483539,0.000110835592451992
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,29433,0.00878593771317483,0.00228244600993915,0.00431234353369409,0.0132595318926556,0.000118681129978969
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ALPI,Intestinal-type alkaline phosphatase,24229,0.0336812300523339,0.00877533550070673,0.0164815724709487,0.0508808876337191,0.00012426951048831
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PGLYRP1,Peptidoglycan recognition protein 1,29673,0.0115558817052313,0.00301645926879802,0.0056436215383872,0.0174681418720754,0.000127916233129008
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,24240,-0.0071253005419412,0.00186639316943888,-0.0107834311540414,-0.003467169929841,0.000135045182029029
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,S100G,Protein S100-G,24867,-0.0126399410535088,0.00331232917686722,-0.0191321062401685,-0.00614777586684905,0.000135945511902173
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCDC28A,Coiled-coil domain-containing protein 28A,24195,0.00808971674128455,0.0021222799144731,0.00393004810891728,0.0122493853736518,0.000138297754549713
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LIFR,Leukemia inhibitory factor receptor,29434,-0.00658868347329343,0.00173122021436789,-0.0099818750934545,-0.00319549185313235,0.000141630935684577
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FOLR1,Folate receptor alpha,29383,0.00779979501028303,0.00205570118087846,0.00377062069576125,0.0118289693248048,0.000148401677067912
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PADI2,Protein-arginine deiminase type-2,28931,0.0152553359819703,0.0040209639171575,0.00737424670434163,0.023136425259599,0.000148571440465015
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RBP7,Retinoid-binding protein 7,24805,0.0162586712165901,0.0042919786242607,0.0078463931130391,0.024670949320141,0.000152129866028745
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,29820,0.0188720186410396,0.0049839438754956,0.00910348864506818,0.0286405486370109,0.00015304474884178
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AMBN,Ameloblastin,28931,-0.00770088195268266,0.00203759743608387,-0.011694572927407,-0.00370719097795829,0.000157526477230098
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,29218,0.0163538871001201,0.00433861949463519,0.00785019289063512,0.0248575813096051,0.00016397831762951
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SPINK4,Serine protease inhibitor Kazal-type 4,29434,0.017543658399947,0.00466719526559771,0.00839595567937547,0.0266913611205185,0.000170971620645139
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,29517,-0.0131414926038989,0.00349961717953037,-0.0200007422757784,-0.00628224293201935,0.000173589057880751
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",24229,0.0165651986890776,0.00442120310422768,0.00789964060479132,0.0252307567733638,0.000179546978929237
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,28393,0.0170509495966837,0.0045543214087199,0.00812447963559269,0.0259774195577747,0.000181539289644028
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PEAR1,Platelet endothelial aggregation receptor 1,29820,0.00605924166956239,0.00161847809122923,0.0028870246107531,0.00923145872837167,0.000181605914268372
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TFF2,Trefoil factor 2,29536,0.0153473766569506,0.00410417086762464,0.00730320175640632,0.0233915515574949,0.000184765379144547
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,24111,-0.0107063483770096,0.00286499852295734,-0.016321745482006,-0.00509095127201324,0.000186697936523965
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,24445,0.0138899377732019,0.00373142079190178,0.00657635302107439,0.0212035225253294,0.000197760454707798
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IGFBP7,Insulin-like growth factor-binding protein 7,29820,0.00802977240079685,0.00216068538085044,0.00379482905433,0.0122647157472637,0.000202524544347233
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ASPN,Asporin,24922,0.00729349380636001,0.00196320960028731,0.00344560298979688,0.0111413846229231,0.000203577779427631
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PNLIPRP2,Pancreatic lipase-related protein 2,29454,0.0780653124862351,0.0210138465858681,0.0368781731779337,0.119252451794537,0.000203622343964803
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,29673,0.00911124464138265,0.0024611169449974,0.00428745542918774,0.0139350338535776,0.00021422872402151
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,24111,0.0120998567208527,0.00326947959614487,0.00569167671240879,0.0185080367292967,0.000215355886594235
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KIRREL2,Kin of IRRE-like protein 2,28774,0.0105092913966437,0.00284673033943863,0.00492969993134396,0.0160888828619434,0.00022316638401788
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MMP8,Neutrophil collagenase,29640,0.0188877802766664,0.00515303990763509,0.00878782205770166,0.0289877384956312,0.000247415702562277
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCAR2,Cell cycle and apoptosis regulator protein 2,24845,0.0146300592249895,0.00399313067483621,0.00680352310231053,0.0224565953476685,0.000249011065001882
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FSTL1,Follistatin-related protein 1,24240,-0.00596593762267762,0.00163046804260737,-0.00916165498618806,-0.00277022025916718,0.000253705021630252
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",24101,0.00839238649992422,0.00229371566219415,0.00389670380202369,0.0128880691978248,0.000253879221068501
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CAPS,Calcyphosin,24845,0.0245135123062449,0.00675750873561234,0.0112687951844447,0.0377582294280451,0.000286645505875179
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SCP2,Non-specific lipid-transfer protein,28797,0.0196208289427137,0.00542827077192843,0.00898141822973392,0.0302602396556934,0.000301367198728213
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NPTXR,Neuronal pentraxin receptor,29478,0.00871933073393522,0.00242370451758586,0.00396886987946693,0.0134697915884035,0.000321788893968415
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",24867,0.0174346137527912,0.00486245860559671,0.00790419488582169,0.0269650326197608,0.000337006428967443
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SH3GL3,Endophilin-A3,24307,0.0214096601269035,0.00598135039895295,0.00968621334495566,0.0331331069088512,0.000345051654952055
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MYO6,Unconventional myosin-VI,24867,0.00953559890852533,0.00266482313937468,0.00431254555535096,0.0147586522616997,0.000346463146381847
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AKR1B10,Aldo-keto reductase family 1 member B10,24195,0.0159037122017553,0.00445701363897882,0.00716796546935683,0.0246394589341538,0.000360076897722546
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FCRL5,Fc receptor-like protein 5,29443,-0.0145980904465499,0.00409341481344618,-0.0226211834809044,-0.00657499741219538,0.000362717152775747
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SPESP1,Sperm equatorial segment protein 1,24922,0.00772062417331312,0.00216548004723388,0.00347628328073472,0.0119649650658915,0.000364096137847555
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RALB,Ras-related protein Ral-B,24229,0.00752391623349271,0.0021103213898712,0.00338768630934516,0.0116601461576403,0.000364148372234517
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,24111,-0.0148907177000086,0.00418513841176862,-0.0230935889870751,-0.00668784641294213,0.000374408527401949
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PCDH17,Protocadherin-17,29478,0.00910706475816705,0.00256565931920333,0.00407837249252853,0.0141357570238056,0.000386417174263931
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NLGN2,Neuroligin-2,24101,-0.012023162171314,0.00339345809434289,-0.0186743400362261,-0.00537198430640194,0.000396288748406656
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,24111,-0.00516186917665792,0.00145831688872172,-0.00802017027855249,-0.00230356807476335,0.000401477495381362
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MANSC4,MANSC domain-containing protein 4,24111,0.0167014436321042,0.00475245767667094,0.00738662658582915,0.0260162606783792,0.000441764434048273
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SCG3,Secretogranin-3,29497,-0.00827466882189723,0.00236789571455927,-0.0129157444224334,-0.00363359322136106,0.00047560441520485
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GFRAL,GDNF family receptor alpha-like,24025,-0.0155934105394017,0.00446975705636055,-0.0243541343698683,-0.00683268670893498,0.000486338635714519
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,24195,-0.0078798017104781,0.00226533665560365,-0.0123198615554613,-0.00343974186549494,0.000505258172551881
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,INHBB,Inhibin beta B chain,24381,0.0128484732883863,0.00369814220713215,0.00560011456240729,0.0200968320143653,0.000513068745863089
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,29581,0.0105161266925983,0.00303136521604785,0.00457465086914449,0.016457602516052,0.000522937250107532
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TSC1,Hamartin,24229,0.0185727981937775,0.00535818574739353,0.00807075412888622,0.0290748422586689,0.000528691934006716
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,OLR1,Oxidized low-density lipoprotein receptor 1,29216,0.0143918319712446,0.00415541961461105,0.00624720952660693,0.0225364544158822,0.000534182146300174
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RGMA,Repulsive guidance molecule A,29694,-0.00774561587438369,0.00223994417105915,-0.0121359064496596,-0.00335532529910775,0.000545064377415543
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TGM2,Protein-glutamine gamma-glutamyltransferase 2,29427,0.0179373371906365,0.00524273802394196,0.00766157066371026,0.0282131037175627,0.000623916086390319
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,29434,0.0365107229404902,0.0106837651448282,0.0155705432566269,0.0574509026243536,0.000633073419675611
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AOC1,Amiloride-sensitive amine oxidase [copper-containing],28931,0.0135379216818697,0.00396821574852603,0.00576021881475868,0.0213156245489807,0.000646737361739281
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MYH7B,Myosin-7B,24016,-0.0107900645451408,0.00316776025483213,-0.0169988746446117,-0.0045812544456698,0.000659788262237055
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PKLR,Pyruvate kinase PKLR,29491,0.0155944310304788,0.00459408532666923,0.00659002379020707,0.0245988382707505,0.000688550831874111
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SERPINA6,Corticosteroid-binding globulin,24966,0.00407436889347495,0.0012008380797154,0.00172072625723278,0.00642801152971713,0.000692547605522935
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ID4,DNA-binding protein inhibitor ID-4,24445,-0.0106253945248546,0.00313246776349461,-0.016765031341304,-0.00448575770840516,0.000694892453513432
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CST6,Cystatin-M,28830,0.0117910104062607,0.00347671852333402,0.00497664210052602,0.0186053787119954,0.000696249991417503
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CDH23,Cadherin-23,24845,-0.0064155851550064,0.00189216543669057,-0.0101242294109199,-0.00270694089909287,0.000698471807875876
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SAG,S-arrestin,24101,-0.0127823447112041,0.00377037110195827,-0.0201722720710423,-0.00539241735136586,0.00069951503862614
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FCRL6,Fc receptor-like protein 6,29434,0.0163692564911888,0.00483847730143332,0.0068858409803795,0.0258526720019981,0.000717549329056662
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,THAP12,52 kDa repressor of the inhibitor of the protein kinase,23970,0.0211693855988519,0.00626461855677352,0.00889073322757578,0.033448037970128,0.000728135397804307
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EPN1,Epsin-1,24445,0.0105250152957121,0.00312014588279478,0.00440952936543432,0.0166405012259899,0.000744032696815905
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GABARAP,Gamma-aminobutyric acid receptor-associated protein,24793,0.0118563530551853,0.00352122688781198,0.00495474835507382,0.0187579577552968,0.000760762926861171
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLSPN,Claspin,28719,0.00832611896764431,0.00247401440894346,0.00347705072611512,0.0131751872091735,0.000765249524810602
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FDX1,"Adrenodoxin, mitochondrial",24111,0.0150634232263446,0.00448100160364139,0.00628066008320751,0.0238461863694817,0.000776071930594754
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,28774,0.0113597380751572,0.00338315729431586,0.00472874977829807,0.0179907263720162,0.000786864345819704
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ITGB1,Integrin beta-1,29474,0.00518829722669791,0.00154565695351159,0.00215880959781519,0.00821778485558062,0.000789801195029038
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MRPS16,"28S ribosomal protein S16, mitochondrial",24229,0.00698370643937503,0.00208077865433596,0.00290538027687655,0.0110620326018735,0.000791157905318316
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NRXN3,Neurexin-3,24195,0.00842769295453498,0.00251980344256404,0.00348887820710946,0.0133665077019605,0.000825314711490899
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",28774,0.0119140604277239,0.00356712379114041,0.00492249779708866,0.018905623058359,0.000838961570824856
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CA3,Carbonic anhydrase 3,29761,0.014259296048988,0.00427138390071511,0.0058873836035864,0.0226312084943896,0.000843864863112273
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TIMP2,Metalloproteinase inhibitor 2,24922,-0.00631725123425022,0.00189555861920501,-0.010032546127892,-0.0026019563406084,0.000861454307210313
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NEFL,Neurofilament light polypeptide,28674,0.0106357970398152,0.0031919567984717,0.00437956171481065,0.0168920323648197,0.000863141449663242
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRR4,Proline-rich protein 4,24203,-0.0165552868970397,0.00497616927119533,-0.0263085786685825,-0.00680199512549684,0.000879443131238778
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,24101,-0.0145686546464638,0.00438311948919584,-0.0231595688452877,-0.00597774044763998,0.000889291870494607
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLMP,CXADR-like membrane protein,29725,0.00500877389320448,0.00150755019933084,0.00205397550251603,0.00796357228389293,0.000893354269784857
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",24016,0.0135626038777534,0.00409250813072126,0.0055412879415397,0.021583919813967,0.000921050477808519
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RBM19,Probable RNA-binding protein 19,24111,-0.0113111328914095,0.00341551418553153,-0.0180055406950513,-0.00461672508776774,0.000928697414757486
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL17C,Interleukin-17C,28931,-0.016587184124635,0.00501836200345162,-0.0264231736514002,-0.00675119459786982,0.000949907194557533
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LY6D,Lymphocyte antigen 6D,29283,0.00899951761063618,0.00273516596454339,0.00363859232013113,0.0143604429011412,0.00100198747140743
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MYH4,Myosin-4,24111,-0.0109232921666267,0.00333314646052397,-0.0174562592292536,-0.00439032510399967,0.00105001004577864
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AIDA,"Axin interactor, dorsalization-associated protein",24195,0.0197058957346305,0.00602592267913911,0.0078950872835179,0.0315167041857432,0.00107626589511267
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VCPKMT,Protein-lysine methyltransferase METTL21D,24016,0.0201421854762651,0.00617543557520241,0.0080383317488684,0.0322460392036619,0.0011091554084587
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SEMA3G,Semaphorin-3G,24381,0.0102862896260678,0.00315559166222425,0.00410132996810832,0.0164712492840274,0.00111682121239269
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DDA1,DET1- and DDB1-associated protein 1,24111,0.00923800896158668,0.00285167182078516,0.00364873219284777,0.0148272857303256,0.00119899066665612
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,29372,0.0136970004957673,0.00423274746214249,0.00540081546996804,0.0219931855215666,0.00121368768889319
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CEP112,Centrosomal protein of 112 kDa,24111,0.0105848437751349,0.0032732423763099,0.00416928871756751,0.0170003988327023,0.00122341331456139
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,28916,0.00627357162509889,0.00194225187736079,0.00246675794547175,0.010080385304726,0.00123906692552701
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RYR1,Ryanodine receptor 1,24111,-0.00786377885592744,0.00243546552396627,-0.0126372912829013,-0.00309026642895355,0.00124450821139015
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CUZD1,CUB and zona pellucida-like domain-containing protein 1,24195,0.00874332286374045,0.0027161832901997,0.00341960361494904,0.0140670421125319,0.00128819944535451
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,JUN,Transcription factor AP-1,28931,0.0115004316831682,0.00357373705521031,0.00449590705495596,0.0185049563113804,0.00129211667512706
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,24951,0.00988908938701761,0.00307590012972528,0.00386032513275607,0.0159178536412791,0.00130600200356747
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SPINK5,Serine protease inhibitor Kazal-type 5,29443,-0.00772205923675645,0.00241347473123388,-0.0124524697099749,-0.00299164876353804,0.0013778301850852
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",24016,0.0116623431743612,0.00364791000747785,0.00451243955970464,0.0188122467890178,0.00139048190140965
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,REXO2,"Oligoribonuclease, mitochondrial",24111,-0.0109105022752329,0.00341367778288895,-0.0176013107296953,-0.00421969382077059,0.00139471821125726
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRG3,Proteoglycan 3,24938,-0.0113644282971066,0.00356023504876481,-0.0183424889926856,-0.00438636760152759,0.00141444904900794
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AXL,Tyrosine-protein kinase receptor UFO,29594,0.00626098557286779,0.00196501748264603,0.00240955130688158,0.010112419838854,0.00144292698805053
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,UNG,Uracil-DNA glycosylase,24793,0.00782269984628842,0.00245640571220948,0.00300814465035784,0.012637255042219,0.00145127410083136
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DIPK2B,Divergent protein kinase domain 2B,24381,0.00638811372408292,0.00200935568920392,0.00244977657324324,0.0103264508749226,0.00147874403361885
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SULT1A1,Sulfotransferase 1A1,29694,-0.0289583067449002,0.00913550717483043,-0.0468639008075678,-0.0110527126822325,0.0015266566365708
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NMI,N-myc-interactor,24706,0.0162782453626508,0.00514060714253536,0.00620265536328144,0.0263538353620201,0.00154419986465378
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FGF5,Fibroblast growth factor 5,28931,-0.00746122490251071,0.00235939471081962,-0.0120856385357172,-0.00283681126930426,0.0015666462412223
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GPR158,Probable G-protein coupled receptor 158,24867,0.00807972846632881,0.00255788327797989,0.00306627724148823,0.0130931796911694,0.00158633918046262
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SOX9,Transcription factor SOX-9,24195,0.00615318211032,0.00195048377722551,0.002330233906958,0.00997613031368201,0.0016086253674295
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",24381,-0.014313012609436,0.00457227979245697,-0.0232746810026517,-0.00535134421622036,0.00174781403684413
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GGA1,ADP-ribosylation factor-binding protein GGA1,28774,0.0151501390817424,0.0048498236738479,0.0056444846810005,0.0246557934824843,0.00178676521260749
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL3RA,Interleukin-3 receptor subunit alpha,28931,0.00700956531527744,0.00225377248783871,0.00259217123911357,0.0114269593914413,0.00187175552131584
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",24845,-0.00569807961362704,0.00183293183292764,-0.00929062600616522,-0.00210553322108886,0.00188109319596608
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SEPTIN3,Neuronal-specific septin-3,24867,-0.0167292542978632,0.00540056900787448,-0.0273143695532972,-0.00614413904242928,0.00195256845885066
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DPP10,Inactive dipeptidyl peptidase 10,29434,0.00776152606729329,0.00251223408569048,0.00283754725933994,0.0126855048752466,0.00200686290836896
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HCG22,Protein PBMUCL2,24111,-0.0122042654363438,0.00395797247757706,-0.0199618914923948,-0.00444663938029276,0.0020483711724468
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CPVL,Probable serine carboxypeptidase CPVL,29662,0.00893460229896698,0.00289907115351627,0.00325242283807509,0.0146167817598589,0.00205883229924489
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,24322,-0.0106658049723523,0.00347862023290456,-0.0174839006288452,-0.00384770931585934,0.00217107181684217
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TUBB3,Tubulin beta-3 chain,24101,-0.00613508852408547,0.00200869802128335,-0.0100721366458008,-0.00219804040237011,0.00225861842323676
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AIF1L,Allograft inflammatory factor 1-like,24240,0.0124838218164588,0.00409127997246639,0.00446491307042465,0.0205027305624929,0.00228080832907151
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ACE,Angiotensin-converting enzyme,24951,-0.00568144198179641,0.00186703295806311,-0.0093408265796001,-0.00202205738399271,0.00234450712701345
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,24445,0.00791413180247475,0.00260111698663309,0.0028159425086739,0.0130123210962756,0.00234800847639973
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,OPTC,Opticin,29349,-0.00976892523024656,0.00321314580304666,-0.016066691004218,-0.0034711594562751,0.00236551421767343
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ATP1B4,Protein ATP1B4,24016,-0.00906947469506967,0.00300223346542183,-0.0149538522872965,-0.00318509710284288,0.00252282177697081
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GNPDA1,Glucosamine-6-phosphate isomerase 1,24240,0.00713326291647129,0.00236696949949512,0.00249400269746086,0.0117725231354817,0.00258375933146561
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TEF,Thyrotroph embryonic factor,24111,0.00921121488068485,0.00305894833471002,0.0032156761446532,0.0152067536167165,0.00260456271022925
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD79B,B-cell antigen receptor complex-associated protein beta chain,29786,0.00959300539972556,0.00318646527308364,0.00334753346448163,0.0158384773349695,0.0026099557328162
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ATF2,Cyclic AMP-dependent transcription factor ATF-2,28774,0.0145793057637266,0.00484598064642679,0.0050811836967301,0.0240774278307231,0.00262737106985058
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MRPL24,"39S ribosomal protein L24, mitochondrial",24111,0.00845757988111983,0.00281172123103923,0.00294660626828294,0.0139685534939567,0.00263268446352425
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TFF1,Trefoil factor 1,29319,0.0168590447366483,0.00561810372659665,0.00584756143251884,0.0278705280407777,0.00269460238622091
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CTNNA1,Catenin alpha-1,24101,-0.00752332377430752,0.00250859068382235,-0.0124401615145993,-0.00260648603401571,0.00271122554895426
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SEZ6,Seizure protein 6 homolog,24195,-0.00667925325961054,0.00223035197066509,-0.0110507431221141,-0.00230776339710696,0.00274985545373195
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CSPG5,Chondroitin sulfate proteoglycan 5,24101,-0.0106685831919108,0.0035701765732813,-0.0176661292755422,-0.00367103710827947,0.00280861982235293
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SAT1,Diamine acetyltransferase 1,24111,-0.0107469935605405,0.00359925551178919,-0.0178015343636473,-0.00369245275743368,0.00283035192550447
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CTRC,Chymotrypsin-C,29456,0.0135675668623506,0.00454558841856819,0.00465821356195691,0.0224769201627442,0.0028401833652211
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RETN,Resistin,29362,0.00897014879144815,0.00300638425754771,0.00307763564665464,0.0148626619362417,0.00285020108559402
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,24793,0.0100841264736409,0.0033837783772537,0.00345192085422367,0.0167163320930582,0.0028839809326328
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SEMA6C,Semaphorin-6C,24229,0.00557207082079362,0.00186999865200519,0.00190687346286345,0.00923726817872378,0.00288799040258475
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADGRE5,Adhesion G protein-coupled receptor E5,29673,0.00644926503732604,0.00216712073098477,0.0022017084045959,0.0106968216700562,0.00292308287975976
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLEC7A,C-type lectin domain family 7 member A,29786,0.0124552818521407,0.00419285013671851,0.00423729558417241,0.020673268120109,0.00297455533972205
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ATP5PO,"ATP synthase subunit O, mitochondrial",28774,0.0089563537896286,0.00301975861502515,0.00303762690417931,0.0148750806750779,0.00302029683640699
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SSB,Lupus La protein,28774,0.0125744724898393,0.00424651558699582,0.0042513019393275,0.0208976430403511,0.00306765689089439
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TLR4,Toll-like receptor 4,24229,0.00598422708199127,0.00202432995870284,0.00201654036293369,0.00995191380104884,0.00311803800493631
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HYAL1,Hyaluronidase-1,29265,0.00483301611684403,0.00163782172757857,0.00162288553079004,0.00804314670289802,0.0031712075112319
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,24381,0.00788259782274235,0.00268456359957548,0.0026208531675744,0.0131443424779103,0.00332497839402498
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL13RA2,Interleukin-13 receptor subunit alpha-2,24101,-0.00604511094119624,0.00206253122759869,-0.0100876721472897,-0.00200254973510281,0.0033827888294446
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FLT1,Vascular endothelial growth factor receptor 1,29288,0.00466259966174906,0.00159990736778052,0.00152678122089924,0.00779841810259888,0.00356764436397202
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KRT19,"Keratin, type I cytoskeletal 19",29378,0.014043514171749,0.00482985433566781,0.00457699967384006,0.0235100286696579,0.00364431060715861
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL2RG,Cytokine receptor common subunit gamma,24793,0.0077186347892555,0.00265591548191904,0.00251304044469418,0.0129242291338168,0.00366165628922183
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PLAUR,Urokinase plasminogen activator surface receptor,29278,0.00565785114791174,0.00195808134359904,0.00182001171445761,0.00949569058136586,0.00386153897303462
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,28301,0.00772160472398192,0.00268800168026815,0.00245312143065634,0.0129900880173075,0.00407387410262226
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,STOML2,"Stomatin-like protein 2, mitochondrial",24016,0.0189424453329227,0.00660718989299576,0.00599235314265105,0.0318925375231944,0.00414816569857672
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCND2,G1/S-specific cyclin-D2,24445,0.00754116467343973,0.00263068751076929,0.00238501715233191,0.0126973121945475,0.00415243684017312
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CTHRC1,Collagen triple helix repeat-containing protein 1,24938,0.00572708203063797,0.00200271919507953,0.0018017524082821,0.00965241165299385,0.00424456817818339
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,WASL,Neural Wiskott-Aldrich syndrome protein,24229,-0.0123864919324641,0.00433626086289184,-0.0208855632237321,-0.00388742064119605,0.00428716148837411
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,24793,0.0197758545873627,0.00693166393024588,0.00618979328408073,0.0333619158906446,0.00433480745726954
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",28931,0.0239667300209134,0.00840981885666382,0.00748348506185231,0.0404499749799745,0.0043770635401611
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PNMA2,Paraneoplastic antigen Ma2,24101,0.00889349572966756,0.0031309426203332,0.00275684819381449,0.0150301432655206,0.0045078235177186
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,STX1B,Syntaxin-1B,24195,0.00843155826299986,0.00297352892080009,0.00260344157823169,0.014259674947768,0.00457863441682719
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IFNL1,Interferon lambda-1,28774,0.00915102535357678,0.00322798926357569,0.00282416639696842,0.0154778843101851,0.00458720521635749
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD33,Myeloid cell surface antigen CD33,29566,0.0157536181008408,0.00564369914322422,0.0046919677801213,0.0268152684215602,0.00525200988511119
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PPM1B,Protein phosphatase 1B,24229,0.0124456976617148,0.00446224699839839,0.00369969354485396,0.0211917017785757,0.00528943769560388
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PTTG1,Securin,24445,0.00822112936593957,0.0029543526340512,0.00243059820319922,0.0140116605286799,0.0053947057569841
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,COL5A1,Collagen alpha-1(V) chain,24381,0.00801438425199527,0.0028808239854539,0.00236796924050563,0.0136607992634849,0.00540705079165259
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GBP6,Guanylate-binding protein 6,24111,-0.00912162715699097,0.00329397081016655,-0.0155778099449174,-0.00266544436906453,0.00562390209672466
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL20RA,Interleukin-20 receptor subunit alpha,28931,0.00892591355346737,0.00322907589876738,0.0025969247918833,0.0152549023150514,0.00570931472872594
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DDX39A,ATP-dependent RNA helicase DDX39A,24229,0.00460498552287391,0.00166614501470543,0.00133934129405127,0.00787062975169654,0.00571658361337552
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TJP3,Tight junction protein ZO-3,24101,-0.00842505206311628,0.00305886281864365,-0.0144204231876578,-0.00242968093857473,0.0058860409519307
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BMP4,Bone morphogenetic protein 4,29169,-0.00905355745173849,0.0032923575687889,-0.0155065782865647,-0.00260053661691224,0.00596555290706847
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DEFB104A_DEFB104B,Beta-defensin 104,24101,0.0110092759791679,0.00401909824282229,0.00313184342323621,0.0188867085350996,0.00616266347326783
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BMP10,Bone morphogenetic protein 10,24381,-0.00556765798970267,0.00203491402861797,-0.00955608948579389,-0.00157922649361144,0.00622236756751517
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNR,Tenascin-R,29218,-0.00819395410344401,0.0030042246095126,-0.0140822343380887,-0.00230567386879931,0.00638587908412198
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TTN,Titin,24111,-0.0130150081519995,0.00479384671888096,-0.0224109477210062,-0.00361906858299285,0.0066334898564413
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RLN2,Prorelaxin H2,24326,0.0219419626184394,0.0080978545130864,0.00607016777279005,0.0378137574640887,0.00674112010298748
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PALM3,Paralemmin-3,24111,0.0142650667185958,0.00527135621117555,0.00393320854469175,0.0245969248924999,0.00681167407160402
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HTR1B,5-hydroxytryptamine receptor 1B,24101,-0.00830744507917065,0.0030700997489603,-0.0143248405871328,-0.00229004957120846,0.00681633482114548
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LTO1,Protein LTO1 homolog,28931,0.00792935989094382,0.00293374213071238,0.00217922531474755,0.0136794944671401,0.00687953138540394
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNXB,Tenascin-X,29443,-0.00496162217281031,0.00183784378873095,-0.00856379599872297,-0.00135944834689764,0.0069442215628767
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DTX2,Probable E3 ubiquitin-protein ligase DTX2,24195,-0.0121406639809177,0.00450065020278537,-0.020961938378377,-0.00331938958345836,0.00699032604328012
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PAPPA,Pappalysin-1,28931,0.00905844777651393,0.00336125364543127,0.00247039063146865,0.0156465049215592,0.00704375302302057
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ICAM3,Intercellular adhesion molecule 3,29820,-0.00500183958782716,0.00185694477600788,-0.00864145134880261,-0.00136222782685171,0.00707275609060665
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TIE1,Tyrosine-protein kinase receptor Tie-1,29820,0.00786867500448839,0.00292758222786814,0.00213061383786683,0.0136067361711099,0.00719703252556161
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL36G,Interleukin-36 gamma,24149,0.0130496882128727,0.00485755010640512,0.00352889000431863,0.0225704864214267,0.00722597275511435
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,24111,-0.00970199946714224,0.00362650717479407,-0.0168099535297386,-0.00259404540454585,0.00747125439332908
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CYB5A,Cytochrome b5,24016,0.0137940549902182,0.00516055620156018,0.00367936483516026,0.0239087451452761,0.00752319301267979
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KLK15,Kallikrein-15,24754,0.00986654086687095,0.0036922985211693,0.00262963576537911,0.0171034459683628,0.00754062655920904
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,OSBPL2,Oxysterol-binding protein-related protein 2,24845,0.00745814680965671,0.00279230099526016,0.0019852368589468,0.0129310567603666,0.00756821326647416
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,24101,0.0110275512686651,0.00412868487816612,0.00293532890745955,0.0191197736298707,0.00756855239962
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",29632,0.0134638615976652,0.00506689492580099,0.00353274754309526,0.0233949756522351,0.00788299443337255
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,USP28,Ubiquitin carboxyl-terminal hydrolase 28,24845,0.00700655744263388,0.00263774944202197,0.00183656853627083,0.0121765463489969,0.00790623488295942
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MMP9,Matrix metalloproteinase-9,29411,0.011427806855257,0.00430661345192441,0.00298684448948521,0.0198687692210289,0.00796932006423395
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,REG1A,Lithostathine-1-alpha,29353,-0.00922536643662358,0.0035039570741146,-0.0160931223018882,-0.00235761057135896,0.00847180157732783
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KLK1,Kallikrein-1,29199,-0.0238499838233606,0.00907764454475771,-0.0416421671310857,-0.00605780051563545,0.00861023765878738
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",24101,-0.0101717836193965,0.00388077179244843,-0.0177780963325954,-0.00256547090619759,0.00877087150477254
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ITGB7,Integrin beta-7,29725,0.00852892699197585,0.00326319934747178,0.00213305627093116,0.0149247977130205,0.00896206023160206
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,24111,-0.0088591166805834,0.00341811401683369,-0.0155586201535774,-0.00215961320758937,0.00955288908651874
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CALY,Neuron-specific vesicular protein calcyon,24111,-0.00710280307685343,0.00274443372386956,-0.0124818931756378,-0.00172371297806909,0.00965716046347775
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,24111,-0.00617035240248889,0.00240350487034671,-0.0108812219483684,-0.00145948285660934,0.0102574052655122
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NOP56,Nucleolar protein 56,24111,0.0203409954727991,0.00792493249582444,0.00480812778098321,0.035873863164615,0.0102728564461082
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KIF20B,Kinesin-like protein KIF20B,24101,0.0138985373247389,0.00546288985800613,0.00319127320304691,0.0246058014464309,0.0109598683352638
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL19,Interleukin-19,28654,0.0127460635826526,0.00501537713317712,0.00291592440162545,0.0225762027636798,0.0110462786839595
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MSLNL,Mesothelin-like protein,24195,-0.00680521779755019,0.00269101918281488,-0.0120796153958674,-0.00153082019923302,0.0114495854599378
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HLA_DRA,,29322,-0.00646692090196139,0.00257452309321714,-0.011512986164667,-0.00142085563925579,0.012013953595369
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IFNW1,Interferon omega-1,24111,-0.00639346315553788,0.00257346487473183,-0.0114374543100123,-0.0013494720010635,0.0129844838272203
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",24195,-0.00866507316169315,0.00349934827113194,-0.0155237957731118,-0.00180635055027454,0.0132858469271171
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GKN1,Gastrokine-1,28114,0.00494671212379871,0.00200185825877763,0.00102306993659455,0.00887035431100288,0.013477202295545
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MTR,Methionine synthase,24111,0.0115075986433921,0.00465811017604654,0.00237770269834086,0.0206374945884433,0.013501427529909
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DEFB118,Beta-defensin 118,24101,0.010157762180329,0.00411318764687468,0.00209591439245468,0.0182196099682034,0.0135348273118261
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PSAPL1,Proactivator polypeptide-like 1,24805,-0.00885303056602412,0.00359204795813279,-0.0158934445639644,-0.00181261656808384,0.0137226214809756
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CRHR1,Corticotropin-releasing factor receptor 1,28916,0.0107020450840674,0.00434985383753354,0.00217633156250162,0.0192277586056331,0.0138870122886669
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",24111,-0.00760562926798997,0.00309502911609777,-0.0136718863355416,-0.00153937220043834,0.0140028687428818
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLNS1A,Methylosome subunit pICln,24195,0.00586231775224864,0.00239441778596472,0.00116925889175778,0.0105553766127395,0.0143591864338605
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,23970,-0.00913930192188362,0.00374103925936617,-0.0164717388702413,-0.00180686497352593,0.0145735229765933
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TMEM25,Transmembrane protein 25,24867,-0.0078692091488919,0.00322358420640367,-0.0141874341934431,-0.0015509841043407,0.0146480475995021
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,24173,0.00667672624341288,0.00274880274225369,0.00128907286859564,0.0120643796182301,0.0151495326549164
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MRPL52,"39S ribosomal protein L52, mitochondrial",23975,0.00446913347932355,0.00184412811195603,0.000854642379889727,0.00808362457875738,0.01538165737465
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BATF,Basic leucine zipper transcriptional factor ATF-like,24195,0.0145300305620674,0.00599653511133386,0.00277682174385303,0.0262832393802818,0.0153972099867343
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CSRP3,Cysteine and glycine-rich protein 3,24111,-0.0170034758485524,0.00703353748244381,-0.0307892093141423,-0.00321774238296257,0.0156355226554609
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KLK3,Prostate-specific antigen,24938,-0.015326069248361,0.00634369483872594,-0.0277597111322638,-0.00289242736445816,0.015701223911098
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SUSD5,Sushi domain-containing protein 5,24273,-0.00591348902626474,0.00244796207405631,-0.0107114946914151,-0.00111548336111438,0.0157132677779577
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ATRAID,All-trans retinoic acid-induced differentiation factor,24805,0.00481488883735228,0.00202067847773116,0.000854359020999199,0.00877541865370536,0.0171886418450586
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CPTP,Ceramide-1-phosphate transfer protein,24111,-0.00676753802102467,0.00284262498437445,-0.0123390829903986,-0.00119599305165076,0.017285840904536
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DKKL1,Dickkopf-like protein 1,29349,-0.0145226286728359,0.00611296341624557,-0.0265040369686772,-0.00254122037699456,0.0175216048380998
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MN1,Transcriptional activator MN1,24195,-0.0100411702944199,0.00422933464193474,-0.0183306661926119,-0.00175167439622778,0.0175960889009722
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HIF1A,Hypoxia-inducible factor 1-alpha,24229,0.0111113586918276,0.00468504342546208,0.00192867357792192,0.0202940438057333,0.0177158591190814
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,OSMR,Oncostatin-M-specific receptor subunit beta,29628,-0.00341445087380438,0.00144071423509193,-0.00623825077458457,-0.000590650973024187,0.0177958531970047
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HDDC2,5'-deoxynucleotidase HDDC2,24805,0.00735605848501633,0.00310781012895373,0.00126475063226703,0.0134473663377656,0.017942567443508
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL11,Interleukin-11,28931,0.0105314238972759,0.00444956769473791,0.00181027121558962,0.0192525765789622,0.0179471364718811
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MMP13,Collagenase 3,28774,-0.00551630156921663,0.00233253165654384,-0.0100880636160426,-0.000944539522390708,0.0180395051782932
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SPRING1,SREBP regulating gene protein,24016,0.0100510298683936,0.00425269113296905,0.00171575524777426,0.0183863044890129,0.0181135116122563
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,POF1B,Protein POF1B,24229,0.00772221770478017,0.00327567591229028,0.00130189291669121,0.0141425424928691,0.01840921395061
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,24867,0.00539927959281869,0.00229362907771167,0.000903766600503813,0.00989479258513357,0.018578678699262
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SUMF1,Formylglycine-generating enzyme,24229,0.0111730394661974,0.00474664564997157,0.00186961399225314,0.0204764649401417,0.0185864975578252
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GLI2,Zinc finger protein GLI2,24229,-0.00559389268699921,0.00238274865059716,-0.0102640800421696,-0.000923705331828778,0.0188995704341938
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SCGN,Secretagogin,28931,-0.00730417205907395,0.00314326002247792,-0.0134649617031307,-0.00114338241501723,0.0201454239773984
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,24240,-0.00666253248218071,0.00287432905557246,-0.0122962174311027,-0.00102884753325868,0.0204606757310822
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GSN,Gelsolin,24845,-0.00314753040786324,0.0013584831656212,-0.00581015741248079,-0.000484903403245688,0.0205148366225592
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,29434,0.0139857030126944,0.00605530581029821,0.00211730362450995,0.0258541024008789,0.0209138244108708
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,YY1,Transcriptional repressor protein YY1,24229,0.00460592197939919,0.00199483588467829,0.00069604364542974,0.00851580031336863,0.0209562443946105
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NME3,Nucleoside diphosphate kinase 3,29497,0.00392576099792968,0.0017014415465561,0.000590935566679733,0.00726058642917963,0.0210441782552417
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,24195,-0.00779290627477265,0.00338131270614807,-0.0144202791788229,-0.00116553337072243,0.021191894849935
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LAMA1,Laminin subunit alpha-1,24111,-0.00885223310230695,0.00385912557497676,-0.0164161192292614,-0.00128834697535249,0.0218080084137804
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CADPS,Calcium-dependent secretion activator 1,24195,-0.00704249673585407,0.00307839643706617,-0.0130761537525038,-0.00100883971920439,0.0221626584073968
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PSMC3,26S proteasome regulatory subunit 6A,24016,-0.0049304530433416,0.00216032422226794,-0.00916468851898675,-0.000696217567696444,0.0224818435511145
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SELL,L-selectin,24966,0.00376919720368972,0.00165420387440732,0.000526957609851365,0.00701143679752808,0.0227018463624285
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,THY1,Thy-1 membrane glycoprotein,29694,0.00461590220016208,0.00203279316213439,0.000631627602378673,0.00860017679794549,0.0231711226315593
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",24229,0.00570225333858327,0.00252410447051511,0.000755008576373658,0.0106494981007929,0.023884812997121
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CRNN,Cornulin,28580,0.0107509836074301,0.00476121132151442,0.00141900941726189,0.0200829577975984,0.023950967431505
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ERVV_1,,24111,-0.00741017946540386,0.00329522636307348,-0.0138688231370279,-0.000951535793779838,0.0245366449456978
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CBX2,Chromobox protein homolog 2,24111,-0.00646175281656245,0.00287684107948219,-0.0121003613323475,-0.000823144300777367,0.0247048419904143
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AMIGO1,Amphoterin-induced protein 1,24195,0.00803440101016189,0.0035856408043493,0.00100654503363726,0.0150622569866865,0.0250535489139184
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ANXA10,Annexin A10,28774,0.0130795657121136,0.00584691466404781,0.00161961297057993,0.0245395184536473,0.0252937742749849
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SCARB1,Scavenger receptor class B member 1,28774,0.00914257108241537,0.00409665634781298,0.00111312464070194,0.0171720175241288,0.0256414515930645
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SPINT1,Kunitz-type protease inhibitor 1,29333,0.0041258189146337,0.00185704697332101,0.000486006846924525,0.00776563098234288,0.0263105485412016
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SHPK,Sedoheptulokinase,24445,-0.00655232544928361,0.00296341454507565,-0.0123606179576319,-0.000744032940935339,0.0270400181350876
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL33,Interleukin-33,28931,0.00612806383375368,0.0027779374601313,0.00068330641189633,0.011572821255611,0.0273935026967712
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CXCL14,C-X-C motif chemokine 14,28931,0.00935495752208559,0.00424283292031019,0.00103900499827763,0.0176709100458936,0.0274700270870426
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TMPRSS5,Transmembrane protease serine 5,29079,-0.00597222629629055,0.00271263767981855,-0.0112889961487349,-0.000655456443846188,0.0276992363291065
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SIGLEC15,Sialic acid-binding Ig-like lectin 15,28774,0.0123078425726844,0.00559160828261023,0.00134829033876839,0.0232673948066005,0.0277349165800005
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,OTOA,Otoancorin,24101,-0.00829775669149454,0.00383585394707491,-0.0158160304277614,-0.000779482955227714,0.0305348536318511
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,24867,0.0177970005246907,0.00823813952368641,0.00165024705826538,0.0339437539911161,0.0307575930716626
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MUCL3,Mucin-like protein 3,24016,-0.00675455429833803,0.00313538023834256,-0.0128998995654895,-0.000609209031186601,0.0312264570323345
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",29365,-0.0102407401022855,0.00475460229279711,-0.0195597605961678,-0.000921719608403142,0.0312593936846183
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADGRG1,Adhesion G-protein coupled receptor G1,29349,0.010566284940747,0.00491295831755461,0.000936886638339929,0.020195683243154,0.0315082636008689
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,24016,0.00406432736212946,0.00189420913190951,0.000351677463586829,0.00777697726067209,0.0319101734481493
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ART5,Ecto-ADP-ribosyltransferase 5,24101,-0.00954113528375401,0.00448599022478384,-0.0183336761243303,-0.000748594443177679,0.0334407006613076
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADRA2A,Alpha-2A adrenergic receptor,24111,-0.0106722353621657,0.0050471134877982,-0.0205645777982502,-0.000779892926081282,0.0344808998893413
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADGRG2,Adhesion G-protein coupled receptor G2,29478,-0.00407609550977334,0.00193043729222899,-0.00785975260254216,-0.000292438417004516,0.0347387705465396
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,28797,0.0187883547428006,0.00891386189627789,0.00131718542609594,0.0362595240595053,0.0350596671444509
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HIP1,Huntingtin-interacting protein 1,24111,0.00503242269112005,0.00238951077406834,0.000348981573946114,0.00971586380829399,0.035210560219942
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AKAP12,A-kinase anchor protein 12,24381,-0.00323572814457993,0.00153669632004759,-0.00624765293187321,-0.000223803357286657,0.0352459020132747
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD5L,CD5 antigen-like,24833,0.00707368223828274,0.00337042230996396,0.000467654510753388,0.0136797099658121,0.0358488020947019
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VSIG4,V-set and immunoglobulin domain-containing protein 4,29396,-0.00610571343825501,0.0029201772987922,-0.0118292609438877,-0.000382165932622303,0.0365482166838349
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TCN1,Transcobalamin-1,24546,0.0050695998058319,0.00243798734514648,0.000291144609344799,0.00984805500231901,0.0375891186438269
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RTKN2,Rhotekin-2,24111,-0.00768115682408623,0.00369683470295133,-0.0149269528418708,-0.000435360806301626,0.0377414946497316
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TG,Thyroglobulin,24793,-0.0164881418900621,0.00796788665306091,-0.0321051997300615,-0.00087108405006267,0.0385260017017168
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IMPG1,Interphotoreceptor matrix proteoglycan 1,24101,-0.00443956339863413,0.00214834040138746,-0.00865031058535355,-0.0002288162119147,0.0387911668220994
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FRMD7,FERM domain-containing protein 7,24195,0.00494948829775641,0.00239553639475672,0.00025423696403323,0.00964473963147959,0.0388268826801875
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TLR1,Toll-like receptor 1,24229,0.00387560689187755,0.00188392442716351,0.000183115014637065,0.00756809876911803,0.0396778010752375
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,28797,0.0180474118248797,0.00879142051030081,0.000816227624690153,0.0352785960250693,0.0400967628254529
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FGF9,Fibroblast growth factor 9,23970,0.00595962110228042,0.00291474771711502,0.000246715576734988,0.0116725266278259,0.0409008855920225
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FBLN2,Fibulin-2,24938,-0.00456676281174597,0.00224018700773799,-0.00895752934691242,-0.000175996276579507,0.0415041716554493
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MSMB,Beta-microseminoprotein,29313,0.010080052167365,0.00495452389364004,0.000369185335830484,0.0197909189988994,0.0419087044241818
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,REST,RE1-silencing transcription factor,24016,-0.00509214360758656,0.00250455694016756,-0.010001075210315,-0.000183212004858147,0.0420482034660405
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EDNRB,Endothelin receptor type B,24229,0.00658175625515159,0.0032635620087947,0.000185174717913975,0.0129783377923892,0.0437336629042681
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PGLYRP4,Peptidoglycan recognition protein 4,24111,0.00876160792979047,0.00435387508561615,0.000228012761982808,0.0172952030975981,0.0441920458501328
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TCL1B,T-cell leukemia/lymphoma protein 1B,28916,0.01118354276642,0.00556296311997688,0.000280135051265321,0.0220869504815747,0.0444026729405054
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CORO6,Coronin-6,24101,-0.00537828851389798,0.0026837935346278,-0.0106385238417685,-0.000118053186027481,0.0450825830593166
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD70,CD70 antigen,29434,-0.00605792022174619,0.00304478810826495,-0.0120257049139455,-9.01355295468906e-05,0.0466439035855106
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SERPINA3,Alpha-1-antichymotrypsin,24883,0.00209724002652362,0.00105640447909955,2.66872474884885e-05,0.00416779280555874,0.0471262579137194
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KIAA2013,Uncharacterized protein KIAA2013,24793,0.00783279446504474,0.00397636405279795,3.91209215607619e-05,0.0156264680085287,0.0488680176778168
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TSPAN1,Tetraspanin-1,28916,0.00795781197999602,0.00404117835240623,3.71024092798138e-05,0.0158785215507122,0.0489418373622998
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SPINT3,Kunitz-type protease inhibitor 3,24805,0.0206631623932736,0.0105067812503553,6.98711425772269e-05,0.0412564536439699,0.0492347007587404
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DOCK9,Dedicator of cytokinesis protein 9,24101,0.0165581764291097,0.00845477135823707,-1.31754330349072e-05,0.0331295282912544,0.0501897343483353
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD2,T-cell surface antigen CD2,24111,0.00536668272696492,0.00274364299261607,-1.08575385625743e-05,0.0107442229924924,0.0504716657937988
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SCN2A,Sodium channel protein type 2 subunit alpha,24101,0.00684884862979934,0.00350986276302027,-3.04823857203785e-05,0.0137281796453191,0.0510311352949897
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EIF5A,Eukaryotic translation initiation factor 5A-1,28931,0.00414945341997954,0.00213598505792882,-3.70772935609507e-05,0.00833598413352003,0.0520691716993859
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ENDOU,Poly(U)-specific endoribonuclease,23037,0.00736020368050362,0.00379685557708573,-8.16332505844206e-05,0.0148020406115917,0.0525744851153288
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RASA1,Ras GTPase-activating protein 1,28774,0.00446892764332345,0.00231769701139492,-7.37584990106038e-05,0.0090116137856575,0.0538430767143691
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TSLP,Thymic stromal lymphopoietin,28916,0.00828451896069663,0.00430865711000996,-0.000160448974922888,0.0167294868963161,0.0545198551822776
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CPLX2,Complexin-2,24016,-0.00421209410903154,0.00219842135593573,-0.00852099996666558,9.68117486024912e-05,0.0553816635825557
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLEC4C,C-type lectin domain family 4 member C,29434,0.00639591513156695,0.00334028736473958,-0.000151048103322626,0.0129428783664565,0.0555302650572966
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NGF,Beta-nerve growth factor,29218,0.00165266349897111,0.000866088811239152,-4.48705710576246e-05,0.00335019756899985,0.0563762366321814
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,24867,-0.00399501150551911,0.00211532171794464,-0.00814104207269059,0.000151019061652377,0.0589561360167293
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MAMDC2,MAM domain-containing protein 2,24922,-0.00466661547019369,0.00247159797944996,-0.0095109475099156,0.000177716569528224,0.0590246095582125
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DDX1,ATP-dependent RNA helicase DDX1,24805,0.00671584524061339,0.00357154483498954,-0.000284382635966098,0.0137160731171929,0.0600686402271448
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CXCL12,Stromal cell-derived factor 1,28931,0.00535161601071297,0.0028539975676199,-0.000242219221822041,0.010945451243248,0.0607849324779152
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PLXDC1,Plexin domain-containing protein 1,28797,0.00443081804829214,0.00236447414216027,-0.000203551270341986,0.00906518736692626,0.0609525858832751
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PGM2,Phosphoglucomutase-2,24195,0.00802701402607378,0.00429888872764555,-0.000398807880111506,0.0164528359322591,0.0618815649752173
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",24111,0.00664808176259938,0.00356130181824365,-0.000332069801158176,0.0136282333263569,0.0619477956725703
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LTA4H,Leukotriene A-4 hydrolase,29725,0.00775244479548996,0.00417378484262134,-0.000428173496047869,0.0159330630870278,0.0632622181319672
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NCAN,Neurocan core protein,29694,0.00493829494229615,0.00266010843240189,-0.000275517585211561,0.0101521074698039,0.063402737999308
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LYPLA2,Acyl-protein thioesterase 2,24101,0.014237387516515,0.00772805127816736,-0.000909592988693,0.029384368021723,0.0654435886729861
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,COPE,Coatomer subunit epsilon,28774,0.00621512148407573,0.00337490169847065,-0.00039968584492675,0.0128299288130782,0.065548200307516
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PLXDC2,Plexin domain-containing protein 2,24845,0.00354426513211044,0.00192987032353103,-0.000238280702010385,0.00732681096623126,0.0662912264368019
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DUSP29,Dual specificity phosphatase 29,24195,-0.00876343765406427,0.00477455825310777,-0.0181215718301555,0.000594696522026955,0.0664520991132734
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",24229,0.00367737433283032,0.00200539619285403,-0.000253202205163579,0.00760795087082422,0.0667049292245327
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FBN2,Fibrillin-2,24195,0.00790609547993209,0.00431630061591212,-0.000553853727255679,0.0163660446871199,0.0670109221669138
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,24195,-0.00643812884271876,0.00351997083532043,-0.0133372716799468,0.000461013994509286,0.0674075684088799
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNNI3,"Troponin I, cardiac muscle",28916,0.0109603607253999,0.00599864499530136,-0.000796983465390783,0.0227177049161905,0.0676891167336691
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LSM8,U6 snRNA-associated Sm-like protein LSm8,24445,0.0112623061386812,0.00617070430819197,-0.000832274305375044,0.0233568865827375,0.0679943858823139
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRRT3,Proline-rich transmembrane protein 3,24240,0.00495452447543825,0.00271598916739526,-0.000368814292656463,0.010277863243533,0.0681332056375757
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DNLZ,DNL-type zinc finger protein,24101,-0.0117297899608079,0.00645028523863992,-0.0243723490285421,0.000912769106926342,0.0690014324698996
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RELB,Transcription factor RelB,24229,0.00638825346049215,0.00352682961521089,-0.0005243325853212,0.0133008395063055,0.0701021178376484
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ARHGAP30,Rho GTPase-activating protein 30,24445,0.0049925080359308,0.00276899043771747,-0.000434713221995436,0.010419729293857,0.0713994950104666
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD82,CD82 antigen,24445,-0.00534576362426203,0.00297033495237311,-0.0111676201309133,0.000476092882389269,0.0719175985130546
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DENND2B,DENN domain-containing protein 2B,24111,-0.00651584955239444,0.00362884022352883,-0.0136283763905109,0.000596677285722056,0.0725748886167417
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DHODH,Dihydroorotate dehydrogenase,24111,0.00606098479473542,0.00338358953861692,-0.000570850700953748,0.0126928202904246,0.0732595667029952
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",24111,-0.00778531775149726,0.00435476679581861,-0.0163206606713017,0.000750025168307209,0.0738258210741463
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NPHS2,Podocin,24229,-0.0131483286531249,0.00737819564310428,-0.0276095921136093,0.0013129348073595,0.0747532716509182
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,24101,-0.00826743488595188,0.00464223324522016,-0.0173662120465834,0.000831342274679629,0.074938512004141
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AREG,Amphiregulin,29349,-0.00576919691231323,0.00325015868583589,-0.0121395079365516,0.000601114111925111,0.0758998596008246
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PPT1,Palmitoyl-protein thioesterase 1,24195,0.00983648213562141,0.00554516969034979,-0.00103205045746418,0.020705014728707,0.0760950903165179
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MYBPC1,"Myosin-binding protein C, slow-type",24922,-0.00882618642350437,0.00498132511276745,-0.0185895836445286,0.000937210797519832,0.0764308326869717
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BEX3,Protein BEX3,24016,-0.00597459278125016,0.00337350050326988,-0.0125866537676591,0.000637468205158806,0.0765673079086116
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ESPL1,Separin,24016,-0.00699127858871298,0.00396127588862225,-0.0147553793304126,0.000772822152986619,0.0775923225535683
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRR5,Proline-rich protein 5,24229,0.00599907581021038,0.00340319918284209,-0.000671194588160112,0.0126693462085809,0.0779509899805027
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KRT14,"Keratin, type I cytoskeletal 14",27986,0.00365750498205735,0.00207504736522489,-0.000409587853783438,0.00772459781789813,0.0779767410330157
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADGRV1,Adhesion G-protein coupled receptor V1,24101,-0.00882610399658208,0.00500944285979147,-0.0186446120017734,0.000992404008609197,0.078100003836519
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL1A,Interleukin-1 alpha,28931,0.00696623221355385,0.00396718096244534,-0.000809442472839013,0.0147419068999467,0.0791049147440696
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PROK1,Prokineticin-1,29434,0.00757913747538137,0.00437365181885502,-0.00099322008957446,0.0161514950403372,0.0831224500884234
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DOC2B,Double C2-like domain-containing protein beta,24195,0.00448328518395063,0.00259031049826527,-0.000593723392649304,0.00956029376055057,0.083501867427098
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,24101,-0.00404285029121287,0.00234095857858467,-0.00863112910523882,0.000545428522813094,0.0841793464098224
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AGBL2,Cytosolic carboxypeptidase 2,24101,0.011254342959571,0.00651923251196431,-0.00152335276387904,0.0240320386830211,0.0843009860774121
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,24016,-0.0102574995226324,0.0059943627522134,-0.0220064505169707,0.00149145147170583,0.087058782120473
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ARNT,Aryl hydrocarbon receptor nuclear translocator,28931,0.00453911502152443,0.00265425462765568,-0.000663224048680712,0.00974145409172957,0.087252942844841
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,24111,-0.00451477501163562,0.00265084363508979,-0.00971042853641161,0.000680878513140371,0.0885535543929355
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NPTN,Neuroplastin,28797,0.00988889977391956,0.00581833004192614,-0.00151502710825568,0.0212928266560948,0.0892148591713393
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NXPE4,NXPE family member 4,24111,-0.00417265686524935,0.0024552307759969,-0.00898490918620327,0.000639595455704574,0.0892385221887961
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BRME1,Break repair meiotic recombinase recruitment factor 1,24101,-0.00499899296631201,0.00294542522766165,-0.0107720264125289,0.000774040479904832,0.0896706659037527
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TOP1,DNA topoisomerase 1,24805,0.0136246601285921,0.00807971518334961,-0.00221158163077317,0.0294609018879573,0.0917545116627728
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CDH22,Cadherin-22,24445,-0.00343714439017154,0.00204080733910214,-0.00743712677481173,0.000562837994468646,0.0921542191647871
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ACTN4,Alpha-actinin-4,28931,0.00382408450098788,0.00228149979715221,-0.000647655101430461,0.00829582410340622,0.0937240357996909
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ANGPT2,Angiopoietin-2,29725,-0.0045343838905864,0.00271410538558146,-0.00985403044632607,0.000785262665153261,0.0947967223556812
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SELENOP,Selenoprotein P,24966,0.00268993966465212,0.001613259561073,-0.000472049075050956,0.0058519284043552,0.0954485919099352
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TSPAN15,Tetraspanin-15,24111,-0.00601892399893723,0.00361213241381167,-0.0130987035300081,0.00106085553213365,0.0956651439229298
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD3E,T-cell surface glycoprotein CD3 epsilon chain,24445,0.00420379710896955,0.00253005455672805,-0.000755109822217421,0.00916270404015652,0.0966170588131784
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MZB1,Marginal zone B- and B1-cell-specific protein,29542,-0.00605074245392523,0.00365189041646417,-0.013208447670195,0.00110696276234454,0.0975544590801589
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TEX33,Testis-expressed protein 33,24445,-0.00461264982534114,0.00278499257164273,-0.0100712352657609,0.000845935615078603,0.0976836161439999
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NECTIN4,Nectin-4,29566,-0.00376496631999482,0.00227579259665792,-0.00822551980944435,0.00069558716945471,0.0980662507055319
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ENOPH1,Enolase-phosphatase E1,24793,0.00653350749824067,0.00395569307251146,-0.00121965092388178,0.0142866659203631,0.0986141042120503
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DCUN1D1,DCN1-like protein 1,24101,-0.00882681863932657,0.00535132111973746,-0.019315408034012,0.00166177075535885,0.0990653806492765
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DCLRE1C,Protein artemis,24016,-0.00365697237469404,0.002222099836108,-0.00801228805346572,0.000698343304077629,0.0998328227607771
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DNAJA1,DnaJ homolog subfamily A member 1,24016,-0.00545811344558854,0.00334426600568678,-0.0120128748167346,0.00109664792555754,0.102675514437026
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,H2AP,Huntingtin-interacting protein M,24016,-0.00596425365882665,0.00365955127085893,-0.0131369741497102,0.00120846683205686,0.103161691232614
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,S100A3,Protein S100-A3,24793,0.00516434694597226,0.003169306321282,-0.00104749344374047,0.011376187335685,0.103222442470351
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL36A,Interleukin-36 alpha,24229,-0.00675304182755028,0.00415907886902544,-0.0149048364108401,0.00139875275573958,0.10445566695034
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GUCY2C,Heat-stable enterotoxin receptor,24445,-0.00966087763522926,0.00595414665785577,-0.0213310050846266,0.00200924981416804,0.104699366433634
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,INSL4,Early placenta insulin-like peptide,24793,-0.00589041462688989,0.00366899576273556,-0.0130816463218516,0.0013008170680718,0.108406030294919
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CHP1,Calcineurin B homologous protein 1,24101,0.00838849382109574,0.0052304602380855,-0.00186320824555183,0.0186401958877433,0.108776243189475
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HMCN2,Hemicentin-2,24343,0.00659574619121837,0.00411314928206629,-0.00146602640163156,0.0146575187840683,0.108820594054679
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BHLHE40,Class E basic helix-loop-helix protein 40,24101,-0.00810989800623419,0.00505792968527102,-0.0180234401893654,0.00180364417689701,0.108858891491973
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,24793,0.00712908903893128,0.00444939594262195,-0.00159172700860775,0.0158499050864703,0.109110878681637
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCNE1,G1/S-specific cyclin-E1,24229,0.0105683281110747,0.00660653942352502,-0.0023804891590343,0.0235171453811838,0.109683338183477
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TGOLN2,Trans-Golgi network integral membrane protein 2,24951,0.00295646954499139,0.00184937200094961,-0.000668299576869842,0.00658123866685263,0.109914549276108
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRAME,Melanoma antigen preferentially expressed in tumors,24016,-0.00290213477737353,0.00181635975582535,-0.0064621998987912,0.000657930344044148,0.110106154280909
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SOX2,Transcription factor SOX-2,24826,0.00271351563818801,0.00170067669021348,-0.000619810674630409,0.00604684195100642,0.110601910041497
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SEZ6L,Seizure 6-like protein,29566,0.00308641733565411,0.00195754105644993,-0.000750363134987758,0.00692319780629598,0.114879701735469
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADGRE2,Adhesion G protein-coupled receptor E2,29581,0.0031674466862499,0.00200895154530237,-0.000770098342542734,0.00710499171504254,0.114882971246472
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SLC44A4,Choline transporter-like protein 4,24195,-0.00779931369174535,0.00495510757538084,-0.0175113245394918,0.0019126971560011,0.115501727958543
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,24101,-0.00642316243611731,0.00409327629155173,-0.0144459839675587,0.00159965909532408,0.116614862218001
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADGRB3,Adhesion G protein-coupled receptor B3,29169,-0.00375453811369191,0.00239426239959038,-0.00844729241688905,0.000938216189505233,0.116859366967531
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LELP1,Late cornified envelope-like proline-rich protein 1,24101,-0.00812961230674058,0.00523571057984812,-0.0183916050432429,0.00213238042976174,0.120502277494789
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLEC1A,C-type lectin domain family 1 member A,28916,-0.00367879971731501,0.0023851127768566,-0.00835362075995394,0.00099602132532392,0.122987189498412
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SMC3,Structural maintenance of chromosomes protein 3,24016,0.00595476478966787,0.00386239180485854,-0.00161552314785486,0.0135250527271906,0.123152434860365
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DEFB116,Beta-defensin 116,24101,-0.00846487238131871,0.00551263986617778,-0.0192696465190272,0.00233990175638973,0.124664669531309
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL4R,Interleukin-4 receptor subunit alpha,29434,-0.00400673072615023,0.00262127462227446,-0.00914442898580817,0.00113096753350772,0.12638855026727
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HTR1A,5-hydroxytryptamine receptor 1A,24101,-0.00840606642473135,0.00550248574276747,-0.0191909384805556,0.00237880563109289,0.126603829429388
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MYBPC2,"Myosin-binding protein C, fast-type",24240,-0.00919324580965676,0.00606860559255423,-0.0210877127710631,0.00270122115174952,0.129814316082805
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,L1CAM,Neural cell adhesion molecule L1,29566,0.00311990279057678,0.00206136063831739,-0.000920364060525313,0.00716016964167887,0.130159274748662
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NOTCH2,Neurogenic locus notch homolog protein 2,24938,-0.00232578310339651,0.00153720707617411,-0.00533870897269777,0.000687142765904745,0.130294189405226
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TRPV3,Transient receptor potential cation channel subfamily V member 3,24111,-0.00542656749347499,0.0035955429501232,-0.0124738316757165,0.00162069668876648,0.131248423259875
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ZP4,Zona pellucida sperm-binding protein 4,24016,-0.00342760464693018,0.00227792521681452,-0.00789233807188663,0.00103712877802628,0.132413187461579
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL25,Interleukin-25,23913,0.0037136935133152,0.00247153638187011,-0.00113051779515022,0.00855790482178062,0.132959304457388
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DDX53,Probable ATP-dependent RNA helicase DDX53,24195,0.00382696639456315,0.0025482449145593,-0.00116759363797307,0.00882152642709936,0.133160591003744
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SEPTIN7,Septin-7,24445,0.00564467349429726,0.0037639767260605,-0.00173272088878132,0.0130220678773758,0.133716233958056
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HNF1A,Hepatocyte nuclear factor 1-alpha,24195,0.00756467278219596,0.00509305215052767,-0.00241770943283827,0.0175470549972302,0.137479361441416
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,29508,-0.00519406414681163,0.00350520211311145,-0.0120642602885101,0.00167613199488681,0.138399976409745
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PODXL2,Podocalyxin-like protein 2,29566,0.00293140873393519,0.00198670743928882,-0.000962537847070889,0.00682535531494127,0.140085859829135
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL4,Interleukin-4,28931,0.00964432013662022,0.00654504436853058,-0.00318396682569972,0.0224726070989402,0.140619028307602
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FZD10,Frizzled-10,24195,0.00633024527931526,0.00430209588146239,-0.00210186264835101,0.0147623532069815,0.141187103412632
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ZCCHC8,Zinc finger CCHC domain-containing protein 8,24111,0.00624873304974079,0.00424752011583596,-0.00207640637729768,0.0145738724767793,0.141264006318189
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NENF,Neudesin,24793,0.0115343307945661,0.0078436248999009,-0.00383917400923964,0.0269078355983719,0.141429409249888
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,COL3A1,Collagen alpha-1(III) chain,24938,0.00243534051972684,0.00166237309933338,-0.000822910754966595,0.00569359179442027,0.142939451392809
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CNTNAP4,Contactin-associated protein-like 4,24195,0.010762039731112,0.00736759588331586,-0.00367844820018705,0.0252025276624111,0.144103611240974
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RAB6B,Ras-related protein Rab-6B,28774,0.00499912113565324,0.0034235423602919,-0.00171102189051888,0.0117092641618254,0.144240855744577
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SERPINB5,Serpin B5,28916,0.00502407992505548,0.00346638886172326,-0.00177004224392212,0.0118182020940331,0.147245139971025
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,24793,-0.00892860165827975,0.00620038752930497,-0.0210813612157175,0.00322415789915799,0.149878042477353
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,24016,0.00585965523605364,0.0041003551788535,-0.00217704091449921,0.0138963513866065,0.152999886260434
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,29694,0.00476972687965092,0.00334693708961053,-0.00179026981598572,0.0113297235752876,0.154138221962753
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LCN2,Neutrophil gelatinase-associated lipocalin,28586,0.00389287787683566,0.00273388998527047,-0.00146554649429445,0.00925130224796578,0.154476607410142
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GID8,Glucose-induced degradation protein 8 homolog,24867,0.00343432396930993,0.00241347318403551,-0.00129608347139966,0.00816473141001952,0.154754517230587
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD58,Lymphocyte function-associated antigen 3,29409,-0.00178323966398398,0.00125590278514139,-0.0042448091228611,0.000678329794893147,0.15565127294513
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,REG1B,Lithostathine-1-beta,29820,0.00565781057406796,0.0040122437902376,-0.00220618725479773,0.0135218084029337,0.158509878354486
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IZUMO1,Izumo sperm-egg fusion protein 1,24016,-0.0049380864318668,0.00350215843138673,-0.0118023169573848,0.00192614409365118,0.158549011672975
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TMED10,Transmembrane emp24 domain-containing protein 10,24111,-0.00496146277844756,0.00354523821895279,-0.011910129687595,0.00198720413069991,0.161684263795113
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,29443,0.0036290310335971,0.00260105363175767,-0.00146903408464793,0.00872709615184213,0.162961312704866
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GPA33,Cell surface A33 antigen,29349,0.0132468627026202,0.00960481376377853,-0.00557857227438574,0.0320722976796261,0.167846707506621
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RRP15,RRP15-like protein,24101,-0.00890454789421682,0.00650171865424343,-0.0216479164565339,0.0038388206681003,0.170834462264463
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,UPK3BL1,Uroplakin-3b-like protein 1,24404,-0.00529903670417851,0.00388115121806305,-0.0129060930915821,0.00230801968322506,0.172163199971704
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FHIP2A,FHF complex subunit HOOK interacting protein 2A,24111,0.0045242848761678,0.0033456036952399,-0.0020330983665024,0.011081668118838,0.176289665424128
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GDF15,Growth/differentiation factor 15,29820,0.00426832725663231,0.00316192744538835,-0.00192905053632886,0.0104657050495935,0.177054112721368
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HRAS,GTPase Hras,24421,0.00948737238374801,0.0070375821084679,-0.00430628854884908,0.0232810333163451,0.177638369417242
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KIAA0319,Dyslexia-associated protein KIAA0319,24845,0.00295129150073647,0.00219732849405495,-0.00135547234761123,0.00725805534908418,0.179243089674091
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,UGDH,UDP-glucose 6-dehydrogenase,24111,0.00940331124277154,0.00700785040182975,-0.00433207554481477,0.0231386980303578,0.179665277783642
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GAD1,Glutamate decarboxylase 1,24016,-0.00246930149599251,0.00185888499660722,-0.00611271608934266,0.00117411309735764,0.184065971396869
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,COL4A4,Collagen alpha-4(IV) chain,24405,-0.00500264669971534,0.00377623248477428,-0.0124040623698729,0.00239876897044226,0.185259227297579
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HLA_A,,24867,0.00306263919015979,0.00233234173339969,-0.00150875060730361,0.00763402898762318,0.189155417224072
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HAVCR2,Hepatitis A virus cellular receptor 2,29443,0.00328567848913906,0.00250394873216684,-0.00162206102590795,0.00819341800418607,0.189463305575613
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TXNDC15,Thioredoxin domain-containing protein 15,29566,0.00255003435828303,0.00194657649177499,-0.00126525556559596,0.00636532428216202,0.190202689521249
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PYDC1,Pyrin domain-containing protein 1,24240,-0.00392154715299071,0.00299757866588316,-0.0097968013381217,0.00195370703214029,0.190804914603592
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,OGN,Mimecan,29443,0.00391186916658613,0.00299782597011034,-0.00196386973483014,0.00978760806800241,0.191936416217758
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CDC123,Cell division cycle protein 123 homolog,24016,0.00590095520539979,0.00452779487848098,-0.00297352275642294,0.0147754331672225,0.192493896751591
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MORC3,MORC family CW-type zinc finger protein 3,24845,0.00261272504764873,0.00200590256479079,-0.00131884397934122,0.00654429407463869,0.192751304061551
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SHH,Sonic hedgehog protein,24229,-0.00399589054488593,0.00307036888797314,-0.0100138135653133,0.00202203247554142,0.193121423265427
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",24101,-0.00420738600925252,0.00325426548335698,-0.0105857463566322,0.00217097433812717,0.196063770401394
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MFAP3,Microfibril-associated glycoprotein 3,28916,0.00448468681042388,0.00347679895059883,-0.00232983913274981,0.0112992127535976,0.197099312696675
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PMCH,Pro-MCH,24111,-0.00764151016760455,0.00597491713122357,-0.0193523477448027,0.00406932740959364,0.200933469037587
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,24101,-0.00290139284422244,0.00228186420380717,-0.00737384668368449,0.00157106099523962,0.20356271374385
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GSTM4,Glutathione S-transferase Mu 4,24111,-0.0066087110127644,0.00520300269089909,-0.0168065962869266,0.00358917426139782,0.204035449945414
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RBM25,RNA-binding protein 25,24016,-0.00420767443696013,0.00331865539212065,-0.0107122390055166,0.00229689013159635,0.204851207959498
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TMEM132A,Transmembrane protein 132A,24240,0.00564472207334343,0.0044756284250963,-0.00312750963984532,0.0144169537865322,0.207244154519321
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TCN2,Transcobalamin-2,29757,-0.00268064604267315,0.0021363654311719,-0.00686792228777007,0.00150663020242376,0.209572331083148
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MAPT,Microtubule-associated protein tau,28774,0.00472923971247516,0.00376940988123898,-0.00265880365475324,0.0121172830797036,0.209620895305162
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",24229,-0.00392586528992347,0.0031681008877546,-0.0101353430299225,0.00228361245007554,0.215288748561288
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BTLA,B- and T-lymphocyte attenuator,24016,0.00769502645735459,0.00623450140696088,-0.00452459630028874,0.0199146492149979,0.217116282889656
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,24101,0.00643216160609176,0.00526327567787378,-0.00388385872254085,0.0167481819347244,0.221688065363075
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ITGB5,Integrin beta-5,29566,0.00327481047378827,0.00268315873260157,-0.00198418064211081,0.00853380158968735,0.22228297616915
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,24445,0.00549710570011512,0.00450447261639216,-0.00333166062801352,0.0143258720282438,0.222337899535149
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GH2,Growth hormone variant,28797,0.0142550477516285,0.0117952954620429,-0.00886373135397549,0.0373738268572325,0.226850806628528
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HDAC8,Histone deacetylase 8,24229,0.00529039678662002,0.00438147262776822,-0.00329728956380569,0.0138780831370457,0.227271767090759
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GAMT,Guanidinoacetate N-methyltransferase,24111,-0.00319976623679076,0.00266224600491113,-0.00841776840641658,0.00201823593283505,0.229412228114512
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,UHRF2,E3 ubiquitin-protein ligase UHRF2,24111,-0.0030272590410736,0.00252078951691354,-0.00796800649422414,0.00191348841207694,0.22979519460592
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SIGLEC5,Sialic acid-binding Ig-like lectin 5,29443,0.0101070941921889,0.00845625465909607,-0.00646716493963937,0.0266813533240172,0.232010279101392
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ANXA5,Annexin A5,28650,0.00258375525019605,0.00216925136788675,-0.00166797743086198,0.00683548793125407,0.233631450127386
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ARMCX2,Armadillo repeat-containing X-linked protein 2,24101,-0.00528489511077738,0.00446823653466007,-0.0140426387187111,0.00347284849715637,0.236912077704211
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DCUN1D2,DCN1-like protein 2,24016,-0.00677832946672575,0.0057313663856013,-0.0180118075825043,0.0044551486490528,0.236950678264
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CRTAC1,Cartilage acidic protein 1,29820,0.00252767077017606,0.00214120123830428,-0.00166908365690034,0.00672442519725246,0.237814040938634
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,WNT9A,Protein Wnt-9a,28931,0.00242783390383829,0.00205698399711028,-0.00160385473049786,0.00645952253817443,0.237895325346148
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FGF7,Fibroblast growth factor 7,24016,-0.00666733511650451,0.00567237021583673,-0.0177851807395445,0.00445051050653549,0.239844185825317
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PITHD1,PITH domain-containing protein 1,23970,-0.00668831480949757,0.0056992058428834,-0.017858758261549,0.0044821286425539,0.240586156595516
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ZPR1,Zinc finger protein ZPR1,24101,0.00809577419905236,0.00690372379678681,-0.00543552444264978,0.0216270728407545,0.24094066908884
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD177,CD177 antigen,29413,-0.0106684972582599,0.00911624117859588,-0.0285363299683078,0.00719933545178802,0.241900330206768
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SCN3A,Sodium channel protein type 3 subunit alpha,24195,-0.00314152303082893,0.00269983828059351,-0.00843320606079221,0.00215015999913435,0.244598953191387
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SLAMF1,Signaling lymphocytic activation molecule,28931,0.00491849158785239,0.00424189062130239,-0.00339561402990029,0.0132325972056051,0.246260146200836
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",24867,-0.00345805118112626,0.00301321263190582,-0.00936394793966168,0.00244784557740915,0.251132665054717
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DUOX2,Dual oxidase 2,28916,0.00579404010714978,0.00508394301004985,-0.00417048819254792,0.0157585684068475,0.254431387833139
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,THBS2,Thrombospondin-2,29443,0.00301032580351342,0.00266330606891852,-0.00220975409156688,0.00823040569859371,0.25836047711078
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KIRREL1,Kin of IRRE-like protein 1,24101,-0.00473770746801083,0.00421613735570905,-0.0130013366852006,0.00352592174917891,0.261148101136475
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MORF4L2,Mortality factor 4-like protein 2,24016,-0.00292887563273718,0.00263937878019931,-0.00810205804192783,0.00224430677645347,0.26714646317478
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GRIK2,"Glutamate receptor ionotropic, kainate 2",24867,0.00331202991137293,0.00299055712395622,-0.00254946205158126,0.00917352187432712,0.268090279532217
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,24805,-0.00238189246687644,0.0021531265287791,-0.00660202046328347,0.00183823552953059,0.26862981607813
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,28916,0.00250084803574806,0.00226452199904212,-0.00193761508237449,0.00693931115387061,0.269446099221551
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SLK,STE20-like serine/threonine-protein kinase,24445,0.0061609888373389,0.00557883137249832,-0.0047735206527578,0.0170954983274356,0.269451719269315
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VWA5A,von Willebrand factor A domain-containing protein 5A,24016,0.00629186317729894,0.00569769057356524,-0.00487561034688894,0.0174593367014868,0.269481439318229
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CTSV,Cathepsin L2,29618,0.00325680725641401,0.00294999261443125,-0.00252517826787125,0.00903879278069927,0.269599845054859
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RBP1,Retinol-binding protein 1,24195,0.00547196620499095,0.00495665464975704,-0.00424307690853286,0.0151870093185148,0.269619922587521
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CNTF,Ciliary neurotrophic factor,24101,-0.002687491283273,0.00243703406752802,-0.00746407805562791,0.00208909548908191,0.270137502254327
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GHRHR,Growth hormone-releasing hormone receptor,28774,0.00430728814534724,0.00391875099302515,-0.00337346380098205,0.0119880400916765,0.271712624532449
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,24195,-0.00324334291744555,0.00296107359073743,-0.0090470471552909,0.00256036132039981,0.273384450455172
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CTAG1A_CTAG1B,Cancer/testis antigen 1,24396,-0.00393132717504831,0.00360122385005871,-0.0109897259211634,0.00312707157106677,0.274991510605392
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,23494,0.00387524916650261,0.0035704204153516,-0.00312277484758652,0.0108732731805918,0.277766234251971
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",24229,0.0037540552118039,0.00349450609521681,-0.00309517673482105,0.0106032871584289,0.282710833429033
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CHIT1,Chitotriosidase-1,29579,0.0115467268140782,0.0108554009891195,-0.00972985912459592,0.0328233127527524,0.287480125526692
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CGN,Cingulin,24195,0.00303092267859805,0.00285104534073909,-0.00255712618925056,0.00861897154644666,0.287750977919963
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ZP3,Zona pellucida sperm-binding protein 3,24240,-0.0200147265210188,0.0188493902225392,-0.0569595313571957,0.0169300783151581,0.288326379450946
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,29527,0.00433398687650901,0.0040824501532845,-0.00366761542392861,0.0123355891769466,0.288419571325347
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FZD8,Frizzled-8,24101,0.00333110259403984,0.00314305844711226,-0.00282929196230019,0.00949149715037987,0.289233302809689
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CRISP2,Cysteine-rich secretory protein 2,29725,-0.00433673443366019,0.00410020858912923,-0.0123731432683535,0.00369967440103311,0.290207084491452
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,C1GALT1C1,C1GALT1-specific chaperone 1,24111,0.00245683259261952,0.00233113331058686,-0.00211218869613072,0.00702585388136977,0.291929214213921
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,29694,0.00205994655088145,0.00196497055050252,-0.0017913957281035,0.0059112888298664,0.294493025473634
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EPHA10,Ephrin type-A receptor 10,28774,0.00487843466518708,0.00466204383740023,-0.00425917125611737,0.0140160405864915,0.295378060316267
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,24016,-0.00330271000248506,0.00316122333530283,-0.0094987077396786,0.00289328773470848,0.29614584492943
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TCP11,T-complex protein 11 homolog,24445,-0.0044111620764674,0.00423970880948407,-0.0127209913430562,0.00389866719012138,0.298145883243147
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CA11,Carbonic anhydrase-related protein 11,28797,0.00233183798696576,0.0022730221344035,-0.00212328539646509,0.00678696137039662,0.304958837971866
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TGFBR1,TGF-beta receptor type-1,24229,0.00158453103854751,0.00154889014478315,-0.00145129364522747,0.00462035572232248,0.306313053054813
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MMP15,Matrix metalloproteinase-15,24922,0.00357657021778899,0.0035111879086923,-0.00330535808324792,0.0104584985188259,0.308392759487461
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CREB3,Cyclic AMP-responsive element-binding protein 3,24016,-0.00413297852435661,0.00405808782705539,-0.0120868306653852,0.00382087361667196,0.308472195057096
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NEB,Nebulin,24111,-0.00275657186208884,0.00270680969319422,-0.00806191886074951,0.00254877513657183,0.308505695658483
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ACTA2,"Actin, aortic smooth muscle",28916,-0.00313376395196441,0.00310316012056736,-0.00921595778827644,0.00294842988434763,0.312569792943045
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CHEK2,Serine/threonine-protein kinase Chk2,28916,0.00240058273001013,0.00237801365632705,-0.00226032403639088,0.00706148949641114,0.312747798671924
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GAD2,Glutamate decarboxylase 2,24229,-0.00333973695800955,0.00330945988694881,-0.00982627833642922,0.00314680442041013,0.312913435319293
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IGLC2,Immunoglobulin lambda constant 2,24915,-0.00176673746955548,0.00177253470101436,-0.00524090548354362,0.00170743054443266,0.318905554834649
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RNASE10,Inactive ribonuclease-like protein 10,24240,-0.00341650241775813,0.0034334779210708,-0.0101461191430569,0.00331311430754063,0.319719022364734
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,STC2,Stanniocalcin-2,29396,0.00183705035613513,0.00184736998129147,-0.00178379480719615,0.0054578955194664,0.320029601220633
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PCNA,Proliferating cell nuclear antigen,24016,0.004480764470469,0.00452109234270033,-0.00438057652122364,0.0133421054621616,0.32165647960428
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KDM3A,Lysine-specific demethylase 3A,24229,-0.00636358632375101,0.00647304189111282,-0.0190507484303321,0.00632357578283012,0.325572696164569
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ZNF75D,Zinc finger protein 75D,24445,0.00418965565171371,0.00429490039139662,-0.00422834911542366,0.0126076604188511,0.329324232107856
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,WIF1,Wnt inhibitory factor 1,29725,-0.00235777388590655,0.00242505670159188,-0.00711088502102664,0.00239533724921354,0.33093154143445
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RICTOR,Rapamycin-insensitive companion of mTOR,24229,-0.00334870665135108,0.00345241908371044,-0.0101154480554235,0.00341803475272139,0.332076373275892
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCDC50,Coiled-coil domain-containing protein 50,24867,0.00528631224374944,0.0054572810590597,-0.00540995863200757,0.0159825831195064,0.33271857831633
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CDH17,Cadherin-17,29478,-0.0046756700794098,0.00483778119065654,-0.0141577212130966,0.00480638105427702,0.333806677595707
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PSMD5,26S proteasome non-ATPase regulatory subunit 5,24195,-0.00381158877863218,0.00397396076262721,-0.0116005518733815,0.00397737431611716,0.337497297968365
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FGF20,Fibroblast growth factor 20,24229,-0.00300056887652149,0.00313629169300061,-0.00914770059480269,0.00314656284175971,0.338715594223372
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CA8,Carbonic anhydrase-related protein,24229,0.00185299511245465,0.00194508338937857,-0.00195936833072734,0.00566535855563664,0.340773967457206
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DBH,Dopamine beta-hydroxylase,24919,0.00742180477942512,0.00779134208096792,-0.007849225699272,0.0226928352581222,0.340816834143198
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TBR1,T-box brain protein 1,24195,0.00328753860310612,0.00345197146019093,-0.00347832545886811,0.0100534026650803,0.340921157748128
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FH,"Fumarate hydratase, mitochondrial",24101,0.00570987451732872,0.00599699605559581,-0.00604423775163907,0.0174639867862965,0.341044443582991
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,29536,-0.00438364339659845,0.00460728782771345,-0.0134139275389168,0.00464664074571992,0.341379439688425
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HBZ,Hemoglobin subunit zeta,24922,0.00718468256837159,0.00755406391427802,-0.00762128270361333,0.0219906478403565,0.341562011527341
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,24938,-0.00172172731356586,0.001813065318229,-0.00527533533729471,0.00183188071016298,0.342313395235823
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RPGR,X-linked retinitis pigmentosa GTPase regulator,24195,0.00282969067846967,0.00298079296178125,-0.00301266352662157,0.00867204488356092,0.342473460698687
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VSTM2B,V-set and transmembrane domain-containing protein 2B,24445,0.00277714043777367,0.00293142418076389,-0.00296845095652356,0.0085227318320709,0.343460144579072
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL10,Interleukin-10,28931,0.00548898739443832,0.00583308247284773,-0.00594385425234322,0.0169218290412199,0.34670773086662
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FGF12,Fibroblast growth factor 12,24229,0.00313261915582602,0.00334338809974351,-0.00342042151967127,0.0096856598313233,0.348788748746171
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EVPL,Envoplakin,24445,-0.0022673204191713,0.00242377803950569,-0.00701792537660245,0.00248328453825984,0.34956626952324
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,OSTN,Osteocrin,24195,-0.00279205211196269,0.00298703919369357,-0.00864664893160209,0.00306254470767671,0.349940771084807
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,24867,-0.00158816124801837,0.0016994494648183,-0.00491908219906224,0.0017427597030255,0.35004731131228
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL31,Interleukin-31,24229,-0.0037957822640062,0.00406505355925486,-0.0117632872401457,0.00417172271213333,0.35043729032519
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,24016,0.00383037485783604,0.00412109621404104,-0.00424697372168441,0.0119077234373565,0.352662510096529
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ATP2B4,Plasma membrane calcium-transporting ATPase 4,24111,-0.00414935253605908,0.00446872893868169,-0.0129080612558752,0.00460935618375704,0.353141590094184
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MB,Myoglobin,29820,-0.00345547584693018,0.00373564926453603,-0.0107773484054208,0.00386639671156045,0.35497335757548
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CDAN1,Codanin-1,24845,0.00148375901009008,0.00161020402189404,-0.00167224087282224,0.0046397588930024,0.356812652628319
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IGFL4,Insulin growth factor-like family member 4,24229,0.00494700046968252,0.00538084830329705,-0.00559946220477969,0.0154934631441447,0.357910264892784
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,24111,-0.00431546578079545,0.0046995564947539,-0.0135265965105131,0.00489566494892219,0.358486270338958
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CINP,Cyclin-dependent kinase 2-interacting protein,24445,0.00285549678295184,0.00311661772407021,-0.00325307395622578,0.00896406752212945,0.359562362849783
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MORF4L1,Mortality factor 4-like protein 1,24445,-0.00262622898702132,0.00286656561756672,-0.00824469759745208,0.00299223962340944,0.359592714284058
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VNN2,Vascular non-inflammatory molecule 2,29349,0.00298259527068228,0.00327084415335565,-0.0034282592698948,0.00939344981125937,0.3618429408197
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,APOH,Beta-2-glycoprotein 1,29443,-0.00232788761380388,0.00255846188079248,-0.00734247290015714,0.00268669767254938,0.362894421568439
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MED21,Mediator of RNA polymerase II transcription subunit 21,24111,0.00315025162810023,0.00347057147467441,-0.00365206846226161,0.00995257171846207,0.364043704449561
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,28797,0.00227810614122576,0.00252550698206961,-0.00267188754363067,0.00722809982608219,0.367043625596326
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MYOC,Myocilin,29443,-0.00292522983083478,0.00325161583346573,-0.00929839686442761,0.00344793720275804,0.368328038253154
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CNTN5,Contactin-5,29511,-0.00236556533282923,0.00263821367687792,-0.00753646413950995,0.00280533347385148,0.369910792896163
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ATP5F1D,"ATP synthase subunit delta, mitochondrial",24111,-0.00328071604814882,0.00366236062697953,-0.0104589428770287,0.00389751078073106,0.370372418090015
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TPRKB,EKC/KEOPS complex subunit TPRKB,24016,-0.00421157966080206,0.00470755712144216,-0.0134383916188287,0.00501523229722457,0.370987311058933
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,24195,-0.00324539334981979,0.00366457888580754,-0.0104279679660026,0.00393718126636299,0.375835697527295
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRTN3,Myeloblastin,28671,0.00299129173201677,0.00338257158133283,-0.00363854856739558,0.00962113203142911,0.376528356367376
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KLK12,Kallikrein-12,28797,-0.00868514763722183,0.00987815111928449,-0.0280463238310194,0.0106760285565758,0.379284973495713
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,24938,-0.00862385541063612,0.00983855346640866,-0.0279074202047971,0.0106597093835249,0.380746659284604
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RAC3,Ras-related C3 botulinum toxin substrate 3,24195,0.00432848380056106,0.00496615493529786,-0.00540517987262275,0.0140621474737449,0.383437134780879
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ERCC1,DNA excision repair protein ERCC-1,24016,0.00208131715653673,0.00238940509437734,-0.00260191682844285,0.00676455114151632,0.383729658471526
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GJA8,Gap junction alpha-8 protein,24016,0.00382276347619012,0.00444381624910397,-0.00488711637205365,0.0125326433244339,0.389663493155358
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TPPP2,Tubulin polymerization-promoting protein family member 2,24445,-0.00486088611552341,0.00568149355404951,-0.0159966134814605,0.00627484125041364,0.392246916213657
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PDCL2,Phosducin-like protein 2,24016,0.00322848695747426,0.00378985417473316,-0.00419962722500273,0.0106566011399512,0.394291250730566
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CRYBB2,Beta-crystallin B2,24845,0.00417064859846809,0.00493515067229482,-0.00550224671922976,0.0138435439161659,0.398068494256158
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CNGB3,Cyclic nucleotide-gated cation channel beta-3,24101,0.00326363696292754,0.00387820917016011,-0.00433765301058627,0.0108649269364414,0.400058342927231
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",29566,-0.00208688782160115,0.00248196419749867,-0.00695153764869855,0.00277776200549625,0.400454977922525
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CBLN1,Cerebellin-1,24101,-0.00572914858176526,0.00682371466535126,-0.0191036293258537,0.0076453321623232,0.401144504982452
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",24111,-0.00399571739086617,0.00478437024821993,-0.0133730830773772,0.0053816482956449,0.403635586227252
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MYL4,Myosin light chain 4,24240,0.00306788211652315,0.00371600569584732,-0.00421548904733759,0.0103512532803839,0.409047133886587
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CSF2RB,Cytokine receptor common subunit beta,24229,-0.002555301370958,0.00310061857236864,-0.00863251377280053,0.00352191103088454,0.409875904111271
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HSP90B1,Endoplasmin,28626,0.00391473244613914,0.00478201559335749,-0.00545801811684154,0.0132874830091198,0.413000661157158
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FAM171A2,Protein FAM171A2,24867,0.00922665802013267,0.0113040244279163,-0.0129292298585833,0.0313825458988487,0.414377731717641
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NCAM1,Neural cell adhesion molecule 1,29594,-0.00173624644952203,0.0021500570727089,-0.00595035831203148,0.00247786541298742,0.419364781899531
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NAAA,N-acylethanolamine-hydrolyzing acid amidase,29087,0.00339855240234512,0.00423298076231315,-0.00489808989178866,0.0116951946964789,0.422053827278158
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SPRR1B,Cornifin-B,24445,0.00486874570439774,0.00611213992268265,-0.00711104854406025,0.0168485399528557,0.425708698287783
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TAP1,Antigen peptide transporter 1,24445,-0.00340793803226072,0.00428904522756233,-0.0118144666782829,0.00499859061376144,0.426872564667454
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EDDM3B,Epididymal secretory protein E3-beta,24793,0.00290477439253727,0.00371578461171251,-0.00437816344641924,0.0101877122314938,0.434375343791923
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KCNIP4,Kv channel-interacting protein 4,28774,0.00283675524685653,0.00363801256382376,-0.00429374937823804,0.00996725987195109,0.435542039336442
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,24111,-0.00383463458070656,0.004952913690987,-0.0135423454150411,0.00587307625362796,0.438809523317337
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PFDN4,Prefoldin subunit 4,24016,0.0029484648840262,0.00382407454914299,-0.00454672123229405,0.0104436510003465,0.440698493463418
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ICAM2,Intercellular adhesion molecule 2,29820,0.00174623073178144,0.00226687550908838,-0.00269684526603179,0.00618930672959467,0.441113273529285
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PLAU,Urokinase-type plasminogen activator,29443,0.00158243183723632,0.00207091493477266,-0.0024765614349181,0.00564142510939073,0.444800618882501
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PTPRF,Receptor-type tyrosine-protein phosphatase F,29820,-0.00156717580897082,0.00205514250630113,-0.00559525512132103,0.00246090350337939,0.445730041818431
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KRT17,"Keratin, type I cytoskeletal 17",24111,0.00212941039088751,0.00279713208564078,-0.00335296849696842,0.00761178927874343,0.446495227679709
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FOLR3,Folate receptor gamma,29461,-0.0101528961321052,0.0133513539394626,-0.0363215498534519,0.0160157575892414,0.446998043430725
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EPB41L5,Band 4.1-like protein 5,24195,0.0034005932818379,0.004492994434364,-0.00540567580951553,0.0122068623731913,0.449137713538423
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL5,Interleukin-5,28931,0.00766724647155659,0.0101340426222481,-0.0121954770680497,0.0275299700111629,0.449305768799338
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DLGAP5,Disks large-associated protein 5,24867,-0.00276970978667241,0.00369117612414952,-0.0100044149900055,0.00446499541666064,0.45304520291635
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL12RB2,Interleukin-12 receptor subunit beta-2,24229,-0.00221528381040061,0.00297456314380346,-0.0080454275722554,0.00361485995145418,0.456434584465124
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,POLR2A,DNA-directed RNA polymerase II subunit RPB1,24229,-0.00154977429106007,0.00211018628458061,-0.00568573940883806,0.00258619082671792,0.462696655727443
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SHD,SH2 domain-containing adapter protein D,24059,0.00445579535589834,0.0060870528987671,-0.00747482832568517,0.0163864190374819,0.464168419077336
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLEC2L,C-type lectin domain family 2 member L,24195,0.00262709815756839,0.00358946766986481,-0.00440825847536664,0.00966245479050342,0.464242350081458
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ITGAX,Integrin alpha-X,24445,0.00279725742406934,0.0038237426919642,-0.0046972782521805,0.0102917931003192,0.464450538649248
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KLHL41,Kelch-like protein 41,24867,0.0025883207815639,0.00354771245193614,-0.00436519562423093,0.00954183718735874,0.465657147773182
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CDSN,Corneodesmosin,29676,-0.00221895011896744,0.00308856407456152,-0.00827253570510802,0.00383463546717314,0.472491261457857
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DAND5,DAN domain family member 5,24229,-0.00277543754259757,0.00388743588005391,-0.0103948118675032,0.00484393678230809,0.475264550332141
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MERTK,Tyrosine-protein kinase Mer,29786,0.00129171060075481,0.00181203875658888,-0.00225988536215939,0.00484330656366901,0.475944587733967
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VASN,Vasorin,29065,0.00139461346940889,0.00195860362687434,-0.00244424963926482,0.00523347657808259,0.476442770984756
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ZNF830,Zinc finger protein 830,24793,-0.00399971288228689,0.00565568493503769,-0.0150848553549608,0.00708542959038698,0.479447476338993
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,24111,-0.00261106012767923,0.00374864260007802,-0.00995839962383215,0.00473627936847369,0.486100672723866
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",24016,-0.00273651120271004,0.00393216936984539,-0.010443563167607,0.00497054076218693,0.48647995273037
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LY96,Lymphocyte antigen 96,29218,-0.00176240052104113,0.00253253389038068,-0.00672616694618726,0.003201365904105,0.486494475976811
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MAPRE3,Microtubule-associated protein RP/EB family member 3,24016,0.00712678869296468,0.0102575903299458,-0.0129780883537291,0.0272316657396584,0.487198681989432
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,24111,-0.00128330005231209,0.00184800212603754,-0.00490538421934568,0.0023387841147215,0.487422015989134
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NOS1,"Nitric oxide synthase, brain",28774,-0.00267618359007933,0.00385676289745273,-0.0102354388690867,0.00488307168892802,0.487754460726597
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TP53INP1,Tumor protein p53-inducible nuclear protein 1,28916,0.00154309929501965,0.00223065108145881,-0.00282897682463962,0.00591517541467891,0.489086830360485
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRND,Prion-like protein doppel,24845,-0.00253340631853581,0.00367659283390423,-0.00973952827298811,0.00467271563591648,0.490789679270605
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PSCA,Prostate stem cell antigen,24805,0.0127485099492256,0.018504939728938,-0.0235211719194928,0.049018191817944,0.490877105546783
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GFRA3,GDNF family receptor alpha-3,29157,-0.001378685346517,0.00200582876996283,-0.00531010973564414,0.00255273904261015,0.491874281687991
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,29478,-0.00153872308679246,0.00226766054573491,-0.00598333775643289,0.00290589158284797,0.497427796507821
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ECSCR,Endothelial cell-specific chemotaxis regulator,24101,0.00239291015448785,0.0035867253184879,-0.00463707146974843,0.00942289177872413,0.504678022481749
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TMED4,Transmembrane emp24 domain-containing protein 4,24111,-0.00268751846424323,0.00404955861698141,-0.0106246533535268,0.00524961642504032,0.506916130118217
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,24867,-0.00123975527409848,0.00186921683263016,-0.00490342026605358,0.00242390971785662,0.507177560879168
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ENPEP,Glutamyl aminopeptidase,24111,0.00209962362224384,0.00318053696217166,-0.00413422882361262,0.00833347606810029,0.509165469154541
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ISM2,Isthmin-2,24938,-0.00206502351018781,0.0031375739330881,-0.00821466841904048,0.00408462139866486,0.510441843848433
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ATF4,Cyclic AMP-dependent transcription factor ATF-4,24016,-0.00159383794121857,0.0024304020580294,-0.00635742597495618,0.00316975009251905,0.511964325834998
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RAP1A,Ras-related protein Rap-1A,24229,-0.00320228084112076,0.00494978688222626,-0.0129038631302842,0.0064993014480427,0.51766831583783
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MYL6B,Myosin light chain 6B,24195,0.00422647968377566,0.00655560043408405,-0.00862249716702907,0.0170754565345804,0.519119418826905
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KHDC3L,KH domain-containing protein 3,24016,-0.00311116086173572,0.00482813497689526,-0.0125743054164504,0.00635198369297898,0.519334235473016
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ENG,Endoglin,29820,0.000783185409822722,0.00122553314109263,-0.00161885954671884,0.00318523036636428,0.522790827744315
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PLB1,"Phospholipase B1, membrane-associated",24845,0.00270375802976635,0.00427839074967504,-0.00568188783959673,0.0110894038991294,0.527420939241919
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CYTH3,Cytohesin-3,24016,0.00325984177747115,0.00523915731364901,-0.00700890655728091,0.0135285901122232,0.533811495645299
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AMY2B,Alpha-amylase 2B,27585,-0.00217390551033866,0.00349537373640532,-0.00902483803369309,0.00467702701301576,0.533987824924198
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EVI2B,Protein EVI2B,24016,-0.00180144862585053,0.00293519755899922,-0.00755443584148899,0.00395153858978794,0.539392860632038
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LPO,Lactoperoxidase,28452,-0.00263062895821582,0.00429139617759793,-0.0110417654663078,0.00578050754987612,0.539880764031456
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ESR1,Estrogen receptor,24229,0.00252103962400396,0.00411335274304728,-0.00554113175236871,0.0105832110003766,0.539953728706906
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TPSG1,Tryptase gamma,24229,0.00116892462683343,0.0019097919214625,-0.00257426753923307,0.00491211679289992,0.540497785916311
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNPO1,Transportin-1,24445,0.00153083062184767,0.00252854773796702,-0.00342512294456768,0.00648678418826303,0.54490631149091
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PXDNL,Peroxidasin-like protein,24793,0.00249938033213458,0.0041298817782829,-0.00559518795329991,0.0105939486175691,0.545055538262918
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SCIN,Adseverin,24101,0.00316913797618028,0.0052473716486695,-0.00711571045521193,0.0134539864075725,0.545884109825848
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GAGE2A,G antigen 2A,24016,0.0027115144695303,0.00454014770082824,-0.00618717502409305,0.0116102039631537,0.550359163492655
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CDC25A,M-phase inducer phosphatase 1,24016,-0.00171609911066957,0.00289135131364147,-0.00738314768540685,0.0039509494640677,0.552833177303811
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SLC34A3,Sodium-dependent phosphate transport protein 2C,24016,-0.00209228085612713,0.00353027318756176,-0.00901161630374817,0.00482705459149391,0.553408772643704
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,24445,-0.00301491372614994,0.00510581194163555,-0.0130223051317556,0.00699247767945574,0.554869903434912
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,UBQLN3,Ubiquilin-3,24111,-0.00211769982542196,0.00359466155217267,-0.0091632364676804,0.00492783681683648,0.555783909745535
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DCDC2C,Doublecortin domain-containing protein 2C,24016,0.00263967601667652,0.00452644283015513,-0.00623215193042754,0.0115115039637806,0.559785778425009
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RGS8,Regulator of G-protein signaling 8,28931,0.00266515441242247,0.00464798569657065,-0.006444897552856,0.0117752063777009,0.566378434706237
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TAGLN3,Transgelin-3,24016,-0.00246939545671812,0.00431748642633711,-0.0109316688523389,0.00599287793890262,0.567359777991544
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PALLD,Palladin,24229,-0.00163032718457341,0.00285159516278713,-0.00721945370363619,0.00395879933448936,0.56751385338835
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL9,Interleukin-9,24445,-0.00230597298249115,0.00405512407143409,-0.010254016162502,0.00564207019751966,0.56959444706935
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RUVBL1,RuvB-like 1,28797,0.00414028395304107,0.00737471310790136,-0.0103141537384456,0.0185947216445277,0.57451816351932
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GIPR,Gastric inhibitory polypeptide receptor,24229,0.00187167893657153,0.00336732376334959,-0.00472827563959366,0.00847163351273673,0.578328277749912
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CTLA4,Cytotoxic T-lymphocyte protein 4,24938,-0.00117752549831894,0.00212640673276914,-0.00534528269454646,0.00299023169790858,0.579745980135176
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SLC4A1,Band 3 anion transport protein,24938,0.00183291120013329,0.00333695400130049,-0.00470751864241567,0.00837334104268226,0.582820471440169
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRC1,Protein regulator of cytokinesis 1,24793,0.00176972969148981,0.00324179637979829,-0.00458419121291483,0.00812365059589444,0.585132585060039
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BRD2,Bromodomain-containing protein 2,24101,0.00133209065143613,0.00247851286375519,-0.00352579456152404,0.00618997586439631,0.590957902145181
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NELL1,Protein kinase C-binding protein NELL1,29566,-0.00161526805999215,0.00301060128715185,-0.00751604658280977,0.00428551046282548,0.591598606933598
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TP53BP1,TP53-binding protein 1,24229,0.00334893456580046,0.00624215363015984,-0.00888568654931282,0.0155835556809137,0.591615845566703
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,29820,-0.00103760556924971,0.00193883352860477,-0.00483771928531506,0.00276250814681563,0.5925362909634
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PHLDB2,Pleckstrin homology-like domain family B member 2,24016,-0.00357484434714221,0.00668115527459985,-0.0166699086853579,0.0095202199910735,0.59261069591109
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HBQ1,Hemoglobin subunit theta-1,29725,-0.00227775042795828,0.0042826539295681,-0.0106717521299117,0.00611625127399518,0.594830480174364
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BSND,Barttin,24016,-0.00127905416868737,0.00242079322117966,-0.0060238088821995,0.00346570054482476,0.597253272587882
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SMPD3,Sphingomyelin phosphodiesterase 3,24229,0.00217649983561727,0.0041262125465394,-0.00591087675559996,0.0102638764268345,0.597864252364705
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,29694,-0.00168051819144071,0.00324068498381581,-0.00803226075971971,0.00467122437683828,0.604065322294785
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IFNL2,Interferon lambda-2,24101,0.00228257151117064,0.00442230194673305,-0.00638514030442613,0.0109502833267674,0.605754329602009
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CNTNAP2,Contactin-associated protein-like 2,29434,-0.00150007083945678,0.00294891894826403,-0.00727995197805427,0.00427981029914071,0.610976851654058
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CDH4,Cadherin-4,24101,0.00173646293338403,0.00343615021549935,-0.0049983914889947,0.00847131735576276,0.613316750579703
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,24101,0.0020731324500057,0.00425408694432914,-0.00626487796087941,0.0104111428608908,0.62603088151307
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BTNL10,Butyrophilin-like protein 10,24016,-0.00141694904854848,0.00292151261527055,-0.00714311377447876,0.00430921567738181,0.627677025374368
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,24805,-0.00591417337023082,0.0123052387818716,-0.0300324413826991,0.0182040946422375,0.630789134910388
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TSPAN7,Tetraspanin-7,24101,-0.00319212306099929,0.00672743292854549,-0.0163778916009484,0.00999364547894987,0.635152347909001
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NRN1,Neuritin,24867,-0.00119889538028306,0.00254930021881397,-0.00619552380915843,0.00379773304859231,0.638156176485016
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DPEP2,Dipeptidase 2,29349,-0.000975709786846356,0.00208529115828236,-0.00506288045707979,0.00311146088338707,0.639858875146913
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CRTAM,Cytotoxic and regulatory T-cell molecule,29218,0.00165896637536925,0.00361464708334357,-0.00542574190798415,0.00874367465872265,0.646268700464046
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KRT6C,"Keratin, type II cytoskeletal 6C",24111,-0.00130346124200819,0.00284091541046919,-0.00687165544652779,0.00426473296251142,0.646369482309824
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EXOSC10,Exosome component 10,24111,-0.00198006045211213,0.0043324293618177,-0.0104716220012748,0.00651150109705057,0.647651900193775
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SHC1,SHC-transforming protein 1,24016,-0.00377633383421535,0.00833448320435357,-0.0201119209147484,0.0125592532463177,0.650482602692785
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PSMA1,Proteasome subunit alpha type-1,28797,0.00148220979420337,0.00330442386522871,-0.00499446098164491,0.00795888057005164,0.653757400176028
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL21R,Interleukin-21 receptor,24229,0.00175301581461018,0.00393094039720019,-0.0059516273639022,0.00945765899312256,0.655634972195821
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADA2,Adenosine deaminase 2,29328,0.00135783872148195,0.00304626955318543,-0.0046128496027615,0.00732852704572539,0.65578965599015
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TEX101,Testis-expressed protein 101,24195,0.0016091898508908,0.00361774324227689,-0.0054815869039719,0.00869996660575349,0.656464748200281
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LRP2,Low-density lipoprotein receptor-related protein 2,24195,0.00114159158101124,0.00259064849070414,-0.00393607946076887,0.00621926262279136,0.659464099310965
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VWC2L,von Willebrand factor C domain-containing protein 2-like,24867,0.00146397691904019,0.00332468516052053,-0.00505240599558004,0.00798035983366043,0.659697958675553
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LCN15,Lipocalin-15,24867,-0.0019164522155176,0.00444307176705695,-0.0106248728789492,0.00679196844791403,0.666228569838466
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RNF168,E3 ubiquitin-protein ligase RNF168,24229,0.00124717868391144,0.00291574197840606,-0.00446767559376443,0.00696203296158731,0.668844425365012
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ARG2,"Arginase-2, mitochondrial",24793,0.00132123017843425,0.00309354283297881,-0.00474211377420422,0.00738457413107272,0.669315375301773
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TFAP2A,Transcription factor AP-2-alpha,24101,0.00182801372661321,0.00428780136018366,-0.00657607693934677,0.0102321043925732,0.669871996650534
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LTBR,Tumor necrosis factor receptor superfamily member 3,29326,0.000861750577153656,0.00202766367858493,-0.0031124702328728,0.00483597138718011,0.670842126332106
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RANGAP1,Ran GTPase-activating protein 1,28797,-0.0014788859438583,0.00349098516329143,-0.0083212168639095,0.00536344497619289,0.671838859534809
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ITGB2,Integrin beta-2,29274,0.000859549752020934,0.00204736913003045,-0.00315329374283876,0.00487239324688063,0.67461174147132
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IDI2,Isopentenyl-diphosphate delta-isomerase 2,28774,0.00141178160793744,0.0033881855544428,-0.00522906207877045,0.00805262529464533,0.676917224674999
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CEP350,Centrosome-associated protein 350,24016,0.00108935931141574,0.00264257063302237,-0.00409007912930811,0.00626879775213958,0.680171087491286
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SLC39A14,Zinc transporter ZIP14,28774,-0.000977866120944978,0.00238776902139379,-0.0056578934028768,0.00370216116098685,0.682152861028508
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EPGN,Epigen,24793,-0.00139872614503451,0.00342512954654494,-0.00811198005626259,0.00531452776619356,0.683004299425522
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BCL7A,B-cell CLL/lymphoma 7 protein family member A,24016,0.00184810567813016,0.00455829645852834,-0.0070861553805854,0.0107823667368457,0.685159345734447
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TPBGL,Trophoblast glycoprotein-like,24195,-0.0011790062050339,0.00294170932218654,-0.00694475647651952,0.00458674406645172,0.68857865199647
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ANK2,Ankyrin-2,24111,-0.0020642141772541,0.00515212809931111,-0.0121623852519039,0.00803395689739567,0.688679371261703
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MRPL28,"39S ribosomal protein L28, mitochondrial",24867,-0.00103729632973566,0.00260625190257527,-0.00614555005878319,0.00407095739931187,0.690631321197105
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GPHA2,Glycoprotein hormone alpha-2,24805,-0.00131921551424023,0.00332240317882692,-0.00783112574474099,0.00519269471626053,0.691321727164536
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TLR2,Toll-like receptor 2,24445,0.000651441399244991,0.00164338847597044,-0.00256960001365706,0.00387248281214705,0.691812437412508
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FGF3,Fibroblast growth factor 3,24229,0.000846079494053775,0.00214430068392099,-0.00335674984643138,0.00504890883453893,0.693162777686124
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LAYN,Layilin,29163,-0.000967277435460075,0.00248916788089976,-0.0058460464820236,0.00391149161110345,0.697578829310592
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,24793,-0.00211589685769369,0.00547049951265546,-0.0128380759024984,0.008606282187111,0.698920097800955
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PPIE,Peptidyl-prolyl cis-trans isomerase E,24445,-0.00171796958837063,0.00449769560826929,-0.0105334529805784,0.00709751380383718,0.702489446506345
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,29566,0.00121276904182427,0.00322206474797896,-0.00510247786421449,0.00752801594786302,0.706625969148691
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",24195,0.00205387212898889,0.00555307947552614,-0.00883016364304233,0.0129379079010201,0.711488683174757
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ARHGEF5,Rho guanine nucleotide exchange factor 5,24101,-0.00195891145926845,0.00532568997924802,-0.0123972638185946,0.00847944090005767,0.713008422730011
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FOS,Proto-oncogene c-Fos,23970,-0.000929739815684707,0.00253543954492249,-0.00589920132373278,0.00403972169236337,0.713847771000872
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,S100A16,Protein S100-A16,28722,-0.00157603905544591,0.00438271466444319,-0.0101661597977546,0.00701408168686274,0.719146392345033
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HDAC9,Histone deacetylase 9,24101,-0.00165156464185756,0.00463080005218492,-0.01072793274414,0.00742480346042489,0.721358613831715
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PCARE,Photoreceptor cilium actin regulator,24101,0.00214471546738263,0.00604967997901328,-0.0097126572914834,0.0140020882262487,0.722954437080439
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",24101,-0.00142128545805542,0.00403410708789738,-0.00932813535033428,0.00648556443422344,0.724603445915375
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TXK,Tyrosine-protein kinase TXK,24445,0.0018696602610778,0.00532315048897587,-0.0085637146973149,0.0123030352194705,0.72541740862184
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,24445,-0.00157674455006928,0.0046090415245356,-0.0106104659381591,0.0074569768380205,0.732279976995009
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,UNC5D,Netrin receptor UNC5D,24229,0.000636374665098806,0.00188546548895924,-0.00305913769326131,0.00433188702345892,0.735730920223333
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,24445,0.00118032460811749,0.00352180367625581,-0.00572241059734389,0.00808305981357887,0.737516505367218
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SUSD4,Sushi domain-containing protein 4,24793,-0.00097860609177989,0.00298986602553154,-0.00683874350182171,0.00488153131826193,0.743437954411831
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BTN1A1,Butyrophilin subfamily 1 member A1,24751,0.000930925333382437,0.00287889716201619,-0.0047117131041693,0.00657356377093417,0.746423998590766
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SEMA4C,Semaphorin-4C,29349,0.000641073746862466,0.00200336039608409,-0.00328551262946236,0.00456766012318729,0.748971207372329
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DIPK1C,Divergent protein kinase domain 1C,24195,0.000953444186842297,0.00303115256749298,-0.00498761484544393,0.00689450321912853,0.753107277183669
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KCNC4,Potassium voltage-gated channel subfamily C member 4,24101,0.00126041972363018,0.00400751228957356,-0.006594304363934,0.00911514381119436,0.753133219052003
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NLGN1,Neuroligin-1,24195,-0.00153652525359382,0.00488861475747827,-0.0111182101782512,0.00804515967106358,0.753290684639483
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SLC1A4,Neutral amino acid transporter A,24195,0.00115881359476288,0.00369036202113388,-0.00607429596665952,0.00839192315618529,0.753515531719669
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MORN4,MORN repeat-containing protein 4,24016,0.00173061600275222,0.00560509444366618,-0.00925536910683349,0.0127166011123379,0.757508537138682
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL2RB,Interleukin-2 receptor subunit beta,28931,-0.00081113798599314,0.00268487493886509,-0.00607349286616871,0.00445121689418243,0.762567424324009
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SPINK8,Serine protease inhibitor Kazal-type 8,24111,0.000782613228124875,0.00267876383370751,-0.00446776388594184,0.00603299034219159,0.770170922319941
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,THSD1,Thrombospondin type-1 domain-containing protein 1,24059,0.000713644806222228,0.00245924986400602,-0.00410648492722957,0.00553377453967403,0.77167491638189
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IGLON5,IgLON family member 5,24016,-0.00191730683695084,0.00666665761519758,-0.0149839557627381,0.0111493420888364,0.773658171569762
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SLITRK1,SLIT and NTRK-like protein 1,24229,-0.000662968487469492,0.00231234434516302,-0.00519516340398902,0.00386922642905003,0.774338078064657
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,24445,0.00139858822706038,0.00491115257050826,-0.00822727081113581,0.0110244472652566,0.775816638697434
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL20RB,Interleukin-20 receptor subunit beta,24229,0.000812371079924787,0.00301654834088393,-0.00510006366820772,0.00672480582805729,0.787697399521152
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AMY2A,Pancreatic alpha-amylase,28334,-0.000907831537437402,0.00341267343753301,-0.00759667147500211,0.0057810084001273,0.790227514202154
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CHGB,Secretogranin-1,29590,0.000777733957446892,0.00293024559084669,-0.00496554740061263,0.00652101531550641,0.790690889591861
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TOP1MT,"DNA topoisomerase I, mitochondrial",24016,-0.000903495191788051,0.00348856803808348,-0.00774108854643168,0.00593409816285558,0.795647177476686
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CEND1,Cell cycle exit and neuronal differentiation protein 1,24101,0.00105424861096993,0.00421001415102104,-0.00719737912503131,0.00930587634697118,0.802268949032527
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ALMS1,Alstrom syndrome protein 1,24445,-0.000788549364449765,0.00319066332647073,-0.00704224948433241,0.00546515075543288,0.804799813132062
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RSPO1,R-spondin-1,29218,0.000614535098052046,0.00249605622233713,-0.00427773509772873,0.00550680529383282,0.805527267773569
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LMOD2,Leiomodin-2,24101,0.00109319959509,0.00452398902220601,-0.00777381888843377,0.00996021807861377,0.809057261369568
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TPT1,Translationally-controlled tumor protein,28931,0.001070041375218,0.0046551292994229,-0.00805401205165088,0.0101940948020869,0.818199956062372
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TP73,Tumor protein p73,24195,0.000557054666753318,0.00247047063904922,-0.00428506778578315,0.00539917711928978,0.821603711492846
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HK2,Hexokinase-2,28916,-0.00043806071790981,0.00195519748022442,-0.00427024777914968,0.00339412634333006,0.822720489728739
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IKZF2,Zinc finger protein Helios,28797,0.00143841737362755,0.0065123093865392,-0.0113257090239893,0.0142025437712444,0.825190010730722
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DDX4,Probable ATP-dependent RNA helicase DDX4,24229,-0.000845697905392721,0.00388889957721896,-0.00846794107674189,0.00677654526595645,0.827848141354557
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TET2,Methylcytosine dioxygenase TET2,24421,0.00154683250113422,0.00716939838451865,-0.0125051883325223,0.0155988533347908,0.829180643706922
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MAGEA3,Melanoma-associated antigen 3,24445,0.00126204031597843,0.00607791273796341,-0.0106506686504298,0.0131747492823867,0.835508907555371
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD164L2,CD164 sialomucin-like 2 protein,24195,-0.000538225814422021,0.00261741773187501,-0.00566836456889704,0.004591912940053,0.837079820372855
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,29632,0.00050418440956065,0.00245237131389169,-0.00430246336566706,0.00531083218478836,0.837112159314801
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CAPN3,Calpain-3,24793,-0.00052926612947107,0.00270781975625549,-0.00583659285173182,0.00477806059278968,0.845035700574338
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MEGF11,Multiple epidermal growth factor-like domains protein 11,24111,0.00045286670133637,0.00232399854718974,-0.00410217045115552,0.00500790385382826,0.845500033631622
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,OMG,Oligodendrocyte-myelin glycoprotein,29349,0.000860293307161202,0.00467514326758822,-0.00830298749731171,0.0100235741116341,0.854003493273695
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HMMR,Hyaluronan mediated motility receptor,23975,0.00062730816140222,0.00346080819137451,-0.00615587589369181,0.00741049221649625,0.856164565275054
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL18RAP,Interleukin-18 receptor accessory protein,29038,0.00218457839720248,0.0122395688088392,-0.0218049764681223,0.0261741332625273,0.858343412883861
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL20,Interleukin-20,28931,0.000617481185263195,0.00349201965336851,-0.00622687733533909,0.00746183970586548,0.859646007702955
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SKIV2L,Helicase SKI2W,24111,-0.000497027362637916,0.00285898800514809,-0.00610064385272817,0.00510658912745233,0.86198692591795
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TPSD1,Tryptase delta,24867,0.00045264084648547,0.00266847633790639,-0.00477757277581106,0.005682854468782,0.865306279466637
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CSH1,Chorionic somatomammotropin hormone 1,24951,-0.000386870186920026,0.00229178924456911,-0.00487877710627547,0.00410503673243542,0.865949780098231
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CASP4,Caspase-4,24445,-0.00200876614805184,0.0120226837226217,-0.0255732262443903,0.0215556939482866,0.867307428247168
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ABO,Histo-blood group ABO system transferase,24951,-0.00167822114719098,0.0102879514518957,-0.0218426059929066,0.0184861636985246,0.870421409559139
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HEBP1,Heme-binding protein 1,28916,-0.000611108030719508,0.00379489926352322,-0.00804911058722502,0.00682689452578601,0.87206770126634
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FLT3,Receptor-type tyrosine-protein kinase FLT3,28797,-0.000348514691291634,0.00218073144948209,-0.00462274833227654,0.00392571894969327,0.873027533642767
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NOS2,"Nitric oxide synthase, inducible",24111,-0.000449667748876153,0.00283250056283836,-0.00600136885203933,0.00510203335428703,0.873864869272958
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,OMP,Olfactory marker protein,24101,0.00054524682903395,0.00352580553795637,-0.00636533202536054,0.00745582568342844,0.877102793515788
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PGR,Progesterone receptor,24229,0.00111105796706309,0.00727172709480311,-0.013141527138751,0.0153636430728772,0.878563987471602
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,24101,0.00052666234636646,0.00350788057125665,-0.00634878357329658,0.0074021082660295,0.880657857866143
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD27,CD27 antigen,29566,0.000438143472630001,0.0029617121130325,-0.0053668122689137,0.00624309921417371,0.882394384904475
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLEC11A,C-type lectin domain family 11 member A,29388,-0.000497591720017917,0.00342786203836019,-0.00721620131520388,0.00622101787516805,0.88458479034352
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TFRC,Transferrin receptor protein 1,29565,-0.000396656196182361,0.00274486976805266,-0.00577660094156557,0.00498328854920085,0.885100165267568
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL22,Interleukin-22,24793,0.000688700203665654,0.00482636419938586,-0.00877097362713062,0.0101483740344619,0.886531871777518
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SLC51B,Organic solute transporter subunit beta,24111,-0.000769210166921881,0.0054541000416057,-0.011459246248469,0.00992082591462528,0.887844750877034
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CRX,Cone-rod homeobox protein,28916,-0.00107030317314497,0.0076442500816519,-0.0160530333331827,0.0139124269868928,0.888649786548454
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,24111,-0.000485587155278083,0.00347802452827627,-0.00730251523069958,0.00633134092014341,0.888964728033862
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD3G,T-cell surface glycoprotein CD3 gamma chain,24229,0.000896982491842838,0.00647925693111684,-0.0118023610931462,0.0135963260768318,0.889894549107923
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TMPRSS11B,Transmembrane protease serine 11B,24101,-0.000755674209458156,0.00551815064626457,-0.0115712494761367,0.0100599010572204,0.891076692847702
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL17F,Interleukin-17F,28931,-0.000747698697481461,0.00546442156676674,-0.0114579649683443,0.00996256757338136,0.891165848612865
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL2,Interleukin-2,28931,0.000303318201701299,0.00225117445284265,-0.0041089837258703,0.0047156201292729,0.892820155486994
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LRP2BP,LRP2-binding protein,24195,0.000795206037859494,0.00590707254142645,-0.0107826561433363,0.0123730682190553,0.892913992720716
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KCNH2,Potassium voltage-gated channel subfamily H member 2,24195,-0.000748731833616412,0.0055860149689721,-0.0116973211728017,0.0101998575055689,0.893374553114964
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,OFD1,Oral-facial-digital syndrome 1 protein,24445,-0.000638522394803776,0.00478564245008445,-0.0100183815969693,0.00874133680736176,0.89385869603843
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TFF3,Trefoil factor 3,29426,0.00040101332502558,0.00329873602695749,-0.0060645092878111,0.00686653593786226,0.903243768867056
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,UPK3A,Uroplakin-3a,24101,-0.000414423192996509,0.00351804523049721,-0.00730979184477104,0.00648094545877802,0.906227682762075
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DLL1,Delta-like protein 1,29566,0.000249568293344349,0.00212867194179731,-0.00392262871257838,0.00442176529926708,0.906669626366783
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MLLT1,Protein ENL,24016,-0.000566857098749814,0.00494153000520207,-0.0102522559089459,0.00911854171144624,0.908673670478359
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL13,Interleukin-13,28931,0.000380741326118897,0.00343461468197345,-0.00635110345054907,0.00711258610278687,0.911732765685164
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLINT1,Clathrin interactor 1,24016,0.000374540637683181,0.00340734134370548,-0.00630384839597956,0.00705292967134592,0.912472418530887
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NCLN,Nicalin,28931,-0.000393873803840707,0.00373001807569977,-0.00770470923221226,0.00691696162453085,0.915903883022371
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MFAP3L,Microfibrillar-associated protein 3-like,24195,0.00048922919495579,0.00470118622903831,-0.0087250958139593,0.00970355420387088,0.917118586806183
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,STEAP4,Metalloreductase STEAP4,24101,0.000546315913573508,0.00529138597555023,-0.00982480059850495,0.010917432425652,0.917768370210711
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MAG,Myelin-associated glycoprotein,24195,-0.00033637300195422,0.00338967868859027,-0.00698014323159115,0.00630739722768271,0.920952921485606
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ARID3A,AT-rich interactive domain-containing protein 3A,24101,0.000280053665042643,0.00286828373704842,-0.00534178245957226,0.00590188978965754,0.922220512257505
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CASQ2,Calsequestrin-2,24111,0.000335049301061843,0.00349087325179696,-0.00650706227246019,0.00717716087458388,0.923538327446485
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL17A,Interleukin-17A,28879,0.000238323833571275,0.00304480549144534,-0.0057294949296616,0.00620614259680415,0.937612018685931
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,28797,-0.000429548352834754,0.00551338142494548,-0.0112357759457279,0.0103766792400584,0.937900070010704
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BCAN,Brevican core protein,29218,0.000187181611614057,0.00242075311745554,-0.00455749449859881,0.00493185772182692,0.938366559368313
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FGF6,Fibroblast growth factor 6,24229,-0.000202937770158755,0.00294116477095262,-0.00596762072122589,0.00556174518090838,0.944990892621659
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PI16,Peptidase inhibitor 16,24951,-0.000119721340190069,0.00174974809584467,-0.00354922760804562,0.00330978492766549,0.945450223417071
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TMED1,Transmembrane emp24 domain-containing protein 1,24445,0.000243044437538703,0.00385667302405269,-0.00731603468960456,0.00780212356468197,0.949751733158289
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",24111,0.000363442086362014,0.0061631076858308,-0.0117162489778663,0.0124431331505904,0.952976023411095
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EFNB2,Ephrin-B2,24195,-0.000230341064042859,0.00412639218600736,-0.00831806974861727,0.00785738762053156,0.955484533444991
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SCN3B,Sodium channel subunit beta-3,24101,0.000176031508391536,0.00329491401033585,-0.00628199995186674,0.00663406296864981,0.957393553699673
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LYPD1,Ly6/PLAUR domain-containing protein 1,28774,-0.000186190508352511,0.00449940908159917,-0.00900503230828689,0.00863265129158186,0.966992365171201
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ANKRA2,Ankyrin repeat family A protein 2,24016,-0.000157759381631083,0.00397911975610368,-0.00795683410359429,0.00764131534033213,0.968375042187358
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,24381,0.000111129780718396,0.00292194710580429,-0.00561588654665801,0.0058381461080948,0.969661855300976
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL3,Interleukin-3,24016,0.000156771703193891,0.00432617236902232,-0.00832252614008986,0.00863606954647764,0.971092911779202
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ACRV1,Acrosomal protein SP-10,24229,-0.000175607761571308,0.00548314728430655,-0.0109225764388121,0.0105713609156695,0.97445092793938
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SAP18,Histone deacetylase complex subunit SAP18,24445,0.000167930229013342,0.00524629786502316,-0.0101148135864321,0.0104506740444587,0.974464910022126
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RNF4,E3 ubiquitin-protein ligase RNF4,24445,-0.000132450110023671,0.00472967140928662,-0.00940260607222544,0.0091377058521781,0.97765912351031
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,24793,7.804390963541e-05,0.00318450242287745,-0.00616358083920438,0.00631966865847521,0.98044806972965
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NGFR,Tumor necrosis factor receptor superfamily member 16,24922,5.06497232131499e-05,0.00212010087835722,-0.00410474799836701,0.00420604744479331,0.980940349131185
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL2RA,Interleukin-2 receptor subunit alpha,29223,-6.51150934698258e-05,0.00288053994081319,-0.00571097337746369,0.00558074319052404,0.981965374669314
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ITGAV,Integrin alpha-V,29725,-2.27661208577899e-05,0.00118179168210405,-0.00233907781778173,0.00229354557606615,0.984630573811007
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ZNF174,Zinc finger protein 174,24229,4.99546440019371e-05,0.00270101146011409,-0.00524402781782168,0.00534393710582556,0.985244284951796
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PFDN6,Prefoldin subunit 6,24195,-7.31597496348821e-05,0.00467417237294641,-0.00923453760060984,0.00908821810134008,0.987512217528685
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,THRAP3,Thyroid hormone receptor-associated protein 3,24111,0.000122649685649559,0.00809210552795038,-0.0157378771491332,0.0159831765204323,0.987907284682203
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL24,Interleukin-24,28931,3.79134307650509e-05,0.00347494171892745,-0.00677297233833275,0.00684879919986285,0.991294910303465
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,WFDC12,WAP four-disulfide core domain protein 12,29662,-2.30329084249011e-05,0.00453636723746104,-0.00891431269384854,0.00886824687699874,0.995948879988646
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PDIA2,Protein disulfide-isomerase A2,24016,-8.44790406836804e-06,0.00291345711348251,-0.00571882384649409,0.00570192803835736,0.997686469265797
